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Abstract 
The high prevalence of osteolysis and aseptic loosening associated with the wear particles of 
conventional metal-on-UHMWPE (MoP) total hip replacements (THRs), and concerns over 
the release of metal wear particles and metal ions around the body from metal-on-metal 
(MoM) THRs, led to the development of alternative ceramic-on-ceramic (CoC) THRs. CoC 
bearings are of great interest due to their superior wear properties, compared to MoP and 
MoM bearings. Historically, ceramic THRs had a reputation for fracture, and recent issues 
have centred around surgical positioning and squeaking. The development of improved 
manufacturing methods allowed major improvements of ceramics which led to the 
introduction of composite ceramics for example, zirconia-toughened, platelet reinforced 
alumina or ZTA, otherwise commercially known as BIOLOX® Delta. The wear performance 
of composite CoC THRs such as those using BIOLOX® Delta has been extensively 
investigated, however no studies have reported the combined characteristics and 
biocompatibility of the wear debris generated from these bearings. 
Understanding wear particle characteristics and their biological activity is an essential step in 
the pre-clinical testing of joint replacements. However, currently for composite ZTA CoC 
bearings there is a lack of relevant studies, due to difficulties in generating high volumes of 
clinically-relevant ceramic wear debris in vitro, in addition current particle isolation methods 
are not sensitive enough to reliably isolate wear particles from hip simulator lubricants, due 
to the inherent low wear rates of the composite ZTA ceramics. Hence, the particles have not 
been systematically characterised and therefore little is known about their size, morphology 
and biological responses. Therefore, the aim of this study was to investigate the characteristics 
and biological activity of wear particles generated from composite BIOLOX® Delta ZTA CoC 
THRs. 
This study developed a two-step particle isolation method and subsequently applied it to hip 
simulator lubricants for the isolation of composite ceramic wear particles generated from 
BIOLOX® Delta CoC bearings tested under edge loading conditions. The high sensitivity of 
this new particle isolation method coupled with its effective removal of protein, allowed the 
successful recovery and characterisation of very low volumes of both micro and nano-scale 
wear particles, generated from composite ZTA CoC hip replacements for the first time. The 
recovered wear particles demonstrated a bimodal size range, which has been previously 
reported for wear particles generated from alumina ceramic hip replacements. 
A comprehensive evaluation of the biological impact of commercially-obtained composite 
BIOLOX® Delta ZTA ceramic model particles and clinically-relevant composite BIOLOX® 
Delta ZTA ceramic wear particles was investigated in terms of cytotoxicity, inflammation, 
genotoxicity and oxidative stress. The clinically-relevant composite ZTA ceramic wear 
particles were generated in water lubricant using a hip simulator under severe edge loading 
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conditions. The biological impact of the ceramic particles was assessed using L929 fibroblast 
cells and peripheral blood mononuclear cells (PBMNCs) isolated from healthy human donors. 
Both the model and clinically-relevant BIOLOX® Delta ceramic wear particles demonstrated 
significant reduction in the viability of L929 fibroblast cells at very high doses (500µm3 of 
particles per cell), however no cytotoxic effects were observed at the lower clinically-relevant 
doses (0.5-0.05µm3 per cell). The BIOLOX® Delta ZTA ceramic model particles failed to 
stimulate an inflammatory response in terms of TNF-α release and did not cause any 
significant DNA damage or production of reactive oxygen species (oxidative stress) in 
PBMNCs from all donors. However, high doses (50µm3 per cell) of clinically-relevant 
BIOLOX® Delta ZTA ceramic wear particles caused significantly elevated levels of TNF-α 
release from PBMNCs. But, there were no significant effects in terms of DNA damage and 
oxidative stress in PBMNCs from all donors. This study demonstrated that there was a 
threshold volume of clinically-relevant ceramic wear particles required to stimulate 
significant TNF-α release from PBMNCs. However, these doses were not clinically-relevant 
and highly unlikely to occur in vivo due to the extremely low wear rates of CoC bearings. 
This comprehensive study indicated that composite ZTA Delta ceramic hip replacements had 
a low biological impact, which may enhance long-term clinical performance. The results from 
this study are only relevant for BIOLOX® Delta ZTA ceramics and not other manufacturers 
ceramics. 
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CHAPTER 1 
 
1 Literature review 
1.1 Introduction  
Osteoarthritis (OA) is a degenerative joint disease that affects many joints within the body. 
Synovial joints are more commonly affected such as the hip and knee joints, hence it is the 
leading cause of lower extremity disability amongst older adults. The disease causes 
breakdown of the articular cartilage and can result from a combination of factors including 
ageing, obesity, muscle weakness, inflammation of the joints and wear and abrasion (Tortora 
and Derrickson, 2009). For patients with severe OA the last resort treatment would be surgery. 
The main surgical treatment that is performed and has a high success rate is total hip 
arthroplasty (THA). This procedure involves surgical replacement of the natural hip joint with 
an artificial prosthesis. THA is a reconstructive surgical technique, which has allowed better 
management of OA of the hip joint, that has otherwise responded inadequately to 
conventional medical treatments (Siopack and Jergesen, 1995).  
Metal-on-polyethylene (MoP) bearings have been the most commonly used bearing 
combination for total hip replacements (THRs) since they were first developed by Sir John 
Charnley in the early 1960’s. The vast majority of total hip replacements implanted today still 
follow the principles of Charnley’s low frictional torque arthroplasty, which consisted of a 
hard metal femoral head that articulated against an ultra-high molecular weight polyethylene 
(UHMWPE) acetabular cup with cement fixation (Knight et al., 2011). The national joint 
registry for the UK reported that out of the approximately 87,733 THRs in 2016, around 
51,236 (58.4%) were MoP bearings (National Joint Registry, 2017). This is because MoP 
bearings are considered to be the gold standard in UK THA and currently provide a safe, 
predictable and cost-effective bearing for the majority of patients over the age of 55. Hard-
on-soft bearings have been shown to be successful in the short term, however, historically 
high rates of failure due to high wear rates resulted in periprosthetic osteolysis and aseptic 
loosening in the longer term. Thus, the need for improved bearing surfaces in THA led to the 
development and study of alternative hard-on-hard bearings such as metal-on-metal and 
ceramic-on-ceramic.  
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These alternative hard-on-hard bearings have been of great interest recently due to their 
superior wear properties. Early generation MoM hip bearings had poor results, and concerns 
over the release of metal wear particles (metallosis) and metal ions that may be associated 
with increased risk of carcinogenicity and/or hypersensitivity resulted in rapid declined use 
of MoM THRs. However, the catastrophic failure of early generation MoM bearings is now 
believed to have been due to poor design, poor manufacturing tolerances/techniques and 
improper implantation techniques, hence there has been renewed interest into these alternative 
bearings throughout the 1990’s which resulted in the development of second and third 
generation MoM bearings (Amstutz and Grigoris, 1996; Knight et al., 2011). Nevertheless, 
soft tissue reactions to metal wear debris and metal ions has been extensively reported and 
resulted in implant failure (Haddad et al., 2011).  The concerns surrounding MoM THRs led 
to an increase in the use of ceramic component bearings, from 23.7% of all uncemented THRs 
in 2003 to 57.7% in 2017 in England and Wales (National Joint Registry, 2017). This is due 
to ceramics being used in combination with UHMWPE cups. Furthermore, ceramic-on-
ceramic (CoC) bearings have demonstrated the best overall tribological and biological 
performance compared to other bearing materials (MoP and MoM), and so are increasingly 
being used in younger and more active patients.  
1.2 Ceramics as a bearing material for THA 
1.2.1 History of ceramic-on-ceramic total hip replacements 
Ceramic-on-Ceramic (CoC) total hip replacements (THRs) were first introduced by the 
French Surgeon Pierre Boutin in 1970 (Boutin, 2000). CoC hip replacements have now been 
in use for more than 40 years, mainly in Europe, Korea and Australia with a much lower usage 
in the USA (Knight et al., 2011). Alumina bearings were initially developed to overcome the 
problems of friction and wear of other bearing materials, since alumina has excellent wear 
resistance properties and high hardness (Table 1.1). Since its introduction, alumina has also 
been widely used in combination with UHMWPE acetabular cups (Callaghan and Liu, 2009; 
Garino, 2011). The first alumina hip implant was performed without cement for the polymer 
acetabular component and cemented for the ceramic head component (Garino, 2011). Fixation 
proved to be inadequate and resulted in aseptic loosening in addition to high rates of fracture 
(Griss and Heimke, 1981; Jeffers and Walter, 2012). A new fixation method was developed 
by Mittelmeier, from Germany in 1985, who used a threaded ceramic cup that was screwed 
into the acetabulum. This new method (Autophor design) also employed a press-fit femoral 
component that eliminated the use of cement fixation, which showed some early success 
(Garino, 2011). Premarket approval of the Autophor design by the Food and Drug 
Administration (FDA) resulted in more than 3500 total hip arthroplasty (THA) procedures 
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being performed in the USA over a three-year period (1982-1985) using the Mittelmeier CoC 
prosthesis. However, very high incidences of stem loosening (>30% within 3 years) resulted 
in the Mittelmeier Autophor design being discontinued by the manufacturer (Smith and 
Nephew, Memphis, Tennessee) (Tateiwa et al., 2008). Clinical studies of the CoC Mittelmeier 
Autophor design conducted by Yoon et al. (1998) and Nevelos et al. (1999) reported that 
osteolysis occurred as a result of ceramic debris in periprosthetic tissues. It was also reported 
that majority of the implants investigated had minimal linear wear penetration (<100µm), but 
some implants showed very high volumetric wear (3mm3), which was comparable with severe 
UHMWPE wear. There was no obvious explanation for this high wear, but it was suggested 
that implant loosening was design related. However, an important finding was that 
periprosthetic osteolysis due to ceramic wear debris was considerably less when compared 
with metal-on-polymer (MoP) bearings (Yoon et al., 1998; Nevelos et al., 1999).       
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Table 1.1: Summary of the mechanical properties of different ceramics used for THA. 
Mechanical Property Units 
Forte - Alumina 
(99.95 Al2O3) 
 
Delta - Zirconia, 
Platelet Toughened 
Alumina (ZTA) 
(Al2O3 + ZrO2 + Y2O3 
+ Cr2O3 + SrO) 
Density g/cm3 3.97 4.37 
Average Grain Size µm ≤ 1.8 --- 
Bending Strength MPa >650 1380 
Compression Strength MPa 5000 4700 
Young’s Modulus GPa 407 358 
Fracture Toughness (KIC) MPa m1/2 3.5 5.9 
Micro-hardness (HV) GPa >8.9 >7.7 
Note: The average grain size values for ZTA are not stated due to their mixed structure (Kuntz and Krueger, 2018).
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1.2.2 Development of manufacturing methods for ceramic hip components 
The early ceramic bearings used for THA had a coarse-grained microstructure with limited 
purity and low density, which led to poor mechanical properties and high rates of fracture of 
up to 13.4% (Willmann, 2000). Alumina implant technology has improved over the past 40 
years with the development of improved manufacturing methods, which included the use of 
laser markings. Laser markings replaced engraving methods in the 1980s, as engraving have 
been a source of stress concentration within the alumina ceramic that could cause fracture. In 
1995, hot isostatic pressing (HIP) was introduced, which produced a highly pure, more dense 
ceramic with a smaller grain size and full density (Figure 1.1) (Tateiwa et al., 2008). The 
manufacturing process of HIPing involves simultaneous application of elevated high 
temperature and isostatic pressure. The pressure is achieved by pumping inert gas such as 
argon or nitrogen, into a pressure vessel and pressurising up to 200 MPa. The elevated 
temperature is achieved by a furnace in the vessel which produces temperatures of up to 
2000oC. Before the HIPing process a green body of the ceramic component is formed which 
is sintered to remove interconnected pores (Loh and Sia, 1992). In 1995, the introduction of 
HIPing led to the development of HIPed alumina  that is commercially known as BIOLOX® 
Forte (CeramTec, Germany), which was reported to have a lower mean wear rate of 0.09 ± 
0.04mm3 per million cycles compared to non-HIPed alumina (0.15 ± 0.06mm3 per million 
cycles) (Nevelos, Ingham, et al., 2001) .   
 
 
Figure 1.1 – Microstructure of alumina before and after hot isostatic pressing.  
1.2.3 Introduction of zirconia femoral heads 
Due to the high rates of fracture associated with alumina, in 1985, zirconia heads were in 
introduced in Europe and then in 1989 the FDA approved zirconia ceramic femoral head-on-
UHMWPE cup combinations (Zr-on-PE) for use in North America. The use of zirconia for 
the femoral head component began to dominate the markets in the USA and Europe, 
particularly for younger patients, due to its significantly greater fracture toughness and 
superior mechanical properties compared to alumina (Table 1.1). However, there were 
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concerns over the hydrothermal degradation of zirconia with its simultaneous ability to 
undergo phase changes that resulted in increased surface roughness (surface degradation and 
compression strength) and thus increased wear (Clarke et al., 2005; Tateiwa et al., 2008; 
Garino, 2011). In 2001, Prozyr St. Gobain Desmarquest the largest manufacture of zirconia 
heads, recalled a selected batch of heads as there were reports of high rates of head fractures 
in vivo (Masonis et al., 2004).    
 Phase changes in zirconia heads  
The most common form of zirconia used for femoral heads is tetragonal zirconia stabilised 
by yttria (Y-TZP), which is a metastable ceramic. The ability of zirconia to transform from 
the tetragonal to the monoclinic phase gives a transformation-toughening mechanism effect 
with a small increase in volume of about 5%. The Y-TZP strengthening effect, while very 
useful in increasing the mechanical strength, can also be a problem as it can cause phase 
transformations after THA, which presents many problems such as an increase in surface 
roughness of the zirconia ceramic femoral head (Clarke et al., 2005).  
Phase transformations in Y-TZP can be induced at room temperatures in the presence of water 
and pressure compared to sintering temperatures. Thus, it is speculated that the heat and 
pressure generated during articulation could be a contributor in the phase transformations 
described in Y-TZP heads (Haraguchi et al., 2001). Lu and McKellop (1997) reported that the 
temperature at the surface of the polyethylene cup increased to 99oC when articulated against 
a Y-TZP head in a hip simulator (Lu and McKellop, 1997). A study by Hernigou et al. (2003) 
reported a six-fold increase in wear for zirconia heads with phase transformation compared 
to alumina heads after 8 years follow-up (Hernigou and Bahrami, 2003). The x-ray diffraction 
results from this study revealed monoclinic transformation increased from <4% to 19-30% in 
conjunction with increased roughness of the zirconia femoral heads from 5 nm to 50 nm. 
Clinical studies of Zr-on-PE have demonstrated mixed results in terms of performance, 
however, the majority of studies have reported higher wear rates, osteolysis and revision rates 
compared to conventional MoP and alumina-on-UHMWPE (Clarke et al., 2005). 
Consequently, the popularity of pure zirconia as a bearing material has decreased, however 
there is still interest in this biomaterial due to its superior mechanical properties and high 
resistance to crack propagation.  
1.2.4 Introduction of composite ceramics  
The introduction of alumina matrix composite (AMC) ceramics began in the 1970s with the 
investigation of transformation toughening as a technique to improve the strength of alumina 
materials (Garvie et al., 1975). Zirconia-toughened alumina (ZTA) is the most commonly 
used composite ceramic for artificial hip joint replacements worldwide. This is due to the 
superior combined material properties of alumina and zirconia, which combines the high 
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hardness and wear properties of alumina with the high strength and toughness of zirconia 
(Burger and Richter, 2000a). BIOLOX® Delta by CeramTec (Plochingen, Germany) is a well-
known ZTA material that contains 80% (volume) alumina, 17% (volume) zirconia and 3% 
(volume) strontium aluminate platelets (Kuntz and Krueger, 2018).  
 Strengthening mechanism in BIOLOX® Delta ceramic hips  
The toughening effect of zirconia in ZTA materials gives this material its high strength. 
Stress-induced phase transformations in zirconia, from the metastable tetragonal phase to the 
monoclinic phase at room temperature causes a volume increase (3-5%). This volume 
increase by phase transformation prevents crack propagation and leads to microcracking, both 
of which increase the fracture toughness and overall strength of the material by dissipating 
the stress effect on the main crack. Hence, phase transformation from tetragonal to monoclinic 
of the zirconia particles gives a toughening mechanism to the ceramic (Chevalier et al., 2009; 
Maccauro et al., 2011; Kurtz et al., 2014).  
The introduction of zirconia (17%) in the alumina matrix results in a significant increase in 
strength and fracture toughness in comparison to pure alumina. The fracture toughness of 
ZTA is approximately 6 MPa m1/2, which is almost double that of pure alumina (3.5 MPa 
m1/2). Furthermore, ZTA is reported to have an average strength of 1380MPa, an increase of 
more than 50% when compared to pure alumina (>650 MPa). However, there is a small 
reduction in hardness of the composite ZTA (>7.7 GPa) ceramic material in comparison to 
pure alumina (>8.9 GPa). Nevertheless, controlling the grain size and density of the ZTA 
composite ceramic material through manufacturing processes ensures the maximum hardness 
of the material is achieved. Furthermore, the addition of other elements such chromium and 
strontium in the form of platelets have been to increase the hardness of this material. However, 
recent studies have shown that the addition of chromium does not affect or increase the 
hardness of ZTA ceramic (Kuntz and Krueger, 2018). The addition of chromium rather slows 
down the hydrothermal degradation in the zirconia and enhances the protective effect against 
phase transformation in zirconia (Pezzotti et al., 2010). The addition of strontium oxide (SrO) 
to ZTA by in situ solid state reaction during sintering produces elongated grains or platelets 
within the structure of a ZTA ceramic (Figure 1.2). These deflect the crack and increase the 
distance the crack needs to travel, thus increasing the energy required for the propagation of 
the crack (Burger and Richter, 2000a; Jeffers and Walter, 2012). The resulting mechanical 
properties of BIOLOX® Delta and other ceramics used for THA are reported in Table 1.1.  
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Figure 1.2 - The microstructure of BIOLOX® Delta. ZTA consists of an alpha matrix, which is 
toughened by phase transformation of dispersed tetragonal zirconia particles. Further reinforcement is 
achieved by the presence of strontium aluminate platelets that are crystallised in a magnetoplumbite 
structure. 
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 Clinical Performance of BIOLOX® Delta ceramic hips 
1.2.4.2.1 Fracture rates 
Many of the fractures reported are related to the early non-HIPed pure alumina ceramics that were 
implanted more than 20 years ago. A study by Willmann et al. (2000) reported the fracture rates 
for BIOLOX® Forte ceramic heads. The fracture rate for HIPed BIOLOX® Forte heads was 
0.004%, which was significantly lower than the early non-HIPed BIOLOX® I: 0.026% and 
BIOLOX® II: 0.014%. This difference in fracture rates was due to the introduction of improved 
materials and manufacturing methods, namely HIPing which significantly improved the 
mechanical properties of pure alumina. These statistics demonstrated a significant decrease in the 
incidence of fractures over the three generations of alumina i.e. more than a six-fold decrease 
from the 1970s to the 1990s (fracture rates ranging between 0.026-13.4%) (Willmann, 2000). 
BIOLOX® Delta CoC bearings have demonstrated a further reduction in fracture rates 
representing 1 in 50,000, as reported by the manufacturer (CeramTec) (Jeffers and Walter, 2012). 
A recent article reported no fractures after a 6-year follow-up for BIOLOX® Delta bearings, where 
more than 100, 000 components (heads and inserts) have been implanted (Masson, 2009). This 
extremely low incidence of fracture as mentioned earlier is due to the superior mechanical 
properties of BIOLOX® Delta described in Table 1.1.  
1.2.4.2.2 Phase Transformations in vivo 
As stated earlier, zirconia has a monoclinic structure at room temperature, but changes to a 
tetragonal structure at temperatures greater than 1100oC with a small change in volume. This 
tetragonal phase can be maintained at room temperature by stabilisation with yttria. It has been 
reported that zirconia can undergo phase transformations in a physiological environment resulting 
in reduced mechanical properties and increased surface roughness that can lead to catastrophic 
failures (Clarke et al., 2005). This concern was also apparent for BIOLOX® Delta when it was 
first introduced, as it may be possible for the zirconia phase in ZTA to become unstable in the 
physiological environment at body temperature as was observed for zirconia-ytrria femoral heads 
in the 1980s and 1990s (Hernigou and Bahrami, 2003). An in vitro study by Pezzotti et al. (2009) 
reported an increase in monoclinic microstructure after BIOLOX® Delta was exposed to a moist 
environment (139oC) for 300 hours. This caused a 30% decrease in fracture toughness, but this 
was still higher than the fracture toughness of pure alumina. However, a more clinically-relevant 
exposure time of 10 hours that was equivalent to 39 years in vivo, demonstrated no significant 
change of monoclinic volume fraction and no change in fracture toughness was detected (Pezzotti 
et al., 2009). However, an interesting study by Medel et al. (2009) reported changes in the zirconia 
microstructure in vivo of BIOLOX® Delta, but no changes in surface roughness. It was stated that 
due to the high content of alumina and low content (17%) of zirconia, the alumina maintains the 
stability of zirconia, thus inhibiting phase transformation (Medel et al., 2009).  
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1.2.4.2.3 Squeaking  
Squeaking is another unusual phenomenon that has attracted much attention in the orthopaedic 
community as it presents an unwanted complication that can affect the performance of the bearing. 
Squeaking from CoC THRs has been attributed to adverse conditions that increased wear or 
impingement (Wu et al., 2016). Squeaking arising from CoC THR may cause patient distress and 
in some cases, lead the patient to seek revision surgery. A recent meta-analysis study by Owen et 
al. (2014), reviewed published literature for the incidence of squeaking for CoC bearings and the 
incidence of revision surgery for squeaking. The incidence of squeaking was reported as 4.2% 
and the incidence of revision surgery for squeaking was 0.2% (Owen et al., 2014). Another recent 
prospective observational study by Restrepo et al. (2010) followed-up patients for a minimum of 
2.5 years after CoC THR. Ninety-five of the 1468 patients or 6% of the patients with CoC THR 
developed squeaking. The squeaking was present during walking for 38% of these patients and 
the intensity and frequency remained similar over time for 70% of the patients (Restrepo et al., 
2010).   
1.3 Wear  
1.3.1 Types of wear  
Wear is defined as the loss of material in the form of wear particles, which results from the relative 
motion between two opposing surfaces (Schmalzried and Callaghan, 2000). This phenomenon 
also occurs in the bearing components of total hip replacements and can limit the performance 
and functional life of a joint replacement. In addition, the relative features (size and shape) of the 
wear particles generated from the bearing surface, can cause many clinical problems, such as 
osteolysis and aseptic loosing, which can ultimately lead to implant failure. There are many types 
of wear that can occur in the complex mechanical-biological environment of the total hip 
replacement, which can include a combination of adhesion, abrasion, third body, fatigue and 
corrosion (Wright and Goodman, 2001). Adhesive wear is the displacement of material as wear 
particles from one surface to another due to shearing of junctions between contacting asperities 
under a sufficient load. Abrasive wear occurs between two materials with different relative 
hardness i.e. asperities on the harder material cut and plow through the surface of the softer 
material, resulting in removal of materials as wear debris. Third body wear is a form of abrasive 
wear that occurs through the embedment of particles (metal, ceramic or bone particles) in a soft 
surface. Surface fatigue occurs when the local stresses exceed the fatigue limit or strength of a 
material. The forces from these cyclic conditions can result in subsurface delamination and 
cracking of the material, thus causing release of wear particles and eventually leading to failure 
of the material. Corrosive wear is an indirect wear mechanism and occurs due to the chemical 
interaction of the material with the surrounding environment. The forces and motions resulting 
from articulation can damage the protective passive layer of the articulating surface and enhance 
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the corrosion of the surface and liberation of corrosive products that can result in removal of 
material and production of wear debris (Schmalzried and Callaghan, 2000; Wright and Goodman, 
2001).  
1.3.2 Friction and Lubrication 
Friction and lubrication have a major influence on the wear of hip bearings. Friction can be 
described as the force that opposes the motion between two articulating surfaces. Lubrication is 
the addition of a fluid to reduce the friction and wear between the two articulating surfaces. There 
are three types of lubrication regimes that can exist between two articulation surfaces i.e. 
boundary, mixed and fluid film lubrication. Boundary lubrication is when the thickness of the 
fluid is less than or equal to the average surface roughness of the articulating surface, which causes 
the articulating surfaces to be in contact at all times. Fluid film lubrication is when there is no 
contact between the articulating surfaces resulting in complete separation between the two 
materials. Mixed lubrication is a combination of fluid film and boundary lubrication. The 
lubrication mechanism of the bearing material is dependent upon several properties, which 
include the lubricant properties, surface roughness, clearance between the bearings, loading and 
sliding distance (Jin et al., 2006; Kamali, 2009).  
The understanding of the tribological performance of bearing materials is important for the 
development of low-wearing and longer lasting bearing materials for total hip replacements. Wear 
is an inevitable phenomenon of any hip replacement and is a major clinical problem that can cause 
periprosthetic osteolysis and aseptic loosening. These adverse tissue reactions, particularly to 
metal wear debris resulted in thousands of revision surgeries every year. According to the 
National Joint Registry, 17% (4,103) of the primary revisions (24,065) were due to adverse soft 
tissue reaction to particulate wear debris (National Joint Registry, 2017). This phenomenon 
therefore necessitates pre-clinical wear testing and validation of a prosthesis in order to gain 
valuable information about the tribological characteristics of a hip implant prosthesis (Affatato et 
al., 2008).   
1.3.3 Wear simulation testing 
Hip wear simulators are complex and sophisticated and can be described as “machines, which 
under appropriate test conditions, cause prostheses to wear in a manner equivalent to that which 
it would experience in typical clinical use in a patient” (Affatato et al., 2008). Specific tests can 
be run on these hip wear simulators using advanced protocols that reproduce severe conditions, 
which thereby allow the optimal performance of a material to be established. These tests are 
necessary and are a prerequisite for a new design or material combination as they provide pre-
clinical validation of hip implants prior to implantation in the human body. In addition to 
predicting the performance of a material, these simulators can be used to develop an 
understanding of wear mechanisms and the influence of environmental, design, and material 
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parameters on wear behaviour. However, the reliability of the results will depend on the validity 
of reproducing in vitro the conditions of a prosthetic implant in vivo (Affatato et al., 2008).   
The data received from hip simulators has been validated through the testing of MoP bearings due 
to the large numbers of retrieved prosthesis available for direct comparison of wear rates, wear 
debris morphology and wear mechanisms (Hatton, 2001). This validation of whether wear 
generated from hip simulators is clinically relevant or not has to be applied for all different bearing 
materials and combinations.  
1.3.4 Simulator testing of CoC bearings 
The wear performance of CoC bearings have been extensively investigated in vitro under standard 
and adverse loading conditions. Previous studies of alumina CoC bearings under standard 
simulation conditions where implants were positioned in their optimum position, reported 
extremely low wear rates, in the order of 0.01-0.1 mm3/million cycles (Taylor et al., 1998; Oonishi 
et al., 1999). These wear rates were, however, considerably lower than those produced by 
retrieved alumina CoC bearings, which have been reported as typically being between 1-5 mm3 
per year (Nevelos et al., 1999). Therefore, it was apparent from previous studies that wear rates 
for failed alumina-alumina bearings in vivo were considerably greater than the wear rates 
produced in physiological hip simulators. In addition, the hip simulators were not reproducing the 
wear stripe and wear patterns observed in retrieval studies of alumina-alumina total hip 
prostheses. This led to studies more focussed on reproducing clinically relevant wear rates in vitro 
(Nevelos et al., 1999). 
Standard simulation tests use ideal conditions, whereby the head and cup are precisely placed in 
the correct position throughout the test cycle. However, the loading conditions experienced 
clinically are more complex and variable (Nevelos et al., 2000a). Nevelos et al. (2001) used water 
as a lubricant, as opposed to serum, to produce harsher testing conditions in an attempt to increase 
the wear rates of alumina CoC bearings and replicate those observed in vivo. However, water 
lubricants had no effect on the wear rates (Nevelos, Ingham, et al., 2001). Retrieval studies of 
alumina ceramic components showed increased wear with steeper cup angles, which indicated 
that an increased angle of inclination of the acetabular cup may be a possible cause of accelerated 
wear of CoC hip bearings in vivo. This phenomenon may be associated with the depletion of 
lubricant film when the contact reaches the edge of the cup, on the other hand it is more likely to 
be associated with increased contact stresses adjacent to the rim of the cup (Nevelos et al., 1999). 
This led Nevelos et al. (2001) to investigate the influence of acetabular cup angle on the wear of 
CoC bearings in a hip joint simulator. These authors found that increasing the inclination angle 
conditions from 45 to 60 degrees in hip simulator studies failed to replicate the higher wear rates 
observed in vivo (Nevelos, Ingham, et al., 2001).  
Stripe wear, associated with early generation alumina-alumina ceramic bearings, was also 
prevalent and has also been observed in modern HIPed alumina-alumina bearings (Nevelos et al., 
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1999; Nevelos et al., 2000a). Fluoroscopy studies by Lombardi et al. (2000) reported the 
occurrence of separation of the ball and socket in patients with MoP THRs during the swing phase 
of the gait cycle. It was previously thought that this “microseparation” of the components was 
more prominent in MoP bearings, however recent studies have reported it could occur in any hip 
prosthesis (Dennis et al., 2001; Glaser et al., 2008). For that reason, Nevelos et al. (2000) 
introduced microseparation of the CoC hip prosthesis components into in vitro hip simulations, 
as it was believed that this could be a factor in stripe wear production as observed on retrieved 
CoC hip implants. These authors for the first time reproduced clinically relevant wear patterns in 
the form of a stripe, wear rates and mechanisms as those observed in vivo.    
 Microseparation in a hip simulator 
Microseparation occurs during swing phase when the load is minimal and could occur clinically 
due to different factors such as head offset deficiency, laxity of the joint, medialised cup, 
impingement or subluxation. These factors cause the femoral head to be translated inferiorly and 
laterally relative to the acetabular cup during swing phase. During heel strike in the stance phase, 
there is a rapid increase in load which results in edge loading and causes the femoral head to 
contact the rim of the acetabular cup before relocating back in the centre of the cup (Figure 1.3) 
(Williams et al., 2003). The high load applied during rim contact results in the production of stripe 
wear and increased wear rates of CoC bearings during in vitro wear testing (Nevelos et al., 2000; 
Al-Hajjar et al., 2010; Al-Hajjar, Fisher, Tipper, et al., 2013; Al-Hajjar, Jennings, Begand, et al., 
2013a). This was the only laboratory condition that successfully reproduced in vitro, stripe wear 
and bimodal micron and nano-metre sized ceramic wear particles that resembled those observed 
in retrieval studies (Hatton et al., 2002; Tipper et al., 2002a). Microseparation during hip 
simulation was achieved by applying a 0.4-0.5 mm lateral displacement of the cup relative to the 
head during swing phase of the gait cycle, which ultimately allowed edge loading to occur at heel 
strike (Nevelos et al., 2000a). The microseparation required to cause edge contact must be greater 
than the radial clearance. It is important to mention that physical separation of the head and cup 
is not essential in microseparation, rather translational malpositioning of the centre of the head 
relative to the cup is sufficient (Al-Hajjar, Jennings, Begand, et al., 2013). Mak et al. (2002) 
reported that a smaller microseparation distance is required to cause edge contact for MoM or 
CoC bearings compared with MoP bearings, since a small clearance is usually required in these 
hard-on-hard bearings. For that reason, microseparation can occur at displacements as low as 0.5 
mm, thus causing edge loading and increased wear (Mak et al., 2002; Al-Hajjar, Jennings, 
Begand, et al., 2013).  
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Figure 1.3: The application of microseparation during hip simulation. (A) Swing phase: microseparation. 
(B) Heel-strike: rim contact. (C) Stance phase: relocation (Williams et al., 2003). Arrows indicate direction 
of femoral head movement/ motion relative to the acetabular cup. 
 
1.3.5 CoC hip simulation under microseparation conditions 
 Wear testing of alumina ceramics 
Considerable research and incorporation of microseparation in hip simulation studies to assess 
the performance of CoC hip joint replacements has been conducted. A study by Affatato et al. 
(2011) investigated the effects of different angles of inclination with microseparation during the 
swing phase of the gait cycle (Affatato et al., 2011). Their findings were in agreement with the 
findings of Nevelos et al. (2001), who found no significant differences between the two different 
angles of inclination in terms of wear for BIOLOX® Forte alumina ceramic bearings. Similarly, 
the introduction of microseparation was found to considerably increase the wear of alumina CoC 
bearings in conjunction with the production of a stripe wear pattern, which was observed to be 
identical to the stripe wear pattern seen clinically. Stewart et al. (2001) investigated the long term 
tribological wear performance of HIPed alumina on alumina bearings under mild (400N swing 
phase load) and severe (50N swing phase load) microseparation conditions. These authors 
reported wear rates of 0.2 and 1.84 mm3 per million cycles under mild and severe conditions, 
respectively, which was considerably greater than the wear rate measured under standard 
conditions (0.09 mm3 /million cycles) (Stewart et al., 2001). The wear rates and wear stripe 
patterns generated under microseparation conditions were comparable to clinically relevant levels 
of wear and wear patterns found in early retrieval studies. Furthermore, the wear debris 
morphology was also similar to debris from retrieved tissues with both small nanometre sized and 
larger micrometre sized particles (Tipper et al., 2002a).  
Femoral heads consisting of zirconium oxide have also been in use to overcome the problems of 
alumina head fracture. Zirconia heads are considered to be less likely to fracture and have been 
reported as having lower wear rates against UHMWPE cups than stainless steel and cobalt 
chromium femoral heads (Derbyshire et al., 1994). Stewart et al. (2003) investigated the wear of 
zirconia femoral heads against alumina acetabular inserts under microseparation conditions. 
These authors reported high wear rates and femoral head fracture associated with severe 
microseparation conditions representative of greater joint laxity. It was concluded that this 
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combination of zirconia femoral head against alumina acetabular cup is not recommended for 
clinical use (Stewart et al., 2003b).  
 Wear testing of composite ceramics  
The introduction of composite ceramics was believed to have overcome the problems of fracture. 
As previously mentioned, the ZTA composite ceramics have double the strength and fracture 
toughness compared to alumina. The ZTA or BIOLOX® Delta CoC bearing has had considerable 
amount of literature published on its wear performance since it was first introduced to the 
marketplace in the year 2000 (Clarke et al., 2007). A study by Stewart et al. (2003) investigated 
the long term tribological wear performance of ZTA composite ceramics (BIOLOX® Delta) under 
severe microseparation conditions. The authors reported the ZTA composite ceramic components 
had significantly lower wear rates (0.16 mm3 /million cycles) compared to the previously tested 
HIPed alumina components, which had an average wear rate of 1.84 mm3 per million cycles 
(Stewart et al., 2003a). In addition, the wear mechanisms and wear debris of the ZTA ceramic 
components were similar to those observed in previous alumina retrieval studies with the presence 
of stripe wear and wear particles with a bimodal size range i.e. smaller particles that were 10-20 
nm and larger particles that were up to 3 µm in size (Tipper et al., 2002a). Another study by Al-
Hajjar et al. (2010) investigated the effects of cup inclination angle during microseparation on 
wear of BIOLOX® Delta hip components. Their findings were consistent with previous studies in 
that the cup inclination angle had no significant effect on the wear rate (Nevelos, Prudhommeaux, 
et al., 2001; Affatato et al., 2011). The introduction of microseparation increased the wear rate of 
BIOLOX® Delta components to 0.13 mm3 per million cycles compared to 0.05 mm3 per million 
cycles under standard conditions. However, this was still very low compared to the third 
generation HIPed alumina ceramic hips (BIOLOX® Forte), which had wear rate of 1.84 mm3 per 
million cycles under the same microseparation conditions (Stewart et al., 2001). A more recent 
study by Al-Hajjar et al. 2013 investigated the wear of different combinations of ceramic matrix 
composites, ZTA and alumina-toughened zirconia (ATZ) compared with alumina-on-alumina 
under microseparation conditions. Both ZTA-on-ZTA and ATZ-on-ATZ bearings showed 
extremely low wear rates of 0.14 mm3 per million cycles and 0.06 mm3 per million cycles, 
respectively, compared with a wear rate of 0.74 mm3 per million cycles for alumina-on-alumina. 
Stripe wear was prevalent for all bearing combinations, however, the stripe wear formed on the 
ZTA and ATZ femoral heads was narrower and shallower than that formed on the alumina heads 
(Al-Hajjar, Jennings, Begand, et al., 2013).  
The superior mechanical properties of BIOLOX® Delta has allowed greater design flexibility to 
produce larger sized femoral heads, which have shown a significant reduction in dislocation rate 
by reduced impingement and improved stability (Zagra and Ceroni, 2007). A study by Al-Hajjar 
et al. (2013) investigated the effect of increasing head size (from 28 mm to 36 mm) on the wear 
of BIOLOX® Delta CoC bearings under microseparation (0.4 -0.5 mm medial displacement) and 
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steep cup inclination angle (65o) conditions. Similar to previous studies, the steep cup inclination 
angle conditions did not affect the wear rates, whereas introduction of microseparation increased 
wear rates and stripe wear pattern on the femoral heads. The wear rate for the larger (36 mm) 
bearings was 0.22 mm3 per million cycles which was significantly higher than the smaller (28 
mm) bearings, which had a wear rate of 0.13 mm3 per million cycles. This increase of wear rate 
for the larger size CoC bearings was attributed to the larger contact area for larger bearings and 
also deprived lubrication due to edge loading conditions (Al-Hajjar, Fisher, Tipper, et al., 2013a).  
Tribological studies of hip implant bearings has demonstrated that edge loading due to separation 
can result in increased wear in hard-on-hard bearings and increased deformation in polyethylene 
bearings (Nevelos et al., 2000; Stewart et al., 2001; Stewart et al., 2003; Williams et al., 2003; 
Al-Hajjar et al., 2010; Al-Hajjar, Fisher, Tipper, et al., 2013; Al-Hajjar, Jennings, Begand, et al., 
2013; Al-Hajjar, Fisher, Williams, et al., 2013). However, all these previous studies used a fixed 
level of separation (0.4-0.5mm) between the head and the cup during swing phase as an input to 
simulate edge loading, thus the wear was measured for a predetermined level of severity of edge 
loading. A recent study by O’Dwyer Lancaster-Jones et al. (2017) investigated surgical 
positioning of CoC hip implants (BIOLOX® Delta) as an input in order to simulate dynamic 
(micro) separation and create edge loading conditions. The experimental setup created a surgical 
mismatch (1-4mm) between the centres of rotation of the femoral head and acetabular cup in the 
medial-lateral axis and the rotational positioning (inclination angle: 45-65 degrees). The resultant 
dynamic separation between the head and acetabular components created from these conditions 
was measured and the wear rates were reported for the different levels of medial-lateral 
translational mismatch. The authors reported that an increase in the mismatch between the centres 
of rotation of the femoral head and acetabular cup resulted in increased levels of dynamic 
separation, thus causing an increase in the severity of edge loading condition, which led to 
increased wear rate in CoC bearings. Furthermore, the mismatch coupled with increased cup 
inclination angles resulted in increased dynamic separation and caused severed edge loading 
condition, which increased the wear rates further. The combination of high levels of mismatch 
(4mm) and steep cup inclination angle (65 degrees) resulted in mean wear rates of up to 1.01 ± 
0.17mm3 per million cycles. These severe edge loading conditions demonstrated >1mm of 
dynamic separation between the femoral head and acetabular cup. This study demonstrated the 
occurrence and severity of edge loading that can occur as a result of mal-positioned implants, and 
the impact these conditions can have on the performance of CoC bearings.  
1.4 Isolation and characterisation of wear particles from THRs  
The isolation and characterisation of wear particles from hip replacements, be it from in vivo or 
in vitro samples is important, as the data obtained can be used to predict the severity of the 
biological response in vivo, which is largely dependent on the relative features (size and shape) 
of the wear particles (Green et al., 1998). Hence, a search of the literature was performed to 
17 
 
identify the current published particle isolation methods to understand their limitations and how 
these could be improved for the isolation of ceramic wear particles. 
1.4.1 Wear particle analysis in vivo 
The generation of wear particles from articulating surfaces of total joint replacements is inevitable 
and wear particles have been implicated as the cause of osteolysis and aseptic loosening. In the 
early 1990s the evidence to support this statement was initially observed through the examination 
of retrieved implants and tissues, whereby particulate metal and/or UHMWPE were observed 
within tissue sections. The relative features of the particles in terms of size, shape, composition 
and quantity were unclear due to the inherent difficulties of particle characterisation. Histologic 
examination of the wear particles had many limitations, which included tissue processing and 
sectioning that affected the final size and appearance of the particles. The resolution of light 
microscopy was limited to large particles only, generally >0.5 µm sized particles. In addition, the 
particles had to be recognised within tissues, so observer bias or experience may have influenced 
the accuracy of the assessment of particles in tissues (Campbell et al., 1994; Campbell et al., 
1995).  
 Isolation of wear particles by tissue digestion 
An alternative approach to tissue sectioning and histologic examination was to isolate the particles 
from the tissues and subsequently characterise them using scanning electron microscopy (SEM). 
In the early 1990s, several studies reported on the use of tissue digestion for isolation of metal or 
bone cement particles (Lee et al., 1992). The high density of metal and bone cement particles 
allowed these particles to pellet during centrifugation. However, the isolation of polyethylene 
particles required new techniques for recovery, due to their intrinsic low density which is less 
than that of water (0.93-0.94 g/cm3). Campbell et al. (1994) devised a suitable method for the 
isolation of both metallic and polyethylene wear particles from periprosthetic tissues (Campbell 
et al., 1994). This method was reported as successful when filtered reagents and 
ultracentrifugation were used to separate the particles from the cellular debris. This was because, 
it was demonstrated that cellular debris and reagent particles could cause contamination of the 
wear particles when examined by SEM. The use of filtered reagents and the inclusion of 
ultracentrifugation overcame these problems. Another study by Campbell et al. (1995) assessed 
the reproducibility of this method for the isolation of UHMWPE wear particles from a number of 
periprosthetic tissues (Campbell et al., 1995). The wear particles isolated had consistent 
morphology, being either rounded or elongated in shape. In addition, the method was described 
as relatively simple, involving fewer steps and less time compared to previous methods (Shanbhag 
et al., 1994). 
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1.4.2 Isolation and characterisation of ceramic wear particles  
 Isolation of ceramic wear particles from retrieved tissues 
The particles generated from CoC bearings have also been investigated through histological 
examination of retrieval tissues. A study by Kummer et al. (1990) investigated pseudosynovial 
tissues obtained from revisions due to aseptic loosening of Autophor CoC prostheses (Kummer 
et al., 1990). The revisions were performed 8 to 54 months following implantation and the results 
revealed numerous particles with a size of 5µm in tissues. Another study by Henssge et al. (1994) 
reported on ceramic wear particles in retrieved pseudocapsules and soft tissue membranes 
retrieved from cemented alumina-on-alumina prostheses that were revised for loosening after 6-
12 years (Henssge et al., 1994). For comparison purposes, autopsy specimens were also retrieved 
from patients that had CoC bearings for more than 5 years. The authors observed ceramic wear 
particles in all the tissue specimens, which appeared as polygonal yellow-brown particles of up 
to 5 µm in diameter and smaller granular wear particles inside macrophages. However, fewer 
particles were observed in the tissue from the autopsy compared to the tissue obtained from 
revision surgery. Yoon et al. (1998) examined tissue samples of interface membranes obtained 
from ten Mittelmeier THRs failed and revised for aseptic loosening. Transmission electron 
microscopy (TEM) revealed the presence of abundant ceramic wear particles with a mean size of 
0.71 µm (range, 0.13 to 7.2 µm) (Yoon et al., 1998).  
All these previous studies, examined wear particles within retrieved tissues using histological 
methods. Lerouge et al. (1996) used two methods to analyse the wear debris in tissues retrieved 
from CoC THA revised for aseptic loosening; 1), semi-quantitative histological analysis and 2), 
tissue digestion to isolate the particles and evaluate them using SEM, EDX and image analysis 
(Lerouge et al., 1996). The non-isolation technique revealed ceramic particles in the submicron 
size, ranging from the limits of the microscope resolution (0.3 µm) up to a few microns in size. 
The isolation technique revealed alumina wear particles with a mean size of 0.44 ± 0.25 µm. In 
addition to alumina wear particles, zirconia and titanium particles were also observed. This study 
highlighted the importance of isolating wear particles for accurate evaluation in terms of 
composition and size distribution. Bohler et al. (2000) used nitric acid for tissue digestion to 
isolate alumina ceramic wear particles from periprosthetic tissues (Bohler et al., 2000). The 
particles were collected using filters and subsequently counted and measured using coulter 
analysis, but this technique had a detection limit of 0.5µm. Hence, particles smaller than 0.5µm 
and larger than 10µm were collected on filters, gold coated and analysed using SEM. The use of 
SEM in parallel with electronic counting methods highlighted the limitations of the available 
methods at that time. Furthermore, the use of nitric acid has been reported as having minimal 
deleterious effects, however, there remain concerns over the use of such strong acids, which may 
have affected the morphology and size of the wear particles. Also, the use of micro-pore filters 
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may have resulted in loss of particles that were smaller than the pore size of the filter (Margevicius 
et al., 1994).   
 Isolation of nanometre-sized ceramic wear particles 
Due to the limitations discussed above, Hatton et al. (2002) used a novel technique, laser capture 
microdissection (LCM) to isolate ceramic wear debris from tissues retrieved at revision (Hatton 
et al., 2002). This method was developed as a research tool at the National Institutes of Health 
(NIH) and originally used to obtain pure populations of targeted cells from specific regions of 
tissue sections for extraction of molecules and analysis (Bonner et al., 1997). This study was the 
first to apply LCM for the isolation and analysis of wear debris in retrieved tissues. LCM would 
effectively preserve the particles in the state in which they were found in vivo allowing accurate 
analysis of their size and morphology. The tissues were obtained from around 10 non-cemented 
Mittlemeier alumina CoC THRs from patients undergoing revision surgery. Wear particles were 
extracted from tissue sections using LCM and subsequently characterised using SEM and TEM. 
TEM of the laser captured tissue revealed the presence of very small alumina wear debris, in the 
size range of 5-90 nm, with a mean size of 24±19 nm, whereas SEM, which has a lower resolution, 
revealed particles in the size range of 0.05-3.2 µm. This study for the first time demonstrated that 
wear particles from alumina CoC bearing have a bimodal size range. Prior to this study, alumina 
ceramic wear particles have been reported as being in the submicron size range, however this 
study reported for the first time descriptions of nanometre sized ceramic wear particles in retrieval 
tissues (Hatton et al., 2002).  
 Isolation of ceramic wear particles from hip simulator lubricants 
The reproduction of clinically relevant wear rates and wear patterns in vitro in hip simulators for 
CoC THRs was not possible until Nevelos et al. (2000), introduced microseparation of CoC hip 
prostheses into the in vitro wear simulation (Nevelos et al., 2000a). This led Tipper et al. (2002) 
to investigate the characteristics of wear particles generated in vitro under standard and 
microseparation conditions from HIPed and non-HIPed alumina CoC hip prostheses and 
compared these particles to those previously studied in vivo (Hatton et al., 2002; Tipper et al., 
2002a). Under standard simulation conditions both HIPed and non-HIPed alumina CoC 
prostheses produced very low wear rates of 0.08 and 0.11 mm3 per million cycles, respectively.  
Contact profilometry revealed no change in surface roughness for either HIPed or non-HIPed 
alumina and the wear particles generated under standard simulation conditions were only 
observed in the nanometre size range. These particles were thought to be generated as a result of 
surface relief polishing of the alumina ceramic and had mean sizes of 9.19 ± 0.52 nm and 9.22 ± 
0.52 nm, respectively for the HIPed and non-HIPed alumina.      
The introduction of microseparation considerably increased the wear rates to 1.24 mm3 per 
million cycles for HIPed alumina and 1.74 mm3 per million cycles for the non-HIPed alumina. 
Both prosthesis types revealed the presence of a wear stripe, which was comparable with those 
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often observed clinically. SEM analysis of the wear stripes revealed intergranular fracture of the 
femoral heads for both types of alumina. In addition, surface roughness increased after 
microseparation for both HIPed and non-HIPed alumina from an average of Ra of 0.007 µm to Ra 
0.03 µm for the HIPed heads and 0.06 µm for the non-HIPed alumina heads. These values of 
surface roughness are comparable with retrieved components indicating that similar wear 
mechanisms may have occurred in vitro during microseparation in the hip simulators. The wear 
particles generated in the serum lubricant were isolated using two different methods for SEM and 
TEM analysis. The particles analysed using TEM were isolated by centrifuging the serum 
lubricant containing the wear particles and fixing the pellet of wear particles in 2.5% (v/v) 
glutaraldehyde in phosphate buffered saline (PBS). The wear particles were stained and fixed 
with 1% (w/v) osmium tetraoxide before being dehydrated using ethanol. The samples were 
polymerised in araldite resin and 100nm sections were cut with a diamond knife for TEM analysis. 
The particles analysed using SEM were isolated by centrifuging the serum lubricant containing 
the wear particles and then washing the pellet of particles and proteins with PBS to remove 
proteins. Thereafter, the wear debris were heat treated at 180oC for four hours to denature any 
residual proteins and remove any bacterial contamination from the wear particles. Thereafter the 
wear particles were filtered onto 15nm pore filters and analysed using SEM. The wear particles 
generated consisted of small (1-35 nm) and larger (0.02-0.94 µm) sizes of particles. TEM analyses 
revealed the small wear particles as dense aggregates with a round/oval shape and were thought 
to be as a result of relief polishing. The larger particles also had a round/oval shape with some 
polygonal particles and were thought to have originated from within the wear stripe by trans-
granular fracture of the alumina ceramic material. This bimodal size range of wear particles 
produced was also observed in the analysis of tissues from retrieved components (Hatton et al., 
2002). Therefore, it is evident from these studies that the introduction of microseparation during 
wear simulation produced clinically relevant wear rates, wear stripe patterns and bimodal 
distribution of wear particles as clearly seen in vivo. The particle isolation methods used by Tipper 
et al. (2002) were successful in characterising alumina ceramic wear particles recovered from 
serum lubricants, but these methods may lack the sensitivity to isolate wear particles generated 
from composite CoC bearings due to their extremely low wear rates, even under microseparation 
conditions. There is a high risk of particle loss during the fixing of the particles in resin and heat 
treatment of the particles to remove proteins and endotoxins may not effectively remove all the 
proteins, which can cause contamination issues and difficulties during imaging of the particles. 
Nevertheless, these studies were a major breakthrough in terms of isolation and characterisation 
of ceramic wear particles, as this study demonstrated for the first time successful isolation of low 
volumes of wear particles generated from alumina CoC bearings and also revealed for the first 
time the characteristics of ceramic wear particles in the nanometre size range (Hatton et al., 2002; 
Tipper et al., 2002a).  
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1.4.3 Comparison of wear particle isolation techniques 
Due to ethical issues associated with retrieved implants and limited number of tissues samples 
from retrieved implants, the isolation and characterisation of wear particles from hip simulator 
lubricants has been the focus of many studies to obtain the characteristics of wear particles in 
vitro. However, as mentioned previously, even with the introduction of severe edge loading 
conditions the superior wear properties of ZTA composite CoC bearings still produces extremely 
low wear volumes, which present major challenges for the isolation and characterisation of wear 
particles generated from composite ceramics such as BIOLOX® Delta. A comparison between the 
different types of digestion techniques was conducted in order to find the most suitable digestion 
technique for ceramic wear particles in hip simulator serum lubricants.  
 Base, acid or enzymatic digestion 
Quantification of wear debris was traditionally and still is practiced using the weight loss method. 
This method has been successful in determining the amount of wear but it is limited in the sense 
that it does not provide valuable information about the wear debris characteristics in terms of size 
distribution and morphology. The conventional isolation methods as described previously used 
the base digestion technique whereby a strong base such as sodium hydroxide (NaOH) was used 
to digest tissue before centrifugation and filtration to isolate the wear particles (Campbell et al., 
1994; Campbell et al., 1995). Niedzwiecki et al. (2001) compared three polymer wear particle 
isolation methods that used different reagents for the digestion of serum i.e. acid, base or enzymes. 
It was concluded that all three methods were viable at preserving the particle morphology and 
yielded similar particle size distributions for the same simulator serum. It was further stated, that 
the acid and enzyme methods did not require ultracentrifugation or gradient filtration. The enzyme 
method was considered as the optimum choice since it generated the least amount of hazardous 
waste (Niedzwiecki et al., 2001). 
The accurate measurements of particle size, shape and composition is important in determining 
the wear performance and tissue response to particulate material from THRs. This can only be 
done by optimising particle isolation methods and minimising wear particle changes due to the 
effects of the reagents. Catelas et al. (2001) investigated the effects of different digestion 
techniques on the isolation and characterisation of wear particles from simulator lubricants 
generated from MoM bearings in vitro. The effects were analysed in terms of particle size, shape, 
composition and the release of metal ions. Metal wear particles present a much more challenging 
problem compared to polymer wear debris because of their smaller size, their tendency to 
agglomerate and their potential for chemical damage and degradation by digestion reagents. TEM 
revealed that particles generated in water experienced changes in size with both enzymatic and 
alkaline digestion treatments. These changes were more pronounced for the alkaline protocols 
and increased with alkali concentration and time in solution (Catelas, Bobyn, J.B. Medley, et al., 
2001). This was previously mentioned by Campbell et al. (1994) who postulated that strong 
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alkaline solutions may affect particle morphology. In contrast, the changes in particles generated 
in hip simulator in 95% (v/v) serum lubricant, were considerably less extensive for both the 
alkaline and enzyme digestion protocols. It was suggested that serum proteins or lipids initially 
covered the particles and protected them against the oxidising action of the solutions. Hence, both 
digestion techniques could be used for particle isolation from simulator serum without extensive 
size and shape changes to the particles. However, it was noticed that alkaline digestion caused the 
particles to agglomerate more easily (Catelas, Bobyn, J.B. Medley, et al., 2001). This problem of 
agglomeration after alkaline treatment was also previously reported by Campbell et al. (1994). In 
addition, particles treated with alkaline solutions appeared to have more uniform and high contrast 
appearance in TEM, whereas particles isolated by enzymatic treatments were more diverse with 
varying contrast intensities. This suggested that the alkaline treatments modified the wear particle 
composition. Furthermore, the release of Co and Cr ions after alkaline treatment also provided 
further evidence of composition change, whereas enzymatic treatment resulted in negligible 
release of Co and Cr ions into solution. It was concluded that from all the protocols tested, the 
enzymatic digestion technique was the least damaging to the wear particles and most likely an 
optimum choice for isolation and characterisation of metal wear particles, especially for those 
generated in serum (Catelas, Bobyn, J.B. Medley, et al., 2001). This may also apply to ceramic 
wear particles, as the characteristics for ceramic particles in terms of size and shape are similar to 
metal wear particles.  
1.4.4 Isolation of nano-metre sized wear particles from hip simulator lubricants 
Brown et al. (2007) developed a novel method for the isolation of wear particles generated from 
MoM hip bearings. This method employed an enzymatic digestion technique to avoid the use of 
acids or bases, thus preventing damage of the wear particles during isolation. The method was 
successful in isolating wear particles from both MoM and alumina ceramic-on-metal (CoM) 
tested under both standard and microseparation simulation conditions. The wear particles were 
characterised using high resolution field emission gun scanning electron microscopy (FEGSEM) 
which revealed significant differences in particle morphology and size distribution for the MoM 
and ceramic-on-metal (CoM) bearing combinations and different simulation conditions. In 
addition, FEG-SEM was used as an alternative to TEM because it provided high resolution 
imaging and avoided inaccurate sampling due to the use of only a small amount of sample, which 
was the case for TEM. Also, the small amount of sample can result in the loss of larger particles 
and unevenly distributed particles. SEM also has its problems, such as resolving small particles 
requires the use of high accelerating voltages to improve the resolution of SEM, which can cause 
particle damage and errors in particle area measurement (Yanez and Barbosa, 2003). 
Nevertheless, the method developed by Brown et al. (2007) presented attractive advantages over 
other methods in that is was successful in isolating wear particles from low volumes of wear (0.3 
mm3 per million cycles) generated from MoM bearings.  
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Due to the limitations of previous particle isolation methods, including particle loss, 
agglomeration and chemical damage, Billi et al. (2012) developed a new award-winning method 
that claimed to overcome all of the shortcomings of previous methods (Billi, Benya, Kavanaugh, 
Adams, McKellop, et al., 2012). The method involved a two-step process; 1) particle isolation, 
and 2) particle purification. This method was designed for wear debris from any material having 
a density greater than 2.0 g/mL i.e. metal or ceramic. The method employed enzymatic digestion 
and was referred to as "Metal and ceramic silicon wafer display" (MC-SWD), since it uses a 
featureless wafer to collect and display the particles without the use of filtration. This was 
previously attempted by Catelas et al. (2004) who used a similar approach where after 
centrifugation, the wear particles were embedded in a resin to minimise particle loss and promote 
dispersion of the wear particles. The results displayed evenly distributed wear particles when 
analysed using TEM (Catelas et al., 2004). The MC-SWD method was evaluated to determine its 
efficiency and accuracy by recovering gold nano-beads and metal and ceramic particles from hip 
simulator wear lubricants. The method demonstrated a 92 ± 5% recovery rate of the gold beads. 
Particle concentration before digestion and decreased handling ensured maximum particle 
recovery and reduced particle loss. This was further supported by particle loss evaluation where 
the concentration of Co before centrifugation was 37.5 ± 1.5 ppm and after centrifugation it was 
37.3 ± 1.6 ppm, which demonstrated that virtually no particles remained in the supernatant. The 
adoption of the wafer instead of filtration ensured the particles were displayed well separated with 
few agglomerates. In addition, the distribution of the wear particles was uniform i.e. similar at 
different locations on the wafer. This allowed for precise and individual chemical characterisation 
of particles as small as 12nm, thus ensuring accurate and reliable morphological characterisation 
of the wear particles.  
Despite the evidence and reported success of the MC-SWD particle isolation method, this method 
has not been reproduced or tested in any other laboratory. There are no other studies that have 
implemented this method, hence a sense of uncertainty exists regarding this protocol as they are 
no external reviews of whether this method produces the results that it claims. Also, the 
complexity of this method will make it very difficult to replicate since many steps are specialised 
and require sophisticated equipment. In addition, the cost of the reagents that this method uses is 
extremely high, for example mussel glue (Cell-Tak) used to coat the silicon wafer display costs 
around two hundred dollars (Fisher Scientific, USA) for one milligram of adhesive. Another issue 
with this method is that the particles are irreversibly stuck to the silicon wafer and cannot be 
recovered for subsequent biological testing. All these factors make the MC-SWD particle 
isolation method less attractive to implement, even though it is reportedly a successful method. 
More recently a novel particle isolation method was developed by Lal et al. (2016), who also 
employed enzymatic digestion and density gradients to separate the proteins from the wear 
particles. However, this method used a different medium i.e. sodium polytungstate to form the 
density gradient. The metal/ceramic wear particles were recovered from the proteins by placing 
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the digested serum containing the wear particles on a sodium polytungstate density gradient and 
centrifuging the samples at an average RCF of 202,048g. After centrifugation, the wear particles 
would collect at the bottom of the tube, whilst the broken-down protein and other impurities were 
suspended higher up the tube due to their lower density compared to the metal/ceramic wear 
particles. This method was developed for the isolation of ultra-low volumes of ceramic or 
ceramic-like coating particles and metal wear particles from serum lubricants. The authors 
demonstrated a particle recovery rate of >80% and they also reported that the enzymatic digestion 
did not alter the size or morphology of ceramic and metal particles during the isolation process. 
The particle recovery rate value for this particle isolation technique could be considered more 
reliable compared to the particle recovery rate value for the particle isolation method developed 
by Billi et al. (2012). This is because Lal et al. (2016), used actual ceramic particles (silicon 
nitride) to assess the particle recovery rate, whereas Billi et al. (2012) used gold beads. 
Nevertheless, Lal et al. 2016 did not test their method on hip simulator serum lubricants, instead 
only results for particles recovered from serum spiked with silicon nitride particles was reported, 
hence the efficacy of this method to recover particles from hip simulator lubricants is unknown.  
An extensive search in the literature found no studies that reported the recovery and 
characterisation of wear particles generated from ZTA composite ceramic hip replacements. This 
may be due to the limitations of the current particle isolation methods not being reliable enough 
to isolate the challenging ultra-low wear volumes exhibited by CoC bearings. This gap in the 
literature presents a difficult challenge for the development of a method that will successfully 
recover wear particles generated from ZTA composite ceramic hip replacements.  
1.5 Failures of Total Hip Replacements 
1.5.1 Introduction 
There is a large body of evidence in the literature that indicates the life expectancy of an artificial 
hip is limited and that small numbers of devices survive beyond 25 years (Learmonth et al., 2007). 
However, the survivorship of the age of the patient is a major contributor to implant survival rate; 
the survivorship for older patients (>55 years) is more than 90% at 15 years, whereas the survival 
rate falls to 70% at 10 years for patients under 55 years of age (Hartofilakidis et al., 2005). It has 
been predicted that the number of THAs will increase by 174% by 2030, because younger and 
more active patients are increasingly having joint replacements (Kurtz et al., 2007). A search in 
the literature was conducted to evaluate the biological responses to wear particles generated from 
different bearing materials used for THA. The longevity of an implant has been reported to be 
directly affected by and related to the biological response to wear particles generated from THRs 
(Suner et al., 2012). Therefore, the need to understand the biological impact of wear particles and 
the mechanisms which may result in implant failure have become more important. Nevertheless, 
the landscape is changing due to the introduction of alternative bearing materials such as MoM 
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and CoC bearings. Hip implants are no longer failing due to osteolysis and/or wear particle 
production as wear rates of current THRs have decreased dramatically. Instead, other factors such 
as mechanical failure and failure of fixation also contribute towards the failure of modern him 
implant bearings. In addition, aseptic loosening is reported to be one of the most commonly cited 
causes of THR failures that were revised during the period between 2003-2016 (National Joint 
Registry, 2016). Aseptic loosening is a process of bone loss without infection and may even occur 
without any symptoms. Osteolysis causing the bone loss may be linear (equally distributed around 
the implant) or focal (specific areas of bone loss relative to the implant) (Sundfeldt et al., 2006). 
The cause of aseptic loosening has been reported as being mainly due to two factors, namely 
mechanical and biological factors. 
1.5.2 Mechanical factors  
 Implant design and material properties 
Implant design, material properties and surgical technique are mechanical factors that contribute 
to the cause of aseptic loosening. For example, a study by White et al. (2012) reported that the 
Accolade cementless femoral stem design was associated with high incidence of migration, as a 
result of poor fixation due to lack of osteointegration, which caused poor initial stability (White 
et al., 2012). Material properties are also an important factor as stress shielding can result, which 
is a mechanical phenomenon caused by stiff and inflexible materials in the femoral component of 
THRs. Stress shielding can cause bone resorption as the intramedullary stem absorbs all the 
stresses that the femur would have carried in its natural state, therefore the bone is subjected to 
reduced stresses, hence shielded from stress. The redistribution of load causes bone resorption as 
an effect of bone adaptation to stress shielding that can eventually result in aseptic loosening. 
Many implant designs have been changed to reduce stress shielding such as introducing a flexible 
stem, implant geometry and shape (hollow stem) (Huiskes et al., 1992; Joshi et al., 2000). 
1.5.2.1.1 Surgical positioning 
Surgical malpositioning of THRs as a result of poor alignment or poor fixation of the implant can 
lead to micromotion and fluid pressure, as well as instability of the implant inevitably resulting 
in aseptic loosening and failure of the implant (Aspenberg and Herbertsson, 1996). The correct 
positioning of the acetabular cup with respect to inclination and anteversion is very important as 
it can affect the rate of wear, range of motion, dislocation and aseptic loosening. Surgical 
experience was reported not to statistically influence the accuracy of acetabular cup positioning, 
rather it was the alignment of devices and insertion guides themselves that determined the 
accuracy of cup positioning (Reize et al., 2008). Jolles et al. (2004) reported that the use of 
computer assisted cup placement was significantly more accurate than conventional methods of 
cup positioning. This technique could provide better or even optimum positioning of hip implants, 
thus resulting in a decrease of revision rates (Jolles et al., 2004).        
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1.5.3 Biological Factors  
 Osteolysis 
Excessive wear particles have been linked with the aetiology of periprosthetic osteolysis and 
aseptic loosening. Osteolysis is the active resorption of bone by osteoclasts and is commonly 
associated with aseptic loosening of artificial joint replacements. The initial stages of osteolysis 
involves wear particles that are generated at the articulating surfaces, entering the periprosthetic 
tissue (Brown et al., 2006). Here, macrophages and multinucleated giant cells engulf the wear 
particles that are in the critical size range (0.2-0.8 µm) for phagocytosis (Ingham and Fisher, 2000; 
Brown et al., 2006). Histological studies of periprosthetic tissues have shown that small particles 
(<10 µm) were engulfed by macrophages whereas larger particles (>10 µm) were engulfed by 
multinucleated giant cells (Pazzaglia et al., 1987; Ingham and Fisher, 2005). Macrophages and 
giant cells are part of the mononuclear phagocyte system and are produced by the differentiation 
of monocytes in tissues. These cells play a key role in the immune response, whereby they detect, 
phagocytose and degrade foreign matter. The primary role of macrophages is to engulf and digest 
micro-organisms and initiate the processes of inflammation by releasing a range of pro-
inflammatory cytokines and other mediators of inflammation (Ingham and Fisher, 2000). The 
release of these mediators results in the recruitment, migration and stimulation of other cell types 
involved in the immune response and host defence. However, in response to wear particles 
macrophages are unable to degrade the wear particles due to their inert nature (Brown et al., 2006). 
Consequently, the macrophages release cytokines and mediators to recruit other cells to the site 
of the foreign wear particles. As a result, the formation of a granulomatous periprosthetic tissue, 
which is rich in macrophages, forms around the implant to isolate the foreign matter from the 
surrounding tissues (Ingham and Fisher, 2005).  
 Cytokines and mediators released by macrophages and their roles in osteolysis 
Previous studies of periprosthetic tissues have shown the presence of many inflammatory 
mediators and cytokines associated with the biological response to wear particles. These include 
tumour necrosis factor-α (TNF-α), receptor activator of nuclear factor kappa-B (RANK)/RANK 
ligand (RANKL), interleukin-1 (IL-1), interleukin-1β (IL-1β),  interleukin-6 (IL-6), interleukin-
8 (IL-8), granulocyte-macrophage colony stimulating factor (GM-CSF), macrophage colony 
stimulating factor (M-CSF), stem cell factor (SCF) and prostaglandin E2 (PGE2) (Kim et al., 1993; 
Sabokbar and Rushton, 1995; Goodman et al., 1998; Neale and Athanasou, 1999; Ingham and 
Fisher, 2000; Abu-Amer et al., 2007; Goodman et al., 2013). 
These inflammatory mediators and cytokines affect the behaviour of many cell types, particularly 
the interaction of osteoblasts, osteoclasts and fibroblasts which ultimately leads to bone loss and 
aseptic loosening (Figure 1.4). The roles that these mediators play in the process of wear particle 
induced-osteolysis are summarised in Table 1.2. 
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Figure 1.4: The potential mechanisms that can occur when macrophages are stimulated by wear particles. 
There are several potential pathways after macrophage activation by wear particles that can result in bone 
resorption and ultimately osteolysis in THRs. (1) The release of pro-inflammatory cytokines and 
chemokines may increase the recruitment of haematopoietic osteoclast precursors from local blood vessels. 
(2) The release of TNF-α/ IL-1 by macrophages may lead to enhanced expression of RANKL and M-CSF 
by osteoblasts/ stromal cells. Binding of RANK to RANKL and release of M-CSF stimulates osteoclast 
differentiation and activates mature osteoclasts to resorb bone. (3) TNF-α may directly enhance the 
differentiation of osteoclast precursors independent of RANK/RANKL mechanisms. (4) TNF-α may 
directly activate mature osteoclasts to resorb bone (Ingham and Fisher, 2005). 
 
TNF-α is a key osteolytic cytokine released by macrophages stimulated by wear particles. TNF-
α enhances the expression of RANKL by acting on mesenchymal and osteoblastic cells. RANKL 
is a surface-bound molecule which is part of the TNF superfamily and is expressed by 
osteoblasts/bone marrow stromal cells (Ingham and Fisher, 2005). The receptor for RANKL, 
RANK is expressed on the surface of osteoclast pre-cursors and mature osteoclasts. The binding 
of RANKL to RANK has been shown to stimulate osteoclast differentiation and activate mature 
osteoclasts to resorb bone (Wei and Siegal, 2008). A study by Mandelin et al. (2003) of 
periprosthetic tissue investigated RANKL/RANK and their association with osteolysis. It was 
found that RANKL and RANK were both upregulated compared to control synovial tissue 
(Mandelin et al., 2003). TNF-α has also been reported to directly stimulate the recruitment of 
osteoclasts (Azuma et al., 2000; Kobayashi et al., 2000; Fuller et al., 2002; Tsuboi et al., 2003). 
The importance of TNF-α has been highlighted by in vitro studies of TNF-knockout mice. Clohisy 
et al. (2002) investigated the effects of PMMA particles on osteoclast precursors derived from 
murine bone marrow. The cells showed an increase in NFкB nuclear translocation which was 
dependent upon TNF-α signalling, whereas cells from TNF-knockout mice demonstrated a null 
response to the PMMA particles (Clohisy et al., 2002; Ingham and Fisher, 2005). Similarly, 
another study on RANK deficient mice exhibited no osteolytic response to wear particles. These 
results indicated that these two mediators; TNF-α and RANK/RANKL work synergistically to 
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directly inducing macrophages towards the osteoclastic phenotype for bone resorption (Wei and 
Siegal, 2008). 
Several in vitro studies have revealed that some of the macrophages within the periprosthetic 
tissue retrieved from revision surgeries may have the potential to differentiate into osteoclasts 
capable of bone resorption. Sabokbar et al. (2003) reported that these cells differentiated into 
tartrate-resistant acid phosphatase positive (TRAP+) and vitronectin positive (VNR+) 
multinucleated cells capable of extensive lacunar resorption in the presence of M-CSF and TNF-
α (Sabokbar et al., 2003). TRAP and VNF are osteoclast markers used to characterise cells in 
vitro. The addition of antibodies to act against the TNFp55 receptor protein resulted in fewer 
TRAP+ cells and so it was concluded that macrophages isolated directly from the periprosthetic 
tissues can differentiate in the presence of TNF-α into multi-nucleated giant cells that can express 
the phenotype of osteoclasts (Sabokbar et al., 1997; Sabokbar et al., 2003). This study added 
weight to previous findings that TNF-α can directly induce macrophages to differentiate into 
osteoclasts independent of RANK mechanisms. These findings were also in agreement with in 
vitro studies by Darowish et al. (2009) who demonstrated that TNF-α can induce its effects on 
osteoclast precursor differentiation independent of RANKL, but only in the presence of M-CSF 
(Darowish et al., 2009). 
IL-1 and IL-6 are also important cytokines released by macrophages during the inflammatory 
response to wear particles. Similar to TNF-α, IL-1 is a osteoclastogenic cytokine that promotes 
the expression of RANKL in bone marrow stromal cells and osteoblasts. IL-1 increases the 
expression of its receptor IL-1R1 and thus mediates TNF-α induction of RANKL expression. Jimi 
et al. (1999) reported that precursors of osteoclasts and osteoclast like cells expressed IL-1R1 
receptors to which IL-1 bonds, and then promotes longer survival, induces fusion, and activates 
osteoclast function (Jimi et al., 1999). The role of IL-1 seems to be one that promotes the 
destruction of cartilage and bone (Dayer, 2002). IL-6 is expressed in high levels by macrophages 
and fibroblasts as a result of stimulation by wear particles in vitro (Darowish et al., 2009). The 
role of IL-6 is not clearly defined, as some studies suggest it functions as a pro-osteoclastogenic 
and pro-inflammatory cytokine, whilst others have suggested it is an inhibitor having both anti-
inflammatory and anti-osteoclastogenic effects. Most studies of IL-6 have reported its role as 
primarily being anti-inflammatory and anti-osteoclastogenic (Table 1.2). IL-1 and IL-6 are also 
involved in the synthesis of collagenase and prostaglandin E2 (PGE2), which are associated with 
the bone remodelling (Goodman et al., 1998).  
Osteoprotegorin (OPG) is also an inhibitory cytokine that is produced by osteoblasts/bone marrow 
stromal cells (Ingham and Fisher, 2005). OPG is an anti-osteoclastogenic decoy receptor which 
binds to RANKL and inhibits nuclear kappa B (NF-кB), thus preventing the differentiation of 
osteoclast precursors. Molecules capable of bone resorption exert their effects by directly 
promoting RANKL expression and inhibiting the synthesis of OPG (Wei et al., 2005). The 
interactions between RANK, RANKL and OPG are illustrated in Figure 1.5.  
29 
 
 
Figure 1.5. Relationship between RANK, RANKL and OPG. OPG acts as a decoy protein, binding to 
RANKL on osteoblasts/stromal cells and preventing interaction with RANK on osteoclast precursors, thus 
inhibiting the process of osteoclastogenesis (Ingham and Fisher, 2005). 
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Table 1.2 - Summary of primary and secondary effects of osteolytic mediators. 
 
Name Type Source Primary effects Secondary effects Reference 
Tumour necrosis 
factor-α (TNF-α) 
Cytokine 
Monocytes and 
macrophages 
Enhances the expression of RANKL on mesenchymal and 
osteoblastic cells. 
Directly stimulates the recruitment of osteoclasts independent of 
RANK/RANKL mechanism in the presence of M-CSF. 
Promotes the survival of terminally differentiated osteoclasts to 
maintain their intensification of osteolysis. 
Directly induces macrophages to differentiate into osteoclasts 
independent of RANK/RANKL mechanisms. 
Interacts with synoviocytes and chondrocytes in the superficial 
layers of cartilage. 
Elevated levels of TNF-α have been reported in retrieved tissues 
from revision hips with osteolysis. 
Binding of RANKL to 
RANK stimulates osteoclast 
differentiation and activates 
mature osteoclasts to resorb 
bone. 
Causes the release of 
enzymes, metalloproteinases 
that breakdown cartilage and 
proteoglycans, which cause 
cartilage destruction. 
Narrowing of the joint space. 
 
(Sabokbar et al., 1997; 
Goodman et al., 1998; 
Azuma et al., 2000; 
Kobayashi et al., 2000; 
Fuller et al., 2002; Clohisy 
et al., 2002; Arend, 2002; 
Sabokbar et al., 2003; 
Mandelin et al., 2003; 
Ingham and Fisher, 2005; 
Darowish et al., 2009) 
 
Macrophage 
colony stimulating 
factor (M-CSF) 
Cytokine 
Osteoblasts/ 
stromal cells 
Plays a role in organising the cytoskeleton of mature osteoclasts 
Induces the fusion of osteoclast precursor cells. 
Reduces caspase activity within osteoclast precursor cells. 
Maintains and prolongs the 
survival and longevity of 
osteoclast precursors. 
Increases bone resorption. 
 
(Jimi et al., 1999; Kitaura 
et al., 2005) 
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Interleuken-1 (IL-
1) 
Cytokine 
Monocytes and 
macrophages 
Promotes the expression of RANKL in bone marrow stromal cells 
and osteoblasts. 
Binds to its receptor IL-1R1 expressed on precursors of 
osteoclasts and osteoclast like cells, which promotes longer 
survival, induces fusion and activates osteoclast function. 
Directly stimulates the differentiation of mononuclear osteoclast 
precursors in the presence of sub-osteoclastogenic concentrations 
of RANKL. 
Directly induces the differentiation of macrophages into 
osteoclasts in the presence of RANKL. 
Interacts with synoviocytes and chondrocytes in the superficial 
layers of cartilage. 
Stimulate fibroblasts and synovial cells to synthesise enzymes. 
Increases bone resorption 
Causes the release of 
enzymes, metalloproteinases 
that breakdown cartilage and 
proteoglycans, which cause 
cartilage destruction. 
Narrowing of the joint space. 
 
(Jimi et al., 1999; Arend, 
2002; Wei et al., 2005) 
Interleuken-6 (IL-
6) 
Cytokine 
Monocytes/macr
ophages and 
fibroblasts 
Functions as an anti-inflammatory and anti-osteoclastogenic 
cytokine. 
Reduces the expression of TNF-α. 
Inhibits the differentiation of osteoblast progenitor cells. 
Stimulate fibroblasts and synovial cells to synthesise enzymes. 
Decreases bone resorption. 
(Kopf et al., 1994; Balto et 
al., 2001; Darowish et al., 
2009) 
Interleukin-8 (IL-
8) 
Cytokine 
Monocytes/macr
ophages and 
fibroblasts 
Stimulates the recruitment of both osteoclasts and mononuclear 
osteoclast-like cells. 
Stimulates the release of degradative enzymes (collagenase) and 
other pro-inflammatory cytokines. 
Elevated levels have been found in retrieved tissues from failed 
THAs. 
Enhances the stimulation of 
osteoclastogenesis and bone 
resorption in osteoclasts. 
(Peichl et al., 1991; 
Sabokbar and Rushton, 
1995) 
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Osteoprotegorin 
(OPG) 
Cytokine 
receptor/ 
glycoprotein 
 
Osteoblasts/bone 
marrow stromal 
cells 
OPG plays a role as an anti-osteoclastogenic decoy receptor which 
binds to RANKL and inhibits nuclear kappa B (NF-кB), thus 
preventing the differentiation of osteoclast precursors 
(monocytes/macrophages). 
Decreases bone resorption. 
(Ingham and Fisher, 2005; 
Wei et al., 2005) 
Collagenase and 
gelatinase 
Enzymes 
Fibroblasts and 
synovial cells 
These enzymes play a role in the digestion and degradation of 
collagen and gelatin found within connective tissue and 
extracellular matrix. 
Collagenase may be directly associated with bone resorption by 
degrading the osteoid layer of bone, thus exposing the surface for 
osteoclast resorption. 
Increases bone resorption by 
exposing the surface for 
osteoclastic activity. 
(Kim et al., 1993; Sabokbar 
and Rushton, 1995) 
Prostaglandin E2 
(PGE2) 
Eicosanoid 
signalling 
molecule 
Fibroblasts and 
monocytes/macro
phages 
Inflammatory mediator associated with the resorption of bone 
Increased production by macrophages in response to wear 
particles. 
Implant loosening. 
(Goodman et al., 1989; 
Sabokbar and Rushton, 
1995) 
Monocyte 
chemoattractant 
protein-1 (MCP-1) 
Chemokines 
Monocytes and 
macrophages 
Regulates the recruitment and migration of lymphocytes and 
monocytes/macrophages to the site of injury. 
Released in response to phagocytosis or adherence to wear 
particles. 
High expression observed in tissues from THAs failed from 
loosening. 
Stimulates the release of IL-1 and IL-6 from 
monocytes/macrophages. 
Stimulates the production of 
osteolytic cytokines and thus 
results in bone resorption. 
(Goodman et al., 1989; 
Nakashima et al., 1999; 
Goodman and Ma, 2010) 
Macrophages 
inflammatory 
protein-1α (MIP-
1α) 
Chemokines 
Monocytes and 
macrophages 
Potent chemoattractants for monocytes/macrophages and 
lymphocytes. 
Stimulates the production of pro-inflammatory cytokines; IL-1, IL-
6 and TNF-α. 
Plays a role in the recruitment 
and differentiation of 
osteoclasts. 
(Goodman et al., 1989; 
Goodman and Ma, 2010) 
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1.5.4 Biological effects of wear particles generated from different bearing materials 
Evidence to support the mechanisms involved in the biological response to wear particles is 
ever increasing. The innovation of new techniques has allowed the analysis of retrieved 
periprosthetic tissues, in addition to in vitro and in vivo studies of the direct biological effects 
of wear debris. In vitro studies provide vital knowledge of cellular responses to wear particles, 
however these controlled environments are limited in the sense that they do not take into 
account other biological systems and mechanical stimuli from other cells and tissues that 
would otherwise be found in a clinical environment. Nevertheless, if replicated as close to a 
clinical situation as possible, vital information can be extrapolated from in vitro experiments. 
It is important to mention that caution should be taken when reviewing literature published 
on in vitro studies of the biological response to wear particles, since sterile, non-endotoxin 
contaminated, wear particles have not been used by many investigators, which may produce 
misleading results (Ingham and Fisher, 2000). Brooks et al. (2002) reported that even a minor 
contamination with endotoxin could result in the release of cytokines and hence, produce 
erroneous results (Brooks et al., 2002).  In addition, clinically-relevant wear particles in terms 
of size and shape, have not been used by many researchers, instead they have used 
commercially available particles that differ greatly in terms of characteristics i.e. size, 
morphology, surface area and texture, from clinically generated particles resulting in 
discrepancies within the data. The prevalence of use of commercially available particles may 
be due to the difficulty in generating clinically-relevant wear particles in vitro that are free 
from endotoxins.   
 Wear particles generated from metal-on-UHMWPE hips 
Following a total hip replacement particulate debris can be generated either due to wear or 
corrosion. Wear generated due to the normal functioning of the bearing is inevitable and can 
have devastating consequences in terms of the biological response. Osteolysis induced by 
polyethylene wear debris is most prevalent in long term implants (Brown et al., 2006). There 
is ample evidence published on the biological effects of UHMWPE wear debris through both 
retrieval analyses of periprosthetic tissue and in vivo/in vitro studies.  
1.5.4.1.1 Biological response to UHMWPE wear particles in vivo 
The formation of a pseudosynovial membrane around the articulation occurs after 
implantation. It has been reported by Bullough et al. (1988) that the formation of this 
membrane can take up to 2 years after implantation (Bullough et al., 1988). The interfacial 
membranes have the same features as synovial membranes i.e. thin in structure with few cells 
and vessels. Retrieval studies of MoP hip implants recovered after revision surgery for aseptic 
loosening have clearly shown the formation of a thicker and highly vascularised fibrous tissue 
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membrane which is highly populated with macrophages and multinucleated giant cells 
(Ingham and Fisher, 2000; Ingham and Fisher, 2005).  
Polyethylene wear particles extracted from periprosthetic tissues have been reported as having 
a wide size distribution ranging from 10nm up to 3mm (Hailey et al., 1996; Richards et al., 
2008). However, the majority of the particles were found to be in the sub-micrometre (0.1-
0.99µm) range (Rajpura, Kendoff et al. 2014). It has been reported that when there is a 
concentration of more than 1 x 1010 wear particles with a size of less than 5µm, per gram of 
tissue, the occurrence of osteolysis is greater (Kobayashi et al., 1997). This was in agreement 
with the findings of Tipper et al. (2000) who isolated particles in the size range 0.1 -0.5µm 
from periprosthetic tissue from patients with osteolysis. Histology studies of retrieved tissues 
have revealed UHMWPE wear particles associated with macrophages and multinuclear giant 
cells. Small wear particles (<5µm) were located within macrophages, whereas larger wear 
particles (>10µm) were located within multinucleated giant cells (Tipper et al., 1999; Ingham 
and Fisher, 2000). Goodman et al. (1990) investigated the effects of implantation of different 
sizes of polyethylene particles in the tibia of rabbits. It was found that smaller particles were 
engulfed by macrophages and larger particles were engulfed by giant cells within the fibrous 
tissue. The largest of particles with an average size of 67.29µm were more readily fibrous 
encapsulated due to their less large size, which was not compatible with phagocytosis by 
macrophages (Goodman et al., 1990). A large variation in the morphology of UHMWPE 
particles is also apparent from many studies, small particles range from granular and round 
shaped to larger particles in the form of platelets, shards and fibrils (Ingham and Fisher, 2000; 
Suner et al., 2012).  
1.5.4.1.2 Biological response to UHMWPE wear particles in vitro 
A considerable amount of literature has been published on in vitro studies of UHMWPE wear 
debris. Shanbhag et al. (1995) investigated the difference in human monocyte response to 
commercially obtained and retrieved UHMWPE particles and demonstrated that cytokines 
IL-1α, IL-1β and IL-6 cytokines were produced at significantly higher levels for commercially 
obtained particles compared to retrieved UHMWPE particles. This study showed that the 
human monocytes responded differently in terms of cytokine release to the different grades 
of polyethylene (Shanbhag et al., 1995). Despite the lack of clinical relevance when using 
commercial particles, important knowledge can still be extrapolated. For example, a study by 
Green et al. (1998) tested the inflammatory response to low molecular weight polyethylene 
(ceridust, GUR416) within different size ranges using primary murine macrophages and 
human peripheral blood mononuclear phagocytes. The critical size range for biological 
activity in terms of cytokine release was reported to be between 0.2 and 0.8 µm.    
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In addition to using clinically relevant wear particles, previous studies have used model cell 
lines such as murine cells that respond differently to human cells (Glant and Jacobs, 1994; 
Algan et al., 1996; Horowitz and Gonzales, 1997). Glant and Jacobs. (1994) distinguished 
that even macrophages from different cell populations may have various responses to the 
same micro-environmental signal. Matthews et al. (2000) reported that different cell types i.e. 
human, nonhuman, transformed and primary, vary in their ability to distinguish the distinct 
morphological characteristics of wear particles. This statement was made due to the fact that 
the size of the most reactive particles for primary human macrophages was different when 
compared to murine macrophages (Matthews, Besong, et al., 2000). Another study by 
Matthews et al. (2000) using human primary peripheral blood mononuclear cells revealed a 
great deal of variation in the level of cytokines produced in response to the UHMWPE 
particles between individuals. One donor consistently produced a response that was between 
2 and 15-fold lower compared to the other five donors. This study demonstrated that the 
heterogeneity of humans can result in a variation in the reactivity of different individuals to 
particle stimulation for the first time. The observed variation in the reactivity of different 
human individuals to particle stimulation may have highlighted another major contributory 
factor in determining implant failure (Matthews, Green, et al., 2000). There has been much 
interest in the role that cytokine gene polymorphisms play in various diseases such as 
rheumatoid arthritis. Evidence is now emerging that the severity of a disease such as 
rheumatoid arthritis is determined by the genetic capacity of an individual to express genetic 
factors that activate or deactivate immunological processes. These factors will most definitely 
have implications for clinical implantation and may also be a major element in determining 
the life of an implant in vivo (Wilkinson et al., 2003; Kotake and Kamatani, 2005; Pawlik et 
al., 2005; Paradowska and Lacki, 2006; Correia et al., 2007; Xu et al., 2014).    
Furthermore, the low-density of polyethylene wear particles presents difficulties where it is 
inherently difficult to manipulate in in vitro studies as it is less dense than culture medium 
and invariably floats on the medium surface preventing interaction with cultured monolayers 
of macrophages. Many studies have conducted experiments where no physical interaction 
existed between the cells and the polymer particles as they were not in the same plane. 
However, solutions to overcome this problem have been employed by many researchers, for 
example, cells have been cultured on the underside of culture well inserts and inverted over 
floating particles to allow interaction between the particles and cells (Horowitz and Gonzales, 
1997). This method termed as the ‘inversion technique’ (Figure 1.6) has since been adapted by 
many studies (Matthews, Besong, et al., 2000; Matthews, Green, et al., 2000b). Other studies 
have utilised agarose gel (Green et al., 1998; Green et al., 2000) or collagen coated coverslips 
(Voronov et al., 1998) as an alternative for the immobilisation of particles to expose to cells.  
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The employment of these methods allowed a more accurate evaluation of the response to 
polyethylene wear debris in vitro.  The size and dose of clinically relevant UHMWPE wear 
particles has been reported by Green et al. (2000) as being critically important in determining 
the biological response of macrophages in vitro. It was found that particles of size 0.24 µm of 
volumetric concentration 10µm3 debris per cell was required for stimulation of release of pro-
inflammatory cytokines TNF-α, IL-1β and IL-6 and the mediator of inflammation PGE2, 
whereas a volumetric concentration of 100µm3 debris per cell of size 0.45 and 1.7µm were 
required to stimulate macrophages to release these cytokines and mediators. The largest 
particles (88µm) were found not to activate the cells at any volumetric concentrations. Other 
studies using murine and human macrophages also confirmed that the most biologically active 
size range was sub-micrometre particles (0.1-1.0 µm) (Green et al., 1998; Matthews, Green, 
et al., 2000a; Green et al., 2000).  
The introduction of crosslinking of UHMWPE has been employed to improve the wear 
characteristics resulting in a highly cross-linked polyethylene (HXPE). Even though the 
crosslinking resulted in a reduction of volumetric wear of between 73 - 87%, HXPE generated 
a higher proportion of wear debris in the size range of 0.1 - 0.5µm (88%) compared with 
conventional UHMWPE (68%) (Rajpura et al., 2014). Ingram et al. (2004) reported that just 
0.1µm3 of HXPE wear particles per cell was needed to significantly increase the levels of 
TNF-α release whereas 10µm3 of conventional UHMWPE wear particles per cell was needed 
to stimulate macrophages to produce elevated levels of cytokines in vitro, indicating the 
increased biological activity of HXPE wear particles (Ingram et al., 2004). This study was in 
agreement with Illgen et al. (2009), who reported HXPE was significantly more inflammatory 
than conventional UHMWPE in vitro and in vivo with regards to elevated levels of TNF-α 
and vascular endothelial growth factor (Illgen  II et al., 2008; Illgen  II et al., 2009). This 
increased inflammatory response was attributed to the generation of more wear particles in 
the nanometre range as a result of crosslinking. Richards et al. (2008) isolated wear particles 
in the nanometre size range from tissues retrieved from hip replacements which confirmed 
the presence of nanometre sized wear particles retained in periprosthetic tissue. It has been 
previously suggested that wear particles in the nanometre range have the potential to 
disseminate throughout the body via the lymphatic system and end up in lymph nodes and 
distal organs (Urban et al., 2000; Richards et al., 2008).  
A study by Liu et al. 2015 showed that nanometre particles have the potential to provoke 
inflammatory cytokine release from macrophage activation. UHMWPE particles in the 40nm 
size range were reported to show a higher inflammatory response in terms of cytokine release 
than micrometre-sized UHMWPE wear particles. The mechanism by which the nanometre 
wear particles were taken up by and activated the macrophages was believed to be by non-
active processes such as pinocytosis. The authors investigated the cellular uptake of 
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UHMWPE wear particles and found that pinocytosis via the clathrin- and caveolae-mediated 
endocytosis pathways were responsible for the uptake of both nanometre-sized and 
micrometre-sized UHMWPE wear particles. Furthermore, it was reported that these cellular 
uptake mechanisms are affected by particle size and morphology, as it was observed that only 
one of the pinocytosis pathways, clathrin-mediated endocytosis was involved in the cellular 
uptake of 40nm UHMWPE manufactured by FluoSpheres. These 40nm particles had a more 
regular morphology and narrow size distribution which may have contributed to the different 
cellular uptake mechanism (Liu et al., 2015).   
While the particle size and volumetric concentration of wear particles are critical factors in 
determining the biological reaction, the shape/morphology and composition of wear particles 
are just as important as indicated in a study by Fang et al. (2006). These authors investigated 
the ability of macrophages to engulf wear particles of different shapes (phagocytic capacity) 
and found that elongated particles had a smaller phagocytic capacity than spherical particles 
of the same volume (Fang et al., 2006).  Other studies by Yang et al. (2002) and Ren et al. 
(2003) demonstrated that elongated UHMWPE particles were more inflammatory than 
globular/round UHMWPE particles. This was characterised by a more severe local 
inflammatory response in terms of over-expression of IL-1β and TNF-α and macrophage 
infiltration.  Hence, these studies showed that the shape of wear debris from failed THRs 
influences the severity of the biological response where elongated fibrils could provoke a 
more adverse inflammatory reaction (Yang et al., 2002; Ren et al., 2003).   
 
Figure 1.6: Diagrams showing the inversion technique that is used for co-culturing polyethylene 
particles with cells. 
 
 Wear particles generated from metal-on-metal hips 
MoP has been the most common choice bearing combination for THRs since the early 1960’s 
(Knight et al., 2011). However, problems with osteolysis induced by polyethylene wear 
particles led to increased interest in and development of low wearing alternative bearing 
materials such as metal-on-metal and ceramic-on-ceramic THRs. MoM bearings 
demonstrated lower wear rates compared to MoP bearings, however the release of nano-scale 
wear particles and metal ions was of great concern in terms of biological response.   
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1.5.4.2.1 Biological response to metal wear particles in vivo 
The release of large numbers of nano-scale wear particles and metal ions is of great biological 
concern to clinicians in the long term. Doorn et al. (1998) used an enzymatic tissue digestion 
method to isolate metal wear particles from periprosthetic tissues followed by characterisation 
using TEM. The tissues were obtained from 13 patients undergoing revision of cobalt-
chromium-molybdenum (CoCrMo) THR implants. The study revealed metal wear particles 
in the size range of 51-116nm, with a mean size of 81nm, which was substantially smaller 
than the UHMWPE particles. The shapes of the particles were mostly round or oval-like with 
some shard/needle-like particles, and remarkably there was very little difference in the shape 
and size of the particles between different patients. Using volumetric wear data from previous 
studies, Doorn et al. (1998) estimated that between 6.7 x 1012 to 2.5 x 1014 metal particles 
were produced per year in three of the patients. This was stated as being 13 to 500 times more 
than the 5 x 1011 UHMWPE wear particles generated from MoP hips (Doorn et al., 1998a). 
An in vitro study by Firkins et al. (2001), of metal wear particles generated from MoM hip 
prostheses in a physiological hip simulator was in agreement with the annual estimation of 
wear particle generation reported by Doorn et al. (1998). Firkins et al. (2001) reported that an 
average number of between 1013 and 1014 wear particles would be generated per year based 
on estimates of wear in the hip simulator (Firkins et al., 2001a). The size and shape of the 
particles were also consistent with the findings of Doorn et all. (1998) i.e. the particles 
generated in the hip simulator were round/oval and of uniform shape with sizes in the range 
of 25-36nm. These studies therefore provide evidence that wear particles generated from 
MoM hips are consistently in the nanometre size range and uniform in size and shape.  
There are concerns over the possible distribution of these small particles in the body, and their 
biological effects on cells and tissues. Metal particles have been shown to disseminate 
throughout the body and have been found in the lymph nodes, liver, spleen and bone marrow 
(Case et al., 1994; Urban et al., 2000). The release of metal wear particles and metal ions from 
MoM hips can thus have potential local and systemic effects in the body. Potential local 
effects may include the deposition of metal particles which can lead to metallosis which has 
been reported by many retrievel studies of revision THR (Chang et al., 2005). Metallosis is 
defined as the infiltration of metallic wear debris into periprosthetic hard and soft tissues, and 
its occurrence has been reported as frequently causing osteolysis (Korovessis et al., 2006). In 
addition to metallosis, the the production of cytokine and osteolytic mediators by 
macrophages in response to metallic wear debris can lead to periprosthetic osteolysis and 
aseptic loosening (Campbell et al., 2004). Campbell et al. (2002) reported that MoM hips had 
similar cytokine profiles to MoP hips, in terms of IL1β, IL-6 and PDGF-α release, 
demonstrating that CoCr particles can induce cytokine production that can result in osteolysis, 
despite the small size of the metal wear particles. However, only low levels of TNF-α were 
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observed, which may explain the lower incidence of osteolysis assoaciated with MoM 
implants compared with MoP implants (Campbell et al., 2002). Overall, in comparison to 
MoP hip implants, significant amounts of literature state that MoM implants demonsrate a 
lower incidence of osteolysis (Long, 2005). Despite the low incidence of osteolysis, MoM 
implants have been reported to be assoaciated with pseudotumours, described as soft tissue 
masses that can lead to devestating short term implant faliures. The cause of these reactions 
is highly controversial, however some studies have associated pseudotumours with excessive 
wear and/or metal hypersensitivity (Haddad et al., 2011; Catelas, 2011).  Mahendra et al. 
(2009) reported the presence of macrophages and lymphocytes in the periprosthetic tissues 
(pseudocapsule and psuedomembrane) of revised MoM implants, which was indicative of an 
inflammatory reaction to the metal wear debris. Tissue necrosis and psuedotumors were 
observed in the periprosthetic tissues of all 28 cases studied, the pathogenisis of which was 
mainly associated with both a cytotoxic and delayed hypersensitivty response to the metal 
wear debris (Mahendra et al., 2009). Campbell et al. (2010) reported that pseudotumours can 
also occur around implants with low wear, suggesting hypersensitivty as the underlying cause 
which was the case for some patients (Campbell et al., 2010).   
The release of metal ions and metal particles from MoM bearings can act as antigens and 
stimulate allergic reactions causing hypersensitivity. Hypersensitivity is defined as an 
overreation of the specific immune system to an allergen and can be mediated by either 
antibodies (type I, II, III) or cells (type IV/delayed type hypersensitivity) (Brown et al., 2006). 
Metals and metal ions elicit type IV hypersensitivity which is mediated by class II restricited 
CD4 positive T-lymphocytes, reactive against metal-ion specific major histocompatibility 
complexes (MHC) which are presented on antigen presenting cells (APCs) (Jacobs et al., 
2008). A study by Howie et al. (1993) reported the presence of lymphocytes associated with 
metal wear particles in tissues around failed MoM hip implants, suggesting a substantially 
different immune response than the histocytic response observed with UHMWPE wear debris 
(Howie, 1993). The lymphocytic response to metal wear debris is well documented, and has 
been linked to metal hypersensitivity reactions in patients with MoM bearings as suggested 
by increased Co and Cr ions levels in patient serum (Kwon et al., 2010).  
1.5.4.2.2 Biological response to metal wear particles in vitro 
Previous studies have established that wear particles generated from MoM implants are in the 
nanometre size range (Doorn et al., 1998a; Firkins et al., 2001b; Brown et al., 2007). It is 
important to take into consideration the relevance of in vitro studies on metal wear particles, 
as only those studies that use metal wear particles in the nanometre size range are relevant. 
Brown et al. (2006) used clinically relevant endotoxin-free CoCr wear particles to investigate 
the response of human peripheral blood mononuclear cells in terms of TNF-α production in 
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vitro. TNF-α production was observed when the cells were stimulated with doses of 50µm3 
per cell of CoCr wear particles. As well as cytokine release, high concentrations of CoCr 
particles were found to be cytotoxic to the cells. Brown et al. (2006) suggested that the metal 
wear particles may have become aggregated, forming larger particles. These larger particles 
may have then been phagocytosed by macrophages, resulting in activation of the macrophages 
and release of cytokines (TNF-α).   
The cytotoxic effects of clinically relevant CoCr nanoparticles and ions on macrophages were 
investigated by Kwon et al. (2009). The authors reported that only cobalt ions at high 
concentrations were cytotoxic to macrophages suggesting the possible consequences that 
could occur from high levels of metal wear particles in vivo. Cobalt ions have been extensively 
studied in vitro where they have been shown to reduce cell viability at low concentrations 
(Ingham and Fisher, 2000; Kwon et al., 2009). A more recent study by VanOs et al. (2014) 
investigated the effects of chromium oxide particles on macrophages in vitro. They found an 
increase in necrosis and decrease in cell viability with high concentrations of chromium oxide. 
These authors also reported no significant increase in TNF-α cytokine release in response to 
the chromium oxide particles, when compared to the cell only control. Overall this study 
concluded that chromium oxide presents low cytotoxic effects on macrophages and these 
particles may not be the main contributor to the inflammatory reaction around MoM implants 
(VanOs et al., 2014). Another study by Behl et al. (2013) investigated the biological effects 
of clinically relevant CoCr nanoparticles and ions on dural fibroblasts and dural epithelial 
cells. It was reported that specific concentrations of CoCr particles (6.05, 60.5, 121µm3 per 
cell) and ions (121µm3 per cell) significantly reduced the viability of epithelial cells, whereas 
no effect on the cell viability of fibroblasts was observed. In terms of cytokine release, both 
cell types released IL-8 in response to particle concentrations of 60.5µm3 per cell (epithelial 
cells) and 121µm3 per cell (epithelial and fibroblast cells). In addition to cell viability and 
cytokine release, oxidative stress was also assessed and observed at a concentration of 50 
µm3/cell for both cell types at 24 hours. This study indicated that different cell types showed 
different responses to CoCr nanoparticles and ions (Behl et al., 2013). 
Genotoxicity is also another phenomenon that is cause for concern regarding CoCr wear 
particles (Brown et al., 2006; Suner et al., 2012). Numerous studies have investigated 
chromosome aberrations in patients with MoM implants. Ladon et al. (2004) observed an 
increase in chromosomal aberrations and aneuploidy in the peripheral blood of patients after 
2 years of MoM implantation (Ladon et al., 2004). The cause for these changes is not known, 
but it was suggested that it may have been due to exposure to metal wear particles (Doherty 
et al., 2001). A more recent in vitro study by Tsaousi et al. (2010) demonstrated high numbers 
of chromosomal aberrations and variation of lesions in primary human fibroblasts induced by 
CoCr wear particles. It was suggested that the in vitro genotoxicity of CoCr particles is a 
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chemically induced effect rather than a particle effect whereby after phagocytosis the build-
up of Cr ions at the surface of particles may induce genotoxic effects (Tsaousi et al., 2010).  
 Wear particles generated from ceramic-on-ceramic hips 
CoC hip implants have now been in clinical use for more than 40 years, however they are not 
as commonly used as MoM or MoP hip implants, hence there are a limited number of studies 
available on the biological response to ceramic wear debris. Even so, studies that have been 
conducted, have shown that out of the three main types of bearing combinations (MoP, MoM 
and CoC), CoC bearings have the best tribological performance, produced the lowest wear, 
and generated wear particles with the lowest biological reactivity (Fisher et al., 2006).  
1.5.4.3.1 Biological response to ceramic wear particles in vivo 
Early retrieval studies of alumina CoC hip replacements reported no difference in terms of 
the tissue reaction around the implant compared with tissues from failed MoP implants. Both 
groups of tissues had an intense macrophage reaction. However, it was concluded that the 
tissue reaction in the CoC implant was due to the abundant zirconia particles from the cement, 
which represented 76% of the debris present, rather than the alumina particles which 
represented only 12% of the wear debris present (Lerouge et al., 1997).  A more recent study 
by Esposito et al. (2013) analysed pseudocapsules retrieved from revision surgeries of 
alumina-on-alumina hip replacements and found that none of the patients developed evidence 
of osteolysis. None of the patients showed severe local tissue reactions characteristic of MoM 
implants or severe foreign body reaction characteristic of MoP implants. They instead found 
a rather moderate infiltration of mononuclear macrophages and occasional lymphocytes 
which are typical features of a response to foreign material. However it should be noted that 
the initial reasons for revision were not osteolysis (Esposito et al., 2013). In contrast, Nam et 
al. (2007) reported a case report of a 63-year-old female patient, that had revision surgery due 
to osteolytic lesions identified during follow-up radiographs. Histological analysis of these 
osteolytic lesions showed the presence of abundant ceramic wear particles (≤5 µm) and 
macrophage and lymphocyte infiltrates. This study demonstrated that if alumina wear 
particles were in the critical size (<5 µm), shape and volume (100 µm3 per cell), they can 
induce biological responses similar to those induced by UHMWPE wear particles. However, 
it should be noted that this was an isolated case where extensive volumes of wear particles 
were generated due to grain pull-out (Nam et al., 2007). Osteolysis in association with CoC 
bearings has rarely been reported, and is generally limited to isolated cases of excessive wear 
(Shishido et al., 2006; Nam et al., 2007).  
Hatton et al. (2002) analysed tissues retrieved from around CoC bearings compared with 
tissues retrieved from around MoP bearings at revision surgery. All the CoC tissues showed 
the presence of wear particles either as agglomerates or in distinct channels in the tissues. The 
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CoC tissues showed mixed pathology and were relatively rich in macrophages as well as over 
half of the tissues showing necrosis/necrobiosis. On the other hand, the MoP tissues showed 
a granulomatous cellular reaction infiltrated with a dense population of macrophages and 
giant cells and less than 30% of tissues demonstrated necrosis/necrobiosis. Interestingly, the 
CoC tissues also showed the presence of neutrophils and lymphocytes. The mixed pathology 
observed in the CoC tissues was suggested as being attributed to the bimodal size ranges of 
the wear particles. The larger particles may have been phagocytosed by macrophages 
resulting in cytokine release and further recruitment of macrophages. The smaller particles 
may have contributed to the necrosis/necrobiosis via the release of ions that may be toxic to 
cells. However, other reasons suggested as being the possible causes of necrosis/necrobiosis 
included fretting wear of the stem, or even physical damage to the surrounding tissues as a 
result of micro-motion (Hatton et al., 2002).  
1.5.4.3.2 CoC wear particles in vitro 
There have been few studies of the biological effects of ceramic wear debris in comparison 
to other bearing materials. However, of the studies that are available, very few researchers 
use clinically relevant wear particles, and so their studies are not representative of what may 
occur in vivo. Endotoxin-free particles are not as much as an issue with wear particles 
generated from hard-on-hard bearings such as MoM and CoC as it is with UHMWPE wear 
particles due to the fact that ceramic and metal wear particles can be heat treated to remove 
the endotoxins. The low melting point (130-136oC) of UHMWPE wear particles prevents the 
use of heat to destroy endotoxins; instead many studies used gamma irradiation (Premnath et 
al., 1996; Besong et al., 1998). More recently however, many studies have resorted to 
generating clinically relevant wear particles in a sterile environment such as Class I laminar 
flow cabinet using an aseptic technique throughout. All the components of the wear test rigs 
are sterilised by either exposure to UV light or dry heat sterilisation. This innovative technique 
ensures minimal contamination by endotoxin giving more accurate results in terms of 
biological response to wear debris (Ingram et al., 2004; Liu et al., 2015).   
The use of commercially-obtained ceramic wear particles is a very common practice in 
previous studies. For example, a study by Catelas et al. 1998 used commercially obtained 
alumina and zirconia particles in the phagocytosable range; 0.6-4.5µm and 0.6 µm, 
respectively. These authors found that the cell viability decreased with increased alumina 
particle size and concentration in that a higher concentration of smaller particles (1.3µm) 
compared to larger particles (2.4µm) was required to induce cytotoxic effects. This pattern 
was also observed for the release of TNF-α from macrophages. Another similar study by 
Catelas et al. (1999) investigated the ability of alumina ceramic particles to induce apoptic 
cell death. This study showed that ceramic particles induced DNA fragmentation into 
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oligonuclesomes, which is a characteristic of apoptosis. However, it was hypothesised that 
the programmed cell death in response to the ceramic particles may explain the lower levels 
of TNF-α released from the macrophages in response to alumina particles. This observation 
may explain the low incidence of osteolysis observed in CoC bearings (Petit et al., 2002).  
Different biological effects between alumina and zirconia particles have also been reported. 
Nkamgueu et al. (2000) observed a higher cytotoxicity associated with alumina particles 
(10%) compared to zirconia particles (8%). The zirconia and alumina particles affected the 
intracellular electrolyte concentration, where sodium concentration increased and potassium 
content decreased, thus resulting in increased cell mortality. Changes in cellular ionic 
concentration reduced phagocytic activity and oxidative metabolism, thus resulting in reduced 
production of hydrogen peroxide. These effects were attributed to the wear particles inhibiting 
or altering the oxidative metabolism mechanism within cells  (Nkamgueu et al., 2000a). All 
these results from the previous mentioned studies give vital information about the response 
of cells to wear particles in vitro, however it should be taken into account that certain aspects 
of these types of studies are not accurately representative of the in vivo scenario. 
The differences between biological activity of ceramic wear particles compared to UHMWPE 
wear particles has been reported in many studies. Savarino et al. (2009) compared the 
biological activity of alumina ceramic wear particles with polyethylene wear particles that 
were both clinically relevant as they were extracted from tissue sections obtained from 
revision THA. These authors reported a higher release of PGE2 for the polyethylene (150-160 
ng.ml-1) compared to ceramic (40-65 ng/mL) wear particles. PGE2 is an inflammatory 
mediator which functions in the recruitment and differentiation of macrophages and pre-
osteoclast cells (Savarino et al., 2009).  Granchi et al. (2004) also highlighted the differences 
between alumina ceramic and polyethylene wear particle in terms of the wear particles effects 
on osteoblast-osteoclast interaction. These authors reported that the alumina particles were 
less inductive of osteoclastogenesis compared to polyethylene wear particles. The 
polyethylene wear particles increased the release of RANKL, whilst simultaneously 
decreasing the release of OPG, which as mentioned earlier is an inhibitor of 
osteoclastogenesis. This study demonstrated that alumina ceramic wear particles were less 
active in promoting osteoclast formation (Granchi et al., 2004). Other studies have compared 
the biological activity of alumina ceramic wear particles with CoCr wear particles that are 
generated from MoM hip bearings. Tsaousi et al. (2010) reported that alumina ceramic wear 
particles were weakly genotoxic to human cells in vitro when compared with metal CoCr 
wear particles, because the CoCr wear particles caused a greater number of and variation of 
chromosomal aberrations and lesions (Tsaousi et al., 2010).  
The lack of relevant studies is hypothesised to be due to the difficulties in generating high 
volumes of clinically relevant ceramic wear particles in vitro. The recent introduction of 
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microseparation during hip simulation of CoC bearings has allowed the generation of 
clinically relevant wear rates, wear patterns and wear particles in vitro (Tipper et al., 2002a). 
Very few studies have used this technique to generate and investigate the biological effects 
of ceramic wear particles in vitro. A study by Hatton et al. (2003) investigated the effects of 
clinically relevant alumina ceramic wear particles on human peripheral blood mononuclear 
cells (PBMNCs) in vitro. The alumina ceramic wear particles were generated using a hip 
simulator under microseparation conditions. The clinically-relevant alumina ceramic wear 
particles showed a bimodal size distribution with nanometre sized (5-20 nm) particles and 
larger particles (0.2 - >10 µm). The results were compared with commercially-obtained 
alumina powder which had a uniform morphology and average particle size of 0.5 µm. The 
effects of the particles were measured in terms of TNF-α production by PBMNCs. Higher 
volumes (500µm3 per cell) of the clinically-relevant wear particles were required to stimulate 
the PBMNCs than the alumina powder (100µm3 per cell). The authors suggested that this may 
be due to the clinically relevant wear particles having fewer particles in the critical size range 
(0.1-1µm) for macrophage activation compared to the alumina powder which had 
considerably larger particles. This study therefore demonstrated that clinically relevant 
ceramic wear particles can stimulate the release of osteolytic cytokines by macrophages. 
However, extremely large volumes are required to initiate this response, which is very 
unlikely to occur in vivo, even under microseparation, due to the superior low wear rates 
(<1.74mm3 per million cycles) of alumina CoC bearings (Tipper et al., 2002a). A similar study 
by Germain et al. (2003) compared the effects of clinically-relevant alumina ceramic and 
CoCr wear particles on the viability of U937 histiocytes and L929 fibroblasts in vitro. The 
clinically-relevant alumina ceramic wear particles were generated in a hip simulator under 
microseparation conditions and the CoCr wear particles were generated using a pin-on-plate 
tribometer. The cytotoxicity of the clinically-relevant alumina wear particles was compared 
with commercially-obtained CoCr and alumina powder. It was found that the clinically-
relevant alumina ceramic wear particles were mildly cytotoxic in only histiocytic cells at a 
concentration of 50µm3 per cell, all other concentrations induced no effect. On the other hand, 
clinically relevant CoCr wear particles were cytotoxic to both histiocytes and fibroblasts, at 
all concentrations (50 and 5 µm3 per cell, respectively). Interestingly the commercial CoCr 
and alumina particles did not affect the viability of either histiocytes and fibroblasts. The 
authors concluded that the composition, size and volume of the wear particles were critical 
factors in determining the biological effects of wear debris on cells in vitro (Germain et al., 
2003a).  
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1.6 Summary 
Overall, the literature review has highlighted the concerns and problems that exist for different 
bearing materials. All bearing combinations have advantages and disadvantages. Some have 
completely fallen out of favour, particularly MoM bearings. It is evident that there is a lack 
of studies that accurately represent the in vivo situation. This may be due to the difficulties of 
methods and technologies available at the time of the studies. However, as methods and 
research technologies develop, the experimental designs should reflect the in vivo and clinical 
situation more accurately. 
Clinically-relevant sterile endotoxin-free UHMWPE wear particles in the critical size range 
and volumetric concentration, when cultured in vitro, activate macrophages to release a range 
of osteolytic cytokines i.e. IL-1 and IL-6, TNF-α and M-CSF.  In vitro studies of both human 
and murine macrophages have shown that wear particles in the size range 0.1-1.0 µm are the 
most biologically active (Green et al., 1998). In addition, these studies have allowed us to 
extrapolate that from all the many cytokines that are released, TNF-α is a key cytokine 
released by wear particle activated macrophages (Matthews, Green, et al., 2000a). MoM 
bearings were considered to be an alternative bearing to MoP bearings, however, implants 
that are malfunctioning can produce high wear rates that can have devastating consequences 
and in some cases, osteolysis. In addition, the release of nanometre sized metal wear particles 
and metal ions are of concern, as they can cause adverse biological reactions as discussed 
earlier (Haddad et al., 2011). Thus, the need for alternative bearing materials, such as ceramic-
on-ceramic hip implants has become more important.   
CoC bearings have demonstrated the best tribological performance compared to other bearing 
materials (Fisher et al., 2006). Wear simulation testing of CoC bearings under edge loading 
conditions has allowed reproduction of wear rates and wear mechanisms similar to those 
observed in vivo (Nevelos et al., 2000a). The wear performance of composite ceramic hip 
replacements has been extensively investigated using standard and severe edge loading 
conditions (Al-Hajjar, Jennings, Begand, et al., 2013). However, no studies have reported the 
characteristics or biological activity of the wear particles generated from composite ZTA CoC 
bearings. Alumina ceramic wear particles have shown to produce a minimal biological 
response, with low cytotoxicity and inflammatory potential at the volumes representative of 
alumina CoC bearings (I Catelas, Petit, Zukor, et al., 1999; Germain et al., 2003a). The 
number of studies carried out for MoP and MoM bearings in terms of assessing 
biocompatibility far exceed those for CoC bearings. However, these studies are largely limited 
to the cytotoxic and inflammatory effects (cytokine release) of wear particles. Other assays 
that measure DNA damage or oxidative stress in response to wear particles are also important, 
especially for ceramic wear particles as they are generally considered to be biocompatible. 
Moreover, these subtle changes such as DNA damage and oxidative stress have been linked 
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to osteolysis, hence it is important to investigate these biological effects, in addition to 
cytotoxicity testing and cytokine release. Cytotoxicity and inflammatory cytokine release has 
predominantly been linked to high volumes of wear particles. However, CoC bearings have 
lower wear rates compared to other bearing materials and the long-term effects of these low 
volumes of ceramic wear particles in terms of genotoxicity and oxidative stress is currently 
unknown.   
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1.7 Project aims and objectives 
1.7.1 Aims 
The aim of this project was to understand the characteristics and conduct a comprehensive 
evaluation of the biological impact of clinically-relevant ceramic wear particles generated 
from composite ZTA BIOLOX® Delta ceramic-on-ceramic total hip replacements. This 
project will generate benchmark data on composite ZTA Delta ceramic bearings, which could 
be used for the evaluation of new biomaterials against this data. In addition, this project will 
provide a more clinically-relevant understanding of the biological impact of the wear particles 
generated from composite ZTA Delta ceramic hip replacements. Thus, clinicians and 
surgeons will have more confidence in this bearing and will be better able to provide a long- 
term prognosis to patients.  
1.7.2 Objectives 
The objectives of the study were as follows: 
• To develop and optimise a novel particle isolation method for the recovery and 
characterisation of very low volumes of composite ZTA ceramic wear particles 
generated under edge loading conditions in hip simulator serum lubricants 
• To generate clinically-relevant ceramic wear particles from alumina (BIOLOX® 
Forte) and composite ZTA (BIOLOX® Delta) CoC hip replacements under severe 
edge loading conditions for subsequent testing of biological impact 
• To investigate the biological impact of composite ZTA Delta ceramic model particles 
and composite ZTA Delta ceramic wear particles generated from ceramic-on-ceramic 
total hip replacements, in terms of cytotoxicity, inflammatory cytokine release, 
genotoxicity and oxidative stress. 
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CHAPTER 2 
 
2 Optimisation and validation of a novel particle 
isolation method for ultra-low volumes of ceramic 
wear debris 
2.1 Introduction 
Excessive wear particles have been linked with the aetiology of periprosthetic osteolysis and 
aseptic loosening. The initial stages of osteolysis involve wear particles which are generated 
at the articulating surfaces, entering the periprosthetic tissue where they are phagocytosed by 
macrophages. The macrophages then initiate the processes of inflammation by releasing pro-
inflammatory cytokines and other mediators of inflammation that stimulate osteoclastic bone 
resorption, leading to osteolysis and inevitable loosening of the hip implant (Ingham and 
Fisher, 2000; Ingham and Fisher, 2005; Brown et al., 2006; Purdue et al., 2006; Sukur et al., 
2016; Kandahari et al., 2016). The relative features of prosthetic wear particles in terms of 
their size and shape determines the severity of the biological response. It is well established 
that polyethylene wear particles within the critical size range (0.2–0.8µm) cause macrophage 
activation (Green et al., 1998). In addition to particle size, the volume of particles has also 
been reported as being critically important in determining the biological response (Isabelle 
Catelas et al., 1999; Ingham and Fisher, 2000; Matthews, Besong, et al., 2000). The 
characteristics data of wear particles in conjunction with the wear rates of different types of 
bearing couples has previously been used to predict the functional biological activity of wear 
debris generated from THRs (Fisher et al., 2001; Tipper et al., 2003). Hence, understanding 
wear particle characteristics and their biological activity is an essential step in the pre-clinical 
testing of joint replacements (Ingham and Fisher, 2000). Currently, the best technique to 
obtain the characteristics of prosthetic wear particles is to isolate the particles from tissues or 
simulator lubricants, and analyse the characteristics of the recovered particles using SEM 
(Galvin et al., 2007; Brown et al., 2006). Whilst this has been successful for polyethylene and 
metal wear debris from MoP and MoM, respectively, the isolation of ceramic wear particles 
from CoC bearings has been very challenging. Hence, there is currently a lack of clinically-
relevant studies on the characteristics and biological activity of ceramic wear particles.   
The wear performance of the composite CoC total hip replacements such as those using 
BIOLOX® Delta (CeramTec, Germany), has been extensively investigated (Stewart et al., 
2003a; Al-Hajjar, Jennings, Begand, et al., 2013b; Al-Hajjar, Fisher, Tipper, et al., 2013a; 
O’Dwyer Lancaster-Jones et al., 2017), however no studies have reported the characteristics 
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of the wear debris generated from these bearings. The lack of clinically-relevant studies may 
be due to difficulties in generating high volumes of clinically-relevant ceramic wear debris in 
vitro. In addition, current particle isolation methods are not sensitive enough to reliably isolate 
the extremely low wear volumes (0.1-1mm3 per million cycles) of composite wear particles 
that are generated in hip simulator lubricants. Current particle isolation methods have many 
limitations including multiple steps, insufficient speeds for nano-particle sedimentation and 
ineffective protein digestion, which all increase particle loss during the process of isolation 
(Doorn et al., 1998b; Catelas, Bobyn, J.B. Medley, et al., 2001; Brown et al., 2007). Such 
particle loss cannot be tolerated for ceramic wear debris due to the inherent low wear rates of 
CoC bearings. A particle isolation method developed by Lal et al. (2016) recently reported 
recovery rates of >80% for ceramic-like particles at very low wear rates in the order of 0.01 
mm3 - 0.1 mm3 per million cycles from serum. These wear rates are comparable with the wear 
rates of composite ceramic bearings, hence this method was optimised and validated for the 
isolation of ZTA ceramic particles generated from composite CoC couples tested in a hip 
simulator under microseparation conditions. The work in the current chapter in relation to the 
other chapters is presented in Figure 2.1.    
 
 
Figure 2.1 – Flow diagram showing the work in this chapter in relation to other chapters, with the 
current chapter highlighted in yellow. 
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2.2 Aims and objectives  
Aims: 
The aim of the study presented in this chapter was to optimise and validate a novel particle 
isolation method for ultra-low wearing ceramic materials. This was subsequently applied to 
hip simulator lubricants for the isolation and characterisation of very low volumes of 
composite ZTA ceramic wear particles generated under edge loading conditions. 
Objectives: 
• To validate the sensitivity and repeatability of the novel particle isolation method in 
terms of particle recovery rates using spiking of serum with composite ZTA ceramic 
model particles. 
• To optimise the method for the isolation of composite ZTA ceramic wear debris from 
hip simulator lubricant serum. 
• To characterise the recovered ceramic wear particles in terms of their size, 
morphology and composition.  
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2.3 Materials and Methods 
2.3.1 Introduction 
The method developed by Lal et al. (2016) was initially validated in terms of sensitivity and 
repeatability to obtain the recovery rates using serum pre-loaded with a known volume of 
ZTA ceramic model particles (0.05-5mm3). Thereafter, the validated method was applied to 
hip simulator serum lubricant, which contained ZTA ceramic wear particles generated from 
BIOLOX® Delta CoC bearings under microseparation conditions. The validated method 
demonstrated insufficient digestion of the hip simulator serum lubricant as considerable 
protein contamination was observed when the recovered particles were analysed using SEM. 
Hence, the method was further optimised and as a result a two-step digestion protocol 
followed by density gradient purification was devised.  
2.3.2 Materials 
2.3.2.1 Ceramic particles 
Commercially-obtained zirconia-toughened alumina (ZTA) powder was used to validate the 
method as it had a similar composition to that of BIOLOX® Delta i.e. ~80% (w/w) alumina 
and ~20% (w/w) zirconia (Table 2.1).  
Table 2.1 - Supplier of the ceramic powder used in this chapter.  
Material name Composition (wt.%) Supplier/Source 
Zirconia toughened alumina 
(ZTA) ceramic powder 
(agglomerated particle size: 
20-150 µm) 
Al2O3 ~80% (w/w) and 
ZrO2 ~20% (w/w) 
Inframat Advanced 
Materials, Connecticut, 
USA 
2.3.2.2 Chemicals and reagents used in this study 
The chemicals and reagents used in this study are listed in Table 2.2.  
Table 2.2 – List of chemicals and reagents used in this study. 
Chemical/Reagent Supplier Storage/Preparation 
Calcium chloride Fisher Scientific, 
Loughborough, UK 
4oC 
Foetal Bovine Serum (FBS) Lonza Biologics, 
Cambridge, UK 
-20oC 
HEPES buffer Melford Laboratories LTD, 
Ipswich, UK 
Room temperature 
Lysozyme Sigma-Aldrich, Irvine, UK -20oC 
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Methanol Atom Scientific LTD, 
Manchester, UK 
Room temperature 
Non-pyrogenic water Baxter, UK Room temperature 
Proteinase K (20 mg per ml) VWR International LTD, 
Poole, UK 
-20oC 
Sodium dodecyl sulphate 
(SDS) 2 % (w/v) and 10% 
(w/v) 
Sigma-Aldrich, Irvine, UK 
Room temperature 
Sodium polytungstate 
solution - 85 % (w/v) 
Sigma-Aldrich, Irvine, UK 
Room temperature 
SurfaSil™ Silconizing 
Fluid 
Thermo Scientific, 
Rockford, USA 
Room temperature 
Tris (trizma base) (50 mM) Sigma-Aldrich, Irvine, UK Room temperature 
2.3.2.3 Equipment  
The equipment used in this chapter are listed in Table 2.3.  
Table 2.3 - List of equipment used in this chapter. 
Materials and Equipment Supplier 
Aluminium stubs, adhesive carbon tabs 
and conductive carbon cement 
Agar scientific, Elektron 
Technology UK Ltd, Essex, UK 
Balance X205 Mettler Toledo Ltd., Beaumont 
Leys, Leicester, UK 
Beckman polypropylene centrifuge 
tubes (331374) SW40 and SW32 
Beckman Coulter Ltd., High 
Wycombe, UK 
Filtration kit Millipore  
Hitachi SU8230 Cold FE SEM Hitachi High-Technologies Europe 
Gmbh, Maidenhead, Berkshire, UK 
Incubator Sanyo Electronic Co. Ltd, China 
Infrared (IR) lamp Goldmark, China 
Lint-free wipes RS Components Ltd, Corby, UK 
Optima L-90K ultra-centrifuge, SW-40 
titanium (Ti) rotor and Ti swinging 
buckets, SW32 Ti rotor and Ti 
swinging buckets.  
Beckman Coulter Ltd., High 
Wycombe, UK 
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Polycarbonate filter membranes 
(0.015µm pore size) 
Whatman, UK  
PSU-10i orbital shaker Grant instruments, Cambridgeshire, 
UK 
Quorum Q15OT carbon coater Quorum Technologies Ltd., East 
Sussex, UK 
Ultra-sonic water bath VWR International Ltd. 
Leicestershire, UK 
X-Max EDX system Oxford Instruments Aztec Energy, 
Oxford, UK 
2.3.2.4 Consumables, plasticware and glassware  
The consumables, plasticware and glassware used in this chapter are listed in Table 2.4.  
Table 2.4 – List of consumables, plasticware and glassware used in this study 
Item Size Supplier 
Bijous 5ml 
Scientific Laboratory 
Supplies, Nottingham, UK 
Falcon tubes 50ml Starstedt Ltd, Leicester, UK 
Glass duran bottles 100ml, 500ml 
Duran Group, Wertheim am 
Main, Germany 
Glass bijous 5ml 
Faculty of Biological 
Sciences, University of 
Leeds, UK 
Serological pipettes 25ml, 10ml, 5ml Starstedt Ltd, Leicester, UK 
Sterile pipette tips 1000µl, 200µl, 20µl, 2µl 
Starlab UK, Milton Keynes, 
UK 
Sterile plastic pots 250ml, 150ml, 60ml 
Thermo Scientific, 
Massachsetts, USA 
Universals 20ml 
Scientific Laboratory 
Supplies, Nottingham, UK 
2.3.3 Validation of sensitivity for the novel particle isolation method 
2.3.3.1 Introduction 
Commercially-obtained ZTA ceramic model particles were used to assess and validate the 
sensitivity of the ceramic wear particle isolation method in terms of recovery rates. Foetal 
bovine serum (25% (v/v)) was spiked with a range of volume concentrations of ZTA particles 
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(5mm3, 1mm3, 0.5mm3, 0.1mm3 and 0.05mm3), which were subsequently digested with 
proteinase K. The digested serum was centrifuged on a sodium polytungstate gradient at 
270,000g. The ZTA ceramic model particles were filtered onto pre-weighed 0.015µm filter 
membranes which were subsequently dried and weighed to obtain the recovery weight of the 
ZTA ceramic model particles. The ZTA particles were characterised in terms of size and 
morphology using SEM, EDX analysis and image analysis software. The ZTA ceramic model 
particles were compared before and after isolation to assess if the digestion caused any 
changes in size distribution and particle morphology.  
2.3.3.2 Characterisation of the particles 
2.3.3.2.1 Calculating particle volumes 
The ZTA particles at a volume of 0.1 mm3 (n=3) were suspended in 10 ml sterile water and 
sonicated for 10 mins to disperse the particles. The following formula was used to calculate 
the weight of ZTA powder required for a specific particle volume: - 
Equation 1 
𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑚𝑎𝑠𝑠
𝑣𝑜𝑙𝑢𝑚𝑒
 
For example, the calculations to work out how many milligrams (mg) of ZTA powder was 
required for a volume of 5mm3 is presented below: - 
1. Rearrange formula to make mass the subject 
𝑚𝑎𝑠𝑠 = 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 × 𝑣𝑜𝑙𝑢𝑚𝑒 
 
2. Input the required volume and density of ZTA (5.0g/cm3 or 0.005g/mm3) 
𝑚𝑎𝑠𝑠 = 0.005 × 5 
3. Mass= 0.025g or 25mg of ZTA powder required for 5mm3  
2.3.3.2.2 Filtration and characterisation using SEM 
The ZTA particle solution was filtered in a class II cabinet through a 0.015µm pore size 
polycarbonate filter membrane using the Millipore filtration kit, before being dried under an 
infrared lamp for at least 1 hour. The filter membrane was mounted on to an aluminium stub 
before coating with carbon to a thickness of 5 nm using the Quorum Q15OT carbon coater. 
The filter membrane was then imaged using the Hitachi SU8230 Cold field emission gun 
scanning electron microscope (CFE-SEM) at 1 kV (beam deceleration mode), mixed signal; 
secondary electrons (SE) and back-scattered electrons (BSE) and at a working distance (WD) 
of 1-3 mm. The use of the Hitachi SU8230 CFE-SEM allowed a resolution of approximately 
1.0nm/15kV (SE resolution). Five random fields of view were imaged for each magnification; 
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5K, 60K, 90K and 150K. Chemical characterisation of the ZTA model ceramic particles was 
carried out by energy dispersive x-ray (EDX) analysis (X-Max EDX system, Oxford, UK) to 
confirm the chemical composition of the particles. The CFE-SEM micrographs of the ZTA 
particles were subsequently analysed using computer software, ImageJ version 1.49, to 
measure the Feret’s diameter (dmax), aspect ratio and circularity of the particles. The Feret’s 
diameter is the longest distance between any 2 points along the particle boundary. A minimum 
of 150 were characterised in accordance with the standard practice for characterisation of 
particles; ASTM F1877-05:2010 and international standard for Wear of implant materials – 
Polymer and metal wear particles – Isolation and characterisation; BS ISO 17853:2011.  
2.3.3.3 Preparation of particle spiked serum lubricants 
A range of volumes of ZTA ceramic model particles (5mm3, 1mm3, 0.5mm3, 0.1mm3 and 
0.05mm3), were directly spiked into 38ml of fresh 25% (v/v) foetal bovine serum (FBS). Each 
sample was prepared in triplicate (n=3) using 38.5ml thin wall polypropylene tubes. The 
weights of the ZTA powder required for different volumes of ZTA particles are shown in 
Table 2.5.  
Table 2.5 – Weights of the ZTA powder required for different volumes of ZTA particles. 
Volume 5mm3 1mm3 0.5mm3 0.1mm3 0.05mm3 
Weight of ZTA 
powder (mg) 
25 5 2.5 0.5 0.25 
 
The lower volumes of ZTA particles (0.1mm3 and 0.05mm3) are representative of the 
clinically relevant wear rates of BIOLOX® Delta CoC hip replacements (0.1-1 mm3/million 
cycles). The serum lubricants spiked with different volumes (0.05-5mm3) of commercially-
obtained ZTA ceramic particles were used to assess and validate the sensitivity and 
repeatability of the novel ceramic wear particle isolation method in terms of recovery rates. 
The control sample contained 25% (v/v) FBS with no ZTA particles added. Each sample was 
sonicated for 10 minutes and incubated at 37oC for 24 hours before being treated according 
to an optimised proteolytic digestion protocol which is illustrated in Figure 2.2 (Lal et al., 
2016). 
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Figure 2.2 – The particle isolation technique described in three main steps; (1) concentration, 
(2) enzymatic digestion and (3) separation. The concentration step involves reducing the sample 
volume by concentration the particulate matter in the serum lubricant. Thereafter the 
concentrated pellet of particles and proteins is digestion using proteolytic enzymes before 
separating the particles from the digested proteins using density-gradient ultra-centrifugation in 
the isolation step (Lal et al., 2016). 
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2.3.3.4 Particle isolation methodology 
All solutions used within this study were filtered using 20 nm Whatman® Anodisc membrane 
filters (GE Whatman, UK) to minimise contamination by external impurities. 
2.3.3.4.1 Pre-treatment of the centrifuge tubes 
All centrifuge tubes were pre-treated with siliconising fluid surfactant using lint free wipes 
and tweezers. Specifically, lint-free wipes were immersed in the surfactant before wiping the 
inside of the tubes. This was done twice before wiping away the excess with a dry lint-free 
wipe. The coating was set by rinsing the tubes with methanol (maximum volume capacity of 
the tube) before finalising the pre-treatment by rinsing the tubes with non-pyrogenic water. 
The purpose of the coating was to prevent adhesion of the ceramic particles to the sides and 
bottom of the tube, hence minimising particles loss. 
2.3.3.4.2 Concentration of particles using centrifugation 
Since CoC bearings exhibit extremely low wear, a centrifugation step (Beckman Optima L-
90K ultra-centrifuge and SW-32 rotor) at 125,755g for 3 hours at 25oC, preceded the 
enzymatic digestion to concentrate the ZTA ceramic model particles and proteins present in 
the 25% (v/v) FBS. The supernatant was carefully removed by aspiration leaving behind a 
volume of 3ml to re-suspend the pellet, which was located at the bottom of the tube. 
Centrifugation speeds and times were calculated based on the Stokes law equations; particle 
sedimentation:  
Equation 2 
 
In Equation 2, ‘g’ is acceleration of gravity, ‘d’ is particle diameter, ‘pp’ is density of particle, 
‘pm’ is density of medium and ‘μ’ is viscosity of medium was used to calculate the terminal 
velocity (Vt), which in turn was used to calculate the time it took the particles to travel the 
length of the centrifuge tube. For instance, during the concentration step, the serum lubricant 
was centrifuged at 125,755g using a Beckman Coulter SW32Ti rotor. Based on the centrifugal 
sedimentation calculations, the time required to cover the distance of 89mm (maximum 
displacement of particles in SW-32 tubes) for 20nm sized particles would be 2 hours and 31 
minutes. However, centrifugation was carried out for 3 hours, which was theoretically 
sufficient to completely sediment all particles >18nm.  
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2.3.3.4.3 Enzymatic digestion 
The concentrated pellet of particles and proteins from the 25% (v/v) FBS spiked with ZTA 
particles was subsequently re-suspended in 500µl of HEPES buffer (working concentration 
0.1M) and digested with 250µl of 20mg.ml-1 proteinase-K (working concentration 1mg.ml-1) 
at 50oC for 18 hours in the presence of 0.5% (w/v) sodium dodecyle sulphate (SDS) and 3mM 
calcium chloride. During incubation, the tubes were shaken at 320 rpm using the PSU-10i 
orbital shaker. After digestion, the particle solution was sonicated for 10 minutes before the 
enzymatic digestion was repeated by the addition of proteinase K (working concentration 
(1mg.ml-1) and the samples were incubated for a further 22 hours at 50oC, whilst being shaken 
at 320 rpm.   
2.3.3.4.4 Separation of proteins from particles 
Sodium polytungstate (SPT) gradients were prepared by sequentially layering 60% (v/v) SPT 
(ρ=2.0 g/cm3), 40% (v/v) SPT (ρ=1.6 g/cm3) and 20% (v/v) SPT (ρ=1.2 g/cm3) in thin wall 
Polypropylene 14ml tubes. After 40 hours of enzymatic digestion, the digest was sonicated 
for 10 minutes before it was dispensed slowly on top of the sodium polytungstate density 
gradient. The tubes were then filled to the top of the tube with sterile water. The samples were 
centrifuged (Beckman Optima L-90K ultra-centrifuge and SW40 rotor) at 202,048g for 4 
hours at 25oC. After centrifugation, the particles were collected at the bottom of the tube in 
the form of a pellet, whilst the proteins fragments and other impurities with lower density 
remained higher up the tube. The supernatant was slowly aspirated and discarded, and the 
pellet of particles was re-suspended in 1ml of sterile water and sonicated for 10 minutes before 
being transferred to clean pre-coated (section 2.3.3.4.1) centrifuge tubes (14ml, Thinwall 
Polypropylene, Beckman, UK). The transfer step was repeated three times to ensure all the 
particles were transferred to the clean tube.  
2.3.3.4.5 Washing of the recovered particles 
The recovered particles were then washed three times in sterile water using Beckman Optima 
L-90K ultra-centrifuge and SW40 rotor at 154,693g for 1 hour at 37oC. Between each wash, 
the supernatant was collected and the particles were re-suspended in sterile water before 
sonication for 10 minutes.  
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2.3.3.5 Gravimetric measurements of the recovered particles 
After washing, the recovered particles were re-suspended in 1ml of sterile water and sonicated 
for 10 minutes before being transferred to pre-weighed sterile glass vials. This transfer step 
was repeated three times to ensure all the particles were transferred to the glass vial. The 
weight of each glass vial was measured three times using the X205 balance (sensitive to 10-5 
grams) ensuring each reading was within 10μg of each other to produce a mean weight of 
each glass vial. The balance was zeroed if necessary, between each repeat. Thereafter the 
glass vial was heat treated for 4 hours at 190oC to remove the water from the particles. The 
glass vial was then weighed gravimetrically to obtain the recovery rate of the ZTA particles 
using the same technique as described above.  
2.3.3.6 Characterisation of the recovered ZTA particles  
The isolated ZTA ceramic model particles were re-suspended in sterile water, filtered onto 
0.015µm filter membranes and analysed using CFE-SEM as described in section 2.3.3.2.2.   
2.3.3.7 Statistical analysis 
Statistical differences in the particles size distributions, aspect ratio values and circularity 
values before and after the isolation process were tested using an Independent Samples T-
Test (SPSS Statistics Version 24, IBM Corp. USA). The tests were carried out on the original 
un-binned data for increased accuracy.  
2.3.4 Application of validated novel particle isolation method to hip simulator serum 
The validated method was subsequently applied to a range of hip simulator serum lubricant 
samples (25% (v/v) foetal calf serum (FCS), supplemented with 0.03% (v/v) sodium azide to 
inhibit bacterial growth) provided by Dr Mazen Al-Hajjar (School of Mechanical 
Engineering, University of Leeds), which was collected from a previous wear test on the 
Leeds MkII hip simulator, which were stored at -20oC. The method was initially applied to 
two serum samples, which were collected at the 3 million cycles (Mc) time point (2-3Mc) and 
contained a reported volume of 0.01mm3 and 0.85mm3, of ceramic wear debris generated 
from 36mm BIOLOX® Delta ceramic-on-ceramic bearings under standard gait or severe 
microseparation conditions, respectively. The severe microseparation condition was similar 
to that as previously described by Nevelos et al. (2000) and Stewart et al. (2001).  
The serum was thawed in a water bath at 37oC and sonicated for 10 minutes before three 
aliquots of 38ml from each sample were subjected to the particle isolation method described 
in section 2.3.3.4. The recovered particles were analysed using CFE-SEM, as described in 
section 2.3.3.2.2.   
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2.3.5 Optimisation of the novel particle isolation method  
Further optimisation of the digestion regime was required to isolate the particles from the 
serum proteins. The incorporation of papain and other enzymes that breakdown the cell wall 
of bacteria e.g. lysozyme was investigated to improve the efficiency of protein removal from 
the wear particles.  
2.3.5.1 Incorporation of papain enzymatic digestion  
The efficacy of the digestion was assessed using serum from 36mm cobalt-chromium metal-
on-metal hip replacements tested under high inclination angle (65o) and microseparation 
conditions. The serum (stored at -18oC) was provided by Dr Mazen Al-Hajjar (School of 
Mechanical Engineering, University of Leeds), which was collected from 2.33 Mc time point 
and contained a reported volume of 4.05mm3 metal wear debris. The rationale for using serum 
with MoM wear debris was because unlike the ceramic wear particles, the black colour of the 
metal wear debris permitted easier visualisation of the wear debris during the isolation 
process.  
The serum was thawed in a water bath at 37oC and sonicated for 10 minutes before three 
aliquots of 38ml were taken and concentrated using the method described in section 2.3.3.4.2. 
Thereafter, the supernatant was discarded and the pellet was digested with papain at a working 
concentration of 0.21mg.ml-1 in 9mM TCEP in MOPS (pH 6.5) at 55oC for 3 hours. This was 
repeated in total for three times, whereby the third addition of papain was followed by 
overnight incubation at 55oC (Brown et al., 2007). The digested particle solutions were 
centrifuged at 125,755g using a Beckman Coulter SW32Ti rotor. Thereafter, the supernatant 
was discarded and the remainder of the particle isolation was performed in the same manner 
as described in section 2.3.3.4.3-2.3.3.4.5. Briefly, the pellet was digested with 20mg.ml-1 
proteinase-K (working concentration 1mg.ml-1) at 50oC for 40 hours in the presence of 0.5% 
(w/v) sodium dodecyle sulphate (SDS) and 3mM calcium chloride. After 40 hours of 
enzymatic digestion, the digest was sonicated for 10 minutes before it was dispensed slowly 
on top of the sodium polytungstate density gradient. The samples were centrifuged (Beckman 
Optima L-90K ultra-centrifuge and SW40 rotor) at 202,048g for 4 hours at 25oC. After 
centrifugation, the particles were collected at the bottom of the tube in the form of a pellet, 
whilst the protein fragments and other impurities with lower density remained higher up the 
tube. The supernatant was slowly aspirated and discarded, and the recovered particles were 
then washed three times in sterile water using Beckman Optima L-90K ultra-centrifuge and 
SW40 rotor at 154,693g for 1 hour at 37oC. Between each wash, the supernatant was collected 
and the particles were re-suspended in sterile water before sonication for 10 minutes. 
Following this, samples were then filtered onto 0.015µm filter membranes and analysed using 
CFE-SEM as detailed in section 2.3.3.2.2.  
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2.3.5.2 Incorporation of lysozyme enzyme 
The efficacy of the digestion was assessed using serum from 36mm CoC BIOLOX® Delta 
bearings tested under severe edge loading conditions that caused dynamic separation due to 
high cup inclination angle (65o) and 4mm translational mismatch in the centres of rotation of 
the femoral head and acetabular cup. The lubricant serum (stored at -18oC) was provided by 
Dr Mazen Al-Hajjar (School of Mechanical Engineering, University of Leeds), which was 
collected from one million cycles of testing on the hip simulator (0-1 Mc), and contained a 
reported volume of 0.98mm3 ceramic wear debris.  
The serum was thawed in a water bath at 37oC and sonicated for 10 minutes before two 
aliquots of 38 ml were taken and concentrated using the method described in section 2.3.3.4.2. 
One aliquot was processed through the standard method described in section 2.3.3.4. 
However, after the enzymatic digestion with proteinase-K, aliquot two was concentrated at 
125,755g for 3 hours at 25oC, the supernatant was discarded and the pellet was digested with 
freshly prepared lysozyme (20mg.ml-1 in 10mM Tris-HCl, pH 8.0) in the presence of STET 
(Saline/Tris/EDTA/Triton) buffer (10 mM Tris-HCl, pH 8.0, with 0.1 M NaCl, 1 mM EDTA, 
and 5% (v/v) Triton X-100) at a working concentration of 10mg.ml-1. Lysozyme hydrolyses 
linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues in 
peptidoglycan and between N-acetyl-D-glucosamine residues in chitodextrin. Gram-positive 
bacteria are more susceptible to this hydrolysis due to the high proportion of peptidoglycan 
in their cell walls. (Osserman, 2012). After incubation, the tube containing the lysis mixture 
was placed in boiling water for exactly 40 seconds. Thereafter both samples were subjected 
to density gradient ultra-centrifugation and washing as described in section 2.3.3.4. Following 
this, the samples were washed with sterile water, filtered onto a 0.015µm filter membrane and 
then analysed using CFE-SEM as detailed in section 2.3.3.2.2.  
2.3.6 Particle isolation from serum lubricants produced from one million cycles of 
hip simulation 
Gaiters made of silicon were used to hold the 25% (v/v) FCS lubricant during wear simulation 
and have a volume capacity of approximately 500ml. The serum lubricant is changed every 
330,000 cycles, as a result approximately 1.5L of serum lubricant is produced for every 
million cycles of simulation. Due to the extremely low volume of ceramic wear debris 
generated from BIOLOX® Delta CoC bearings (0.1-1mm3/million cycles), the entire batch of 
serum from one million cycles was processed using the optimised digestion protocol (2.3.5.2). 
This approach was taken to manipulate the volume of the wear particles by pooling together 
the concentrated pellets obtained from serum concentration steps in order to increase the 
volume of wear debris. The sample of lubricant serum (stored at -18oC) was provided by Dr 
Mazen Al-Hajjar (School of Mechanical Engineering, University of Leeds), which was 
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collected from one million cycles of testing on the hip simulator (0-1 Mc), and contained a 
volume of 1.29mm3 of  BIOLOX® Delta ceramic wear debris. The ceramic wear debris were 
generated from 36mm CoC BIOLOX® delta bearings tested under severe edge loading 
conditions due to by dynamic separation due to high cup inclination angle (65o) and 4mm 
translational mismatch in the centres of rotation of the femoral head and acetabular cup.   
The serum lubricant from one million cycles of hip simulator testing was thawed in a water 
bath at 37oC and sonicated for 10 minutes before aliquots of 38ml were taken and concentrated 
by centrifugation using the method described in section 2.3.3.4.2. This was repeated until all 
(approximately 1.5L) of the serum lubricant had been concentrated. Thereafter the 
concentrated pellets were processed through the standard method described in section 2.3.3.4. 
However, after the enzymatic digestion with proteinase-K, the samples were pooled together 
in six tubes and concentrated at 125,755g for 3 hours at 25oC. The supernatant was discarded 
and the pellets were digested with freshly prepared lysozyme (20mg.ml-1) by the method 
described in section 2.3.5.2. Thereafter, all the samples were subjected to density gradient 
ultra-centrifugation as described in section 2.3.3.4. Following this, the thick band of protein 
along with the rest of the supernatant was removed, before the particles collected at the base 
of the tube were resuspended in water, sonicated for 10 minutes and transferred to clean tubes 
for washing with sterile water as described in section 2.3.3.4.5. During the transfer step, the 
six tubes were pooled into two tubes. During the washing steps a pellet was observed, which 
was filtered onto a 0.015µm filter membrane and then analysed using CFE-SEM as detailed 
in section 2.3.3.2. 
2.3.6.1 Isolation of metal particle contaminants using a magnet 
Due to the presence of stainless-steel wear particle contaminants in the lubricant serum 
containing ceramic wear debris, an attempt was made to remove or minimise the stainless-
steel wear particles using a magnet. The particle suspension from section 2.3.6 was added to 
a clear polypropylene tube, which was placed on top of a powerful magnet (Miltenyi Biotec 
Ltd). The particle suspension was immediately removed using a p1000 Gilson pipette, leaving 
behind the magnetic metal particles. This step was repeated three times whereby a clean clear 
polypropylene tube was used each time. The particle suspension was then filtered onto a 
0.015µm filter membrane and analysed using CFE-SEM as detailed in section 2.3.3.2.  
2.3.7 Particle isolation using two-step digestion and density gradient ultra-
centrifugation 
Particle isolation from the entire volume of lubricant serum produced from one million cycles 
on the hip simulator serum became necessary due to the extremely low volumes of ceramic 
wear debris present in serum lubricant. However, this presented a large protein burden on the 
nano-scale particles, whereby it was hypothesised that the protein adsorption layer, otherwise 
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known as the protein corona that forms on the surface of colloidal nano-scale particles was 
changing their intrinsic density, thus inhibiting particle sedimentation during density gradient 
ultra-centrifugation. For this reason, a two-step digestion protocol followed by density 
gradient purification was devised, which theoretically allowed the sedimentation of the nano-
scale particles with attached proteins during the initial modified density gradient ultra-
centrifugation step.  The density of the SPT layers in the initial density gradient ultra-
centrifugation step were changed in that the density (p=1.1g/cm3) of the bottom layer was less 
than the average density (p=1.22g/cm3) of proteins (Quillin and Matthews, 2000). This would 
theoretically allow the nano-scale particles to pellet with the attached proteins after the initial 
density gradient ultra-centrifugation step. The recovered particles would then be subjected to 
further enzymatic digestion and purification.  
The hip simulator serum lubricant (stored at -18oC) was provided by Oscar O’Dwyer 
Lancaster Jones (School of Mechanical Engineering, University of Leeds), which was 
collected from one million cycle’s (0-1Mc) of testing on the hip simulator and contained a 
volume of 1.58mm3 of ceramic wear debris. The wear debris were generated from 36mm CoC 
BIOLOX® Delta bearings tested under severe edge loading conditions due to by dynamic 
separation due to high cup inclination angle (65o) and 4mm translational mismatch in the 
centres of rotation of the femoral head and acetabular cup.   
The serum lubricant from one million cycles of hip simulator testing was thawed in a water 
bath at 37oC and sonicated for 10 minutes before aliquots of 38 ml were taken and 
concentrated by centrifugation using the method described in section 2.3.3.4.2. This was 
repeated until all the approximately 1.5L of serum was concentrated. Thereafter, the 
concentrated pellets were processed through the standard method described in section 2.3.3.4. 
However, after the 18 hours enzymatic digestion step with proteinase-K, the samples were 
pooled together in six tubes and concentrated at 125,755g for 3 hours at 25oC. The supernatant 
was discarded and the pellets were digested with freshly prepared lysozyme by the same 
method described in section 2.3.5.2. Thereafter, the samples were pooled together in two tubes 
and concentrated at 125,755g for 3 hours at 25oC. The supernatant was discarded and the 
pellets were digested with proteinase K for 22 hours as described in section 2.3.3.4.3. 
Subsequently, the particles were separated from the proteins via density gradient ultra-
centrifugation as described in section 2.3.3.4.4. However, the density of the gradient layers 
was modified in this step whereby sodium polytungstate (SPT) gradients were prepared by 
sequentially layering 45% (v/v) SPT (ρ=1.5 g/cm3), 39% (v/v) SPT (ρ=1.3 g/cm3) and 33% 
(v/v) SPT (ρ=1.1 g/cm3) in thin walled polypropylene 14ml tubes. Following this, the band of 
protein was first carefully aspirated, before discarding the rest of the supernatant. The 
particles collected at the base of the tube were then re-suspended in water, sonicated for 10 
minutes and transferred to clean tubes for washing as described in section 2.3.3.4.5. The 
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isolated particles were only washed once before commencing a further enzymatic digestion 
for 40 hours using proteinase K at a working concentration of 2 mg/ml following the method 
described in section 2.3.3.4.3. An additional dose of proteinase (working concentration of 2 
mg.ml-1) was added after 18 hours. Thereafter, both the samples were subjected to the original 
density gradient ultra-centrifugation as described in section 2.3.3.4.4. Following this, the band 
of separated protein was carefully aspirated, before discarding the rest of the supernatant. The 
particles collected at the base of the tube were re-suspended in water, sonicated for 10 minutes 
and transferred to clean tubes for washing as described in section 2.3.3.4.5. During the 
washing steps, a pellet was observed for both samples, which was filtered onto a 0.015µm 
filter membrane and then analysed in terms of size, composition and morphology using CFE-
SEM as detailed in section 2.3.3.2. EDX analysis was used to identify the elemental 
composition of every particle imaged to ensure that the particles being measured were indeed 
ceramic i.e. particles that showed aluminium (Al) and zirconia (Zr) and/or strontium (Sr) 
peaks were imaged and subsequently measured using Image J software. This technique 
minimised the incorrect measurement of contaminating particles, which may otherwise have 
the same geometry/morphology as ceramic particles and therefore be indistinguishable.  
In order to obtain three replicates, the two-step particle isolation protocol was repeated on two 
more samples of serum lubricants (stored at -18oC) that contained 1.93mm3 and 1.65mm3 of 
ceramic wear debris generated from 36mm CoC BIOLOX® Delta bearings tested under severe 
edge loading conditions due to by dynamic separation due to high cup inclination angle (65o) 
and 4mm translational mismatch in the centres of rotation of the femoral head and acetabular 
cup. The serum lubricant was collected from one million cycle’s testing on the hip simulator 
by Oscar O’Dwyer Lancaster Jones (School of Mechanical Engineering, University of Leeds). 
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2.4 Results 
2.4.1 Validation of sensitivity for the novel particle isolation method  
2.4.1.1 Particle recovery rates for the isolation method using serum spiked with ZTA 
ceramic model particles 
The particle isolation method was validated for sensitivity and repeatability by determining 
the recovery rates of different volumes (0.05-5mm3) of ZTA ceramic model particles which 
had been spiked into 25% (v/v) FBS. The measured weights of the ZTA particles for different 
volumes used in this study are shown in Table 2.6. The variability in the weights was due to 
difficulties in accurately measuring such small weights. The serum spiked with ZTA powder 
was then processed through the novel particle isolation method and the mass of the recovered 
ZTA model particles was measured gravimetrically in order to determine the particle recovery 
rates. The spiked and recovered masses for the different volumes of ZTA particles is shown 
in Figure 2.3. For the control sample, a recovered mass of 0.02 mg was measured. The 
percentage particle recovery rates for the novel method are presented in Figure 2.4. The 
control sample generated an average recovery rate of 0% from the non-spiked 25% (v/v) FBS. 
The high volumes (0.5-5mm3) of ZTA particles had a percentage particle recovery rate 
ranging between 93-96%. The lowest volumes of ZTA particles (0.1 and 0.05 mm3), which 
are representative of the wear rates of CoC bearings, both demonstrated an average percentage 
recovery rate of approximately 89%.  
Table 2.6 – Weights of the ZTA powder for each particle volume. 
 Volume of ZTA particles 
Repeat 5mm3 1mm3 0.5mm3 0.1mm3 0.05mm3 Control 
i 25.18mg 5.24mg 2.50mg 0.54mg 0.28mg 0mg 
ii 25.25mg 5.08mg 2.52mg 0.52mg 0.28mg 0mg 
iii 25.09mg 4.94mg 2.52mg 0.55mg 0.25mg 0mg 
Average 25.17mg 5.09mg 2.51mg 0.54mg 0.27mg 0mg 
±95% CL 0.20 0.37 0.03 0.04 0.04 0.00 
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Figure 2.3- The spiked and recovered masses for the different volumes of ZTA ceramic model particles 
isolated using the novel particle isolation method. Each sample was performed in triplicate (n=3). The 
values are expressed as mean and the error bars represent ± standard deviations.  
 
Figure 2.4- The percentage particle recovery rates of the different volumes of ZTA ceramic model 
particles isolated using the novel particle isolation method. Each sample was performed in triplicate 
(n=3). The values are expressed as mean and the error bars represent ± standard deviations.  
2.4.2 Characterisation of ZTA ceramic model particles before and after isolation  
The characteristics in terms of size and morphology, and the composition of the ZTA particles 
before and after isolation from spiked 25% (v/v) FBS were determined and analysed after 
filtration on 0.015µm filter membrane using CFE-SEM and EDX analysis as described in 
section 2.3.3.2.2. Image analysis software (ImageJ version 1.49) was used to measure the 
Feret diameter (dmax), aspect ratio and circularity of the particles (minimum of 150 particles). 
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CFE-SEM analysis of the ZTA ceramic model particles revealed larger micrometre particles 
that had a polygonal shard-like morphology. The smaller nano-scale particles were round in 
morphology and existed as large agglomerates (Figure 2.5). EDX analysis of the larger 
irregular/shard-like micron and sub-micron sized particles shown in Figure 2.6 were 
comprised of alumina or zirconia as indicated by EDX analysis that showed elemental peaks 
of Al (aluminium), O (oxygen) and Zr (zirconia). The nano-scale particles mainly consisted 
of zirconia as indicated by EDX analysis that showed elemental peaks of Zr (zirconia), Al 
(aluminium) and O (oxygen). Furthermore, a peak of Na (sodium) and W (tungsten) was 
observed due to the sodium polytungstate density gradient medium during the isolation 
process. The carbon (C) peak that can be seen in all EDX spectra was due to the carbon coating 
and polycarbonate membrane. 
The mean feret diameter, mean aspect ratio and mean circularity values (value of 1.0 indicates 
a perfect circle) are shown in Table 2.7. An independent-samples t-test was conducted to 
compare the size distribution (feret diameter) and morphology (aspect ratio and circularity) 
of ZTA ceramic model particles before and after isolation. The morphology of the particles 
was unaffected by the isolation process, as there were no significant differences in the aspect 
ratio and circularity values before and after the isolation process (Table 2.7). Moreover, there 
was no significant difference in size distribution of the ZTA ceramic model particles before 
and after isolation from 25% (v/v) FBS. The frequency as a function of size of the ZTA 
ceramic model particles before and after isolation is presented in Figure 2.7, which revealed 
a bimodal size distribution. Before isolation, the larger micron and submicron size particles 
ranged between 100-9915nm with a mean size of 2655.09 ± 267.27nm, whereas the small 
nano-scale particles ranged between 10-80nm with a mean size of 38.43 ± 1.49nm. After 
isolation, the larger micron and submicron size particles ranged between 100-8834nm with a 
mean size of 2993.88 ± 254.21nm, whereas the small nano-scale particles ranged between 10-
80nm with a mean size of 44.30 ± 1.61nm. The ZTA particles before isolation had a mode 
size distribution of 2000-3000nm for the larger particles and a mode size of 30-40nm for the 
small nano-scale particles, whereas the ZTA particles after isolation had a mode size 
distribution of 1000-2000nm for the larger particles and a mode size of 30-40nm for the small 
nano-scale particles. 
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Figure 2.5 - CFE-SEM images of (A) larger micron size alumina particles and (B) smaller nano-scale 
zirconia/alumina particles before the particle isolation protocol. CFE-SEM images of (C) larger micron 
size alumina particles and (D) smaller nano-scale zirconia/alumina particles after the particle isolation 
protocol. The proteolytic digestion did not affect the size or morphology of the particles. The particles 
were imaged at 5K, 60K, 90K and 150K magnification at a 1-2kV voltage and at a working distance 
of 3mm. 
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Figure 2.6 - EDX analysis of ZTA ceramic model particles (A) before particle isolation and 
corresponding EDX spectrum (B). EDX analysis of ZTA ceramic model particles (C) after particle 
isolation and (D) corresponding EDX spectrum. Pin-point or area selection analysis of the particles 
was performed at a working distance of 15mm, 10 kV and suitable magnification to maintain focus.  
.  
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Figure 2.7 - Comparison of frequency size distribution of the ZTA particles before and after the particle 
isolation protocol. A minimum of 150 particles were measured.  
 
Table 2.7 - Mean size (feret diameter) and morphology (aspect ratio and circularity) values 
for ZTA ceramic model particle before and after isolation. 
 
BEFORE 
ISOLATION; 
Larger particles 
(100 - >5000nm) 
BEFORE 
ISOLATION; 
Smaller particles 
(0 - 100nm)  
AFTER 
ISOLATION; 
Larger particles 
(100 - >5000nm) 
AFTER 
ISOLATION; 
Smaller particles 
(0 - 100nm) 
Feret diameter (nm) 2655.09 ± 267.27  38.43 ± 1.49 2993.88 ± 254.21 44.30 ± 1.61 
Aspect ratio 1.48 ± 0.04 1.34 ± 0.24 1.44 ± 0.36 1.28 ± 0.13 
Circularity  0.80 ± 0.01 0.93 ± 0.01 0.83 ± 0.09 0.92 ± 0.01 
Note: All values expressed as mean ±95% Confidence Interval. 
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2.4.3 Application of validated particle isolation method to hip simulator lubricants  
The validated method was subsequently applied to hip simulator lubricant serum containing 
a reported wear volume of either 0.01mm3 or 0.85mm3 of ceramic wear debris generated from 
36mm BIOLOX® Delta ceramic-on-ceramic bearings under standard gait or severe 
microseparation conditions, respectively. The two serum samples were collected from 2-3 
million cycles time point, from which three aliquots of 38ml was taken from each sample and 
subjected to the particle isolation method described in section 2.3.3.4. CFE-SEM and EDX 
analysis revealed that the recovered wear debris generated under standard gait conditions were 
nano-scale in size, and appeared as large (>5µm) agglomerates (Figure 2.8). EDX analysis 
showed elemental peaks of a range of elements including aluminium (Al), strontium (Sr), 
zirconia (Zr), oxygen (O), sodium (Na), sulphur (S), titanium (Ti), iron (Fe) and tungsten (W). 
The recovered wear debris generated under severe microseparation conditions was not 
adequately separated from the proteins (Figure 2.9), which made it very difficult to identify 
the ceramic wear debris. The proteins appeared as globular-like structures that had irregular 
morphology and covered a large proportion of the filter membrane.  However, EDX analysis 
confirmed the particles within the proteins were indeed ceramic wear debris with elemental 
peaks of aluminium (Al), oxygen (O), zirconia (Zr), and strontium (Sr). Additionally, it was 
extremely difficult to identify the ceramic particles due to the inherently low volumes of 
ceramic wear debris present in the serum. 
 
Figure 2.8 – (A) CFE-SEM image of particles isolated from CoC hip simulator lubricant tested under 
standard gait conditions and (B) corresponding EDX spectrum. The area selection tool was used to 
analyse the composition of the particles at a working distance of 15 mm and 10 kV and suitable 
magnification to maintain focus. 
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Figure 2.9 – (A) CFE-SEM image of particles isolated from CoC hip simulator lubricant tested under 
severe microseparation conditions and (B) corresponding EDX spectrum. The area selection tool was 
used to analyse the composition of the particles at a working distance of 15 mm and 10 kV and suitable 
magnification to maintain focus. 
 
2.4.4 Optimisation of digestion regime for novel particle isolation method  
The application of the particle isolation method developed by Lal et al. 2016 was not 
successful at recovering purified ceramic wear debris from hip simulator serum, which could 
be used for subsequent characterisation. This led to the optimisation of the method where 
numerous alterations were made to the digestion regime, whereby papain and lysozyme was 
incorporated into the digestion, the results of which are documented below.  
2.4.4.1 Incorporation of papain enzyme digestion step 
Papain was incorporated into the digestion regime to address the issue of inefficient 
proteolysis, which was observed in previous experiments (section 2.3.4) where the initial 
digestion method was applied.  Lubricant containing cobalt-chrome wear debris generated 
from metal-on-metal total hip replacements in a hip simulator was used to assess the 
efficiency of the enzymatic digestion. Three aliquots of 38ml were taken and concentrated 
using the method described in section 2.3.3.4.2. The pellet of CoCr wear particles and 
concentrated proteins was initially digested with papain followed by proteinase K. Thereafter 
the remainder of the particle isolation was performed in the same manner as described in 
section 2.3.3.4.3-2.3.3.4.5. Post-density gradient ultra-centrifugation revealed that the metal 
wear debris did not form a pellet at the bottom of the tube, instead the debris formed a band 
at the interface between the bottom two layers of the SPT density gradient (Figure 2.10).  
CFE-SEM analysis of the wear debris recovered from the band of CoCr wear particles located 
between the 2x and 4x SPT layers, revealed that the particles were nano-scale in size and 
round in morphology (Figure 2.11A). However, the CoCr nano-particles were highly 
agglomerated and contaminated with proteins (Figure 2.11B).  
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Figure 2.10 - Formation of a band of CoCr wear debris at the interface between the bottom two layers 
of the SPT density gradient after ultra-centrifugation. The digested serum containing CoCr wear debris 
generated from MoM bearings was centrifuged on a SPT gradient at 40,000 rpm (average RCF 
202,048g) for 4 hours at 25oC.  
 
   
Figure 2.11 - CFE-SEM images of CoCr nano-particles isolated from the band of CoCr wear debris 
separated using density gradient ultra-centrifugation. (A) The CoCr wear particles were nano-scale in 
size and round in morphology. (B) The recovered CoCr nano-particles were heavily contaminated with 
proteins. The particles were imaged at 7-90K magnification at 2kV voltage and at a working distance 
of 2-3mm. 
2.4.4.2 Incorporation of lysozyme enzyme 
Lysozyme enzyme was incorporated into the digestion regime to target the breakdown of 
bacterial proteins, which may have contaminated the serum lubricant during wear simulation 
testing. Lubricant containing ceramic wear debris generated from 36mm CoC BIOLOX® 
Delta bearings tested under severe edge loading conditions due to dynamic separation due to 
high cup inclination angle (65o) and 4mm translational mismatch in the centres of rotation of 
the femoral head and acetabular cup was used to assess the efficiency of the lysozyme 
digestion. Six aliquots of 38ml were taken and concentrated using the method described in 
section 2.3.3.4.2. Three aliquots were processed through the standard method described in 
section 2.3.3.4. However, after the enzymatic digestion with proteinase-K, the other three 
aliquots were digested with freshly prepared lysozyme (section 2.3.5.2). Thereafter both sets 
of samples were subjected to density gradient ultra-centrifugation and washing as described 
in section 2.3.3.4. SEM analysis of the recovered wear particles subjected to this digestion 
revealed that the filter membrane had lower levels of contaminating proteins (Figure 2.12A) 
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compared to the standard method, which had large areas of the filter membrane covered with 
proteins (Figure 2.12B).  
 
Figure 2.12 - CFE-SEM images of BIOLOX® Delta ceramic wear particles (A) standard digestion 
method and (B) standard digestion method with lysozyme digestion. Lower levels of protein 
contamination were observed on the filter membrane that incorporated lysozyme digestion. The 
particles were imaged at 2kV voltage, working distance of 2-3mm and 1-3k magnification.    
2.4.5 Application of optimised method to hip simulator lubricants collected from one 
million cycles (0-1Mc)  
Due to the extremely low volume of ceramic wear debris present in the lubricant serum, the 
entire batch of serum lubricant collected from one million cycles (0-1Mc) was processed 
using the particle isolation method. Three different serum lubricant samples were used that 
were provided by Dr Mazen Al-Hajjar, which were collected from one million cycles (0-1Mc) 
time point and contained a volume of 1.29mm3 BIOLOX® Delta ceramic wear debris. The 
ceramic wear debris were generated from 36mm CoC BIOLOX® Delta bearings tested under 
severe edge loading conditions created by dynamic separation due to high cup inclination 
angle (65o) and 4mm translational mismatch in the centres of rotation of the femoral head and 
acetabular cup.   
All the serum lubricant from one million cycles (0-1Mc) of hip simulator testing was 
concentrated in aliquots of 38ml by centrifugation using the method described in section 
2.3.3.4.2. Thereafter the concentrated pellets were processed through the standard method 
described in section 2.3.3.4, with the additional lysozyme step that preceded density gradient 
ultra-centrifugation. After density gradient ultra-centrifugation, it was clear that the digested 
protein was successfully separated, as a thick band of protein was formed above the third 
layer of the SPT (Figure 2.13). During the washing step, it became visibly apparent that a 
large volume of wear particles was recovered from the hip simulator lubricant (Figure 2.14). 
CFE-SEM analysis of the recovered wear debris revealed large irregular-shaped particles that 
were up to 50µm in size. High magnification revealed these larger particles were comprised 
of smaller nano-particles. EDX analysis revealed these larger particles may be stainless-steel 
as they had a high percentage composition of iron, as confirmed by the Fe (iron) elemental 
peaks in the EDX spectrum (Figure 2.15).  
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Figure 2.13 - Centrifuge tubes containing digested serum lubricant on top of the SPT density gradient 
layers. The arrow is pointing at the separated band of digested protein after density gradient ultra-
centrifugation. The digested proteins containing ceramic wear particles was centrifuged at 202,048g.  
 
 
 
Figure 2.14 - Particles recovered from hip simulator lubricant that was collected from one million 
cycles of testing (0-1Mc). The serum lubricant contained a volume of 1.29mm3 BIOLOX® delta 
ceramic wear debris generated from 36mm BIOLOX® Delta CoC bearings tested under severe edge 
loading conditions due to dynamic separation due to high cup inclination angle (65o) and 4mm 
translational mismatch in the centres of rotation of the femoral head and acetabular cup.  
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Figure 2.15 CFE-SEM analysis of the recovered particles from hip simulator lubricant that was 
collected from one million cycles of testing (0-1Mc). (A) Large irregular shaped particles, (B) Small 
nano-scale particles that constituted the large particles, (C) Image of particles analysed using EDX and 
(D) corresponding EDX spectrum). The particles were imaged at 1kV (deceleration mode) voltage, 
working distance of 2-3mm and 1.5-90k magnification. Area selection EDX analysis of the particles 
was performed at a working distance of 15mm, 10kV and a suitable magnification to maintain focus.  
2.4.5.1 Separation of stainless-steel wear particle contaminants from ceramic wear 
debris 
A magnet was used to attempt to separate the stainless-steel particles from the ceramic 
particles. CFE-SEM analysis of the particles recovered from serum lubricant described in 
section 2.4.5, revealed an abundance of stainless-steel wear particles. These particles were re-
suspended in sterile water and dispensed in a plastic tube that was placed on top of a magnet. 
After the particle solution was aspirated from the plastic transparent tube placed on the 
magnet, it could be clearly seen the magnetic metal particles were left behind (Figure 2.16).  
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Figure 2.16 Magnetic particle isolation technique showing the separation of the magnetic metal 
particles from the ceramic wear debris. (A) Plastic transparent tube placed on the magnet. (B) Inside 
of plastic transparent tube BEFORE dispensing the particle suspension. (C) Inside of plastic transparent 
tube AFTER aspirating the particle suspension.  
 
2.4.5.2 Recovery of large micrometre ceramic wear particles from hip simulator 
lubricants 
After the magnetic particle separation technique, the particle suspension was filtered and 
analysed using CFE-SEM. CFE-SEM analysis revealed a significant reduction in the presence 
of stainless-steel particles, thus allowing the identification of BIOLOX® Delta ceramic wear 
debris in the form of large micrometre ceramic wear particles, that were up to 10 microns in 
size (Figure 2.17). Furthermore, nano-scale ceramic particles were also identified, however 
these we enveloped in protein. EDX analysis of the larger micrometre ceramic wear particles 
showed elemental peaks of aluminium (Al), carbon (C), oxygen (O), copper (Cu) and tungsten 
(W) and EDX analysis of the nanoscale ceramic particles showed elemental peaks of 
aluminium (Al), zirconia (Zr), iron (Fe), oxygen (O), carbon (C), and tungsten (W), thus 
confirming these particles were indeed from BIOLOX® Delta ceramic. The elemental peaks 
of W were contamination from the sodium polytungstate density gradient. 
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Figure 2.17 CFE-SEM and EDX analysis of the recovered ceramic wear debris. The lubricant serum 
contained a volume of 1.29mm3 BIOLOX® Delta ceramic wear debris generated from 36mm BIOLOX® 
Delta CoC bearings tested under severe edge loading conditions due to dynamic separation due to high 
cup inclination angle (65o) and 4mm translational mismatch in the centres of rotation of the femoral 
head and acetabular cup. (A) CFE-SEM of the recovered of large micrometre ceramic particles. (B) 
CFE-SEM of the recovered small nano-scale ceramic particles. (C) EDX image of the large micrometre 
particles and (D) corresponding EDX spectrum. EDX image of the small nano-scale particles and (E) 
corresponding EDX spectrum. Area selection and pin point EDX analysis of the particles was 
performed at a working distance of 15mm, 10kV and a suitable magnification to maintain focus.  
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2.4.6 Recovery of clinically-relevant BIOLOX® Delta ceramic wear debris from hip 
simulator lubricants using two-step particle isolation protocol 
A two-step particle isolation protocol (section 2.3.7) was devised to enable the sedimentation 
of the nano-scale ceramic wear particles. The serum lubricant contained a volume of 1.58mm3 
of ceramic wear debris. The wear debris were generated from 36mm CoC BIOLOX® Delta 
bearings tested under severe edge loading conditions due to dynamic separation due to high 
cup inclination angle (65o) and 4mm translational mismatch in the centres of rotation of the 
femoral head and acetabular cup. The density of the STP layers in the initial density gradient 
ultra-centrifugation step were changed in that the density (p=1.1g/cm3) of the bottom layer 
was less than the average density (p=1.22g/cm3) of proteins, which would theoretically allow 
the nano-scale particles to pellet with the attached proteins after the initial optimised digestion 
regime (section 2.3.5.2) and density gradient ultra-centrifugation step (section 2.3.7). The 
recovered particles were then subjected to further enzymatic digestion and purification using 
the original published  method (Lal et al., 2016) as described in section 2.3.3.4.   
CFE-SEM analysis of the recovered ZTA ceramic wear particles using the two-step particle 
isolation protocol method revealed both large micrometre and small nano-scale particles 
(Figure 2.18). EDX analysis confirmed the large micrometre particles were indeed Alumina 
with elemental peaks of aluminium (Al) and oxygen (O) (Figure 2.19A, B). The small nano-
scale particles were comprised of Alumina, Zirconia and Strontium as confirmed by the 
elemental peaks of aluminium (Al), oxygen (O), zirconia (Zr) and strontium (Sr) from EDX 
analysis (Figure 2.19C, D). The elemental peaks of tungsten (W) represents contamination 
from the sodium polytungstate density gradient. 
 
   
 
Figure 2.18 - CFE-SEM of the recovered large alumina micrometre ceramic particles. (B) CFE-SEM 
of the recovered small Zirconia nano-scale ceramic particles. The larger particles were imaged at 10kV 
voltage, working distance of 15mm and 5K magnification to capture groups of the particles. The 
smaller nano-scale particles were imaged at 1kV (deceleration mode) voltage, working distance of 2-
3mm and 90k magnification. 
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Figure 2.19 - EDX analysis of the BIOLOX® Delta ceramic wear debris recovered from hip simulator 
lubricant. (A) EDX image of the large alumina micrometre particles and (B) corresponding EDX 
spectrum. (C) EDX image of the small zirconia nano-scale particles and (D) corresponding EDX 
spectrum. Area selection and pin point EDX analysis of the particles was performed at a working 
distance of 15mm, 10kV and a suitable magnification to maintain focus. 
2.4.6.1 Characterisation of the clinically-relevant BIOLOX® Delta ceramic wear 
particles recovered from hip simulator lubricants 
The recovered clinically-relevant BIOLOX® Delta ZTA ceramic wear particles showed a 
bimodal size distribution of larger micron sized particles and nano-scale particles. The 
frequency as a function of size of the recovered particles are presented in Figure 2.20. The 
larger micron/submicron sized particles ranged between 100–32,980nm with a mean size of 
2308.11 ± 243.58 nm, whereas the small nano-scale particles ranged between 10-100nm with 
a mean size of 43.73 ± 0.97nm. The larger alumina particles had a mode of distribution in the 
1-2µm size range and were irregular/shard-like in morphology, whereas the smaller zirconia 
particles were round in morphology with a mode size of 30-40nm. The mean ferret diameter, 
mean aspect ratio and mean circularity values (value of 1.0 indicates a perfect circle) are 
shown in Table 2.8. The larger particles (100 - >5000nm) had a higher mean aspect ratio (1.47 
± 0.02), which indicated that they were more elongated and irregular in shape compared to 
the smaller (0-100nm) nano-scale particles (1.29 ± 0.01), as they were more round and 
consistent in shape. The smaller (0-100nm) nano-scale particles had a higher mean circularity 
value (0.91 ± 0.02nm) compared to the larger particles (0.80 ± 0.01nm), which indicated the 
smaller nano-scale particles were more circular in shape than the larger particles. 
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Figure 2.20 - Frequency size distribution of clinically-relevant BIOLOX® Delta ceramic wear particle 
recovered from three different samples of hip simulator serum lubricants. The ceramic wear particles 
were generated under edge loading conditions due to dynamic separation between the head and cup 
centres. A minimum of 150 particles were analysed from each sample (n=3).  
 
Table 2.8 - Mean size (feret diameter) and morphology (aspect ratio and circularity) values 
for clinically-relevant BIOLOX® Delta ZTA ceramic wear particle recovered from three 
different samples of hip simulator serum lubricants. 
 
Larger 
micron/submicron 
sized particles 
(100 - >5000nm) 
Nano-scale particles 
(0 - 100nm) 
Feret diameter (nm) 2308.11 ± 243.58 43.73 ± 0.97 
Aspect ratio 1.47 ± 0.02 1.29 ± 0.01 
Circularity 0.80 ± 0.01 0.91 ± 0.02 
Note: All values expressed as mean ±95% Confidence Interval. 
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2.5  Discussion  
This study had the following two aims: - 
1. To optimise and validate a novel particle isolation method for ultra-low wearing 
ceramic materials. 
2. To isolate and characterise composite ZTA ceramic wear particles generated under 
edge loading conditions. 
In order to meet these aims, commercially-obtained ZTA ceramic model particles were 
initially spiked into 25% (v/v) FBS at a range of volumes to assess the sensitivity of the novel 
particle isolation method in terms of recovery rates. Thereafter the method was applied to hip 
simulator lubricant serum that contained composite ZTA ceramic wear debris generated under 
edge loading conditions. However, the method demonstrated ineffective removal of 
contaminating proteins from the ceramic wear particles, thus the particle isolation method 
was further optimised. The optimisation process ultimately resulted in a two-step particle 
isolation method, which allowed for the first time the successful recovery and characterisation 
of very low volumes of both micrometre and nano-scale wear particles, generated from 
composite CoC hip replacements (BIOLOX® Delta). The discussion is divided into the 
following sections: - 
1. Current particle isolation methods  
2. Validation of a novel particle isolation method 
3. Optimisation of particle isolation method 
4. Successful recovery of composite ceramic wear particles  
2.5.1 Current particle isolation methods  
Characterisation of wear particles from CoC bearings has historically been extremely 
challenging due to the low volume and nano-scale nature of the wear particles. The composite 
CoC bearings have extremely low wear rates, which are approximately twenty-to eighty-fold 
lower than the current generation of highly cross-linked UHMWPE-on-metal total hip 
replacements (Galvin et al., 2007; Al-Hajjar, Fisher, Tipper, et al., 2013a). Whilst these low 
wear rates of composite ceramic hip replacements are highly beneficial, it has made it 
extremely challenging to isolate the wear particles generated in vitro using hip simulators, 
and so at present no studies have reported their characteristics or biological activity. Current 
established particle isolation methods (Doorn et al., 1998b; Catelas, Bobyn, J.B. Medley, et 
al., 2001a; Catelas, Bobyn, J.J. Medley, et al., 2001b; Brown et al., 2007; Billi et al., 2012) 
lack the sensitivity to reliably isolate very low wear volumes such as those produced by the 
latest generation composite or BIOLOX® Delta CoC bearings. However, a novel particle 
isolation method was developed by Lal et al. (2016) to tackle the challenge of isolating ultra-
low volumes of particles from large volumes of serum lubricants, which is often used in hip 
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simulators. This novel method was originally developed for the isolation of silicon-nitride 
ceramic-like particles from coatings for total hip replacements. Hence, this study was 
undertaken to optimise and validate this recently published novel particle isolation method 
(Lal et al., 2016) for the recovery and characterisation of wear particles generated from 
BIOLOX® Delta CoC hip replacements using hip simulation. The validated method was 
applied to hip simulator serum lubricant that contained ceramic wear debris generated from 
BIOLOX® Delta CoC bearings.  
This novel particle isolation method developed by Lal et al. (2016) has many attractive 
features over other methods, as it was developed for the isolation of ultra-low wearing 
materials, such as composite ZTA CoC bearings. The method used enzymatic digestion and 
sodium polytungstate density gradient ultra-centrifugation technology to isolate wear 
particles from low wearing ceramic bearing materials. Enzymatic digestion is advantageous 
over other digestion methods i.e. acid or base digestion in that it preserves the characteristic 
features of wear particles and minimises chemical damage (Catelas, Bobyn, J.B. Medley, et 
al., 2001a; Catelas, Bobyn, J.J. Medley, et al., 2001b). The protein digestion process in this 
method also utilised a denaturing agent; sodium dodecyl sulphate (SDS) to breakdown the 
secondary and non–disulfide–linked tertiary structures of the serum proteins, thus increasing 
the efficiency of the digestion. The uniqueness of this method however, is in employment of 
a novel gradient technique, which uses sodium polytungstate. A recently developed particle 
isolation method (Billi, Benya, Kavanaugh, Adams, Ebramzadeh, et al., 2012) used caesium 
trifluoroacetate for density gradients, however this is highly toxic and not readily available. 
Common conventional gradient materials consist of sucrose or caesium chloride (Chauhan, 
2008), these have a limited density range and hence are not suitable for particle separation 
from proteins. On the contrary, sodium polytungstate has a wide density range of 1.1 to 3.0 
g/cm3 in water. The average density of proteins is 1.22g/cm3, which is approximately four-
fold lower than alumina ceramic particles and six-fold lower than CoCr metal particles 
(Quillin and Matthews, 2000). This large difference in density allows easy separation of the 
particles from the proteins using density gradients, however in contrast this is difficult for 
UHMWPE particles as it has a lower intrinsic density (0.928-0.941g/cm3) compared to the 
average density of proteins (1.22g/cm3). Furthermore, sodium polytungstate is non-toxic and 
has a low viscosity, hence it is easy to work with (Savage, 1988). It also comes with an 
additional benefit, whereby it has been reported to act as a protein denaturant and so can assist 
in the breakdown of the proteins present in the serum lubricant (Seidl et al., 2012). However, 
a limitation of this novel method is that the medium used for the density gradient i.e. sodium 
polytungstate, contaminated the recovered particles and thus necessitated a subsequent wash 
step to remove this medium before analysing the particles. The EDX spectrum clearly showed 
peaks of sodium and tungsten, which are the major constituents of sodium polytungstate. 
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Nevertheless, the soluble nature of sodium polytungstate allowed easy separation from the 
isolated particles by repeated washing steps. 
2.5.2 Validation of novel particle isolation method 
The particle isolation method was validated for sensitivity and repeatability by determining 
the recovery rates of different volumes (0.05-5mm3) of ZTA ceramic particles which had been 
spiked into 25% (v/v) FBS. The serum spiked with ZTA powder was then processed through 
the novel particle isolation method and the mass of the recovered ZTA particles was measured 
gravimetrically in order to determine the particle recovery rates. The method demonstrated a 
high average recovery rate of 89% for the low volumes of ZTA particles (0.1-0.05mm3), 
which was comparable with the recovery rate of 84.7% reported by Lal et al. (2016) who 
developed the method for isolation of silicon-nitride particles. The control sample recovered 
a mass of 0.02mg, which may have been due to the unavoidable introduction of contamination 
during the particle isolation process. The high recovery rate observed in this study may result 
from fewer steps, decreased handling, fewer vessel changes and sufficient ultracentrifugation 
speeds, all of which contribute towards minimising particle loss. Whereas previous methods 
(Doorn et al., 1998b; Catelas, Bobyn, J.B. Medley, et al., 2001a; Catelas, Bobyn, J.J. Medley, 
et al., 2001b; Brown et al., 2007; Billi et al., 2012) have multiple and complex steps, many 
vessel changes and lower centrifugation speeds, which collectively reduce particle recovery. 
Moreover, the sensitivity of this novel method was comparable with the 92% ±5% reported 
by Billi et al. (2012) for their metal-ceramic silicon wafer display (MC-SWD) protocol. 
However, the advantages of this method over the Billi et al. (2012) method are its simplicity, 
cost effective reagents and non-specialist equipment, and most importantly, the ability to use 
the recovered particles for subsequent assays, for example biocompatibility testing of 
clinically-relevant wear particles. This is not possible with the Billi et al. (2012) protocol as 
the particles become embedded within the silicon wafer during the purification process, thus 
only allowing visualisation of the particles using SEM/TEM. The MC-SWD method does not 
allow physical recovery of the wear particles, hence subsequent biocompatibility testing of 
the particles is not possible.  
The relative features of wear particles in terms of their size, morphology, quantity and 
composition determine the severity of the biological response (Green et al., 1998). Hence it 
is essential to understand the characteristics of wear particles and their biological activity for 
the pre-clinical testing of joint replacements (Ingham and Fisher, 2000). Particles of less than 
1µm are considered to be more biologically active than larger sized particles (Green et al., 
1998; Ingham and Fisher, 2000; Ingham and Fisher, 2005). Similarly elongated particles may 
induce a stronger biological response than round particles (Billi et al., 2009). Therefore, it is 
important that particle isolation methods preserve the size and morphological characteristics 
of wear particles. There was no significant difference observed for the size distribution of the 
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ZTA particles before and after the isolation protocol. Similarly, there was no significant 
difference in the aspect ratio and circularity of the ZTA particles before and after the isolation 
method. Thus, the method employed here demonstrated effective proteolytic digestion and 
particle recovery without effecting the particle size and morphology of the ZTA particles 
spiked into 25% (v/v) FBS. Catelas et al. (2001) reported that enzymatic digestion techniques 
were least damaging to metal wear particles and hence were an optimum choice for isolation 
and characterisation of wear particles. Furthermore, effective removal of protein minimised 
agglomeration of the particles, as a result the method in the present study allowed for precise 
chemical characterisation of the ZTA ceramic model particles using EDX analysis. However, 
as mentioned previously, contamination by sodium polytungstate was observed as indicated 
by the Na (Sodium) and W (Tungsten) elemental peaks observed during EDX analysis. 
However, incorporation of centrifugal washes and subsequent CFE-SEM analysis found that 
this did not affect characterisation of the recovered particles.  
2.5.3 Optimisation of particle isolation method 
The validated method was subsequently applied to hip simulator serum lubricant from 
BIOLOX® Delta CoC bearings tested under severe edge loading conditions due to dynamic 
separation due to high cup inclination angle (65o) and 4mm translational mismatch in the 
centres of rotation of the femoral head and acetabular cup (Al-Hajjar et al., 2015; O’Dwyer 
Lancaster-Jones et al., 2017). These kinematic conditions have been reported to produce wear 
patterns (stripe wear) and wear mechanisms in CoC bearings, similar to those found in vivo 
(Nevelos et al., 2000a). The initial application of the validated novel method was unsuccessful 
in isolating the ceramic wear debris generated from 36mm BIOLOX® Delta ceramic-on-
ceramic bearings under standard gait or severe microseparation conditions. The serum 
proteins were not fully removed, thus making it difficult to identify and observe the ceramic 
wear debris, which were enveloped in the protein. The use of EDX confirmed that the ceramic 
wear debris were indeed present, as elemental peaks of Al, O, Zr, and Sr were observed in the 
EDX spectrum. However, the protein corona that forms on the surface of colloidal nano-
particles was not successfully removed causing a charging effect that resulted in abnormal 
contrast and made the particles appear flat and deformed. Furthermore, in addition to the 
protein contamination, very few particles were recovered making it extremely difficult to 
conduct a comprehensive characteristic analysis. Thus, a more robust digestion protocol was 
required for the complete removal of serum proteins from the particles. 
Other enzymes to breakdown the serum proteins were introduced, such as papain, as previous 
methods have used this enzyme and demonstrated successful recovery of wear particles from 
tissues or simulator lubricants (Schmiedberg et al., 1994; Doorn et al., 1998a; Tipper et al., 
1999; Catelas, Bobyn, J.B. Medley, et al., 2001; Catelas, Bobyn, J.J. Medley, et al., 2001; 
Brown et al., 2007). Hence, this enzyme was incorporated into the digestion protocol, 
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whereby it is reported to hydrolyse esters, amides and breakdown peptide bonds of basic 
amino acids e.g. leucine and glycine (Barrett et al., 2013). In order to visibly assess the 
efficacy of this enzyme, serum containing CoCr wear debris generated from metal-on-metal 
bearings tested under microseparation conditions was used as the black colour of the CoCr 
wear particles could be easily observed. The results from this digestion demonstrated that the 
metal wear debris formed a band at the interface between the bottom two layers of the SPT 
density gradient and did not pellet at the bottom of the tube as expected. This was indicative 
of insufficient digestion of the proteins, which remained attached to the metal wear debris, 
thus altering the density and preventing sedimentation. The physico-chemical properties 
(surface charge, size, shape and composition) of the nano-particles determines the structure 
and composition of the protein corona (Rahman et al., 2013). Metal nano-particles typically 
have a high surface charge, hence a hard protein corona forms as protein adsorption increases 
with increasing surface charge (Abbas et al., 2008; Rahman et al., 2013). The protein corona 
on the metal wear debris may have changed the intrinsic density of the CoCr nano-particles, 
thus inhibiting sedimentation. Furthermore, CFE-SEM of the particles recovered from the 
metal band revealed the CoCr nano-particles were highly agglomerated and contaminated 
with proteins. This showed that papain was ineffective at breaking down the proteins in serum 
lubricants and an alternative solution was required. 
The elevated temperatures generated during wear simulation coupled with the serum proteins 
provides ideal conditions for microorganisms to thrive (Liao and Hanes, 2006). For that 
reason, it became necessary to introduce lysozyme into the digestion protocol. Lysozyme is 
an enzyme that breaks down the cell wall of both Gram-positive and Gram-negative bacteria 
resulting in the formation of protoplasts and spheroplasts. Lysozyme is found naturally in the 
human body and is abundant in secretions including tears, saliva, human milk and mucus. The 
enzyme occurs in the innate immune system, which forms the first line of defence against 
infections (Osserman, 2012). SEM analysis of the recovered wear particles subjected to 
digestion with lysozyme revealed that the filter membrane had a lower level of protein 
contamination compared to the standard digestion method, in which large areas of the filter 
membrane were observed to be covered with proteins. However, despite the reduced protein 
contamination observed on the filter membranes after lysozyme digestion, the identification 
of ceramic wear particles was unsuccessful.  
Previous attempts at ceramic particle isolation in this study processed aliquots taken from 
serum lubricants that contained approximately 0.02-0.05mm3 of ceramic wear debris, as the 
particles were diluted due to the high volume of serum. The aliquot technique was clearly not 
a viable approach, since the ratio of volume of particles to volume of serum was extremely 
high (0.1:1500 - 2:1500). Furthermore, the serum lubricant was heavily contaminated with 
bacteria and other contaminants from the hip simulators, thus making it even more difficult 
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to isolate the ultra-low volume of ceramic wear debris. Therefore, it became necessary to 
process the entire batch of serum produced from one million cycles of hip simulation, which 
equated to approximately 1.5 litres of serum lubricant and contained between 1.58-1.93mm3 
of ZTA ceramic wear particles.  
During the batch processing of the lubricant serum, the volumes of the wear particles were 
manipulated by pooling together the concentrated pellets obtained from the serum 
concentration steps in order to increase the volume of wear debris present in a small volume 
of solution. This enabled the visualisation of a particle pellet after the washing step, which 
was not previously observed when isolating particles from smaller aliquots of serum lubricant. 
This was indicative of successful recovery of ceramic particles from the hip simulator serum 
lubricant, which was confirmed by CFE-SEM analysis that showed an abundance of particles 
on the filter membrane. However, EDX analysis confirmed that the majority of the recovered 
particles were stainless-steel as indicated by the Fe elemental peaks. The source of these 
stainless wear particle contaminants is unknown, however it was postulated that they may 
have been released from fretting wear of the taper or fixtures of the Leeds II hip simulator. 
Nonetheless, the overwhelming large volume of these stainless-steel particle contaminants 
masked the presence of the ceramic wear debris that were recovered from the serum lubricant. 
Therefore, a separation technique using a magnet was devised to separate the stainless-steel 
particle contaminants from the ceramic wear particles.  
A clear polystyrene tube placed on top of a MidiMACS™ magnet was used to capture the 
stainless-steel particles from the particle suspension. The taper and fixtures of the hip 
simulator are made from type 316 stainless-steel which is a non-magnetic austenitic 
chromium-nickel stainless-steel containing molybdenum. Nevertheless, this technique 
significantly reduced the number of stainless-steel particles present in the particle suspension. 
The ferromagnetic properties exhibited by some of these stainless-steel particles may have 
been due to their small size (nm-µm) or a change in their microstructure from austenitic to 
martensitic. It has been reported that deformation induced phase transformation of stainless-
steel can occur under cyclic loading, which may have taken place during wear simulation 
(Solomon and Solomon, 2010). Furthermore, the adhesive sliding during fretting wear of the 
taper or fixtures may also induce martensitic phase transformation, rendering the particles 
magnetic (Maruyama et al., 2013). The reduction in stainless-steel particle contaminants 
allowed the identification of larger micrometre-sized ceramic wear particles that were up to 
10 microns in size. Additionally, agglomerated nano-scale zirconia particles (30-50nm) were 
also identified, however these were enveloped in proteins, which demonstrated insufficient 
digestion. It was therefore postulated that despite the sedimentation of the larger micrometre 
particles, the protein corona on the surface of the nano-scale particles may be inhibiting their 
sedimentation during density gradient ultra-centrifugation. For this reason, a two-step 
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digestion and density gradient protocol was devised, whereby the density of the initial SPT 
layers were modified to allow the sedimentation of nanoscale particles and proteins during 
the first step. This was followed by a second proteolytic digestion and a second density 
gradient ultra-centrifugation step utilising densities of SPT as described by Lal et al. (2016). 
This resulted in successful isolation of both large micrometre and small nano-scale BIOLOX® 
Delta ceramic wear particles. 
2.5.4 Successful recovery of composite ceramic wear particles  
The high sensitivity of this optimised novel two-step particle isolation method coupled with 
its effective removal of protein, allowed for the first time the successful recovery and 
characterisation of very low volumes (0.1-1.93mm3) of both micrometre and nano-scale wear 
particles, generated from composite ZTA CoC hip replacements (BIOLOX® Delta), from 
protein containing lubricants. CFE-SEM analysis revealed that the particles had a bimodal 
size range, with larger polygonal shaped particles of alumina that ranged between 100-
>5000nm with a mean size of 2308nm, and small round (granular) zirconia particles that were 
agglomerated and ranged between 10-100nm with a mean size of 43.7nm. Since no previous 
studies have reported the characteristics of wear particles generated from composite ceramic 
hip replacements, a comparison with the early generation pure alumina ceramic was made. 
The bimodal size range of the recovered ceramic wear particles is in agreement with previous 
studies (Hatton et al., 2002; Tipper et al., 2002b; Stewart et al., 2003a), since analysis of 
retrieved tissues from CoC THR revision surgeries has identified ceramic wear particles as 
having a bimodal distribution of particle sizes ranging from 5 – 90 nm (mean size: 24 ± 19nm), 
and larger particles similar to UHMWPE debris ranging in size from 46 – 3,200 (mean size: 
438 ± 325nm) (Hatton, 2001). The large size distribution for clinically-relevant ZTA ceramic 
wear particles is thought to be caused by the introduction of microseparation conditions 
during articulation, causing a bimodal size distribution. The nanometre-sized particles are 
believed to be produced by relief polishing of the ceramic bearing, whereas the larger particles 
are produced by trans-granular fracture of the ceramic bearing that results in the formation of 
a wear stripe during edge loading (Nevelos et al., 2000a; Tipper et al., 2002b). The larger 
micrometre/ submicron sized wear particles generated from this wear mechanism i.e. 
transgranular/intergranular fracture as a result of rim contact during edge loading, may be 
critical in determining the severity of the biological response as it is well established that this 
size range can induce an inflammatory response (Green et al., 1998). This novel two-step 
particle isolation is a major breakthrough since it has allowed for the first time comprehensive 
particle characteristic analysis of clinically-relevant ZTA ceramic wear particles generated in 
vitro. 
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2.6 Limitations of study 
The work in the current chapter demonstrated successful recovery of wear particles generated 
from composite ZTA BIOLOX® Delta CoC THRs for the first time. However, the recovered 
particles from the hip simulator lubricants also contained stainless-steel wear particle 
contaminations, the likely source of which may have been from the fixtures and components 
of the hip simulator. This is a limitation of the current study as it cannot be certain that all the 
particles characterised were indeed ceramic. However, a technique was devised using EDX 
analysis to ensure the elemental composition of every particle that was being imaged. This 
technique minimised the incorrect measurement of contaminating particles, and increased the 
reliability of the findings of the present study. This work continues to increase the 
understanding of the characteristics of wear debris generated from ceramic hip replacements. 
2.7 Summary of findings 
• Validation of the novel method developed by Lal et al. (2016), demonstrated a recovery 
rate of 89% for wear volumes (0.05-0.5mm3) that were representative of the wear rates 
of CoC bearings 
• Further optimisation of the novel method resulted in the development of a two-step 
particle isolation method that allowed successful recovery of extremely low volumes of 
wear particles generated from composite ZTA BIOLOX® Delta CoC hips 
• CFE-SEM analysis revealed that the composite ZTA ceramic wear particles had a 
bimodal size range, with larger polygonal shaped particles of alumina that had a mean 
size of 2308 ± 243.58nm, and small round granular zirconia particles that had a mean 
size of 43.7 ± 0.97nm 
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CHAPTER 3 
 
3 Wear Simulation of clinically-relevant ceramic 
wear particles 
3.1 Introduction 
The wear performance of composite ZTA CoC total hip replacements such as those using 
BIOLOX® Delta has been extensively investigated using hip simulators, however no studies 
have reported the characteristics and biological impact of the wear debris generated from 
these bearings. The lack of studies may be due to difficulties in generating high volumes of 
clinically-relevant ceramic wear debris in vitro, in addition to the fact that current particle 
isolation methods are not sensitive enough to reliably isolate the wear particles from hip 
simulator lubricants, due to the inherent low wear rates of composite ZTA ceramics (Doorn 
et al., 1998a; Catelas, Bobyn, J.J. Medley, et al., 2001; Brown et al., 2007; Billi, Benya, 
Kavanaugh, Adams, McKellop, et al., 2012). Whilst these extremely low wear rates of CoC 
bearings are highly beneficial, the high ratio between the volume of serum lubricant and 
volume of ceramic wear debris has made it extremely challenging to reliably isolate ceramic 
wear debris generated in vitro using hip simulators to be used for biological testing. Hence, 
the majority of previous studies have used commercially available ceramic powders to assess 
biological activity (Nagase et al., 1995; Isabelle Catelas et al., 1999; Nkamgueu et al., 2000b; 
Granchi et al., 2004; Tsaousi et al., 2010). However, these particles may not be clinically-
relevant in terms of their characteristics, which is extremely important as the relative features 
of wear particles in terms of their size, morphology, quantity and composition determines the 
severity of the biological response (Green et al., 1998). But with the recent development and 
optimisation of a novel particle isolation method (Lal et al., 2016), the challenge of being 
unable to recover ceramic wear debris has now been addressed to some extent.  
The present study successfully recovered composite ZTA ceramic wear particles from hip 
simulator serum lubricants that were generated under edge loading conditions (Chapter 2). 
The recovered particles demonstrated a bimodal size range, which consisted of large 
micron/submicron size alumina particles and smaller nano-scale zirconia granular particles. 
This was in agreement with previous studies (Hatton et al., 2002; Tipper et al., 2002b; Stewart 
et al., 2003a), where analysis of retrieved tissues from first generation alumina CoC THR 
revision surgeries also identified ceramic wear particles with a bimodal size distribution. 
However, these particles could not be used for biological testing due to the potential problem 
of adherent endotoxins and a protein corona that may be present on any particles recovered 
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from simulator testing, which may lead to cell activation that may not have been due to the 
ceramic wear particles, thus causing misleading results. In addition, the extremely low 
volumes of ceramic wear particles generated from CoC bearings mean that particles lost 
during the isolation process is potentially very costly.  Hence, Hatton et al. (2003) used the 
hip simulators as a tool to generate clinically-relevant ceramic wear particles in water 
lubricant for subsequent biological testing. The particles were generated under 
microseparation conditions to replicate stripe wear, which is known to produce wear particles 
with bimodal size distribution. Thereafter the ceramic wear particles were subsequently heat 
treated (180oC for 4 hours) to evaporate the water, leaving behind sterile wear particles for 
biological testing. This technique was also employed in the present study, however the use of 
water as the lubricant necessitated subsequent characterisation of the wear particles generated 
to ensure that they were clinically relevant i.e. comparable with those wear particles generated 
in serum lubricant. The characteristics data of the composite ZTA ceramic wear particles 
obtained from simulator testing in serum lubricants (Chapter 2) was used to verify that the 
characteristics (size and morphology) of the composite ZTA ceramic wear particles generated 
in water in the present chapter were the same as those generated in serum. Following this, the 
particles were used for testing biological impact using a range of biological assays (Chapter 
4). The work in this chapter in relation to other chapters is presented in Figure 3.1. 
Previous wear simulation studies (Stewart et al., 2003c; Al-Hajjar et al., 2010; Affatato et al., 
2011; Al-Hajjar, Fisher, Tipper, et al., 2013a; Al-Hajjar et al., 2015; O’Dwyer Lancaster-
Jones et al., 2017) of the composite ZTA BIOLOX® Delta ceramic bearings have reported 
extremely low wear rates of between 0.1-1mm3 per million cycles, which is twenty to eighty 
fold lower than the highly cross-linked UHMWPE-on-metal bearings (Galvin et al., 2007). 
Furthermore, retrieval studies of CoC bearings have shown extremely low volumes of wear 
compared to other bearing couples (Refior et al., 1997; Nevelos et al., 1999; Nevelos, Ingham, 
et al., 2001c). However, recent issues centred around component positioning have revealed 
that CoC bearings can exhibit component separation, which can result in edge loading 
(Nevelos et al., 2000b; Dennis et al., 2001; Fisher, 2011), and increased wear of hard-on-hard 
bearings, thus eventually leading to implant failure. Microseparation is introduced into wear 
simulation tests to replicate stripe wear that was often seen on retrieved ceramic hip implants 
(Nevelos et al., 2000a). This was achieved by applying a 0.4-0.5mm medial-lateral 
displacement of the cup relative to the head using a spring during the swing phase of the gait 
cycle, which ultimately caused edge loading during heel strike (Nevelos et al., 2000a; Stewart 
et al., 2001; Stewart et al., 2003a; Stewart et al., 2003b). Nevertheless, fluoroscopic studies 
of patients with total hip replacements has shown that the level of dynamic (micro) separation 
and severity of edge loading can vary considerably i.e. 1.9-5.2mm (Lombardi et al., 2000; 
Dennis et al., 2001). Hence, the effect of variations in translational positioning with different 
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levels of mismatch between the centres of the cup and head on the magnitude of dynamic 
separation and severity of edge loading have been investigated by Lancaster-Jones., et al. 
(2016). In the present study, dynamic separation due to translational mismatch of up to 4mm 
in the centres of rotation of the femoral head and acetabular cup were employed to create 
severe edge loading conditions to ensure maximum wear rates in order to produce enough 
volume of wear particles for determination of biological impact of composite ZTA ceramic 
wear particles.  
 
 
Figure 3.1 – Flow diagram showing the work in this chapter in relation to other chapters, with the 
current chapter highlighted in yellow.   
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3.2 Aims and objectives 
Aims: 
The aim of this chapter was to generate clinically-relevant ceramic wear particles from 
alumina (BIOLOX® Forte) and composite ZTA (BIOLOX® Delta) CoC hip replacements for 
subsequent testing of biological impact.  
 
Objectives: 
• To generate ceramic wear debris (in water lubricant) from BIOLOX® Forte and 
BIOLOX® Delta ceramic bearings under severe edge loading conditions caused by 
dynamic separation due to translational mismatch in the centres of rotation of the 
femoral head and acetabular cup 
• To quantify the wear rates and surface characteristics of the ceramic bearings after 
testing 
• To recover and characterise the wear particles in terms of their size and morphology 
• To compare the characteristics to ZTA wear particles generated in hip simulator tests 
using serum as a lubricant  
• To generate CoCr wear particles using the pin-on-plate wear rig to use as positive 
particle control 
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3.3 Materials and methods  
3.3.1 Introduction  
Clinically-relevant ceramic wear particles were generated from ceramic-on-ceramic bearings 
under severe edge loading conditions using the hip simulator and clinically-relevant CoCr 
wear particles were generated from CoCr pins and plates using the pin-on-plate wear rig. 
Water was used as the lubricant to generate both the ceramic and metal wear particles. The 
characteristics of the wear particles generated were analysed using cold-field emission gun 
scanning electron microscopy. The water lubricant containing the wear particles was 
processed to recover the wear particles, which were stored at -20OC until required for 
subsequent biological testing. A flow diagram of the method can be seen in Figure 3.2.     
 
 
Figure 3.2 –Overview of the experimental methods for generating clinically-relevant wear particles 
for subsequent testing of biological impact.  
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3.3.2 Materials  
3.3.2.1 Chemicals and reagents used in this study 
The chemicals and reagents used in this study are listed in Table 3.1. 
Table 3.1 - List of chemicals and reagents used in this study 
Chemical/Reagent Supplier Storage/Preparation 
Ethanol, absolute 
VWR International LTD, 
Poole, UK 
Room temperature in 
flammables cupboard 
Grease (Kluber Petamo 
133N) 
Mitchell Fox, Leeds, UK Room temperature 
Isopropanol 
VWR International LTD, 
Poole, UK 
Room temperature in 
flammables cupboard 
Sterile ultra-pure water Baxter Healthcare, UK Room temperature 
Trigene 
Scientific Laboratory 
Supplies Ltd, Nottingham, 
UK 
Room temperature 
3.3.2.2 Equipment  
The equipment used in this study are listed in Table 3.2. 
Table 3.2 – List of equipment used in this study 
Item Model/Size Supplier 
Balance (accuracy of 10µg) XP205 
Mettler-Toledo Ltd, 
Leicester, UK 
Contacting surface 
profilometer 
Talysurf 120L Taylor-Hobson, UK 
Coordinate measuring 
machine 
Legex 322 Mitutoyo, Japan 
Freeze dryer ModulyoD-230 Thermo Savant, UK 
Scanning electron 
microscope 
Carl Zeiss EVO MA15 high 
definition scanning electron 
microscopy 
Zeiss, UK 
Sputter coater and thickness 
monitor 
B7341 and B7348 
respectively 
Agar Scientific Limited, 
Stanstead, UK 
Ultra-sonicator XB3 
Grant Instruments Ltd, 
Shepreth, UK 
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3.3.2.3 Ceramic hip components 
Two different types of ceramics (32mm in diameter) were used for the hip wear simulation 
tests i.e. alumina ceramic, which is known commercially as BIOLOX® Forte (CeramTec, 
Germany) and composite ceramic, zirconia-toughened platelet reinforced alumina (ZTA), 
otherwise commercially known as BIOLOX® Delta (CeramTec, Germany). The composition 
of the different ceramics is shown in Table 1.1, section 1.2. 
Heads of both ceramics (BIOLOX® Forte and BIOLOX® Delta) were mounted onto stainless-
steel C-STEM AMT cemented femoral stems (DePuy Synthes). Cups were mounted in 
titanium alloy acetabular shells (Duraloc® for BIOLOX® Forte and Pinnacle® for BIOLOX® 
Delta, DePuy Synthes, Leeds, UK). The details of the components used in the hip simulator 
are shown in Table 3.3. All the heads, cups, shells and stem components were supplied by 
DePuy Synthes Joint Reconstruction, Leeds, UK.  
 
Table 3.3 – Components used for generation of wear particle from ceramic bearings on the 
hip simulator 
 Stem Head Cup Shell 
BIOLOX® 
Delta 
Stainless-steel 
C-STEM AMT 
Delta head 
(32mm ID) 
Delta insert 
(32mm ID, 
48mm OD) 
Pinnacle 100 
acetabular cup 
(48mm OD) 
BIOLOX® 
Forte 
Stainless-steel 
C-STEM AMT 
Forte head 
(32mm ID) 
Forte insert 
(32mm ID, 
52mm OD) 
Duraloc option 
cup (52mm 
OD) 
ID - inner diameter; OD - outer diameter 
3.3.2.4 Cobalt-chromium pins and plates  
Six pins and plates were manufactured in house (School of Mechanical Engineering, 
University of Leeds) from a high carbon >0.2% (w/w) wrought cobalt-28 chromium-6 
molybdenum alloy (ASTM F1537). The pins were polished to a surface roughness (Ra) of 
0.02-0.04 µm and the plates were polished to a surface roughness of (Ra) of 0.01-0.02 µm to 
create a smooth contact surface. The dimensions of the pins and plates are shown in Figure 
3.3. The pins and plates were engraved with a number on the non-contact face of the 
component for identification and continuity of positioning in the test rig. The pins and plates 
were sonicated in 70% (v/v) isopropanol for 10 minutes to ensure the components were clean 
before using in wear simulation.  
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Figure 3.3 – The dimensions of the pins (A) and plates (B) used in the six-station pin-on-plate wear 
tests. The measurement ‘R’ refers to the 100o radius of the contact face.   
3.3.2.5 Wear simulators  
3.3.2.5.1 Pin-on-plate wear rig 
A six-station pin-on-plate reciprocating wear test rig was used to generate metal wear particles 
from CoCr pins and plates (built in house, School of Mechanical Engineering, University of 
Leeds, UK).  
3.3.2.5.2 Hip joint wear simulator  
The Leeds II B hip joint simulator was used to generate ceramic wear particles from ceramic-
on-ceramic hip bearings. 
3.3.3 Methods 
3.3.3.1 Generation of ceramic wear particles using hip simulation 
Clinically-relevant ceramic wear particles were generated in water under adverse edge 
loading conditions using the Leeds II hip joint simulator. BIOLOX® Forte and BIOLOX® 
 
 
(A) 
(B) 
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Delta ceramic-on-ceramic hip components were used as described in section 3.3.2.3. In total, 
four million cycles over four different tests were completed, which generated sufficient 
volumes of wear debris for subsequent biological testing (chapter 4).   
3.3.3.1.1 Leeds Mark II Physiological Anatomical Hip Joint Wear Simulator  
Hip joint wear simulators are used to predict the wear performance of artificial hip 
replacements in vitro. The Leeds Mark II Physiological Anatomical hip joint simulator B 
Figure 3.4) was used to generate ceramic wear debris from BIOLOX® Forte and BIOLOX® 
Delta ceramic bearing components. The simulator consisted of six stations that simulate 
dynamic vertical loading, flexion/extension and internal/external rotation (Barbour et al., 
1999). 
 
Figure 3.4 - Leeds Mark II Physiological Anatomical Six Station Hip Joint Simulator.  
3.3.3.1.2 Component pre-test preparation 
The ceramic femoral heads and acetabular cups for both BIOLOX® Delta and BIOLOX® 
Forte were inserted on top of their corresponding stainless-steel stems (C-STEM™ AMT, 
DePuy Synthes, UK) and into their corresponding titanium shells (BIOLOX® Forte; Duraloc® 
OPTION CUP and BIOLOX® Delta; PINNACLE™, DePuy Synthes, UK), respectively, to 
allow for metal transfer prior to pre-test gravimetric measurements. The ceramic femoral 
heads were inserted onto the stainless-steel stems (pre-cemented in stem holders by a 
technician) and using a compaction tool and soft-face club hammer the head was impacted 
three times. The heads were removed using a wedge and the compaction was repeated twice 
(Figure 3.5A). The acetabular cups were inserted into the titanium shells (pre-cemented into 
the cup holders by a technician) and using a round plastic piece (similar diameter to ceramic 
cup) and soft-face club hammer the cup was impacted three times (Figure 3.5B). The cup was 
removed by inserting the fixed angle plastic mould into the cup holder and turning the Allen 
key clockwise until the cup was removed from the shell (Figure 3.6). During removal of the 
cup, the screw pushes against a small round plastic piece, which in turn pushes against the 
ceramic cup for removal. The small round plastic piece was placed in the cup holder prior to 
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inserting the acetabular cup to ensure no damage is inflicted on the ceramic cup during 
removal.  
  
Figure 3.5 – Tools used for compacting the (A) femoral heads and (B) acetabular cups on their 
corresponding stems and shells, respectively.  
 
Figure 3.6 – Removal of acetabular cup from the cup holder after impaction.  
3.3.3.1.3 Simulator set up 
The components were set up on the machine to ensure the centres of rotation of the femoral 
head and acetabular cup coincided with the centre of rotation of the simulator. All the 
components and fixtures were etched/marked with identification numbers and alignment 
marks to ensure they could be re-assembled in the same position after measurement. The 
BIOLOX® Forte components were fixed into the odd numbered stations (one, three and five) 
whereas the BIOLOX® Delta components were fixed into the even numbered stations (two, 
four and six). This gave n=3 for each of the two different types of ceramic bearing materials. 
The femoral heads were mounted on the taper of stainless-steel stems ensuring the alignment 
mark on the head was aligned with a manufacturing mark on the stem. The head was then 
taper locked by impacting the heads with a soft-face club hammer. The stem was previously 
mounted by a technician in stainless steel holders using poly-methyl methacrylate (PMMA) 
resin and a bespoke alignment jig to ensure the stem was cemented centrally and vertically in 
the holder. The same stainless-steel stems were used for all tests, however new ceramic 
bearing components were used for test 1-3. The the stem holder was attached to the simulator 
Soft-face 
club 
hammer 
Wedges 
Head compaction tool Cup holder 
Fixed 
angle 
mould 
Cup 
compaction 
tool 
Allen key 
A B 
Allen key 
Cup holder 
Fixed angle 
mould 
Plastic 
round 
piece 
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at its corresponding station and silicon was used to seal any gaps to prevent leaking of the 
lubricant. The silicon gaiters were attached to each station and secured in place using jubilee 
stainless-steel high torque hose clips (Figure 3.7A). Using a soft-face club hammer and fixed 
angle plastic mould (35o or 45o), each acetabular cup was tapped and taper locked into a 
titanium shell (BIOLOX® Forte; Duraloc® OPTION CUP and BIOLOX® Delta; 
PINNACLE™) which were previously cemented into a stainless-steel cup holder using 
PMMA cement. Shells cemented at 45o (clinically 55o) inclination angle were used for test 
one, whereas new shells cemented at 55o (clinically 65o) inclination angle were used for the 
remaining tests (Table 3.5). The alignment marks on both the cup and shell were matched to 
ensure continuity of the positioning throughout the test. Thereafter, grease was applied to the 
cup holder and inserted into its corresponding test station (Figure 3.7B). The silicon gaiters 
were then placed over the cup holder and secured in place using jubilee stainless-steel high 
torque hose clips (Figure 3.7C). The simulator could not be kept sterile during the test, but in 
order to reduce contamination from microorganisms, all of the components coming into 
contact with the water lubricant were cleaned by spraying with 1% (v/v) Trigene followed by 
70% (v/v) ethanol. The components were dried using paper towels.  
 
  
Figure 3.7 – Simulator set-up of stem and cup holder. (A) Stem holders were attached to the simulator 
at their corresponding station and thereafter the silicon gaiters were attached. (B) Cup holders were 
placed into their corresponding stations. (C) Cup holders were covered with the silicon gaiters.  
3.3.3.1.4 Lubricant used in test stations 
Sterile ultra-pure water was used as the lubricant for all the wear simulation tests. The water 
lubricant was held in silicon gaiters for the initial tests 1 and 2, but these were replaced with 
open plastic baths for tests 3 and 4 due to silicon contamination issues. Approximately, 450ml 
of water lubricant was added to each station, which was checked regularly during the test and 
topped up if the water level dropped. The water lubricant was changed every 330,000 cycles 
and stored in plastic pots at -20oC.  
Stem holder with 
head and stem 
Silicon gaiter 
Cup holder 
Silicon gaiter secured 
onto cup holder 
A 
B 
 
C 
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3.3.3.1.4.1 Contamination of water lubricant 
During the lubricant changes the water was noticeably contaminated as indicated by a change 
in colour and opacity (Figure 3.8). This was of great concern for subsequent biological testing, 
which required a pure yield of ceramic wear debris. Hence, many changes were made for 
subsequent tests (Tests 2-4) in an attempt to reduce the contamination levels (Table 3.4). 
Despite all these changes, the contamination of the water lubricant was still prominent. It was 
therefore decided to proceed with wear simulation with the contamination issues and resort 
to post-test processing of the water in order to purify the yield of ceramic wear debris. 
 
Table 3.4 – Changes in simulator set-up to reduce contamination of water lubricant 
Test 
number 
Number of cycles 
(million) 
Change in set-up 
2 0.77 Silicone barrier applied at the taper-head interface 
3 1 -Marine silicone applied to all metal surfaces (Figure 
3.9) 
-Conventional-bath set-up was implemented 
- Cup holders were covered with duct-tape to reduce 
the number of metal surfaces in contact with the 
water lubricant 
4 1 
  
 
Figure 3.8 – Water lubricant collected from Test 2 after 779634 cycles. The water was visibly 
discoloured, mainly in stations 2 and 4 due to contaminants present in the water from the simulator. 
 
Discoloured water lubricant 
102 
 
 
Figure 3.9 – Conventional bath set-up of the ceramic components in the Leeds II hip simulator. Marine 
silicone was applied to all the metal surfaces (stem and stem holder) that were contact with the 
lubricant. 
3.3.3.1.5 Simulator kinetics and kinematics  
The Leeds II hip simulator is capable of generating multi-directional motion between the 
femoral head and acetabular cup, which includes flexion/extension (applied to the head) and 
internal/external rotation (applied to the cup). It can generate between 50-3000N of load, 
which was applied vertically through the centre of the acetabular component. The load was 
applied and controlled via a single feedback loop system and the input was controlled by 
SimSol software, the profile of which is shown in Figure 3.10. 
Each test was run for one million cycles at a frequency of 1 Hz. A gait cycle was simulated 
for each cycle that comprised flexion/extension of -15o/+30o on the femoral head and 
internal/external rotation (±10o) on the cup using a Paul-type twin-peak dynamic vertical load 
of 50N swing phase load and 3kN peak load that was applied through the centre of the 
acetabular cup. A mismatch or medial-lateral displacement between the centres of rotations 
of the head and the cup, representing translational surgical mal-positioning, was applied to all 
the stations using a spring to the lateral side of the cup holder (see Table 3.5). Two acetabular 
cup inclination angles (45o and 55o) were used throughout this study (Table 3.5). An 
inclination of 45o that is clinically equivalent to 55o was used for test 1. An inclination angle 
of 55o that is clinically equivalent to 65o was used for tests 2-4, in order to simulate severe 
edge loading conditions and attempt to increase the wear rates. The cup inclination angle was 
increased after Test 1 to increase the wear rates and volume of ceramic wear debris generated. 
However, the increased cup inclination angle coupled with the high medial-lateral mismatch 
resulted in fracturing of the BIOLOX® Delta cups in stations 4 and 6. Hence, the medial-
lateral mismatch was decreased from 4mm to 3mm. The medial-lateral displacement or 
dynamic (micro) separation was measured and monitored routinely using a calibrated linear 
variable differential transformer (LVDT) position sensor, which was connected to an 
oscilloscope (Tektronix, USA) that displayed a graph of the displacement being produced.  
B 
Marine silicone Marine silicone 
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Table 3.5 - Conditions used for each test for both materials. Two simulator inclination angles 
of 450 and 55o were used in the tests, which are equivalent to 55o and 65o clinical inclination 
angles, respectively.  
Test number 
Simulator inclination angle (clinical 
equivalent inclination angle) 
Medial-lateral 
mismatch 
1 45 (55) degrees 4mm 
2 55 (65) degrees 4mm 
3 55 (65) degrees 3mm 
4 55 (65) degrees 3mm 
  
 
  
Figure 3.10 - Loading and motion profiles for one gait cycle on the Leeds II hip simulator.  Loading 
and motion profiles for one gait cycle on the Leeds II hip simulator illustrating the relationship between 
the twin peak axial load and simultaneous motion in the flexion-extension, anterior-posterior and 
internal-external directions.  
3.3.3.2 Pre-test and Post-test analysis of the ceramic hip components 
The weight, geometry and surface topography of the ceramic heads and cups was analysed 
before and after the test to determine the effects of the testing conditions on the components 
in terms of wear rates, wear stripe pattern, surface roughness and changes in geometry.  
3.3.3.2.1 Cleaning of the ceramic hip components 
The test components (femoral heads and acetabular cups) were carefully removed from the 
stems and shells and cleaned using household detergent to remove visible contaminants 
followed by sonication in 1% (v/v) Trigene solution for 10 minutes. Thereafter the 
components were rinsed with deionised water and then sonicated for 10 minutes in 70% (v/v) 
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isopropanol. The components were air dried for 1hr and then transferred to the measurements 
lab for post-test analysis. 
3.3.3.2.2 Measuring clearance between the head and cup ceramic hip components 
The diameter and form of the components were measured using the coordinate measuring 
machine. The option “measure a sphere” was used to obtain twenty-five measurement points 
(a ring of 10 points at approximately 20 degrees and a ring of 14 points at approximately 110 
degrees), which commenced after the initial manual point was measured at the pole. The 
clearance was calculated by subtracting the external diameter of the head from the internal 
diameter of the cup.   
3.3.3.2.3 Gravimetric measurements of ceramic hip components  
The components were weighed before and after the wear simulation testing to determine the 
volume of wear that was generated. Prior to testing, the ceramic heads and cups were 
compacted into their corresponding metal backings to allow for metal transfer (section 
3.3.3.1.2). Gravimetric measurements were obtained using the XP205 microbalance, where 
each component was weighed five times and an average weight was determined. A control 
head and cup component for both BIOLOX® Delta and BIOLOX® Forte (stored in the 
measurements lab climate controlled room) was used as a reference weight to ensure the 
difference in weight of the components between different tests was due to wear and no other 
factors. Cumulative volumetric wear was calculated using the Equation 3 and 3.98g/cm3 
density for BIOLOX® Forte and 4.36g/cm3 density for BIOLOX® Delta. 
Equation 3 
 
𝑉𝑜𝑙𝑢𝑚𝑒 =
𝑊𝑒𝑖𝑔ℎ𝑡
𝐷𝑒𝑛𝑠𝑖𝑡𝑦
 . 
3.3.3.2.4 Geometric analysis of ceramic hip components 
Three-dimensional geometrical characteristics of the surface of the femoral heads and 
acetabular cups were obtained by using a coordinate measuring machine and RedLux 
software. The femoral heads and acetabular cups were measured by taking 72 traces over each 
surface with five degrees spacing about the vertical axis (Figure 3.11). Each trace started at 
the crest of the component and had a 0.2mm pitch resulting in a total number of 9,936 points 
on the femoral heads and 8,928 points on the acetabular cups. In order to get the best 
resolution, for these particular measurements, a 3mm stylus was used with a vertical probe. 
RedLux software was used to visualise the size, shape and penetration depth of the wear areas. 
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Figure 3.11 - Data points taken using a CMM on the surfaces of the (A) femoral heads and (B) 
acetabular cups to ascertain the geometrical changes after wear simulation testing. 
3.3.3.2.5 Surface topography analysis of the ceramic hip components 
3.3.3.2.5.1  Surface roughness of the ceramic hip components  
Surface roughness of the articulating surfaces for the heads and cups was measured using the 
Form Talysurf 120L contacting surface profilometer, which maps out irregularities on a 
surface. The arithmetic mean deviation, also known as the average roughness or centre line 
average (Ra), is the average from the centre line of the sampling length. Ra values are high 
when the surface is rough, represented by a large number of peaks across the sampling 
area. The skewness (Rsk) measured the symmetry of the profile about the mean line and 
therefore allowed differentiation between asymmetrical profiles that may have the same Ra. 
The maximum peak height (Rp) and the minimum valley height (Rv) were also investigated 
together with Ra and Rsk to provide a more accurate description of the bearing surface.  
Roughness parameters Ra, Rsk, Rp and Rv were assessed before and after wear simulation test 
1 in accordance with ISO 4288:1998. Three 15mm traces (P1, P2 and P3) were taken in 
relation to the alignment mark (Figure 3.12). P1 and P2 were perpendicular to each other and 
taken along the flexion-extension path. The P3 trace was taken on an area of the bearing not 
in contact during the test. The femoral head was positioned on its side, by rotating the 
component 90o so trace P3 could be obtained. The acetabular cup was tilted approximately 
45o so trace P3 could be obtained. Due to the hemispherical nature of ceramic hip components, 
the traces were taken using least square arcs with a Gaussian filter to suppress the waviness 
and form of the components, allowing only roughness to be assessed. A Gaussian cut-off of 
0.08mm with a bandwidth of 100:1 was used as recommended in ISO 4288:1998 for ceramic 
components with initial Ra below 0.02µm. 
 
(A) (B) 
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Figure 3.12 - Schematic of the three traces performed on the femoral head and acetabular cup 
components in relation to the alignment mark in order to obtain the surface roughness before and after 
the wear simulation test.  
3.3.3.2.5.2 Scanning electron microscopy of the wear scar on the ceramic femoral 
heads 
A Carl Zeiss EVO MA15 high definition scanning electron microscopy was used to obtain 
high magnification images of the wear areas of the bearing surfaces after simulator testing. 
The images were used to analyse the features of the wear pattern and in turn identify the wear 
mechanism. Prior to imaging, the ceramic wear surface was coated with 20nm layer of Iridium 
to allow conduction of the electron beam. The whole femoral head component was placed on 
the stage of the SEM for imaging. 
3.3.3.3 Generation of cobalt chromium wear particles using a six-station pin-on-plate 
wear simulator 
Clinically-relevant CoCr wear particles were generated in water using the six-station pin-on-
plate wear simulator. Smooth, high carbon CoCr alloy pins and plates were used as described 
in section 3.3.2.4. 
3.3.3.3.1 Cleaning of rig components 
The CoCr pins and plates were cleaned by ultra-sonication in 70% (v/v) isopropanol for 10 
minutes at room temperature. The components of the six-station rig were cleaned using 
household detergent solution and then immersed in 1% (v/v) Trigene for 20 minutes. 
Thereafter all the components were rinsed in deionised water before drying using disposable 
paper towels Figure 3.13. The cleaning of the components was to minimise contamination of 
from previous tests.  
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Figure 3.13 – Components of the six-station pin-on-plate wear rig simulator. (A) Ball bearing assembly 
components, (B) threaded nut, (C) bridge section, (D) polymer baffle, (E) connecting rod, (F) collet, 
(G) toothed rack, (H) pin holder with polymer gear, (I) stainless-steel bath with seal inside the side 
groove. 
3.3.3.3.2 Assembly of the six-station pin-on-plate wear rig  
The plates were fixed into the stainless-steel baths noting the orientation and numbers of both 
the plates and bath to ensure this remained constant throughout the test. A rubber seal was 
placed into the groove of the bath before a plastic baffle was inserted into the bath and secured 
in place using screws. The toothed racks were then screwed onto the side of each bath before 
each numbered bath was fixed on the rig at the corresponding station number (Figure 3.14A). 
The pins were assigned to individual stations and remained constant throughout the test. The 
pins were placed in a pin collet, using metal spacers to ensure that at least 5mm of the pin was 
protruding from the pin holder (Figure 3.14B). The pin collet containing the pin was then 
placed into the pin holder outer sleeve, which was then inserted into the corresponding bridge 
section and secured in place using a threaded nut that was screwed onto the end of the pin 
holder (Figure 3.14C). Thereafter the complete bridge section and pin holder was slotted into 
the support brackets of the corresponding station and secured in place by tightening the 
clamps (Figure 3.14D). The pins were checked to ensure contact with the plates, and that the 
threaded nut was not in contact with the bridge. This was to ensure that the loading was 
applied axially throughout the test. Thereafter, the connecting rods were screwed into place, 
connecting the scotch yolk mechanism to the trays (Figure 3.14E).  
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Figure 3.14 – Assembly of the six-station pin-on-plate wear rig simulator. A - The pre-assembled 
stainless-steel bath (1) containing the CoCr plate (2), corresponding baffle (3) and toothed rack (4) was 
secured into position on the rig. B – The pin (1) was placed in the collet and pin holder (2) with plastic 
gear wheel attached. C – The pin holder (1) was slotted into the corresponding bridge section (2) and 
secured into position using a threaded nut (3). D – The bridge section and pin holder were secured into 
position over the bath. E – The plastic connecting rods (1) were screwed into place, connecting the 
scotch yolk mechanism to the trays. 
3.3.3.3.3 Generation of cobalt-chromium wear particles using the six-station pin-on-
plate wear rig simulator 
Using a syringe, approximately 50ml of ultra-pure water was added to each bath, ensuring the 
level of water was sufficient enough so the pin surface was under water. Thereafter, the 
appropriately numbered cantilever arm was secured onto each station using the pivot pins and 
levelled using a spirit level. The thrust bearing assembly was inserted in the top of the threaded 
nut to provide a sitting point for the load screw in the cantilever.  
The cycle counter was set to zero before the rig was started. The frequency was increased 
slowly to the required setting i.e. 1 Hz or 60 cycles per minute (cpm), with a stroke length of 
28mm and a rotation of ±30o (calibration of the stroke length and reciprocating speed was 
109 
 
performed by a lab technician). Thereafter the weights were placed onto each cantilever arm 
at the correct position to give an application load of 80 N (Figure 3.15). The test was run for 
continuously for 2 weeks whereby the lubricant was topped up to ensure the fluid level was 
1-2mm above the plate wear surface. Upon completion of the wear test, the water lubricant 
containing the wear particles for each station was transferred into appropriately labelled sterile 
plastic pots and stored at -20oC. The number of cycles was recorded and the rig was 
dismantled.  
 
 
Figure 3.15 – Assembled station on the six-station wear rig simulator with (1) cantilever arm and (2) 
weight.  
3.3.3.4  Recovery of the wear particles generated  
The water lubricants containing the ceramic or metal wear particles were processed to recover 
the wear particles, which were stored until required for subsequent testing to determine 
biological impact. 
3.3.3.4.1 Ceramic wear particles 
The water lubricants containing the ceramic (BIOLOX® Forte or BIOLOX® Delta) wear 
particles generated using the hip simulator were initially reduced in volume using a freeze 
dryer. The water lubricant was dried for 1-2 weeks until all or most of the ice sublimed away, 
leaving behind particulate matter. Thereafter, the remaining particle matter was re-suspended 
in a 10ml of sterile water and sonicated for 10 minutes before pooling the particle suspensions 
for BIOLOX® Forte from stations 1, 3 and 5 and for BIOLOX® Delta from stations 2, 4 and 
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6. Thereafter, the particle suspensions were transferred to SW32 polypropylene centrifuge 
tubes and centrifuged at 125,755g for 1 hour at 25oC. The supernatant was removed and the 
particle pellets were re-suspended in 3ml of ultra-pure deionised water. Each particle 
suspension was then placed on a sodium polytungstate density gradient and centrifuged 
(Beckman Optima L-90K ultra-centrifuge and SW40 rotor) at 202,048g for 4 hours and 25oC 
(section 2.3.3.4.4). After centrifugation, the particles were collected at the bottom of the tube 
in the form of a pellet, whilst the contaminating particulate matter and other impurities, which 
was darker in colour and had a lower density remained higher up the tube. The supernatant 
was slowly aspirated and discarded, and the pellet of particles was re-suspended in 1ml of 
sterile water and sonicated for 10 minutes before being transferred to a clean centrifuge tube 
(14ml, Thinwall Polypropylene). This was repeated three times to ensure all the particles were 
transferred to the clean tube. The recovered particles were then washed five times in sterile 
water using Beckman Optima L-90K ultra-centrifuge and SW40 rotor at 154,693g for 1 hour 
at 37oC. Between each wash, the supernatant was discarded and the particles were re-
suspended in sterile water before sonication for 10 minutes. After the final wash, the particle 
pellet was re-suspended in 3ml of ultra-pure deionised water and stored at -20oC until 
required. 
3.3.3.4.2 Cobalt-chromium wear particles 
The water lubricant containing the CoCr nano-particles that were generated using the six-
station pin-on-plate wear simulator was thawed at 37oC for 1 hour before being sonicated for 
30 minutes to disperse the particles. Thereafter, the particle suspension was transferred to 
SW32 polypropylene centrifuge tubes and centrifuged at 125,755g for 1 hour at 25oC. The 
supernatant was removed and the particle pellet was re-suspended in 3ml of ultra-pure 
deionised water and stored at -20oC until required.  
3.3.3.5 Characterisation of the recovered ceramic wear particles  
The characteristics of the ceramic wear particles generated in water required subsequent 
validation against the ceramic wear particles generated in the conventional serum lubricant 
(25% FBS (v/v)). An aliquot from the particle suspension containing the wear particles 
recovered from the water lubricant used in wear simulation was subjected to sonication and 
filtered through a 0.015 filter membrane.  Images and the composition of the wear particles 
generated in vitro were captured and analysed using CFE-SEM and EDX analysis as 
described in section 2.3.3.2.2. The CFE-SEM micrographs of the wear particles were 
subsequently analysed using computer software, ImageJ version 1.49, to measure the Feret 
diameter (dmax), aspect ratio and circularity of the particles. A minimum of 150 particles were 
characterised in accordance with the standard practice for characterisation of particles; ASTM 
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F1877-05:2010, and International Standard for wear of implant materials; BS ISO 
17853:2011.  
3.3.3.5.1 Calculating percentage ratio between ceramic and stainless-steel wear 
particles using EDX elemental mapping 
The ceramic wear particles generated using the hip simulator were contaminated with 
stainless-steel wear particles, which could not be separated from the ceramic wear particles. 
This resulted in a mix population of ceramic and stainless-steel wear particles that would be 
presented to the cells. Hence, EDX elemental mapping was used to calculate the percentage 
ratio between the ceramic wear particles (BIOLOX® Forte and BIOLOX® Delta) and 
stainless-steel particle contaminants. 
An aliquot (100µl) from the recovered wear particle suspension (1mg/ml) was subjected to 
sonication and filtered through a 0.015 filter membrane. Thereafter, images and the 
composition of the wear particles generated in vitro were captured and analysed using CFE-
SEM and EDX analysis. The CFE-SEM was set to a working distance of 15mm and 10Kv 
voltage. Using the EDX elemental mapping tool, five random fields of view at 100x 
magnification were analysed for the major elements (wt%) iron (Fe) for the stainless-steel 
wear particles and aluminium (Al) for the ceramic wear particles. An average of the weight 
% for each element was calculated and presented in a histogram.  
3.3.3.6 Preparation of particles for cell culture studies 
A glass vial was cleaned by sonication in sterile water and 70% (v/v) ethanol before heat 
treatment at 180oC for 4 hours. The glass vial was then weighed using the XP205 
microbalance, which is sensitive to 10-5 grams. A reference glass vial was also weighed as 
changes in atmospheric conditions can cause differences that need to be accounted for before 
and after adding particles to the glass vial. The glass vials were weighed five times (within 
100µg) to provide an average weight. The particle suspension (section 3.3.3.4) was thawed 
and transferred to the glass vial; all of the particle suspension for the ceramic particles and a 
small amount (2-3ml) for the CoCr particles was transferred into the pre-weighed glass vial. 
The glass vials containing the particle suspensions were then heat treated in the oven at 190oC 
for 4 hours to sterilise the particles and remove the water and endotoxins. Thereafter, the glass 
vials with the particles were weighed again using the same technique described previously. 
The mass of the particles was calculated by subtracting the average weight of the vial without 
the particles from the average weight of the glass vial with the particles. This mass was then 
adjusted according to the average weight of the reference glass vial before and after adding 
the particles to the other glass vials. The particles were suspended in an appropriate volume 
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of sterile water to produce a stock particle suspension with a concentration of 1mg.ml-1 which 
were stored at -20oC until required.   
3.3.4 Statistical Analysis 
3.3.4.1 Wear rates and Penetration depths 
Statistical analysis was performed on measurements data using one-way analysis of variance 
(ANOVA) and 95% confidence limits (95% CL) were calculated. 
3.3.4.2 Characteristics of wear particles 
Statistical differences in the particles size distributions, aspect ratio values and circularity 
values between different types of particles were tested using an Independent Samples T-Test 
(SPSS Statistics Version 24, IBM Corp. USA). The tests were carried out on the original un-
binned data produced from Image J.  
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3.4 Results 
The aim of this study was to generate clinically-relevant ceramic wear particles to be used for 
subsequent determination of biological impact of ceramic wear particles. In order to do this 
the Leeds II hip simulator was used to generate clinically relevant ceramic wear particles from 
CoC bearings and the pin-on-plate wear rig was used to generate clinically-relevant CoCr 
wear particles from CoCr pins and plates. The wear rates were determined using gravimetric 
analysis, which are presented in this section.   
3.4.1 Wear testing of ceramic-on-ceramic hip bearings 
3.4.1.1 Gravimetric analysis  
The Leeds II hip simulator was used to generate clinically-relevant ceramic wear debris from 
the BIOLOX® Forte (n=3) and BIOLOX® Delta (n=3) ceramic-on-ceramic hip replacements. 
Four tests were completed in total, where each test was run for one million cycles under severe 
edge loading conditions caused by dynamic separation due to translational mismatch between 
the centres of rotation of the femoral head and acetabular cup (test conditions used are shown 
in Table 3.5).  A Paul-type twin-peak dynamic vertical load of 50N swing phase load and 3kN 
peak load was applied through the centre of the acetabular cup. Two acetabular cup inclination 
angles (45o and 55o) were used throughout this study (Table 3.5). 
3.4.1.1.1 Wear simulation – Test 1 
During Test 1, the components were tested under 4mm translational mismatch with a 55o 
(clinical equivalence) cup inclination angle for one million cycles. The three stations for 
BIOLOX® Forte and stations 4 and 6 for BIOLOX® Delta generated similar amounts of wear, 
however the components in station 2 for BIOLOX® Delta generated considerably lower wear 
compared to the other stations (Figure 3.16). Overall, the test generated higher cumulative 
wear from BIOLOX® Delta (1.27mm3) than BIOLOX® Forte (0.94mm3). BIOLOX® Delta 
experienced a higher mean wear rate of 0.42 ± 0.66mm3/million cycles compared to 
BIOLOX® Forte (0.31 ± 0.12mm3/million cycles) (Figure 3.17) using water as the lubricant, 
however there was no significant difference in wear rate between the two different materials 
(p>0.05, ANOVA). 
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Figure 3.16 - Wear volumes generated by ceramic-on-ceramic bearings after 1 million cycles of testing 
under 4mm translational mismatch and 55o (clinical equivalence) cup inclination angle conditions (Test 
1). Stations 1, 3 and 5 housed BIOLOX® Forte components and stations 2, 4 and 6 housed BIOLOX® 
Delta components. Total wear volume across stations for both materials is also shown. 
 
 
Figure 3.17 - Mean wear rate of ceramic-on-ceramic bearings after 1 million cycles of testing under 
4mm translational mismatch and 55o (clinical equivalence) cup inclination angle conditions (Test 1). 
Error bars represent 95% confidence limits (n=3). 
3.4.1.1.2 Wear simulation – Test 2 
During Test 2, the components were tested under 4mm translational mismatch with 65o 
(clinical equivalence) cup inclination angle. The increase in inclination angle was 
implemented as higher volumes of wear particles was required from the ceramic bearings. 
The simulator was stopped at 780,000 cycles due to fracturing of the BIOLOX® Delta cup 
components on stations 4 and 6. However, the BIOLOX® Delta components on station 2 
generated extensive amounts of wear compared to the BIOLOX® Forte components (Figure 
3.18), where the volume of wear from BIOLOX® Delta (4.66mm3) was higher than the 
cumulative wear volume (4.07mm3) for BIOLOX® Forte. The components from Stations 4 
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and 6 were not analysed due to fracture of the acetabular cup components. Hence only the 
mean wear rate for BIOLOX® Forte was calculated, which was 1.36 ± 0.12mm3/0.78 million 
cycles (Figure 3.19). 
 
Figure 3.18 - Wear volumes generated by ceramic-on-ceramic bearings after 1 million cycles of testing 
under 4mm translational mismatch and 65o (clinical equivalence) cup inclination angle conditions (Test 
2). Stations 1, 3 and 5 housed BIOLOX® Forte components and stations 2, 4 and 6 housed BIOLOX® 
Delta components. Total wear volume across stations for both materials is also shown. The components 
from Stations 4 and 6 were not analysed due to fracture of the acetabular cup components. 
   
 
Figure 3.19 - Mean wear rate of BIOLOX® Forte ceramic-on-ceramic bearings after 1 million cycles 
of testing under 4mm translational mismatch and 65o (clinical equivalence) cup inclination angle 
conditions (Test 2). The mean wear rate of BIOLOX® Delta was not presented due to the fracture of 
the acetabular cup components that resulted in n=1. Error bars represent 95% confidence limits (n=3). 
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3.4.1.1.3 Wear simulation – Test 3 
The cup inclination angle was increased in test 2 to increase the wear rates and volume of 
ceramic wear debris generated. However, the increased cup inclination angle coupled with 
the high medial-lateral mismatch resulted in fracturing of the BIOLOX® Delta cups in stations 
4 and 6. Therefore, the medial-lateral mismatch was decreased from 4mm to 3mm. Hence 
during test 3, the components were tested under 3mm translational mismatch with 65o (clinical 
equivalence) cup inclination angle for one million cycles. All three stations for BIOLOX® 
Forte and stations 2 and 4 for BIOLOX® Delta generated similar amounts of wear, whereas 
the wear volume generated in station 6 for BIOLOX® Delta was considerably higher 
(0.92mm3), in the order of 10-fold higher compared to station 2 (0.09mm3) and station 4 
(0.07mm3) (Figure 3.20). The higher wear rate for station 6 was due to stainless steel third 
body wear, which was generated from the cup holder impacting against the stem holder 
because of a failed screw that holds the cup holder in place. For this reason, station 6 was not 
included in the cumulative wear and the mean wear rate was not calculated for BIOLOX® 
Delta components. Overall, the test generated higher cumulative wear from BIOLOX® Forte 
(0.34mm3) than BIOLOX® Delta (0.16mm3) components. The BIOLOX® Forte components 
experienced a mean wear rate of 0.11 ± 0.05mm3/million cycle (Figure 3.21). 
 
Figure 3.20 - Wear volumes generated by ceramic-on-ceramic bearings after 1 million cycles of testing 
under 3mm translational mismatch and 65o (clinical equivalence) cup inclination angle conditions (Test 
3). Stations 1, 3 and 5 housed BIOLOX® Forte components and stations 2, 4 and 6 housed BIOLOX® 
Delta components. Total wear volume across stations for both materials is also shown. The BIOLOX® 
Delta components from station 6 were not included in the cumulative wear due to complications during 
the test. 
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Figure 3.21 - Mean wear rate of BIOLOX Forte ceramic-on-ceramic bearings after 1 million cycles of 
testing under 3mm translational mismatch and 65o (clinical equivalence) cup inclination angle 
conditions (Test 3). The mean wear rate of BIOLOX® Delta components was not presented due to 
complications during the test, which resulted in n=2. Error bars represent 95% confidence limits (n=3). 
3.4.1.1.4 Wear simulation – Test 4 
During Test 4, the components were tested under 3mm translational mismatch with 65o 
(clinical equivalence) cup inclination angle for one million cycles. The same conditions as 
test 3 were employed as these conditions generated a sufficient volume of ceramic wear debris 
required for biological testing. The three stations which housed BIOLOX Forte and BIOLOX 
Delta components varied in the amount of wear generated (Figure 3.22). Station 6 for 
BIOLOX® Delta experienced high levels of contamination by stainless steel wear particles, 
which may have been due to the complications from test 3 that may have resulted in a faulty 
testing station. For this reason, station 6 was not included in the cumulative wear and the 
mean wear rate was note calculated for BIOLOX® Delta components. Overall, the test 
generated higher cumulative wear volumes from BIOLOX® Forte (0.95mm3) compared to 
BIOLOX® Delta (0.29mm3). The BIOLOX® Forte components experienced a mean wear rate 
of 0.32 ± 0.19mm3/million cycle (Figure 3.23). 
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Figure 3.22 - Wear volume generated from ceramic-on-ceramic bearings after 1 million cycles of 
testing under 3mm translational mismatch and 65o (clinical equivalence) cup inclination angle 
conditions (Test 4). Stations 1, 3 and 5 housed BIOLOX® Forte components and stations 2, 4 and 6 
housed BIOLOX® Delta components. Total wear volume across stations for both materials is also 
shown. The BIOLOX® Delta components from station 6 were not included in the cumulative wear due 
to complications during the test. 
 
 
Figure 3.23 - Mean wear rate of BIOLOX Forte ceramic-on-ceramic bearings after 1 million cycles of 
testing under 3mm translational mismatch and 65o (clinical equivalence) cup inclination angle 
conditions (Test 4). The mean wear rate of BIOLOX® Delta components was not presented due to 
complications during the test, which resulted in n=2. Error bars represent 95% confidence limits (n=3). 
 
 
 
 
0.26
0.18
0.51
0.11
0.19
0.57
0.95
0.29
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
Station 1 Station 2 Station 3 Station 4 Station 5 Station 6 Forte
Cumulative
Wear
Delta
Cumulative
Wear
W
e
a
r
 v
o
lu
m
e
 (
m
m
3
)
0.32
0.00
0.10
0.20
0.30
0.40
0.50
0.60
BIOLOX forte
M
ea
n
 W
ea
r 
ra
te
 (
m
m
3
/m
il
li
o
n
 c
y
cl
es
)
119 
 
3.4.1.2 Dynamic separation 
The dynamic (micro) separation achieved from each station was measured using a LVDT and 
plotted against the wear rate for both BIOLOX® Forte (Figure 3.24) and BIOLOX® Delta 
(Figure 3.25). A weak positive correlation was observed for both BIOLOX® Forte (R2=0.56) 
and BIOLOX® Delta (R2=0.59), where an increase in the level of dynamic (micro) separation 
resulted in increased wear.  
 
Figure 3.24 – Wear rate of BIOLOX® Forte components plotted against the medial-lateral displacement 
or dynamic (micro) separation measured using a LVDT (Tests 1-4).  
 
 
Figure 3.25 - Wear rate of BIOLOX® Delta components plotted against the medial-lateral displacement 
or dynamic (micro) measured using a LVDT (Tests 1-4). 
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3.4.1.3 Surface analysis ceramic hip components 
3.4.1.3.1 Roughness of ceramic hip components 
The introduction of translational medial-lateral mismatch between the head and the cup 
resulted in the formation of stripe wear on the femoral head and a corresponding wear scar on 
the acetabular cup. The surface roughness of the articulating surfaces was measured using the 
Form Talysurf 120L contacting surface profilometer, which maps irregularities on the surface. 
The severe edge loading conditions caused an increase in the surface roughness (Ra) for all 
the heads and cups for both BIOLOX® Forte and BIOLOX® Delta (Table 3.6). However, there 
was no significant difference in all the surface roughness parameters (Ra, Rsk, Rp and Rv), 
before or after the wear simulation test.  
 
Table 3.6 - The mean surface roughness characterisation parameters before and after wear 
simulation testing for BIOLOX® Forte and BIOLOX® delta heads and cups.  
Pre-test Post-test 
 
Forte Heads Forte Cups Forte Heads Forte Cups 
Ra (µm) 0.004 ± 0.001 0.006 ± 0.001 0.006 ± 0.002 0.015 ± 0.008 
Rp (µm) 0.011 ± 0.003 0.016 ± 0.001 0.018 ± 0.004 0.039 ± 0.008 
Rv (µm) 0.016 ± 0.005 0.022 ± 0.002 0.023 ± 0.007 0.062 ± 0.028 
Rsk -1.475 ± 1.037 -0.780 ± 0.076 -2.226 ± 1.911 -1.370 ± 0.828 
 
Pre-test Post-test 
 
Delta Heads Delta Cups Delta Heads Delta Cups 
Ra (µm) 0.005 ± 0.000 0.007 ± 0.001 0.006 ± 0.001 0.010 ± 0.001 
Rp (µm) 0.013 ± 0.001 0.018 ± 0.004 0.014 ± 0.003 0.029 ± 0.003 
Rv (µm) 0.016 ± 0.002 0.025 ± 0.006 0.018 ± 0.004 0.037 ± 0.002 
Rsk -0.389 ± 0.203 -0.720 ± 0.072 -0.703 ± 0.125 -0.972 ± 0.557 
Note: All values expressed as ±95% confidence interval.  
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3.4.1.3.2 Scanning electron microscopy of wear scar  
A high definition scanning electron microscope was used to obtain high magnification images 
of the wear area of the femoral head bearing surfaces from test 1 (wear stripes of test 1 
components are representative of all the tests). High magnification (x200) images of the 
femoral head articulation surfaces showed a smooth uniform surface in the unworn areas and 
a roughened surface in the adjacent worn areas for both BIOLOX® Forte and BIOLOX® Delta 
(Figure 3.26 & Figure 3.27). The lower magnification (x200) images also showed the overall 
wear track and the distribution of grain pull-outs, which resulted in the formation of pits 
within the surface. Pits ranging between 0-20µm in length were observed for BIOLOX® Forte 
(Figure 3.26), whereas BIOLOX® Delta (Figure 3.27) had larger pits ranging between 0-60µm 
in length at x1000 magnification. The x200 magnification images for BIOLOX® Delta 
showed the boundary between the unworn and worn surface areas that was characterised by 
a line of exposed grains and individual grain pull-outs in the unworn area, which may 
eventually wear away a resemble the unworn surface. 
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Figure 3.26 - SEM images of a BIOLOX® Forte ceramic femoral head post wear simulation (Test 1, 
station 1). The components were tested under 4mm translational mismatch with a 55o (clinical 
equivalence) cup inclination angle for one million cycles. (A) BIOLOX® Forte ceramic femoral head 
coated with iridium over the wear scar; (B) x200 magnification of wear scar and unworn surface; (C) 
x500 magnification of wear scar; (D) x1000 magnification of wear scar.  
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Figure 3.27 - SEM images of a BIOLOX® Delta ceramic femoral head post wear simulation (Test 1, 
station 2). The components were tested under 4mm translational mismatch with a 55o (clinical 
equivalence) cup inclination angle for one million cycles. (A) BIOLOX® Delta ceramic femoral head 
coated with iridium over the wear scar; (B) x200 magnification of wear scar and unworn surface; (C) 
x500 magnification of wear scar; (D) x1000 magnification of wear scar. 
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3.4.1.3.3 Stripe analysis  
Three-dimensional representation of the surface of the heads and cups from test 1 
(representative of all tests as all components were tested under same conditions) were 
generated using a CMM to analyse the characteristics of the wear scar after wear simulation 
for one million cycles. Furthermore, a CMM was used to ascertain the penetration depth of 
the wear scar. The wear stripes for BIOLOX® Forte and BIOLOX® Delta produced under the 
severe edge loading conditions due to dynamic (micro) separation are shown in Figure 3.28. 
The wear stripes on the BIOLOX® Forte heads appeared to be wider compared to the wear 
stripes on the BIOLOX® Delta heads. The wear stripe on the BIOLOX® Forte heads had a 
mean penetration depth of 9.25µm, whereas the wear stripe on the BIOLOX® Delta heads had 
a mean penetration depth of 15.91µm (Figure 3.29). However, there was no significant 
difference in the mean penetration depth between the two different materials. Furthermore, 
there was a larger variation in penetration depths for BIOLOX® Delta compared to BIOLOX® 
Forte, as illustrated by the large error bar (95% confidence limit) in Figure 3.29.           
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Figure 3.28 – Three-dimensional reconstruction of the wear stripe area over three BIOLOX® Forte and 
BIOLOX® Delta femoral heads tested (test 1) under severe edge loading conditions (4mm translational 
mismatch and 45o (clinical equivalence) cup inclination angle).  
  
126 
 
 
Figure 3.29 – Mean penetration depths for BIOLOX® Forte and BIOLOX® Delta tested under severe 
edge loading conditions (4mm translational mismatch and 45o (clinical equivalence) cup inclination 
angle). Error bars represent 95% confidence limits.  
3.4.2 Characterisation of the recovered wear particles 
The characteristics in terms of size and morphology, and the composition of the recovered 
wear particles generated in water were determined and analysed after filtration on 0.015µm 
filter membrane using CFE-SEM and EDX analysis as described in section 2.3.3.2.2. Image 
analysis software (ImageJ version 1.49) was used to measure the Feret diameter (dmax), aspect 
ratio and circularity of the particles (minimum of 150 particles). 
3.4.2.1 Characterisation of ceramic wear particles  
CFE-SEM analysis of the ceramic wear particles generated using the Leeds II hip simulator 
revealed an abundance of stainless steel particle contaminants from all the tests as indicated 
by detection of the iron (Fe) elemental peaks in EDX analysis (Figure 3.30). This was also 
observed for the particles isolated from serum lubricant as described in section 2.4.5, and was 
of great concern for accurately obtaining the characteristics of ceramic wear particles and also 
for subsequent biological testing. Hence, the same imaging technique was also applied here 
whereby EDX analysis was used to identify the elemental composition of every particle 
imaged to ensure that the particles being measured were indeed ceramic i.e. particles that 
showed aluminium (Al) peak for the BIOLOX® Forte samples were measured and particles 
that showed aluminium (Al) and zirconia (Zr) and/or strontium (Sr) peaks for the BIOLOX® 
Delta samples were measured. For example, Figure 3.30 shows an SEM image of the particles 
analysed using EDX and corresponding EDX spectrums (Figure 3.30B, C). The Al 
(aluminium) and O (oxygen) peaks in Figure 3.30B are indicative of alumina, similarly the 
Fe (iron) peaks in Figure 3.30C are indicative of stainless steel. This technique minimised the 
incorrect measurement of contaminating particles, which may otherwise have the same 
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geometry/morphology as ceramic particles and therefore be indistinguishable. The carbon (C) 
peak was due to the carbon coating and the other peaks of silica (Si) and chromium (Cr) may 
have been due to contaminants that were present in the water lubricant from wear simulation 
testing.  
 
 
  
Figure 3.30 - CFE-SEM and EDX analysis of the recovered BIOLOX® Delta ceramic wear particles 
and stainless-steel particle contaminants generated in the Leeds II hip simulator. (A) SEM image of the 
particles analysed using EDX and (B & C) corresponding EDX spectra. (B) EDX spectrum of alumina 
particles as indicated by Al (aluminium) and O (oxygen) peaks and (C) EDX spectrum of stainless-
steel particles as indicated by the Fe (iron) peaks. Pin point EDX analysis of the particles was performed 
at a working distance of 15mm, 10kV and a suitable magnification to maintain focus.  
3.4.2.1.1 Characteristics of BIOLOX® Forte ceramic wear particles  
CFE-SEM analysis of the recovered ceramic wear particles from BIOLOX® Forte revealed 
large micrometre particles (Figure 3.31A) that were irregular/shard-like in shape and small 
nano-scale particles (Figure 3.31B) that were round in morphology. EDX analysis confirmed 
these larger wear particles were indeed comprised of alumina as indicated by the elemental 
peaks of aluminium (Al) and oxygen (O) (Figure 3.32B). The presence of stainless steel 
particle contaminants was also detected, which were indicated by the elemental peaks of iron 
(Fe) in the EDX spectrum (Figure 3.32C). EDX analysis confirmed that the smaller nano-
scale particles were also alumina as indicated by the elemental peaks of aluminium (Al) and 
oxygen (O) (Figure 3.33). The carbon (C) peak was due to the carbon coating and the tungsten 
(W) peak was due to the sodium polytungstate density gradient medium that was used to 
separate the wear particles from the low-density contaminants.  
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The frequency as a function of size of the recovered particles is presented in Figure 3.34, 
which revealed a bimodal size distribution. The larger micron and sub-micron size particles 
ranged between 100-4000nm with a mean size of 736 ± 99.45nm (±95% CL), whereas the 
small nano-scale particles ranged between 10-90nm with a mean size of 50 ± 7.11nm (±95% 
CL). The BIOLOX® Forte wear particles had a mode size distribution of 300-400nm for the 
larger particles and a mode size of 40-50nm for the smaller nano-scale particles. The mean 
feret diameter, mean aspect ratio and mean circularity values (value of 1.0 indicates a perfect 
circle) are shown in Table 3.7. The larger particles (100 - >5000nm) had a higher mean aspect 
ratio (1.52 ± 0.06), thus they were more elongated and irregular in shape compared to the 
smaller (0-100nm) nano-scale particles (1.34 ± 0.04), which were more round and consistent 
in shape. The smaller (0-100nm) nano-scale particles had a higher mean circularity value 
(0.91 ± 0.01) compared to the larger particles (0.76 ± 0.02), which indicated that the smaller 
nano-scale particles were more circular in shape than the larger particles.   
 
  
Figure 3.31 - CFE-SEM images of wear particles generated from BIOLOX® Forte using the Leeds II 
hip simulator. (A) SEM image of large micron size alumina particles and (B) smaller nano-scale 
alumina. The larger particles were imaged at 10kV (secondary electrons; SE) voltage, working distance 
of 15mm and 15K magnification to capture groups of large particles. The smaller nano-scale particles 
were imaged at 1kV (deceleration mode) voltage, working distance of 2-3mm and at 60k, 90k and 150k 
magnification.  
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Figure 3.32 - CFE-SEM and EDX analysis of the recovered BIOLOX® Forte ceramic wear particles 
and stainless-steel particle contaminants generated using the Leeds II hip simulator. (A) SEM image 
of the larger alumina particles analysed using EDX and (B & C) corresponding EDX spectra. Pin point 
EDX analysis of the particles was performed at a working distance of 15mm, 10kV and a suitable 
magnification to maintain focus. EDX spectrum B showed elemental peaks of Al (aluminium) and O 
(oxygen), which is indicative of alumina ceramic particles. EDX spectrum C showed elemental peaks 
of Fe (iron), which is indicative of stainless steel. The W (tungsten) peak was from the particle isolation 
procedure.  
 
 
Figure 3.33 - CFE-SEM and EDX analysis of the recovered BIOLOX® Forte ceramic wear particles 
(A) SEM image of the nano-scale alumina particles analysed using EDX and (B) corresponding EDX 
spectrum. Pin point EDX analysis of the particles was performed at a working distance of 15mm, 10kV 
and a suitable magnification to maintain focus. The W (tungsten) peak was from the particle isolation 
procedure. 
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Figure 3.34 - Frequency size distribution of BIOLOX® Forte ceramic wear particles that were generated 
in water lubricant using the Leeds II hip simulator under edge loading conditions due to dynamic 
separation between the head and cup centres. A minimum of 150 particles were measured. 
 
Table 3.7 – Morphology (ferret diameter, aspect ratio and circularity) values for BIOLOX® 
Forte ceramic wear particles generated in water. 
 BIOLOX
®
 Forte wear debris 
generated in water; Larger 
particles 
(100 - >5000nm) 
BIOLOX
®
 Forte wear debris 
generated in water; Smaller 
particles 
(0 - 100nm) 
Feret diameter (nm) 736.48 ± 99.45 50.16 ± 7.11 
Aspect ratio 1.52 ± 0.06 1.34 ± 0.04 
Circularity 0.76 ± 0.02 0.91 ± 0.01 
Note: All values expressed as mean ±95% Confidence Interval. 
3.4.2.1.2 Characteristics of BIOLOX® Delta ceramic wear particles 
CFE-SEM analysis of the recovered ceramic wear particles from BIOLOX® Delta revealed 
large micrometre particles (Figure 3.35A) that were irregular/shard-like in shape and smaller 
nano-scale particles (Figure 3.35B) that were round in morphology. EDX analysis confirmed 
the larger micron-size particles were alumina with elemental peaks of aluminium (Al) and 
oxygen (O) (Figure 3.36B), whereas the smaller nano-scale particles consisted of alumina and 
Zirconia as indicated by the elemental peaks of aluminium (Al) and zirconia (Zr) (Figure 
3.37B). The presence of stainless steel particle contaminants was also detected, which was 
indicated by the elemental peaks of iron (Fe) in the EDX spectrums (Figure 3.36C). The 
carbon (C) peak was due to the carbon coating and the chromium (Cr) peak may have been 
from stainless-steel wear particles as it is present in trace amounts.   
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
F
re
q
u
en
cy
 n
u
m
b
er
 (
%
)
Size dmax (nm)
131 
 
The frequency as a function of size for the recovered BIOLOX® Delta particles generated in 
water is presented in  
Figure 3.38, which revealed a bimodal size distribution. The larger micron and sub-micron 
size particles ranged between 200-20,000nm, with a mean size of 3900 ± 447.52nm (±95% 
CL), whereas the smaller nano-scale particles ranged between 20-90nm with a mean size of 
48 ± 1.41nm (±95% CL). The BIOLOX® Delta particles had a mode size distribution of 2000-
4000nm for the larger particles and a mode size of 40-50nm for the smaller nano-scale 
particles. The mean ferret diameter, mean aspect ratio and mean circularity values (value of 
1.0 indicates a perfect circle) are shown in Table 3.8. The larger particles (100 - >5000nm) 
had a higher mean aspect ratio (1.58 ± 0.08), which indicated that they were more elongated 
and irregular in shape compared to the smaller (0-100nm) nano-scale particles (1.27 ± 0.02), 
as they were more round and consistent in shape. The smaller (0-100nm) nano-scale particles 
had a higher mean circularity value (0.91 ± 0.01nm) compared to the larger particles (0.68 ± 
0.02nm), which indicated the smaller nano-scale particles were more circular in shape than 
the larger particles. The same pattern was observed for the BIOLOX® Delta ceramic wear 
particles generated in serum lubricant. An independent-samples t-test was conducted to 
compare the size distribution (feret diameter) and morphology (aspect ratio and circularity) 
of the BIOLOX® Delta ceramic wear particles generated in water with those generated in 
serum (section 3.3.4.2). Particle morphology of the BIOLOX® Delta ceramic wear particles 
was unaffected by the lubricant i.e. no statistically significant differences in the aspect ratio 
(p=0.571) and circularity (p=0.088) values were observed between the BIOLOX® Delta 
ceramic wear particles generated in serum and water. Moreover, the particle size distribution 
(feret diameter) for the BIOLOX® Delta wear particles generated in water and serum were 
also statistically similar (p=0.057).  
  
Figure 3.35 - CFE-SEM images of wear particles generated from BIOLOX® Delta using the Leeds II 
hip simulator. SEM images of (A) large micron size alumina particles and (B) smaller nano-scale 
alumina and zirconia particles. The larger particles were imaged at 10kV voltage, working distance of 
15mm and 3.5K magnification to capture groups of the particles. The smaller nano-scale particles were 
imaged at 1kV (deceleration mode) voltage, working distance of 2-3mm and 60k, 90k and 150k 
magnification.  
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Figure 3.36 - CFE-SEM and EDX analysis of the recovered BIOLOX® Delta ceramic wear particles 
and stainless-steel particle contaminants generated using the Leeds II hip simulator. (A) SEM image 
of the large alumina particles analysed using EDX and (B & C) corresponding EDX spectra.  EDX 
spectrum B showed elemental peaks of Fe (iron), which is indicative of stainless steel. EDX spectrum 
C showed elemental peaks of Al (aluminium) and O (oxygen), which is indicative of alumina ceramic 
particles. Pin point EDX analysis of the particles was performed at a working distance of 15mm, 10kV 
and a suitable magnification to maintain focus.  
 
 
Figure 3.37 - CFE-SEM and EDX analysis of the recovered BIOLOX® Delta ceramic wear particles. 
(A) SEM image of the nano-scale alumina and zirconia particles analysed using EDX and (B) 
corresponding EDX spectrum. Pin point EDX analysis of the particles was performed at a working 
distance of 15mm, 10kV and a suitable magnification to maintain focus.  
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Figure 3.38 - Frequency size distribution of BIOLOX® Delta ceramic wear particles that were generated 
in water lubricant using the Leeds II hip simulator that were generated under edge loading conditions 
due to dynamic separation between the head and cup centres. A minimum of 150 particles were 
measured. 
 
Table 3.8 – Mean size (feret diameter) and morphology (aspect ratio and circularity) values 
for BIOLOX® Delta ceramic wear particles generated in water and serum. 
  
 
BIOLOX
®
 Delta 
wear debris 
generated in water; 
Larger particles 
(100 - >5000nm) 
BIOLOX
®
 Delta 
wear debris 
generated in 
water; Smaller 
particles 
(0 - 100nm) 
 
BIOLOX
®
 Delta 
wear debris 
generated in 
serum; Larger 
particles 
(100 - >5000nm) 
BIOLOX
®
 Delta 
wear debris 
generated in serum; 
Smaller particles 
(0 - 100nm) 
Feret diameter (nm) 3877.53 ± 447.52 48.19 ± 1.41 2308.11 ± 243.58 43.73 ± 0.97 
Aspect ratio 1.58 ± 0.08 1.265 ± 0.02 1.47 ± 0.02 1.29 ± 0.01 
Circularity 0.68 ± 0.02 0.913 ± 0.01 0.80 ± 0.01 0.91 ± 0.02 
Note: All values expressed as mean ±95% Confidence Interval. 
3.4.2.2 Percentage ratio between ceramic and stainless-steel wear particles using 
EDX elemental mapping 
The mixed population of ceramic and stainless-steel wear particles recovered from the water 
lubricant of both BIOLOX® Forte and BIOLOX® Delta simulations were analysed using EDX 
elemental mapping to calculate the percentage ratio between the ceramic wear particles and 
stainless-steel particle contaminants. The recovered wear particles were filtered onto a 0.015 
filter membrane and analysed using CFE-SEM and EDX analysis. Five random areas of the 
filter membrane were analysed for elements (wt %) iron (Fe) for the stainless-steel wear 
particles and alumina (Al) for the ceramic wear particles. An average of the weight % for each 
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element was calculated, which are presented in Figure 3.39A and Figure 3.39B for both 
BIOLOX® Forte and BIOLOX® Delta, respectively.  
Both types of ceramic had an approximately 50%:50% ratio between ceramic wear particles 
and stainless-steel wear particles. EDX mapping of particle suspension generated in the 
BIOLOX® Forte test stations demonstrated 44.13 ± 31.48% of aluminium (Al), which was 
indicative of alumina ceramic. EDX mapping of particle suspension generated in the 
BIOLOX® Delta test stations demonstrated 47.06 ± 42.75% of aluminium (Al), which was 
indicative of alumina ceramic.   
   
 
 
Figure 3.39 – Percentage (weight %) of ceramic and stainless-steel wear particles present in the (A) 
BIOLOX® Forte and (B) BIOLOX® Delta final particle suspensions. Aluminium (Al) was indicative 
of ceramic and iron (Fe) was indicative of stainless-steel. Error bars represent 95% confidence limits. 
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3.4.2.3 Characteristics of CoCr wear particles  
The clinically-relevant CoCr nano-particles appeared as large agglomerates that were up to 
10µm in size at low magnification (x5k) (Figure 3.40A). At higher magnifications of x90k 
and x150k, small nano-scale particles were revealed that were round to oval in morphology 
(Figure 3.40B, C). The frequency as a function of particle size of the recovered CoCr nano-
particles is presented in Figure 3.41. Characterisation of the CoCr nano-particles indicated 
that the particles ranged between 30-200nm, with a mean size of 66.01 ± 2.65nm (±95% CL) 
and mode size of 50-70nm.  
 
  
  
Figure 3.40 - CFE-SEM images of agglomerated CoCr nano-particles generated using the six-station 
pin-on-plate wear simulator. The particles were imaged at (A) 5K, (B) 90K and (C) 150K magnification 
with a 1kV (deceleration mode) voltage and working distance of 2-3mm.  
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Figure 3.41 - Frequency size distribution of clinically-relevant CoCr nano-particles generated using the 
six-station pin-on-plate wear simulator. The right Y-axis shows the cumulative size frequency of the 
particles (red line). A minimum of 150 particles were measured.  
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3.5 Discussion  
This study had the following two aims: - 
1. To generate clinically-relevant ceramic (alumina and composite ZTA) and CoCr wear 
particles. 
2. To compare the characteristics of the ceramic wear particles generated in water to 
those generated in serum. 
In order to meet these aims, BIOLOX® Forte and BIOLOX® Delta CoC bearings were used 
to generate ceramic wear particles in water lubricants using the Leeds II hip simulator. Severe 
edge loading conditions were employed to maximise the wear rates and volume of ceramic 
wear particles produced. The characteristics of the ceramic wear particles generated in water 
were compared with ceramic wear particles generated in serum lubricants under similar 
kinematic conditions in the same Leeds II hip simulator. The findings of this study are divided 
into the following sections: - 
1. Wear rates of CoC bearings  
2. Dynamic separation 
3. Surface analysis of CoC bearings 
4. Characteristics of recovered wear particles 
5. Limitations of the study 
3.5.1 Wear rates of CoC bearings  
The wear tests conducted in this study produced mean wear rates for BIOLOX® Delta (0.42 
± 0.66mm3 per million cycles; test 1 only) that were comparable with previous studies (0.32 
± 0.04 mm3/million cycles), which employed similar test conditions i.e. severe edge loading 
conditions caused by dynamic separation due to translational mismatch in the centres of 
rotation of the femoral head and acetabular cup (Lancaster-Jones et al., 2016). However, it is 
important to note that in the present study, water was used as the lubricant, whereas previous 
studies used 25% (v/v) new-born calf serum. The mean wear rates for BIOLOX® Forte ranged 
between 0.11 ± 0.5 and 1.36 ± 0.97mm3 per million cycles and were also similar to the wear 
rates reported by Stewart et al. (2001) for BIOLOX® Forte CoC bearings that produced overall 
mean wear rates of 0.2 and 1.84mm3/ million cycles under mild and severe microseparation 
conditions, respectively. The variation in microseparation conditions from mild to severe was 
controlled by altering the swing phase load from 400N for mild to 50N for severe separations. 
There were no significant differences in the mean wear rates (test 1 only) between the two 
different material types in the present study (the mean wear rates for the two different 
materials was not compared in the other tests as the mean wear rates for BIOLOX® Delta was 
not calculated due to complications during the tests that resulted in less than n=3 repeats). 
The cumulative wear volumes produced from all four tests were 6.30mm3 and 6.20mm3 for 
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BIOLOX® Forte and BIOLOX® Delta, respectively. However, due to the complications 
experienced in station 6 (BIOLOX® Delta) from tests 3 & 4, the volumes of wear for this 
station were excluded from the total cumulative wear volume, resulting in a final volume of 
4.70mm3. These wear volumes were believed to be sufficient for subsequent biological impact 
testing as it was calculated that approximately 1mm3 of ceramic wear particles was required 
to complete all four biological assays for PBMNCs from five donors and cytotoxicity testing 
using L929 cells. Hence, no further wear simulation was required. 
The severity of the edge loading conditions (4mm translational mismatch with 65o (clinical 
equivalence) cup inclination angle) applied during test 2 resulted in fracturing of the 
BIOLOX® Delta acetabular liners on stations 4 and 6. The fracturing of the BIOLOX® Delta 
components during in vitro wear simulation testing was unprecedented and in contrast with 
previous studies (Al-Hajjar et al., 2010; Al-Hajjar, Fisher, Tipper, et al., 2013a; Al-Hajjar, 
Jennings, Begand, et al., 2013b; O’Dwyer Lancaster-Jones et al., 2017), hence it was believed 
that the fracturing may have been due to the adverse test conditions employed in the test 
combined with the use of water as the lubricant, which may have increased friction between 
the head and cup during articulation. However, it has been reported that the coefficient of 
friction in water lubricant is relatively similar to that when 25% (v/v) new-born calf serum 
was used to test BIOLOX® Delta discs against a high purity alumina ball using a reciprocating 
ball-on-flat tribometer (Ma and Rainforth, 2012). Furthermore, the thickness of the 32mm 
diameter BIOLOX® Delta acetabular cups used in these tests, was smaller at the rim than the 
36mm components used in previous studies (Al-Hajjar et al., 2010; Al-Hajjar, Fisher, Tipper, 
et al., 2013a; Al-Hajjar, Jennings, Begand, et al., 2013b; Lancaster-Jones et al., 2016), which 
may have been a contributing factor towards failure of the implants. Nevertheless, this is 
highly speculative and further tests would need to be conducted to evaluate the mechanism of 
this failure. Due to the fracturing phenomenon, the medial-lateral mismatch between the head 
and the cup was reduced to 3mm in all subsequent tests, in order to decrease the magnitude 
of dynamic separation and risk of fracturing, whilst ensuring the highest possible volume of 
ceramic wear debris was being generated.  
3.5.2 Dynamic separation 
The medial-lateral displacement or dynamic (micro) separation was measured for each station 
using a LVDT and the results demonstrated a positive correlation between the dynamic 
(micro) separation and wear rate. This was supported by Lancaster-Jones et al. (2016) who 
reported the magnitude of dynamic separation increased as the level of translational mismatch 
between the head and cup increased from 1 to 4mm. These authors reported that dynamic 
separation was at its highest when the 4mm level of mismatch was coupled with high cup 
inclination angles (55-65o). The magnitudes of dynamic separation observed in the present 
139 
 
study were in a similar range to those measured clinically in other studies (Lombardi et al., 
2000; Tsai et al., 2014). Lombardi et al., (2000) reported an average hip separation of 1.2mm 
for stance phase, which increased to 2.4mm during swing phase and recommended that these 
phenomena should be included in hip simulator studies to replicate clinically-relevant wear 
patterns observed in vivo and to assess the detrimental effects that these conditions may pose 
to the components. However, it is important to mention that the separation measured in the 
present study was the medial-lateral separation between the head and the cup, whereas 
Lombardi et al. (2000) reported the total separation between the head and cup centres.  
3.5.3 Surface analysis of wear scar 
Surface analysis of the heads and cups using surface profiliometery did not reveal any 
significant differences in terms of surface roughness, before and after the wear simulation 
tests. The traces post-test may have included unworn areas due to the narrow stripe of wear 
and the curvature of the trace, which may have resulted in the underestimation of surface 
roughness values. Nevertheless, SEM analysis of the surface of the ceramic head components 
revealed both BIOLOX® Forte and BIOLOX® Delta had pit formations over the worn area, 
likely to be as a result of grain pull-out due to edge loading. This was in agreement with 
previous studies (Nevelos et al., 2000; Shishido et al., 2006; Affatato et al., 2011; Ma and 
Rainforth, 2010; Affatato et al., 2012), where wear stripe formation was attributed to inter-
granular fracture and gross deformation of the alumina. Ma and Rainforth (2010) reported 
that BIOLOX® Delta subjected to water lubricated reciprocating wear experienced two 
lubrication regimes during testing, which included full fluid-film lubrication and mixed 
lubrication, the latter being more likely for this study as contact is required to produce the 
magnitude of wear observed in the present study. Fluid-film lubrication occurs in normal hip 
articulation where the articulating surfaces are completely separated by a continuous lubricant 
film, which results in differential wear between the grains in the form of pits and grooves. 
Differential wear is mainly associated with tribochemical wear and occurs under standard 
conditions. The wear from mechanical damage is associated with edge loading conditions, 
which results in wear scar formation. The formation of pits is from inter-granular pull-out of 
single alumina grains, which causes subsequent fracturing around the pit and thus results in 
the initiation of stripe wear formation (Ma and Rainforth, 2010; Ma and Rainforth, 2012).  
The SEM images of the wear stripe for the BIOLOX® Delta femoral head from test 1 showed 
the formation of larger pits, compared to BIOLOX® Forte. However, high magnification of 
the wear stripe on the BIOLOX® Forte head showed a different superficial grain 
microstructure compared to BIOLOX® Forte, where there was a wider distribution of pits in 
the worn surface area indicating higher incidence of inter-granular fracture of the alumina. 
The edge loading conditions caused an inter-granular fracturing wear mechanism in both 
140 
 
materials that resulted in more surface damage on the BIOLOX® Forte femoral head, which 
may be due to the lower material toughness compared to BIOLOX® Delta. However, a 
possible reason for the larger pits observed in the BIOLOX® Delta heads may be due to the 
loss of both alumina and zirconia grains. The size of the pits were much greater than the size 
of alumina grains, suggesting loss of both grain types resulting in the formation of enlarged 
pits (Ma and Rainforth, 2010). Furthermore, the coordinate measurement machine was used 
to produce a three-dimensional construct and provide characteristic information about the 
wear stripes generated on the femoral heads and acetabular cups after wear simulation testing. 
The wear stripe on the BIOLOX® Forte heads had a lower mean penetration depth of 9.25µm, 
compared to the BIOLOX® Delta heads, which had a mean penetration depth of 15.91µm for 
the wear stripe. However, there was no significant difference in the mean penetration depth 
between the two different materials. The wear stripes on the BIOLOX® Forte heads appeared 
to be wider compared to the wear stripes on the BIOLOX® Delta heads, indicating a larger 
wear area due to inter-granular fracturing. The small wear area on the BIOLOX® Delta heads 
may have been due to its improved wear properties, making it more resistant to harsher 
conditions, which younger and more active patients may exert on hip prostheses.  
3.5.4 Characterisation of recovered wear particles 
The ceramic wear particles generated in water lubricant using the Leeds II hip simulator were 
recovered using the density gradient separation technique described in chapter 2 (section 
2.3.3.2.2), and analysed using CFE-SEM and EDX, which revealed an abundance of stainless 
steel particle contaminants present in both BIOLOX® Forte and BIOLOX® Delta recovered 
particle samples. The presence of large volumes of stainless steel particle contaminants 
masked the very low volume of ceramic wear particles generated, making it extremely 
challenging to identify and image the ceramic particles. Hence, the ceramic particles were 
identified using the technique described in section 2.3.6.1, whereby every particle was 
analysed using EDX analysis to confirm its elemental composition in order to ensure that it 
was indeed comprised of ceramic. Characterisation of the wear particles generated from 
BIOLOX® Forte revealed a bimodal size range, with large shard-like shaped particles that 
ranged between 100-4000nm (mean size: 736.48 ± 99.45nm), and smaller round granular 
particles that ranged between 10-90nm (mean size: 50.16 ± 7.11nm), which were observed as 
agglomerations or as single particles. These particles had a similar size distribution to those 
isolated from retrieved tissues by Hatton et al. (2001) using laser micro-dissection. These 
authors used SEM to identify the large micron sized particles and TEM to identify nano-scale 
particles. They reported the presence of large polygonal-shaped micron size alumina particles 
that ranged between 46-3200nm (mean size; 438 ± 325nm) and smaller nano-scale alumina 
particles that ranged between 5-90nm (mean size; 24 ± 19nm).  
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Characterisation of the wear particles generated from BIOLOX® Delta components also 
revealed a bimodal size range, with large shard-like alumina particles that ranged between 
200-20,000nm (mean size: 3877.53 ± 447.52 nm), and smaller round granular 
alumina/zirconia particles that ranged between 20-90nm (mean size: 48.19 ± 1.41nm) that 
were agglomerated. Since no previous studies have isolated BIOLOX® Delta ceramic wear 
particles from retrieved tissues, the size distribution and morphology of these particles was 
compared to the BIOLOX® Delta ceramic wear particles isolated from hip simulator serum 
lubricants in chapter 3. The isolated particles were generated from BIOLOX® Delta CoC 
bearings under severe edge loading conditions using 25% (v/v) serum as the lubricant as these 
conditions are believed to reproduce clinically-relevant wear rates, wear patterns (stripe wear) 
and wear mechanisms as those observed in vivo (Nevelos et al., 2000a). There were no 
significant differences in size distribution and morphology between the BIOLOX® Delta wear 
particles generated in serum or water. The BIOLOX® Delta ceramic wear particles generated 
in serum ranged between 100-32,980nm (mean size: 2308.11 ± 243.58) for the larger alumina 
particles and 10-90nm (mean size: 43.73 ± 0.97nm) for the nano-scale zirconia/alumina 
particles. Despite the use of water as the lubricant, the comparison with ceramic particles 
isolated from tissue for BIOLOX® Forte and from hip simulator serum lubricant for 
BIOLOX® Delta allowed validation of the characteristics of these particles as being 
representative of those generated in vivo, thus successfully addressing the aim of this chapter. 
Having said that, the contamination issues with stainless steel wear particles was not ideal 
and a limitation that needs to be considered for in vitro particle generation using hip 
simulators.  
CoCr nano-scale wear particles were generated using a six-station pin-on-plate wear simulator 
as these conditions have been used previously in the literature for simple pin-on-plate wear 
studies and represent the loading and kinematic conditions of a standard gait cycle in the hip 
(Jin et al., 2000). Hip simulators have also been used previously to generate clinically-relevant 
CoCr nano-particles using 25% (v/v) lubricant serum (Brown et al., 2007). However, as 
mentioned previously the limitations of particle isolation methods and the problem of residual 
serum proteins and endotoxins in causing cell activation necessitated an alternative solution. 
Many previous studies have used a simplified pin-on-plate wear simulator to generate 
clinically-relevant CoCr wear particles for subsequent biological testing (Germain et al., 
2003a; Behl et al., 2013; Papageorgiou et al., 2014). Characterisation of the CoCr nano-
particles revealed round to oval particles that ranged between 30-200nm (mean size; 66.01 ± 
2.65nm), with a mode size of 50-70nm. This was similar to the reported literature where 
Doorn et al. (1998) used an enzymatic tissue digestion method to isolate CoCr wear particles 
from periprosthetic tissues obtained from 13 patients with MoM hips followed by 
characterisation using TEM. This study revealed metal wear particles in the size range of 51-
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116 nm, with a mean size of 81 nm. Furthermore, an in vitro study by Firkins et al. (2001) 
reported the particles generated in the hip simulator were round/oval and of uniform shape 
with sizes in the range of 25-36 nm. These studies therefore provide evidence that wear 
particles generated from MoM hips are consistently in the nanometre size range and uniform 
in size and shape. The small size of the wear particles gives rise to large numbers of particles 
which causes great concern over the possible distribution of these small particles in the body, 
and their biological effects on cells and tissues. Metal particles have been shown to 
disseminate throughout the body and have been found in the lymph nodes, liver, spleen and 
bone marrow (Case et al., 1994). Furthermore, CoCr particles have been shown to cause 
reduced cell viability, TNF- release, DNA damage and oxidative stress (Fleury et al., 2006; 
Tsaousi et al., 2010; Papageorgiou et al., 2014; Posada et al., 2015). Hence, the in vitro 
generated CoCr wear particles were used as a positive particle control in the present study for 
biological impact testing experiments.  
3.5.5 Limitations of study 
The use of water as the lubricant to generate wear particles in vitro eradicates the risk of 
residual proteins and adherent endotoxins that can cause positive mis-leading results, which 
may have not been a response due to the wear particles. However, the present study has shown 
that contamination by stainless steel wear particles in the hip simulator complicated the initial 
purpose of generating ceramic wear debris in vitro. The resultant ceramic particle suspensions 
consisted of both ceramic wear debris and stainless-steel wear particles. The biological impact 
of the stainless-steel wear particles will therefore need to be investigated before commencing 
the in vitro biological testing of the ceramic wear debris. Furthermore, stainless wear particle 
controls will need to be included in all biological tests to elucidate the response to the 
stainless-steel wear particles and the ceramic wear particles as the particles presented to the 
cells will be a mixed population of both ceramic and metal particles. This highlighted the 
limitation of hip simulators when used to generate wear particles in vitro. A more efficient 
technique needs to be developed in order to produce a pure yield of clinically-relevant ceramic 
wear debris in vitro.  
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3.6 Summary of findings 
• Severe edge loading conditions caused by dynamic separation due to translational 
mismatch between the centres of rotation of the femoral head and acetabular cup resulted 
in stripe wear on the CoC bearings. 
• Water lubricant did not alter the characteristics (size and morphology) of the ceramic wear 
particles generated, thus producing ceramic wear particles that were representative of 
those generated in vivo. 
• In vitro wear testing of the CoC bearings using the hip simulator produced unwanted 
stainless-steel wear particles, which contaminated the water lubricant and resulted in a 
mixed population of ceramic and stainless-steel wear particles that will be used for 
subsequent biocompatibility testing.   
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CHAPTER 4 
 
4 Biological impact of ceramic hip replacements 
4.1 Introduction 
The biological activity and mechanisms by which cells interact with ceramic wear particles 
released from CoC THRs is not currently fully understood. Wear simulation studies have 
provided a better understanding of the wear mechanisms of UHMWPE and metal bearings, 
and have also provided a plentiful supply of clinically relevant wear particles that could be 
used for in vitro cell studies. Hence, a considerable amount of literature has been published 
on the biological activity of wear particles generated from MoP and MoM THRs, such as the 
cytotoxic effects and the release of inflammatory cytokines from cells in response to wear 
particles. However, it is important to remember the conditions of these assays do not always 
consistently represent clinically relevant conditions. Biological assays using the conventional 
two-dimensional monolayer cells cultured on flat substrates do not consider the natural three-
dimensional environment of cells in vivo, such as other surrounding cells, extra-cellular 
matrix, blood supply and normal supply of nutrients. Hence, it is extremely important to 
consider these factors when extrapolating in vitro results to predict the phenomena in vivo and 
avoid providing misleading and nonpredictive data for in vivo responses (Edmondson et al., 
2014).  
The ideal THR bearing would consist of an articulating surface that has virtually no wear or 
even if debris were produced, a host immune response should not be evoked (Rajpura et al., 
2014). Biocompatibility is described as “the ability of a material to perform with an 
appropriate host response in a specific application” (Williams, 1999). High density, pure 
alumina is used in load-bearing applications such as hip prostheses because of its excellent 
corrosion resistance, biocompatibility, high wear resistance and high strength (Ratner et al., 
2012). Early studies of the evaluation of the biocompatibility of alumina considered this 
material to be bioinert and so alumina was used as a reference material for biocompatibility 
tests. A bioinert material is defined as a material that induces no tissue response post-surgical 
implantation. While this may be true for alumina in bulk form, the same cannot be said when 
alumina is in particulate form. Indeed, this applies to majority of biomaterials, whereby they 
may elicit an immune response when presented to tissues in particulate form. After 
implantation of alumina in bulk form, a connective tissue capsule is formed at the ceramic-
tissue interface. The features of this encapsulating membrane are indicative of a minimal 
response i.e. many fibroblasts and few inflammatory cells, nevertheless this shows that 
alumina ceramic implants can elicit and maintain a foreign body reaction (Christel, 1992). 
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Having said that, no material is bioinert, instead the characteristics of that induced response 
in terms of cells present at the material-tissue interface can either be categorised as 
biocompatible or cytotoxic (Christel, 1993).  
Wear is an inevitable phenomenon of artificial joint replacements and so the pre-clinical 
testing of any new materials for joint replacements must include an analysis of the wear 
particle characteristics and their biological impact. However, this has been challenging for 
ceramic hip replacements, particularly for ZTA composite ceramic hips (BIOLOX® Delta), 
due to their extremely low wear rates that has made it difficult to generate and recover enough 
clinically-relevant ceramic wear particles for biocompatibility testing. For these reasons, no 
studies have reported the characteristics or biological impact of the wear debris generated 
from ZTA composite ceramic bearings. Wear particles produced by alumina ceramic-on-
ceramic bearings have been reported to cause minimal immunological responses, with low 
cytotoxicity and inflammatory potential (Germain et al., 2003a; Hatton et al., 2003a). 
However, comprehensive immunological and biological studies are yet to be completed for 
the composite BIOLOX® Delta CoC hip replacements due to difficulties in isolating the very 
low volume of clinically relevant wear debris generated by such materials in vitro. Due to the 
extremely low wear rates of CoC bearings, the majority of the previous studies (Nagase et al., 
1995; Catelas et al., 1998; I Catelas, Petit, Zukor, et al., 1999; Nkamgueu et al., 2000a; Petit 
et al., 2002; Warashina et al., 2003; Granchi et al., 2004; Tsaousi et al., 2010; Faye et al., 
2017) have used commercially-obtained ceramic powders to test the in vitro biological 
activity of ceramic particles. The main finding from these studies indicated that the reactivity 
of the commercially-obtained ceramic particles was dose dependent in that cell death 
increased with the concentration of alumina particles. Whilst these studies provided vital 
information about the biological response to ceramic wear particles in vitro, it is important to 
consider that the characteristics i.e. size and shape of these commercially-obtained ceramic 
particles may not accurately represent ceramic wear debris generated in vivo. This is 
extremely important as the relative features of wear particles in terms of their size, 
morphology, quantity and composition determines the severity of the biological response. The 
manufacturing process involves compressing and sintering the ceramic powder to form the 
final components. Thus, the size of the particles in the powder may be different to the particles 
released from the microstructure of the ceramic component.  
The introduction of microseparation by Nevelos et al. (2000) into in vitro wear testing of CoC 
bearings resulted in stripe wear production, which was often observed on retrieved CoC hip 
implants. These authors for the first time reproduced clinically-relevant wear patterns, wear 
rates and wear mechanisms as those observed in vivo (Nevelos et al., 1999; Nevelos, 
Prudhommeaux, et al., 2001; Hatton et al., 2002; Tipper et al., 2002a). The wear particles 
from composite ceramic hip replacements generated under microseparation conditions are 
146 
 
bimodal in size as demonstrated by the work in chapter 3. The literature review revealed only 
two previous studies (Hatton et al., 2003b; Germain et al., 2003a) used clinically-relevant 
ceramic wear particles to test the biocompatibility of alumina ceramic hip replacements. 
Hatton et al., (2003) reported that a larger volume (500µm3) of clinically-relevant alumina 
ceramic wear particles than alumina powder (100µm3) was required to stimulate the release 
of the inflammatory TNF-α (cytokine) from PBMNCs. Similar findings by Germain et al. 
(2003) reported high particle volumes of clinically-relevant alumina ceramic wear particles 
were required to induce cytotoxic effects in U937 human histocytes. These studies 
demonstrated the potential cytotoxic and inflammatory effects of wear particles from alumina 
ceramic hip replacements. However, given the low wear rates of CoC bearings, it is unlikely 
that these high volumes (100-500µm3 per cell) will be produced in vivo, even under mal-
positioning conditions.  
A range of biocompatibility tests can be used to evaluate the biological impact of particulate 
wear debris. The FDA recommends that biocompatibility testing should include the 
identification of any toxicities or adverse effects in response to the material of the medical 
device as per ISO 10993-5 “Biological evaluation of medical devices – Part 5: Tests for in 
vitro cytotoxicity”. The FDA also published a document; Use of International Standard ISO 
10993-1, "Biological evaluation of medical devices - Part 1: Evaluation and testing within a 
risk management process" (Food and Drug Administration, 2016), which recommends the 
consideration of “biological hazards arising from any mechanical failure… For example, if 
coating particles or wear debris are released from a device, those particles could lead to a 
biological response...” (Food and Drug Administration, 2016). However, no specific tests for 
the evaluation of the biological effects of wear particles resulting from mechanical failure was 
specified. Nevertheless, biocompatibility testing of materials as a result of device mechanical 
failure typically involves cytotoxicity evaluation using L929 murine fibroblast cells and a 
suitable biological assay. For example, the cytotoxic effects of a material can be assessed by 
measuring the amount of ATP, which is used as a marker for cell viability because it is present 
in all metabolically active cells. ATP decreases very rapidly within cells when they undergo 
necrosis or apoptosis which can occur in response to cytotoxic materials (Crouch et al., 1993). 
Due to previous experience with UHMWPE wear particles it is known that wear particles 
induce an inflammatory response, whereby macrophages release pro-inflammatory cytokines 
and other mediators of inflammation which stimulate osteoclastic bone resorption leading to 
osteolysis (Ingham and Fisher, 2000). Therefore, it seems pertinent for studies to investigate 
the release of inflammatory cytokines after exposure of cells to other particle types/materials. 
A sandwich ELISA or enzyme-linked immunosorbent assay is a sensitive technique used in 
the previous studies (Table 4.14) to identify the concentration of an antigen such as TNF-α 
that is present in the supernatants collected from the cells. The antigen of interest is quantified 
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between two layers of antibodies i.e. the capture and detection antibody, which bind to the 
non-overlapping epitopes on the antigen. An enzyme binds to this complex, which catalyses 
a substrate added during the process resulting in a colour change, the intensity of which is 
used to determine the concentration of the cytokine in the sample (Grebenchtchikov et al., 
2005).  
Majority of the previous studies (Nagase et al., 1995; Catelas et al., 1998; I Catelas, Petit, 
Zukor, et al., 1999; Nkamgueu et al., 2000a; Petit et al., 2002; Warashina et al., 2003; Germain 
et al., 2003a; Hatton et al., 2003a; Granchi et al., 2004; Tsaousi et al., 2010; Faye et al., 2017) 
demonstrated that ceramic particles, be it clinically-relevant or commercially-obtained have 
demonstrated a benign cellular response, with low cytotoxicity and inflammatory potential at 
the volumes or doses representative of the wear rates of CoC bearings. Therefore, due to the 
low wear rates of CoC THRs, the cytotoxic and inflammatory effects of ceramic wear particles 
was not of real concern. However, the subtle changes that may occur intracellularly because 
of phagocytosis of wear particles also need to be investigated. Hence, the evaluation of DNA 
damage is another common test listed in previous studies, which have reported genotoxicity 
in response to metal wear particles from metal-on-metal hips. Ladon et al. (2004) observed 
an increase in chromosomal aberrations and aneuploidy in the peripheral blood of patients 
after 2 years of MoM implantation. Genotoxicty was also reported for commercially-obtained 
alumina nano-particles, though this was only mildly genotoxic when compared with 
commercially-obtained CoCr alloy particles (Tsaousi et al., 2010). Single-cell gel 
electrophoresis or comet assay is a simple uncomplicated test that can be used to test for DNA 
damage. It works on the principle of measuring DNA strand breaks in eukaryotic cells 
(Collins, 2004).  
Oxidative stress occurs when there is an imbalance between the formation of oxidants and the 
rate of metabolism and the ability of antioxidant systems to remove reactive oxygen species 
(ROS), such as free radicals. Elevated oxidative stress has been suggested to be a critical 
factor in many inflammatory and degenerative disorders resulting in tissue damage and 
fibrosis in different parts of the body (Kinov et al., 2010). Inflammation is a definitive 
characteristic of aseptic loosening of THRs, therefore it is very likely that free radicals play a 
major role in this condition (Kinov et al., 2006). Free radicals can cause damage to cells in 
several ways such as DNA and protein damage, as well as disruption to cell proliferation, 
DNA and protein synthesis and metabolic activity. Thus, many studies (Nagase et al., 1995; 
Wang et al., 2002; Prabhakar et al., 2012; Steinbeck et al., 2014) have investigated the role of 
oxidative stress in aseptic loosening of THAs. It has been reported that wear particles 
generated from MoM bearings induce oxidative stress in cells (osteoblasts, fibroblasts and 
macrophages) where metal ions induce the production of ROS (Fleury et al., 2006; Wei et al., 
2009). Little is currently known about the potential of ceramic wear particles to induce the 
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production of ROS, and hence oxidative stress. Therefore, this remains a gap in knowledge 
and so remains to be investigated.  
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4.2 Aims and objectives 
Aims: 
The aim of the research in this chapter was to investigate the biological impact of wear 
particles generated from ceramic-on-ceramic total hip replacements. The first part of this 
study was concerned with determining if the biological activity of BIOLOX® Delta ceramic 
model particles were comparable to the published literature on commercially-obtained 
alumina and zirconia particles. Hence, a comprehensive evaluation of the biological impact 
of ZTA model ceramic particles in terms of cytotoxicity, inflammation, genotoxicity and 
oxidative stress was initially conducted. Thereafter, the biological impact of clinically-
relevant ceramic wear particles generated in vitro from ceramic bearings using the hip 
simulator was investigated (Figure 4.1).  
Objectives: 
• To assess the cytotoxic effects of BIOLOX® Forte ceramic model particles, 
BIOLOX® Delta ceramic model particles and clinically-relevant BIOLOX® Delta 
ceramic wear particles on the viability of L929 murine fibroblast cells over a period 
of 6 days. 
• To assess the biological impact of BIOLOX® Delta ceramic model particles and 
clinically-relevant BIOLOX® Delta ceramic wear particles on peripheral blood 
mononuclear cells in terms of cytotoxicity (viability), inflammation (release of TNF-
α), genotoxicity (DNA damage) and oxidative stress (production of reactive oxygen 
species) and compare with BIOLOX® Forte ceramic model particles and clinically-
relevant BIOLOX® Forte ceramic wear particles, respectively. 
 
 
 
Figure 4.1 – Flow diagram showing the work in this chapter in relation to other chapters, with the 
current chapter highlighted in yellow.  
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4.3 Materials and methods  
4.3.1 Materials  
4.3.1.1 Particles 
The sources or suppliers of the particles are listed in Table 4.1. The commercial BIOLOX® 
Forte and BIOLOX® Delta powders were manufactured by Ceramtec GmbH (Germany) using 
their pre-approved powder preparation formula, which consists of binding and sintering 
agents in the raw materials (not disclosed by Ceramtec). The resulting powder is subjected to 
a number of milling cycles to avoid agglomeration and homogenise the material. The slurry 
produced is subsequently processed (drying, filtering, moisturising, quality control) to 
produce a final powder ready for pressing (Palmero et al., 2014). 
Table 4.1 – Composition and source of particles used for biological impact experiments 
Material name Composition (wt.%) Supplier/Source 
BIOLOX® Forte powder Al2O3 (99.95%) Ceramtec GmbH, Germany 
BIOLOX® Delta powder 
Al2O3 (76.1%), ZrO2 
(22.5%), Y2O3 (1%), Cr2O3 
(>1%), SrO (>1%) 
Ceramtec GmbH, Germany 
BIOLOX® Forte wear 
particles 
Al2O3 (99.95%) 
Generated in house using 
the Leeds II hip simulator 
BIOLOX® Delta wear 
particles 
Al2O3 (76.1%), ZrO2 
(22.5%), Y2O3 (1%), Cr2O3 
(>1%), SrO (>1%) 
Generated in house using 
the Leeds II hip simulator 
CoCr wear particles 
Co (balance), Cr (30%), Mo 
(6%), C (0.2%), other 
elements (0.8%) 
Generated in house using 
the pin-on-plate wear rig 
4.3.1.2 Cell lines and primary cells  
The cells used in this chapter and suppliers are listed in Table 4.2.  
Table 4.2 – Cells used throughout the study. 
Cells Type Species Supplier 
L929 cells Fibroblasts Murine 
European collection 
of cell cultures 
Primary peripheral 
blood mononuclear 
cells (PBMNCs) 
Monocytes/ 
Macrophages 
Human 
Blood collected 
from healthy 
volunteers 
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4.3.1.3 Chemicals and reagents used in this chapter 
The chemicals and reagents used in this study are listed in Table 4.3  
Table 4.3 – List of chemicals and reagents used in this study 
Chemical/Reagent Supplier Storage/Preparation 
ATPlite™ ATP detection 
assay 
PerkinElmer, 
Massachusetts, USA 
4oC 
Bovine Serum Albumin 
(BSA) 
Sigma-Aldrich, Dorset, UK 4oC 
Camptothecin Sigma-Aldrich, Dorset, UK Room temperature 
Carbon paste 
Agar Scientific, Stanstead, 
Essex, UK 
Room temperature 
DCFDA / H2DCFDA - 
Cellular Reactive Oxygen 
Species Detection Assay Kit 
(ab113851) 
 
Abcam, Cambridge, UK 4oC 
Dimethyl sulphoxide 
(DMSO) 
Sigma-Aldrich, Dorset, UK Room temperature 
Dulbecco’s modified 
Eagle’s medium (DMEM) 
Lonza Biological, 
Cambridge, UK 
4oC 
Dulbecco’s Phosphate 
Buffered Saline (DPBS) 
Sigma-Aldrich, Dorset, UK Room temperature 
ELISA Kit (Human TNFα) Diaclone, France 4oC 
Ethanol, absolute 
VWR International LTD, 
Poole, UK 
Room temperature in 
flammables cupboard 
Ethlenediaminetetraacetic 
acid (EDTA) 
Sigma-Aldrich, Dorset, UK Room temperature 
Foetal bovine serum (FBS) 
Bio-Whittaker, Lonza, 
Verviers, Belgium 
-20oC 
Hydrochloric acid (HCL) 
12M 
Sigma-Aldrich, Dorset, UK Room temperature 
Hydrogen peroxide Sigma-Aldrich, Dorset, UK 4oC 
L-glutamine (200mM) Sigma-Aldrich, Dorset, UK -20oC 
Lipopolysaccharide (LPS) Sigma-Aldrich, Dorset, UK -20oC 
Lymphoprep 
Axis-Shield PoC AS, Oslo, 
Norway 
Room temperature 
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Lysis solution 
Trevigen, Gaithersburg, 
Maryland, USA 
Room temperature 
N-(2- hydroxyethyl) 
piperazine- N'-(2-
ethanulfonic acid) (HEPES) 
Bio-Whittaker, Lonza, 
Verviers, Belgium 
Room temperature 
Penicillin 
(5000U)/Streptomycin 
(5mg.ml-1) 
Bio-Whittaker, Lonza, 
Verviers, Belgium 
-20oC 
Phosphate Buffered Saline 
(PBS) tablets 
Oxoid Thermo Scientific, 
Northumberland, UK 
Room temperature 
Potassium hydroxide Sigma-Aldrich, Dorset, UK Room temperature 
Rosslyn Park Memorial 
Institute (RPMI) 1640 
medium 
Bio-Whittaker, Lonza, 
Verviers, Belgium 
4oC 
Sodium hydroxide (NaOH) 
Fisher Scientific, 
Loughborough, UK 
Room temperature 
Sterile water Baxter Healthcare, UK Room temperature 
Sulphuric acid solution 
VWR International LTD, 
Poole, UK 
Room temperature 
SYBR Gold 
Fisher Scientific, 
Loughborough, UK 
-20oC 
Trigene 
Scientific Laboratory 
Supplies Ltd, Nottingham, 
UK 
Room temperature 
Tris-HCL Sigma-Aldrich, Dorset, UK Room temperature 
Triton X-100 
BDH laboratory supplies, 
Poole, UK 
Room temperature 
Trizma-hydrochloride Sigma-Aldrich, Dorset, UK Room temperature 
Trypan blue (0.4%) Sigma-Aldrich, Dorset, UK Room temperature 
Trypsin-EDTA Sigma-Aldrich, Dorset, UK -20oC 
Tween 20 Sigma-Aldrich, Dorset, UK Room temperature 
Ultra-pure low melting 
point agarose 
Invitrogen Life 
Technologies Ltd, 
Paisley, UK 
Room temperature 
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4.3.1.4 Equipment 
The equipment used in this chapter are listed in Table 4.4.  
Table 4.4– List of equipment used in this study  
Item Model/Size Supplier 
Absorbance plate reader Multiskan Spectrum 
Thermo Labsystems, 
Franklin, USA 
Automatic pipette Multipette® stream 
Eppendorf UK Ltd, 
Stevenage, UK 
Automatic pipette 
(Pipetboy®) 
Ergo One® Starlab, Milton Keynes, UK 
Balance (accuracy of 
0.1mg) 
ABJ 220-4NM 
KERN-SOHN GmbH, 
Balingen, Germany 
Balance (accuracy of 1µg) XP26 
Mettler-Toledo Ltd, 
Leicester, UK 
Balance (accuracy of 10µg) XP205 
Mettler-Toledo Ltd, 
Leicester, UK 
Benchtop centrifuge 5415R 
Eppendorf UK Ltd, 
Stevenage, UK 
Cell culture centrifuge Harrier 15/80 
MSE (UK) Ltd, London, 
UK 
Cell culture incubator Sanyo MCO-2OAIC 
SANYA Biomedical 
Europe BV, UK 
Cell culture water bath NE2-D 
Clifton, Weston-Super-
Mare, UK 
Distilled water reservoir 
and filter 
ELGA, Reservoir 75L 
ELGA, High Wymcombe, 
UK 
Electrophoresis bath SUB-CELL® GT Bio-Rad, Watford, UK 
Electrophoresis power 
supply 
GPS 200/400 Pharmacia LKB, Sweden 
Eppendorf Thermomixer 
comfort 
5355 000.038 
Eppendorf UK Ltd, 
Stevenage, UK 
Luminescent plate reader Chameleon Hidex, Turku, Finland 
Magnetic stirrer Stuart SB161 
Scientific Laboratory 
Supplies Ltd., Nottingham, 
UK 
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Microlitre plate shaker Stuart® SSM5 
Cole-Parmer, Staffordshire, 
UK 
Oven OMT225 
IDEX Health & Science 
GmbH, Wertheim, 
Germany 
pH metre Jenway 3010 VWR International 
Ultra-pure distilled water QEARD00R1 
Merck Millipore, Cork, 
Ireland 
Ultrasonicator XB3 
Grant Instruments Ltd, 
Cambridge, UK 
Vortexer Topomix FB15024 
Fisher Scientific, 
Loughborough, UK 
Water bath JBN12 
Grant Instruments Ltd, 
Cambridge, UK 
4.3.1.5 Consumables, plasticware and glassware  
The consumables, plasticware and glassware used in this study are listed in Table 4.5.  
Table 4.5– List of consumables, plasticware and glassware used in this study 
Item Size Supplier 
Bijous 5ml 
Scientific Laboratory 
Supplies, Nottingham, UK 
Cell culture flasks T175, T75 
Thermo Scientific, 
Massachsetts, USA 
Combi tips 10ml, 5ml Eppendorf, Stevenage, UK 
Comet slides 20 wells 
Trevigen, Gaithersburg, 
Maryland, USA 
Eppendorf tubes 2ml, 1.5ml Starstedt Ltd, Leicester, UK 
Falcon tubes 50ml Starstedt Ltd, Leicester, UK 
Glass duran bottles 
100ml, 500ml, 1000ml, 
2000ml 
Duran Group, Wertheim am 
Main, Germany 
Glass universals 20ml 
Faculty of Biological 
Sciences, University of 
Leeds, UK 
Haemocytometer - Marienfield, Germany 
Maxisorb™ plate 96 well 
Scientific Laboratory 
Supplies, Nottingham, UK 
155 
 
Microplate adhesive sealing 
film 
96 well 
PerkinElmer, Berkshire, 
UK 
Optiplate™ 96 well 
PerkinElmer, Berkshire, 
UK 
Petri dish 30mm diameter 
Bibby Sterilin, 
Staffordshire, UK 
SepMate™ tubes 50ml 
Stemcell technologies UK 
Ltd, Cambridge, UK 
Serological pipettes 25ml, 10ml, 5ml Starstedt Ltd, Leicester, UK 
Sterile pipette tips 1000µl, 200µl, 20µl, 2µl 
Starlab UK, Milton Keynes, 
UK 
Sterile plastic pots 250ml, 150ml, 60ml 
Thermo Scientific, 
Massachsetts, USA 
Sterile plastic syringes 10ml, 5ml, 2ml, 1ml 
Scientific Laboratory 
Supplies, Nottingham, UK 
Universals 20ml 
Scientific Laboratory 
Supplies, Nottingham, UK 
Well plates (Nunc®), flat 
bottomed 
96 well, 48well, 96-Well 
Clear Bottom Black 
Scientific Laboratory 
Supplies, Nottingham, UK 
4.3.2 Methods 
4.3.2.1 Measurement of pH 
The pH of solutions was measured using a Jenway 3510 pH meter. The pH meter was 
calibrated using purchased calibration solutions of pH 4, pH 7 and pH 10, at room 
temperature. The pH of solutions was also measured at room temperature.    
4.3.2.2 Microscopy 
4.3.2.2.1 Bright field  
An optical Olympus CK-40-SLP microscope was used to view cells during cell culture 
experiments, such as cell seeding or culture of cells with particles. The microscope was set 
up for standard Köhler illumination.  
4.3.2.2.2 Confocal 
A Zeiss LSM700 inverted confocal microscope was used to image immunostained slides and 
gels. The laser settings used were laser Diode: 405nm (Hoechst; blue) and 488nm GFP; 
green).  
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4.3.2.2.3 Phase contrast 
An Olympus IX71 inverted microscope setup for phase contrast microscopy was used to view 
and capture images of cells co-cultured with particles. Images were captured using Cell^B 
image acquisition software.  
4.3.2.3 Sterilisation   
All particles were sterilised using heat treatment at 190oC for 4 hours before being used for 
cell culture experiments. 
4.3.2.3.1 Filter sterilisation 
Solutions not suitable for heat sterilisation were filtered using 0.2µm pore sized filters using 
a disposable syringe in a class II safety cabinet.  
4.3.2.4 Stock solutions 
4.3.2.4.1 Phosphate buffered saline  
Phosphate buffered saline (PBS) was prepared by adding one PBS tablets to 100ml of distilled 
water. The pH was adjusted to 7.2-7.4.  
4.3.2.4.2 Supplemented phosphate buffered saline 
PBS supplemented with 2% (v/v) foetal bovine serum was used to dilute the whole blood 
during the PBMNC isolation process. 
4.3.2.4.3 DMEM culture medium for L929 cells 
Dulbecco’s modified Eagle’s medium (DMEM) was used with 10% (v/v) FBS, 2mM L-
glutamine, 100 U.ml-1 penicillin and 100 µg.ml-1 streptomycin. Supplemented cell culture 
medium was stored 4oC for a maximum of 4 weeks.      
4.3.2.4.4 RPMI culture medium for PBMNCs 
Roswell Park Memorial Institute (RPMI) 1640 medium was used with 10% (v/v) FBS, 2mM 
L-glutamine, 100 U.ml-1 penicillin and 100 µg.ml-1 streptomycin. Supplemented cell culture 
medium was stored 4oC for a maximum of 4 weeks.    
4.3.2.5 Cell culture  
4.3.2.5.1 Resurrection of L929 cells 
A cryovial of approximately 1x106 cells was removed from liquid nitrogen and allowed to 
thaw slowly at room temperature. Once the cells were thawed they were immediately 
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transferred to a sterile universal containing 10ml of pre-warmed (37oC) fresh DMEM culture 
medium. The cell suspension was centrifuged at 150g for 10 minutes at room temperature. 
After centrifugation, the supernatant was discarded and the pellet of cells was suspended in 
2ml of DMEM culture medium. The cell suspension was added to a sterile culture flask (T-
75), which was pre-loaded with 10ml of DMEM culture medium. Thereafter, the T-75 culture 
flask containing the L929 cells was incubated at 37oC in 5% (v/v) CO2 in air until the cells 
were approximately 80% confluent, which was determined using a light microscope. The cell 
culture medium was changed every 2-3 days until passaging was required.   
4.3.2.5.1.1 Cell culture maintenance  
Once the cells achieved approximately 80% confluency the cell culture medium was removed 
from the flask, and the cells were gently washed with sterile DPBS (without calcium and 
magnesium). The cells were treated with trypsin-EDTA (2ml for T75 or 5ml for T175) for 
upto 10 minutes in 5% (v/v) CO2 in air at 37oC to detach the cells from the flask. The bottom 
of the flask was tapped gently to dislodge the cells from the plastic and the trypsin-EDTA was 
inhibited by the addition of equivalent volume of culture medium containing 10% (v/v) FBS 
(1:1) to that of trypsin-EDTA. Thereafter, the cell suspension was transferred to a sterile 
universal and centrifuged at 150g for 10 minutes. After centrifugation, the supernatant was 
carefully aspirated and the pellet was suspended in 5ml of DMEM culture medium. A trypan 
blue exclusion assay (section 4.3.2.6) was performed to ascertain the cell number and the cells 
were seeded into a fresh culture flask (T75 or T175) at an appropriate seeding density (1x104 
per cm2). A final volume of DMEM culture medium was added to the culture flask (10ml for 
T75 or 17ml for T175). Thereafter, the cells were incubated in 5% (v/v) CO2 in air at 37oC 
and the cell culture medium was replaced every 3-4 days until confluent. Cells were 
maintained up to 10 passages before being discarded.  
Cells were stored in longer term storage by passaging the cells as described above. The cells 
were suspended at a density of 1x106 cells.ml-1 in DMEM supplemented with 10% (v/v) FBS 
and 10% (v/v) dimethyl sulphoxide (DMSO). A volume of 1.5ml of the cell suspension was 
transferred into each sterile cryovial and placed in a freezing pot containing isopropanol. The 
cryovials were placed in a -80oC freezer for 24hrs before being transferred into liquid nitrogen 
for long term storage.  
4.3.2.5.2 Isolation of primary peripheral blood mononuclear cells  
This study used five healthy donors aged between 24-60 years. The blood was collected by a 
trained phlebotomist (Dr Daniel Thomas, School of Biomedical Sciences, University of 
Leeds) in accordance with the Faculty of Biological Sciences Ethics Committee approval 
(BIOSCI 10-018). Informed consent was obtained from the donor before collecting the blood, 
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which was recorded and tracked using the Achiever tissue tracking system (Leeds Teaching 
Hospital NHS Trust and University of Leeds). Approximately 30ml of blood was collected 
using a 21G needle and sodium heparinised vacuum collection tubes. The blood was collected 
in the morning and processed on the same day to minimise activation of platelets and clotting 
of the blood.  
Isolation of the PBMNCs was performed in a class II safety cabinet designated for human 
tissue only. The blood sample, PBS with 2% (v/v) FBS and density gradient medium 
(lymphoprep) were incubated at room temperature for 1 hour prior to isolation. The 
SepMate™ procedure was used to isolate the PBMNCs from the blood. The SepMate™ tubes 
used in this procedure were specifically designed for the isolation of mononuclear cells from 
human whole peripheral blood and cord samples by density gradient centrifugation.   
Specifically, the whole blood was diluted with an equal volume (1:1) PBS of supplemented 
with 2% FBS (v/v) and mixed gently. The density gradient medium i.e. lymphoprep (15ml), 
was added to the 50ml SepMate™ tube by carefully pipetting it through the central hole of 
the SepMate™ insert. Thereafter, keeping the SepMate™ tube vertical, the diluted blood 
sample was added to the tube by slowly pipetting it down the side of the tube. The loaded 
SepMate™ tube was then centrifuged at 1200g for 10 minutes at room temperature. After 
centrifugation, the enriched layer of isolated PBMNCs was poured into a separate falcon tube 
(50ml) ensuring the SepMate™ tube was not inverted for longer than 2 seconds. The isolated 
PBMNCs were washed in PBS with 2% (v/v) FBS and centrifuged at 300g for 8 minutes at 
room temperature. This was repeated (2-3 times) until the supernatant was clear. The isolated 
PBMNCs were then re-suspended in 5ml of supplemented RPMI culture medium and the cells 
were counted using the trypan blue dye exclusion method, before seeding the cells.  
4.3.2.6 Determination of cell number using Trypan blue exclusion assay 
The trypan blue exclusion assay was used to determine the number of viable cells in an 
isolated cell suspension. The trypan blue dye enters the dead cells due to a loss of membrane 
potential, which results in blue appearance of dead cells, whereas live cells appear colourless. 
To perform a cell count, 90µl was taken from a cell suspension and transferred to a sterile 
bijou. A volume of 10µl of trypan blue dye was added to the cell suspension and thoroughly 
mixed by pipetting up and down. Thereafter, 10µl of the trypan blue: cell suspension mixture 
was added to a haemocytometer and using an inverted light microscope, the viable cells 
(colourless cells) were counted, whilst the dead cells (stained blue) were not included in the 
count. A minimum of 100 cells and a maximum of 300 cells were counted within the 25 
squares of the haemocytometer. The number of viable cells per ml was calculated according 
to Equation 4.  
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Equation 4 
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠. 𝑚𝑙−1 =  
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑣𝑖𝑎𝑏𝑙𝑒 𝑐𝑒𝑙𝑙𝑠
𝑛
  ×  104  ×  𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 
o n= number of grid squares used in cell count 
o dilution factor = 10/9  
4.3.2.7 Biological impact of ceramic particles  
The following assays were used to assess the biological impact of ceramic particles on L929 
murine cell fibroblasts and PBMNCs. All assays were conducted using the PBMNCs, whereas 
only cytotoxicity assessment was conducted with L929 murine cell fibroblasts.   
4.3.2.7.1 Cytotoxicity assessment using ATP-Lite assay 
The ATP detection kit assay (ATP-lite assay) measures the levels of ATP present within cells 
by the production of luminescence caused by the reaction of ATP with added luciferase and 
D-luciferin. Based on this reaction (see below), the concentration of ATP present can be 
determined by measuring the emission of light from the sample, which is proportional to the 
ATP concentration. 
 ATP +  D − Luciferin + 𝑂2  
𝐿𝑈𝐶𝐼𝐹𝐸𝑅𝐴𝑆𝐸
𝑀𝑔2+
 𝑂𝑥𝑦𝑙𝑢𝑐𝑖𝑓𝑒𝑟𝑖𝑛 + 𝐴𝑀𝑃 + 𝑃𝑃𝑖 +  𝐶𝑂2 + 𝐿𝑖𝑔ℎ𝑡 
4.3.2.7.1.1 Performing the ATP Lite assay  
Culture medium was removed from each well of the 96-well plate and either discarded (L929 
cells) or stored (PBMNCs) in 96-well plates for further analysis. A volume of 50µl of 
mammalian cell lysis solution was added to each well and the plate was shaken (320rpm) for 
5 minutes. Reconstituted lyophilised substrate solution at a volume of 50µl was added to each 
well and the plate was shaken (320rpm) for 5 minutes. The solution in each well was 
transferred to the corresponding well of a 96-well Optiplate® and an adhesive clear film seal 
was placed over the plate to prevent contamination. The plate was adapted to the dark for 10 
minutes before measuring the luminescence in each well for 10 seconds using the luminescent 
plate reader and MiroWin 2000 software.  
The output measurements were expressed as counts per second (CPS) and were exported to 
Microsoft Excel software. The average of the blank measurements was subtracted from all 
the results, however for the cells cultured with the highest particle volume, the average of the 
particle control was subtracted instead. This was to ensure that the particles did not interfere 
with the assay reagents and produce false positive or false negative results.   
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4.3.2.7.2 Inflammatory response assessment using ELISA 
A sandwich enzyme-linked immunosorbent assay (ELISA) was used to determine the 
concentration of TNF-α, an important cytokine involved in osteolysis. The assay was 
completed by following these steps: - 
4.3.2.7.2.1 Preparation of reagents for the ELISA 
The reagents used in the ELISA, but not provided with the kit are listed in Table 4.6. Prior to 
the assay, two litres of PBS solution were prepared (section 4.3.2.4.1) and autoclaved at 121oC 
for 20 minutes, at 103 kPa, and stored at room temperature. The reagents were prepared and 
stored at 2-8oC and used for up to one week. The reagents provided with the ELISA kit are 
shown in Table 4.7, which were stored at 2-8oC. 
Table 4.6 – The reagents prepared for use with the ELISA kit 
Reagent Composition 
Coating buffer PBS (pH 7.2-7.4) 
Wash buffer PBS with 0.05% (v/v) Tween 
Reconstitution buffer PBS with 0.09% (v/v) Sodium azide 
Blocking buffer PBS with 5% (w/v) BSA 
Standard dilution buffer and secondary 
antibody dilution buffer 
PBS with 1% (w/v) BSA 
HRP dilution buffer 
PBS with 1% (w/v) BSA and 0.1% (v/v) 
Tween 
 
Table 4.7 – The reagents provided with the ELISA kit and the preparation required prior to 
use  
Reagent Preparation 
TNF- α standard; 800pg.ml-1 
Reconstituted with PBMNCs culture 
medium as directed on the vial 
Capture antibody Sterile and diluted prior to use 
Biotinylated anti-TNF- α detection 
antibody 
Reconstituted with 0.55ml of reconstitution 
buffer prior to use 
Streptavidin-HRP Diluted prior to use 
TMB substrate Ready to use 
4.3.2.7.2.2 Preparation of ELISA plate 
The Diaclone Human TNF-α ELISA set was used in this study to quantify the concentration 
of TNF-α released from PBMNCs in response to different doses of ceramic particles. 
Typically, 100µl of capture antibody was added to 10ml of coating buffer, which was enough 
to coat a full 96-well Maxisorp plate. A volume of 100µl of diluted capture antibody was 
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added to each well using an automated pipette. Thereafter, the plate was incubated overnight 
at 4oC. The diluted capture antibody was discarded and washed with 350µl of wash buffer per 
well. The wash buffer was aspirated and tapped firmly against absorbent paper to remove any 
residual liquid. The wash step was repeated once. A volume of 250µl of blocking buffer was 
added to each well and the plate was covered with the lid and incubated at room temperature 
for 2 hours. After incubation, the plate was washed with wash buffer a further three times and 
either used immediately or wrapped in parafilm and stored at 2-8oC in a seal bag containing 
desiccant for up to one month.  
4.3.2.7.2.3 Performing the ELISA method 
The supernatants collected from the PBMNCs (4.3.2.8.2) cultured with ceramic particles was 
thawed at room temperature for one hour prior to performing the ELISA. The reagents in  
Table 4.7 were prepared as and when required before each step. The following steps were 
performed to complete the ELISA: - 
The TNF-α standards were prepared by reconstituting the standard vial with RPMI 1640 
culture medium to give an 800pg.ml-1 sample. This was dispensed in duplicate at a volume of 
200µl in the appropriate wells (A1 and A2) according to the plate layout illustrated in Figure 
4.2. Thereafter, 100µl of the PBMNCs culture medium (diluent buffer) was added to the 
remaining wells B1 and B2 through to G1 and G2. The highest concentration (800pg.ml-1) of 
the TNF- standard was diluted using these well, whereby 100µl from wells A1 and A2 was 
transferred to B1 and B2, respectively, by mixing the contents of the well by repeated 
aspirations using a P200 Gilson pipette. This 1:1 dilution step was continued using 100µl 
from wells B1 and B2 through to wells G1 and G2 providing a serial diluted standard curve 
ranging from 800pg.ml-1 to 12.5pg.ml-1. The PBMNCs culture medium was added as the 
blank standard in wells H1 and H2. The test samples were dispensed in duplicate at a volume 
of 100µl in each well. The lipopolysaccharide (LPS) positive control sample was diluted 1:2 
using RPMI 1640 culture medium before adding to the plate. This was to ensure the levels of 
TNF-α did not exceed the maximum standard concentration as high levels of TNF-α release 
was anticipated.   
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Standards Sample wells 
1 2 3 4 5 6 7 8 9 10 11 12 
A 800 800           
B 400 400           
C 200 200           
D 100 100           
E 50 50           
F 25 25           
G 12.5 12.5           
H B B           
*Standards were in pg.ml-1. B (Blank). 
Figure 4.2 - Example plate layout for performing one ELISA. 
 
The biotinylated anti-TNF-α detection antibody was reconstituted with 550µl of 
reconstitution buffer prior to use. For one plate, 100µl of the reconstituted detection antibody 
was diluted with 5ml of secondary antibody dilution buffer. Thereafter, 50µl of diluted 
detection antibody was added to each well and the plate was incubated for at room temperature 
for three hours. Following the incubation, the contents in each well was aspirated and washed 
with wash buffer three times using the same technique described previously (section 
4.3.2.7.2.2).  
The streptavidin-HRP (5µl) provided with the kit was diluted with 500µl of HRP dilution 
buffer immediately before use. This was further diluted, whereby for one plate 150µl of the 
diluted streptavidin-HRP solution was added to 10ml of HRP dilution buffer and 100µl of 
this diluted solution was added to each well. The plate was covered and incubated at room 
temperature for 30 minutes. After incubation, the streptavidin-HRP solution was aspirated 
and the wells were washed three times with wash buffer using the same technique described 
previously (section 4.3.2.7.2.2).  
A volume of 100µl of ready-to-use TMB (3,3’,5,5’-Tetramethylbenzidine) substrate was 
added to each well and the plate was covered and wrapped in aluminium foil immediately to 
incubate in the dark at room temperature for 15 minutes. During the incubation period, the 
TMB solution turned blue in the presence of TNF-α. Thereafter, a volume of 100µl of 1M 
sulphuric acid was added to each well, which terminated the reaction and turned the solution 
yellow. The absorbance value of each well was read on a multi-scan spectrum micro-plate 
spectrophotometer using a 450nm as the primary wavelength and 630nm as the reference 
wavelength.      
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4.3.2.7.2.4 Analysis of ELISA results  
The average optical density was plotted against each standard concentration of TNF-α to 
generate a linear standard curve. The standard curve was used to determine the TNF-α 
concentration (pg.ml-1) of each sample using the average optical density, for each sample. The 
positive LPS control was diluted, and so the values obtained were multiplied by the dilution 
factor. The data from the cell only negative control and the treatments that stimulated 
PBMNCs to produce a statistically significant increase in the levels of TNF-α PBMNCs from 
all donors, were used to generate box plots in order to analyse the variability in inflammatory 
response between different donors.  
4.3.2.7.3 Genotoxicity assessment using the Comet assay 
Single cell gel electrophoresis or the comet assay is a sensitive and rapid technique for 
quantifying DNA damage from in vivo and in vitro samples of eukaryotic cells. The assay 
produces images of single cells embedded in agarose gel that resembles a ‘comet’ with a 
distinct head and tail. The head contains intact DNA, whilst the tail is composed of single-
stranded or double-stranded DNA with breaks. The extent of DNA migrated from the head of 
the comet is directly proportional to the level of DNA damage.  
4.3.2.7.3.1 Preparation of reagents 
The reagents prepared for the comet assay are listed in Table 4.8.  
Table 4.8 – The reagents prepared for use with the comet assay  
Reagent Composition Storage 
TE buffer 
10mM Tris-HCL with 1mM 
EDTA (pH 7.5) 
Stored at room 
temperature 
Alkaline unwinding solution 
200mM NaOH with 1mM 
EDTA 
Stored at room 
temperature 
Alkaline electrophoresis 
solution 
300mM NaOH with 1mM 
EDTA 
Stored at 40C 
SYBR Gold 
1µl of 10,000x diluted in 
30ml TE buffer 
Stored at 4oC 
PBMNC detaching solution DPBS with 2.5mM EDTA Stored on ice 
LMAgarose Provided by Trivegen 
Melted using 
microwave and then 
place in thermomixer 
set at 37oC 
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4.3.2.7.3.2 Performing the Comet assay 
The assay was completed by following these steps:  
The cell culture media was aspirated from all the wells in the 48-well plate and discarded, 
before washing the cells with 100µl of sterile DPBS. Thereafter, 1ml of ice-cold PBMNC 
detaching solution was added to each well and the 48-well plate was incubated on ice for 30 
minutes. After incubation, the contents of the well were aspirated and dispensed several times 
to dislodge any remaining attached cells. Thereafter, the cell suspension from each well was 
transferred to pre-labelled sterile 1.5ml Eppendorf tubes, which were centrifuged at 200g for 
10 minutes at 4oC. After centrifugation, the supernatant was carefully discarded ensuring the 
pellet was not disturbed.  
As there were many cell samples due to the different particle dose treatments, the LMAgarose 
was aliquoted (1ml) into 1.5ml Eppendorf tubes and placed in the thermomixer set to 37oC. 
The cells were resuspended in 100µl of molten LMAgarose gel (37oC) and the agarose cell 
suspension was mixed gently by inversion several times to evenly disperse the cells. 
Thereafter, 30µl of agarose cell suspension was immediately pipetted on the 20 well 
CometSlide™. The tip of the pipette tip was used to spread the agarose/cells over the sample 
area to ensure complete coverage of the sample area. This was done for all different samples, 
except for the positive control, which was incubated at 37oC with 5µl of 100µM hydrogen 
peroxide prior to placing the agarose cell suspension on the slide. The slide was incubated at 
4oC in the dark for 30 minutes. This was to set the gel and ensure adherence of the sample to 
the slide. A 0.5mm clear ring appeared at the edge of the CometSlide™ area once the gel was 
set. 
The slides were immersed in pre-cooled (4oC) lysis solution and incubated at 4oC for 1 hour, 
in the dark. Thereafter, the slides were immersed in freshly prepared alkaline unwinding 
solution for 20 minutes at room temperature, in the dark.  
The slides were then placed in the electrophoresis tank containing electrophoresis solution 
that was pre-cooled for 1 hour at 4oC. The electrophoresis tank was set at 1volt/cm e.g. 30V 
in a 30cm tank. The mAmp was adjusted to 300 by adding or removing electrophoresis buffer 
before the samples were electrophoresed at 4oC in the dark for 20 minutes. Thereafter the 
slides were immersed in distilled water for 5 minutes. This was repeated once. The slides were 
then immersed in 70% (v/v) ethanol for 5 minutes, in the dark. The slide was stored in the 
dark at room temperature with a desiccant prior to scoring.  
The SYBR Gold x10,000 was diluted by adding 1µl to 30µl of TE buffer. A volume of 50µl 
of the diluted SYBR Gold stain was placed onto each circle of dried agarose and stained for 
30 minutes at room temperature, in the dark. The slides were gently tapped onto absorbed 
paper to remove the SYBR solution and then rinsed briefly in water. The slides were dried at 
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37oC in an incubator for 2 hours before imaging using a Zeiss upright microscope using the 
following settings: - 
• HXP 120 V power was set to 10 
• 10x objective 
• GFP channel (excitation at 509nm) 
• Exposure time 1500ms 
• Intensity set to min/max after image was taken 
The automatic tiling tool was used to take images of the entire sample area. This technique 
ensured all the cells present in the gel were imaged. Images were captured and exported 
using ZEN 2009 software (Carl Zeiss Microscopy Ltd).  
The SYBR gold nucleic acid gel stain allowed visualisation of the nuclear DNA within the 
cell. Cell nuclei that appeared circular indicated intact nuclei and no (or minimal) detectable 
DNA damage, whereas nuclei that had tails resembling a comet, indicated DNA damage. All 
images were oriented where the head was on the right and the tail to the left for the software 
to correctly detect the comets. Only single cells were measured, cells which were overlapping 
or too close to each other or surrounded by debris were not measured. A minimum of 100 
cells were scored per condition. The data was exported to Microsoft Excel, and the ‘Olive tail 
moment’ was presented for each treatment.   
4.3.2.7.4 Oxidative stress assessment using cellular reactive oxygen species detection 
assay 
The cellular reactive oxygen species (ROS) detection assay uses the 2’,7’ –dichlorofluorescin 
diacetate (DCFDA) fluorogenic dye that measures hydroxyl, peroxyl and other ROS 
activity/presence within the cell. The DCFDA diffuses into the cell via the cell membrane and 
undergoes deacetylation by cellular esterases to a non-fluorescent compound. In the presence 
of ROS, the DCFDA is oxidised into 2’,7’ –dichlorofluorescin (DCF), which is a highly 
fluorescent compound that can be detected by fluorescence spectroscopy by 495nm excitation 
and 529nm emission (Eruslanov and Kusmartsev, 2010).  
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4.3.2.7.4.1 Preparation of reagents 
The reagents prepared for the cellular reactive oxygen species (ROS) detection assay are 
listed in Table 4.9.  
Table 4.9 – The reagents prepared for use with the cellular ROS detection assay  
Reagent Reagent preparation Storage 
1x buffer 
10x buffer supplied with the 
kit was diluted with sterile 
water (1:10) 
Stored at 40C 
1x supplemented buffer with 
10% (v/v) FBS 
1x buffer was supplemented 
with 10% (v/v) FBS 
Stored at 40C 
25µM DCFDA (2’,7’ –
dichlorofluorescin diacetate) 
solution 
20mM DCFDA was diluted 
with sterile water to give a 
25µM final concentration 
solution of DCFDA 
Stored at 40C 
200µM TBHP (tert-Butyl 
hydroperoxide) 
55mM was diluted with 
sterile water to give a 200µM 
final concentration solution 
of TBHP 
Stored at 4oC 
4.3.2.7.4.2 Performing the cellular reactive oxygen species detection assay 
The assay was completed by following these steps: - 
The cell culture media was aspirated from all the wells in the 96-well plate and discarded, 
before washing the cells with 100µl of 1x buffer. Thereafter, the 1x buffer was aspirated and 
discarded before staining the cells by adding 100µl of 25µM DCFDA in 1x buffer and 
incubated at 37oC for 45 minutes. A volume of 100µl of 200µM TBHP was added to the 
column of wells designated as the positive control treatment. The plate was incubated for 2 
hours at 37oC. 
The fluorescence at excitation 485nm and emission 535nm of each well was measured using 
the plate reader and MiroWin 2000 software. The output measurements were expressed as 
fluorescence intensity and was exported to the Microsoft Excel software and the average of 
the blank readings was subtracted from all the measurements. The contents of each well were 
dispensed and the plate was immediately imaged with the Zeiss upright microscope using the 
following settings: - 
• HXP 120 V power was set to 10 
• 20x objective 
• eGFP channel (excitation at 485nm) 
• Exposure time 1000ms 
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The eGFP channel allowed imaging of the green fluorescent ROS (485nm) that was present 
in the cells. Images were captured and exported using ZEN 2009 software (Carl Zeiss 
Microscopy Ltd). Images were captured at random locations, and a minimum of four non-
overlapping images from each treatment were captured (n=4). 
4.3.2.8 Culturing cells with particles to determine the biological impact 
4.3.2.8.1 Culture of L929 cells with particles to determine the cytotoxic effects of 
ceramic model particles and clinically-relevant ceramic wear particles 
The L929 murine fibroblast cell line was used as per ISO 10993-5 “Biological evaluation of 
medical devices – Part 5: Tests for in vitro cytotoxicity”, to determine the cytotoxic effects of 
ceramic model particles and clinically-relevant ceramic wear particles to select the 
appropriate doses for subsequent experiments using PBMNCs. L929 cells were resurrected 
and passaged using standard cell culture methods outlined in section 4.3.2.5.1.  
The effects of the ceramic model particles and clinically-relevant ceramic wear particles on 
the viability of L929 cells in co-culture were determined using the ATP-Lite™ assay, which 
is described in section 4.3.2.7.1. The L929 cells were seeded into 96 well plates at a seeding 
density of 1x104 cells per well and cultured with increasing doses of BIOLOX® Delta ceramic 
model particles (0.05-500µm3 per cell), or BIOLOX® Forte ceramic model particles (0.05-
500µm3 per cell) or clinically-relevant BIOLOX® Delta ceramic wear particles (0.05-500µm3 
per cell). Six wells in total were used for each treatment (n=6). The negative control was 
seeded in the same way but with no particles or treatment. The cytotoxic effects of the ceramic 
particles were compared with clinically-relevant CoCr nano-particles at a dose of 50µm3 per 
cell, which was used as the positive particle control. Camptothecin, at a final concentration of 
2 µg.ml-1 was included as the positive control to induce apoptosis. The plates were incubated 
for 0, 1, 3 and 6 days at 37oC in 5% (v/v) CO2 in air. After the appropriate incubation period 
with the particles, an ATP-Lite™ assay was performed, which is described in section 
4.3.2.7.1. The L929 cells cultured with Delta ceramic model particles is shown in Figure 4.3.      
    
Figure 4.3 – L929 cells cultured with ceramic model particles. (A) L929 cells with no particles and 
(B) L929 cells cultred with 500µm3 per cell of BIOLOX® Delta model ceramic particles.  
   
A B 
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4.3.2.8.2 Culture of PBMNCs with model or clinically-relevant ceramic wear particles 
to determine the biological impact in terms of cytotoxicity, inflammation, 
genotoxicity and oxidative stress  
4.3.2.8.2.1 Methodology to assess the biological impact of ceramic model 
particles  
PBMNCs were isolated from blood taken from five healthy volunteer donors (Donor 2, Donor 
5, Donor 7, Donor 25 and Donor 26) as described in section 4.3.2.5.2. The PBMNCs isolated 
from the blood of a single donor were used to conduct all four assays as described in section 
4.3.2.7  and illustrated in Figure 4.4. 
 
 
Figure 4.4 – Flow diagram showing the different assays completed on PBMNCs isolated from blood 
collected from a single donor.  
 
The PBMNCs from each donor were seeded into the appropriate well plate at the appropriate 
seeding density and repeats for each assay as described in Table 4.10. The effects of increasing 
doses (0.05-50µm3 per cell) of BIOLOX® Delta ceramic model particles was initially 
investigated in terms of cytotoxicity, inflammation, genotoxicity and oxidative stress, and 
compared with the effects of low (0.5 µm3 per cell) and high (50µm3 per cell) doses of 
BIOLOX® Forte ceramic model particles and low (0.5 µm3 per cell) and high (50µm3 per cell) 
doses of clinically-relevant CoCr nano-particles (generated using the PoP wear rig; section 
3.3.3.3), which was used as the positive particle control. The positive controls for each assay 
are listed Table 4.11. The negative control was seeded in the same way but with no particles 
or treatment for all the assays. The plates were incubated for 24 hours at 37oC in 5% (v/v) 
CO2 in air. After the incubation period with the particles, the cytotoxic effects of the particles 
were assessed using the ATP-Lite assay as described in section 4.3.2.7.1. 
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Table 4.10 – Seeding density, type of culture vessel and repeats used for each assay. 
Biological assessment (assay 
type) 
Seeding 
density (per 
well) 
Culture vessel 
Repeats 
Cytotoxicity (ATP-Lite assay) 2x104 
96-well plate 6 wells per 
treatment 
Inflammation (ELISA; TNF-α) 2x104 
96-well plate Supernatants 
harvested from 4 
wells 
Genotoxicity (Comet assay) 1x105 
48-well plate 2 wells per 
treatment (100 cells 
scored per 
treatment) 
Oxidative stress (Cellular ROS 
detection) 
2x104 
96-well plate 
(Clear Bottom 
Black) 
6 wells per 
treatment 
 
Table 4.11 – Positive controls used for each assay. 
Biological assessment  Assay type Positive control (concentration) 
Cytotoxicity  ATP-Lite assay Camptothecin (2µg.ml-1) 
Inflammation  ELISA (TNF-α) LPS (200ng.ml-1) 
Genotoxicity Comet assay Hydrogen peroxide (100µM) 
Oxidative stress  Cellular ROS detection TBHP (200µM) 
 
The inflammatory response to the ceramic model particles was assessed in terms of cytokine 
(TNF-α) release through harvesting of the supernatant to be used in an ELISA. The 
supernatant (200µl) was collected and aliquoted in duplicate (n=4) i.e. a volume of 100µl into 
each well of 96-well plate. These plates were wrapped in Parafilm and stored at -80oC until 
an ELISA was performed as described in section 4.3.2.7.2. 
In addition to the ATP-Lite assay, the other assays for genotoxicity and oxidative stress were 
also performed on the same day. The genotoxic effects of the ceramic model particles were 
assessed using the comet assay as described in section 4.3.2.7.3. The production of ROS in 
response to the ceramic model particles was assessed using the cellular reactive oxygen 
species detection assay as described in section 4.3.2.7.4.  
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4.3.2.8.2.2 Methodology to assess the biological impact of clinically-relevant 
ceramic wear particles  
PBMNCs isolated from blood taken from the same five healthy volunteer donors was co-
cultured with increasing doses (0.05-50µm3 per cell) of clinically-relevant BIOLOX® Delta 
ceramic wear particles that were generated using the Leeds II hip simulator as described in 
section 3.3.3.1. The effects of these wear particles were compared with low (0.5 µm3 per cell) 
and high (50µm3 per cell) doses of clinically-relevant BIOLOX® Forte ceramic wear particles 
(generated using the Leeds II hip simulator) and low (0.5 µm3 per cell) and high (50µm3 per 
cell) doses of clinically-relevant CoCr nano-particles, which was used as the positive particle 
control. The positive controls for each assay are listed in table Table 4.11. Furthermore, due 
to contamination issues with stainless wear particles as described in section Percentage ratio 
between ceramic and stainless-steel wear particles using EDX elemental mapping, stainless 
steel wear particles at dose 50 µm3 per cell were introduced. These stainless-steel wear 
particles were a gift from another researcher (Helen Lee) and were generated using the six-
station pin-on-plate wear rig and smooth (Ra value of ≤0.01µm) medical grade stainless-steel 
pins articulated against smooth stainless-steel plates in water lubricant. The negative control 
cell only was seeded in the same way but with no particles or treatment for all the assays. The 
plates were incubated for 24 hours at 37oC in 5% (v/v) CO2 in air. After the incubation period 
with the particles, the same assays described in section 4.3.2.8.2.1 were used to assess the 
effects of clinically-relevant ceramic wear particles in terms of cytotoxicity (ATP-Lite assay), 
inflammation (ELISA), genotoxicity (comet assay) and oxidative stress (cellular ROS 
detection assay). 
4.3.3 Statistical analysis  
Values were presented as means ±95% confidence limits and analysed using one-way 
ANOVA. Differences between the different treatment groups and the negative control were 
determined by calculating the minimum significant differences (MSD) value (p<0.05) using 
the Tukey-method.  
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4.4 Results 
The results of the characterises of the ceramic model particles is first presented (4.4.1). 
Thereafter the biological impact in terms of cytotoxicity, inflammation, genotoxicity and 
oxidative stress was initially presented for the ceramic model particles (4.4.2) followed by the 
biological impact of the clinically-relevant ceramic wear particles (4.4.3) in terms of the same 
four biological assays.   
4.4.1 Characteristics of the model ceramic particles 
The size, morphology and composition of the ceramic model particles were determined and 
analysed using CFE-SEM and EDX analysis. The ceramic model particles were filtered on a 
0.015µm filter membrane and imaged using CFE-SEM at 1 kV (beam deceleration mode), 
mixed signal; secondary electrons (SE) and back-scattered electrons (BSE) and at a working 
distance (WD) of 1-3 mm. Five random fields of view were imaged for each magnification; 
5K, 60K, 90K and 150K. Chemical characterisation of the ceramic model particles was 
carried out by EDX analysis to confirm the chemical composition of the particles. The CFE-
SEM micrographs of the ceramic model particles were subsequently analysed using computer 
software, ImageJ version 1.49, to measure the Feret’s diameter (dmax), aspect ratio and 
circularity of the particles as described in section 2.3.3.2.2. A minimum of 150 particles were 
measured. 
4.4.1.1 BIOLOX® Forte model ceramic particles 
CFE-SEM analysis of the alumina BIOLOX® Forte ceramic model particles filtered on the 
0.015µm filter membrane revealed large micron sized particles that were irregular/shard-like 
in shape (Figure 4.5A). High magnification of these particles showed the presence of small 
nano-scale particles (Figure 4.5B) that were round in morphology. EDX analysis confirmed 
that the larger particles were indeed comprised of alumina as indicated by the elemental peaks 
of aluminium (Al) and oxygen (O) (Figure 4.6B). The carbon (C) peak was due to the carbon 
coating. The mean ferret diameter, mean aspect ratio and mean circularity values (value of 
1.0 indicates a perfect circle) for BIOLOX® Forte ceramic model particles are shown in Table 
4.12. These values were compared with the values for the morphology of alumina BIOLOX 
Forte ceramic wear particles that were generated in Chapter 3, section 3.4.2.1.1, which are 
also listed in Table 4.12. An independent-samples t-test was conducted to compare the size 
distribution (feret diameter) and morphology (aspect ratio and circularity) of BIOLOX® Forte 
ceramic model particles with clinically-relevant BIOLOX® Forte wear particles generated in 
water (section 3.4.2.1.1). There were no significant differences in the values for aspect ratio 
(p=0.835) and circularity (p=0.179) between the clinically-relevant BIOLOX® Forte ceramic 
wear particles generated in water and BIOLOX® Forte ceramic model particles. Moreover, 
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the particle size distributions (feret diameter) for the clinically-relevant BIOLOX® Forte wear 
particles generated in water and BIOLOX® Forte ceramic model particles were also 
statistically similar (p=0.059). The frequency as a function of size of the BIOLOX® Forte 
ceramic model particles is presented in Figure 4.7, which revealed a bimodal size distribution. 
The larger micron and submicron size particles ranged between 100-3000nm with a mean size 
of 613nm ± 34.93nm, whereas the small nano-scale particles ranged between 10-80nm with 
a mean size of 44nm ± 2.6nm. The BIOLOX® Forte ceramic model particles had a mode size 
distribution of 300-400nm for the larger particles and a mode size of 30-40nm for the small 
nano-scale particles. 
 
  
Figure 4.5 - CFE-SEM images of BIOLOX® Forte ceramic model particles, which consisted of (A) 
large micron sized alumina particles and (B) small nano-scale alumina particles. The particles were 
imaged at 1-2kV voltage and working distance of 2-3mm. The larger particles were imaged at 5K 
magnification to capture groups of particles. The smaller nano-scale particles were imaged at 60k, 90k 
and 150k magnification.  
 
 
Figure 4.6 - CFE-SEM and EDX analysis of the BIOLOX® Forte ceramic model particles. (A) SEM 
image of the large alumina particles analysed using EDX and (B) corresponding EDX spectrum. Pin 
point EDX analysis of the particles was performed at a working distance of 15mm, 10kV and a suitable 
magnification to maintain focus. EDX spectrum B showed elemental peaks of Al (aluminium) and O 
(oxygen), which is indicative of alumina ceramic particles. 
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Figure 4.7 - Frequency size distribution of alumina BIOLOX® Forte ceramic model particles. A 
minimum of 150 particles were measured. 
 
Table 4.12 - Mean size (feret diameter) and morphology (aspect ratio and circularity) values 
for BIOLOX® Forte ceramic wear particles generated in water and BIOLOX® Forte ceramic 
model particles. 
 
BIOLOX
®
 Forte 
wear debris 
generated in water; 
Larger particles 
(100 - >5000nm) 
BIOLOX
®
 Forte 
wear debris 
generated in 
water; Smaller 
particles 
(0 - 100nm) 
 
BIOLOX
®
 Forte 
model; Larger 
particles 
(100 - >5000nm) 
BIOLOX
®
 Forte 
model; Smaller 
particles 
(0 - 100nm) 
Feret diameter (nm) 736.478 ± 99.449 50.162 ± 7.105 613.275 ± 34.924 43.554 ± 2.595 
Aspect ratio 1.521 ± 0.060 1.336 ± 0.042 1.458 ± 0.030 1.337 ± 0.035 
Circularity 0.762 ± 0.017 0.905 ± 0.008 0.790 ± 0.012 0.905 ± 0.006 
Note: All values expressed as mean ±95% Confidence Interval. 
4.4.1.2 BIOLOX® Delta model ceramic particles  
CFE-SEM analysis of the composite BIOLOX® Delta ceramic model particles revealed large 
grain-like structures that formed individual powder grains (Figure 4.8A). At high 
magnification (6-20K), these grain-like structures revealed the micro-structure of the 
BIOLOX® Delta powder, which consisted of tetragonal zirconia particles and strontium 
platelets dispersed within an alumina matrix (Figure 4.8B, C). The individual micron/sub-
micron sized particles can be seen in Figure 4.8D, which were irregular/shard-like in 
morphology. The nano-scale particles were round in morphology and existed as large 
agglomerates (Figure 4.8E, F). EDX mapping of the large grain-like structures clearly showed 
the presence of strontium platelets (yellow) and zirconia particles (blue) within the alumina 
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matrix (green) as indicated by the individual element maps (Sr, Zr and Al) (Figure 4.9). The 
irregular/shard-like micron and sub-micron sized particles shown in Figure 4.8D were 
comprised of alumina or zirconia as indicated by EDX analysis that showed elemental peaks 
of Al (aluminium), O (oxygen) and Zr (zirconia) (Figure 4.10). The nano-scale particles also 
consisted of alumina and zirconia as indicated by EDX analysis that showed elemental peaks 
of Al (aluminium), Zr (zirconia) and O (oxygen) (Figure 4.11). Furthermore, a peak of Sr 
(strontium) was also observed due to the platelet present within the microstructure, which can 
be clearly seen in the corresponding SEM image in  Figure 4.11A. The carbon (C) peak that 
can be seen in all EDX spectra was due to the carbon coating. The mean ferret diameter, mean 
aspect ratio and mean circularity values (value of 1.0 indicates a perfect circle) are shown in 
Table 4.13. An independent-samples t-test was conducted to compare the size distribution 
(feret diameter) and morphology (aspect ratio and circularity) of BIOLOX® Delta ceramic 
model particles with clinically-relevant BIOLOX® Delta ceramic wear particles generated in 
water (section 3.4.2.1.2). There was a significant difference in the values for aspect ratio 
(p<0.05) and circularity (p<0.05) between the clinically-relevant BIOLOX® Delta ceramic 
wear particles generated in serum and BIOLOX® Forte ceramic model particles. Moreover, 
the particle size distribution (feret diameter) for the clinically-relevant BIOLOX® Delta wear 
particles generated in water and BIOLOX® Delta ceramic model particles were also 
statistically different (p<0.05). The frequency as a function of size of the BIOLOX® Delta 
ceramic model particles is presented in Figure 4.12, which revealed a multimodal size 
distribution. The micron and sub-micron size alumina particles ranged between 100-2000nm 
with a mean size of 508nm, whereas the small nano-scale particles ranged between 30-100nm 
with a mean size of 64nm. Furthermore, the large grain-like structures that are represented in 
the >5000µm size range (Figure 4.12), ranged between 4-49.8µm, with a mean size of 
14.5µm. The BIOLOX® Delta ceramic model particles had a mode size distribution of 500-
600nm for the micron/sub-micron size alumina particles and a mode size of 60-70nm for the 
small nano-scale particles. Large grain-like structures (>5µm) made up more than 14% of the 
number of particles that were analysed.  
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Figure 4.8 - CFE-SEM images of BIOLOX® Delta ceramic model particles. (A) Individual powder 
grains, (B & C) Large grain-like structures that shows the microstructure of the composite ceramic. (D) 
Large micron and sub-micron size particles and (E & F) small nano-scale particles. The particles were 
imaged at 1-2kV voltage, working distance of 3mm and magnification ranging between 1.5-150K. 
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Figure 4.9 - EDX element map of BIOLOX® Delta ceramic model particles at 20K magnification 
showing the distribution of elements within the composite ceramic. EDX mapping was performed using 
the EDX element mapping tool at a working distance of 15 mm, 10kV. (A) EDX layered image of the 
elements identified on the area of the filter membrane; (B-D) Individual layers that correlate to the x-
ray map colours of the different elements identified i.e. Al (aluminium), Zr (zirconia) and Sr 
(strontium). 
 
 
Figure 4.10 - CFE-SEM and EDX analysis of the micron and sub-micron BIOLOX® Delta ceramic 
model particles. (A) SEM image of the larger particles analysed using EDX and (B) corresponding 
EDX spectrum. Pin point EDX analysis of the particles was performed at a working distance of 15mm, 
10kV and a suitable magnification to maintain focus. 
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Figure 4.11 - CFE-SEM and EDX analysis of smaller nano-scale BIOLOX® Delta ceramic model 
particles. (A) SEM image of the nano-scale particles analysed using EDX and (B) corresponding EDX 
spectrum. Pin point EDX analysis of the particles was performed at a working distance of 15mm, 10kV 
and a suitable magnification to maintain focus.  
 
Figure 4.12 - Frequency size distribution of composite BIOLOX® Delta ceramic model particles. A 
minimum of 150 particles were measured. 
 
Table 4.13 - Mean size (feret diameter) and morphology (aspect ratio and circularity) values 
for BIOLOX® Delta ceramic wear particles generated in water and BIOLOX® Delta ceramic 
model particles. 
 
BIOLOX
®
 Delta 
model particles; 
Larger particles 
(100 - >5000nm) 
BIOLOX
®
 Delta 
model particles; 
Smaller particles 
(0 - 100nm)  
BIOLOX
®
 Delta 
wear particles 
generated in serum; 
Larger particles 
(100 - >5000nm) 
BIOLOX
®
 Delta 
wear particles 
generated in serum; 
Smaller particles 
(0 - 100nm) 
Feret diameter (nm) 507.895 ± 24.742 64.367 ± 1.753 2308.105 ± 243.576 43.729 ± 0.968 
Aspect ratio 1.344 ± 0.030 1.257 ± 0.020 1.471 ± 0.021 1.289 ± 0.010 
Circularity 0.848 ± 0.009 0.908 ± 0.004 0.801 ± 0.005 0.911 ± 0.002 
Note: All values expressed as mean ±95% Confidence Interval. 
 
 
0.00
2.00
4.00
6.00
8.00
10.00
12.00
14.00
16.00
18.00
P
e
r
c
e
n
ta
g
e
 (
%
) 
n
u
m
b
e
r
 o
f 
p
a
r
ti
c
le
s
Size (nm)
B 
A 
178 
 
4.4.2 Biological impact of ceramic model particles 
The biological response to commercially obtained ceramic powder (ceramic model particles) 
that is used to manufacture ceramic hip replacements BIOLOX® Delta and BIOLOX® Forte, 
was tested in terms of cytotoxic effects on L929 murine fibroblast cells as an initial assessment 
of biocompatibility. These results were used to determine the concentration(s) at which the 
ceramic particles induced cytotoxic effects, which was subsequently used to select the 
appropriate doses of ceramic particles for the biocompatibility assessment using primary cells. 
This step was necessary to elucidate the cytotoxic dose(s) of ceramic particles, as this 
phenomenon is highly unlikely to occur in vivo due to the low wear rates of CoC bearings, 
hence it was important to ensure that the doses were representative of the clinical scenario. A 
comprehensive evaluation of the biological impact of BIOLOX® Delta ceramic model 
particles in terms of cytotoxicity, inflammation, genotoxicity and oxidative stress was 
subsequently conducted using human PBMNCs.     
4.4.2.1 The cytotoxic effects of ceramic model particles on L929 fibroblast cells 
L929 murine fibroblast cells were seeded at a density of 1x104 cells per well (n=6) in 96-well 
plates and cultured in DMEM culture media with increasing doses of ceramic model particles 
(BIOLOX® Forte or BIOLOX® Delta) at low to high volumes ranging from 0.05-500µm3 per 
cell. The negative control was seeded in the same way but with no particles. The cytotoxic 
effects of the ceramic particles were compared with clinically-relevant CoCr nano-particles 
at a dose of 50µm3 per cell, which was used as the positive particle control. Camptothecin, at 
a final concentration of 2 µg.ml-1 was included as the positive control to induce apoptosis. 
The plates were incubated for 0, 1, 3 and 6 days at 37oC in 5% (v/v) CO2 in air. The results 
of the ATP-Lite assay were expressed as average absorbance values (counts per second) and 
as a percentage relative to the cell only negative control. The data was analysed using a one-
way ANOVA and Tukey Post hoc analysis.  
The cytotoxic effect of increasing doses of ceramic model particles in L929 murine fibroblast 
cells is demonstrated in Figure 4.13A (BIOLOX® Forte) and Figure 4.14A (BIOLOX® Delta). 
The average absorbance values, which are indicative of cellular metabolic activity and thus 
viability, for the cell only negative control continued to increase over the course of the 6-day 
culture period. The average absorbance values from day 0 to day 6 for the cells only negative 
control increased by approximately 10-fold in the BIOLOX® Forte particles experiment and 
by 6-fold in the BIOLOX® Delta particles experiment, which was indicative of cell 
proliferation. The cell growth was adversely affected in the presence of high particle volumes, 
whereby the ceramic model particles of BIOLOX® Forte (Figure 4.13) and BIOLOX® Delta 
(Figure 4.14) at a dose of 500µm3 per cell caused a significant reduction in cell viability after 
6 days (ANOVA; p<0.05). Whereas, the CoCr nano-particles at a dose of 50µm3 per cell had 
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a significant cytotoxic affect from day 1 (ANOVA; p<0.05), where viability was reduced to 
84.3% in the BIOLOX® Forte treatment (Figure 4.13B) and to 51.7% in the BIOLOX® Delta 
treatment (Figure 4.14B). There was no significant reduction in cell viability for all the other 
particle doses tested for both BIOLOX® Forte and BIOLOX® Delta ceramic model particles. 
In fact, on occasion the cell viability increased after 1 day with both BIOLOX® Forte (all 
doses) and BIOLOX® Delta (0.5 and 500µm3 per cell) ceramic model particles, however this 
difference was not statistically significant. A significant reduction (ANOVA; p<0.05) in cell 
viability was measured for the positive control (2µg.ml-1 camptothecin), where after 6 days 
cell viability reduced by approximately 93% for both the BIOLOX® Forte (Figure 4.13) and 
BIOLOX® Delta (Figure 4.14) experiments. 
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Figure 4.13 –Effects of BIOLOX® Forte ceramic model particles in L929 murine fibroblast cells using 
the ATP-Lite assay. L929 cells were cultured with bimodal sized micrometre and nanoscale alumina 
ceramic particles for 6 days. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) percentage viability relative to the cell only negative control. 
Positive controls were camptothecin (2 µg.ml-1) and clinically relevant CoCr nano-particles (50µm3 
per cell) as a positive particle control. A statistically significant reduction (p<0.05 ANOVA with post 
hoc Tukey test) in cell viability in comparison to the cell only control, at given time points, is indicated 
by an asterisk (*). Error bars represent ±95% confidence limits, n=6.   
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Figure 4.14 - Effects of BIOLOX® Delta ceramic model particles in L929 murine fibroblast cells using 
the ATP-Lite assay. L929 cells were cultured with bimodal sized micrometre and nanoscale composite 
ceramic particles for 6 days. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) percentage viability relative to the cell only negative control. 
Positive controls were camptothecin (2 µg.ml-1) and clinically relevant CoCr nano-particles (50µm3 
per cell) as positive particle control. A statistically significant reduction (p<0.05 ANOVA with post 
hoc Tukey test) in cell viability in comparison to the cell only control, at given time points, is indicated 
by an asterisk (*). Error bars represent ±95% confidence limits, n=6.  
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4.4.2.2 The cytotoxic and inflammatory effects of BIOLOX® Delta ceramic model 
particles in PBMNCs 
The aim of this part of the study was to determine the release of TNF-α from PBMNCs in 
response to the increasing doses (0.05-50 µm3 per cell) of commercially obtained BIOLOX® 
Delta ceramic model particles. This assessment was completed using PBMNCs isolated from 
five different healthy volunteer donors (donor 2, donor 5, donor 7, donor 25 and donor 26) to 
evaluate the variability in response to the particles and controls.  
4.4.2.2.1 TNF-α release from PBMNCs in response to BIOLOX® Delta ceramic model 
particles  
PBMNCs isolated from five donors (donor 2, donor 5, donor 7, donor 25 and donor 26) were 
seeded at a density of 2x104 cells per well (n=6) in 96-well plates and cultured in RPMI culture 
media with increasing doses (0.05, 0.5, 5 & 50µm3 per cell) of BIOLOX® Delta ceramic 
model particles. The negative control was seeded in the same way but with no particles. LPS 
(20ng.ml-1) was used as the positive control. The cytotoxic and inflammatory effects of the 
BIOLOX® Delta ceramic model particles were compared with high (50µm3 per cell) and low 
(0.5 µm3 per cell) doses of BIOLOX® Forte ceramic model particles and high (50µm3 per cell) 
and low (0.5 µm3 per cell) doses of clinically-relevant CoCr nano-particles (positive particle 
control). The plates were incubated for 24 hours at 37oC in 5% (v/v) CO2 in air. The cell 
viability of the PBMNCs following incubation with the particles and controls was determined 
using the ATP-Lite assay, and an ELISA was conducted on the culture supernatants to 
determine the concentration of TNF-α released from the cells after the 24hr culture period. 
The results of the ATP-Lite assay and ELISA were expressed as average absorbance values 
and were analysed using one-way ANOVA and Tukey Post hoc analysis.     
The cell viability and TNF-α released from PBMNCs after 24 hours incubation with the 
particles and controls are shown in Figure 4.15 (Donor 2), Figure 4.16 (Donor 5), Figure 4.17 
(Donor 7), Figure 4.18 (Donor 25) and Figure 4.19 (Donor 26). None of the particle doses 
(0.05, 0.5, 5 & 50µm3 per cell) had a significant effect on the viability of PBMNCs from any 
of the donors compared to the cell only negative control. There was no significant increase in 
the level of TNF-α released for all the donors in response to the BIOLOX® Delta ceramic 
model particles compared to the cell only negative control, for all the particle volumes tested. 
The BIOLOX® Forte ceramic model particles at low (0.5 µm3 per cell) and high (50µm3 per 
cell) doses also did not elicit a significant increase in TNF-α release for all the donors 
compared to the cell only negative control. In addition, the low dose (0.5 µm3 per cell) of 
clinically-relevant CoCr nano-particles showed no significant increase in TNF-α release in 
any of the donors compared to the cell only negative control. However, the high dose (50µm3 
per cell) of clinically-relevant CoCr nano-particles caused a significant increase in the levels 
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of TNF-α for all the donors tested when compared to the cell only negative control (ANOVA; 
p<0.05). The positive control of 20ng.ml-1 LPS caused significant levels of TNF-α release 
from PBMNCs from all donors compared to the cell only negative control (ANOVA; p<0.05).  
 
  
Figure 4.15 – (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 2 in 
response to BIOLOX® Delta model ceramic particles. PBMNCs were cultured with multimodal sized 
micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic and 
particles, and clinically-relevant CoCr nano-particles for 24 hours. Cell viability was determined using 
the ATP-Lite assay and presented as (A) mean counts per second and (B) release of TNF-α was 
measured using ELISA. The positive control was 200ng.ml-1 lipopolysaccharide (LPS). A statistically 
significant reduction (p<0.05 ANOVA with post hoc Tukey test) in cell viability in comparison to the 
cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence limits, n=6. 
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Figure 4.16 - (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 5 in response 
to BIOLOX® Delta model ceramic particles. PBMNCs were cultured with multimodal sized 
micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic and 
particles, and clinically-relevant CoCr nano-particles for 24 hours. Cell viability was determined using 
the ATP-Lite assay and presented as (A) mean counts per second and (B) release of TNF-α was 
measured using ELISA. The positive control was 200ng.ml-1 lipopolysaccharide (LPS). A statistically 
significant reduction (p<0.05 ANOVA with post hoc Tukey test) in cell viability in comparison to the 
cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence limits, n=6. 
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Figure 4.17 - (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 7 in response 
to BIOLOX® Delta model ceramic particles. PBMNCs were cultured with multimodal sized 
micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic and 
particles, and clinically-relevant CoCr nano-particles for 24 hours. Cell viability was determined using 
the ATP-Lite assay and presented as (A) mean counts per second and (B) release of TNF-α was 
measured using ELISA. The positive control was 200ng.ml-1 lipopolysaccharide (LPS). A statistically 
significant reduction (p<0.05 ANOVA with post hoc Tukey test) in cell viability in comparison to the 
cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence limits, n=6.  
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Figure 4.18 - (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 25 in 
response to BIOLOX® Delta model ceramic particles. PBMNCs were cultured with multimodal sized 
micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic and 
particles, and clinically-relevant CoCr nano-particles for 24 hours. Cell viability was determined using 
the ATP-Lite assay and presented as (A) mean counts per second and (B) release of TNF-α was 
measured using ELISA. The positive control was 200ng.ml-1 lipopolysaccharide (LPS). A statistically 
significant reduction (p<0.05 ANOVA with post hoc Tukey test) in cell viability in comparison to the 
cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence limits, n=6. 
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Figure 4.19 - (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 26 in 
response to BIOLOX® Delta model ceramic particles. PBMNCs were cultured with multimodal sized 
micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic and 
particles, and clinically-relevant CoCr nano-particles for 24 hours. Cell viability was determined using 
the ATP-Lite assay and presented as (A) mean counts per second and (B) release of TNF-α was 
measured using ELISA. The positive control was 200ng.ml-1 lipopolysaccharide (LPS). A statistically 
significant reduction (p<0.05 ANOVA with post hoc Tukey test) in cell viability in comparison to the 
cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence limits, n=6. 
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4.4.2.2.2 Inter-donor and intra-donor variability in TNF-α production by PBMNCs in 
response to CoCr nano-particles and LPS 
The production of TNF-α in response to BIOLOX® Delta ceramic model particles was 
measured and compared to clinically-relevant CoCr nano-particles and LPS (positive control). 
Despite the inherent donor variability in inflammatory response, the BIOLOX® Delta ceramic 
model particles consistently failed to stimulate a statistically significant inflammatory 
response compared to the cell only negative control, in terms of TNF-α production by 
PBMNCs from all donors for all the particle volumes tested. However, LPS (positive control) 
and CoCr nano-particles at a dose of 50µm3 per cell resulted in significant levels of TNF-α 
when compared to the cell only negative control (ANOVA; p<0.05). Hence, the TNF-α data 
for the cell only negative control, CoCr nano-particles and LPS (positive control) from all the 
donors was presented as box plots to demonstrate the inter-donor and intra-donor variability 
in terms of TNF- release from PBMNCs isolated from different donors (Figure 4.20).  
In terms of inter-donor variability, donor 2, donor 5 and donor 7 produced higher 
concentrations of TNF-α compared to donor 25 and donor 26, in the cell only negative control 
and 50µm3 CoCr nano-particles. Donor 2 and donor 5 produced a two-fold increase in TNF-
α when stimulated with 20ng.ml-1 of LPS compared to the other donors. Furthermore, donor 
7 for the cell only negative control showed the highest level of intra-donor variability relative 
to all the other donors. All the donors stimulated with 50µm3 per cell of CoCr nano-particles 
showed high levels of intra-donor variability whereby donor 25 showed the least variation in 
TNF-α production compared to the other donors. Donor 2, donor 5 and donor 7 showed the 
highest level of intra-donor variation in TNF-α production compared to the other donors.   
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Figure 4.20 – Inter-donor and intra-donor variability in PBMNC responses for (A) cell only control 
and PBMNCs cultured with 50µm3 per cell of CoCr nano-particles and (B) PBMNCs treated with LPS.   
 
4.4.2.3 The genotoxic effects of BIOLOX® Delta ceramic model particles in PBMNCs  
The aim of this part of the study was to assess the genotoxicity of increasing doses (0.05-50 
µm3 per cell) of commercially obtained BIOLOX® Delta ceramic model particles in 
PBMNCs. This assessment was completed in PBMNCs isolated from five different healthy 
volunteer donors to evaluate the variability in response to the particles and controls. DNA 
damage in PBMNCs following a 24hr incubation period with the particles and controls was 
determined using the comet assay (protocol described in section 4.3.2.7.3). DNA damage was 
quantified as the comet tail moment (Figure 4.21), which represents the extent of DNA 
damage in individual cells and is defined as the product of the percentage of total DNA in the 
tail and the distance between the centres of the mass of head and tail regions (Equation 5). 
Equation 5  
𝑇𝑎𝑖𝑙 𝑚𝑜𝑚𝑒𝑛𝑡 = 𝑡𝑎𝑖𝑙 𝑙𝑒𝑛𝑔𝑡ℎ × 𝑝𝑒𝑟𝑐𝑒𝑛𝑡𝑎𝑔𝑒 𝑜𝑓 𝐷𝑁𝐴 𝑖𝑛 𝑡𝑎𝑖𝑙 
B 
A 
190 
 
 
 
Figure 4.21 – Tail moment length is measured from the centre of the head to the centre of the tail. 
4.4.2.3.1 DNA damage in PBMNCs in response to BIOLOX® Delta ceramic model 
particles  
PBMNCs isolated from five donors (Donor 2, Donor 5, Donor 7, Donor 25 and Donor 26) 
were seeded at a density of 1x105 cells per well (n=2) in 48-well plates and cultured in RPMI 
culture media with increasing doses of (0.05, 0.5, 5 & 50µm3 per cell) of BIOLOX® Delta 
ceramic model particles. The negative control was seeded in the same way but with no 
particles. Hydrogen peroxide (100µM) was used as the positive control as it is known to 
induce single and double strand DNA damage (Driessens et al., 2009). The genotoxic effects 
of BIOLOX® Delta ceramic model particles were compared with high (50µm3 per cell) and 
low (0.5 µm3 per cell) doses of BIOLOX® Forte ceramic model particles and high (50µm3 per 
cell) and low (0.5 µm3 per cell) doses of clinically-relevant CoCr nano-particles (positive 
particle control). The plates were incubated for 24 hours at 37oC in 5% (v/v) CO2 in air and 
DNA damage in the PBMNCs following incubation with the particles and controls was 
determined using the comet assay (protocol described in section 4.3.2.7.3). During the assay 
protocol, the cells were embedded in agarose gel and underwent single cell electrophoresis. 
The output of the assay output was images of single cells that were analysed using the Comet 
IV software. The results were expressed as the comet tail moment and were analysed using 
one-way ANOVA and Tukey Post hoc analysis. The genotoxic effects of the particles and 
controls are shown in Figure 4.22 (Donor 2), Figure 4.23 (Donor 5), Figure 4.24 (Donor 7), 
Figure 4.25 (Donor 25) and Figure 4.26 (Donor 26). High levels of DNA damage are indicated 
by longer tails in the images and higher values of tail moment relative to the cell only control. 
Cell nuclei that appear completely circular are indicative of no DNA damage. The BIOLOX® 
Delta ceramic model particles did not cause DNA damage in PBMNCs from all donors as 
there was no statistical difference in comet tail moment for all the particle doses when 
compared to the cell only negative control. This was also evident for the BIOLOX® Forte 
ceramic model particles at low doses (0.5 µm3 per cell) where there was no significant increase 
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in tail moment compared to the cell only negative control for all the donors. However, for the 
BIOLOX® Forte ceramic model particles at high doses (50µm3 per cell) there was a significant 
increase in tail moment compared to the cell only negative control for all donors, except donor 
5 (ANOVA; p<0.05). PBMNCs from donor 5 demonstrated no significant increase in DNA 
damage (tail moment) in response to the high dose (50µm3 per cell) of BIOLOX® Forte 
ceramic model particles. Similarly, the high dose (50µm3) of clinically-relevant CoCr nano-
particles caused a significant increase in DNA damage as indicated by the high values for tail 
moment compared to the cell only negative control (ANOVA; p<0.05). The low dose 
(0.5µm3) of clinically-relevant CoCr nano-particles demonstrated no genotoxic effects (no 
significant increase in tail moment) in PBMNCs from all donors when compared to the cell 
only negative control. The positive control of hydrogen peroxide caused significant levels of 
DNA damage in PBMNCs from all donors compared to the cell only negative control 
(ANOVA; p<0.05).  
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Images of comets (from PBMNCs) stained with SYBR Gold.                        
     
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 Delta 50µm3 
     
Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 CoCr 50µm3 Positive control 
Scale bar 50µm  
 
Figure 4.22 – The genotoxic effects of BIOLOX® Delta ceramic model particles in PBMNCs isolated 
from Donor 2. PBMNCs were cultured with bimodal size micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. DNA damage was determined using the comet assay and 
presented as (A) mean tail moment and (B) images of single cells. Cells that appear circular have no 
DNA damage, whereas nuclei that have tails are indicative of DNA damage. A statistically significant 
difference (p<0.05 ANOVA with post hoc Tukey test) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits.  
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Images of comets (from PBMNCs) stained with SYBR Gold.                        
     
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 Delta 50µm3 
     
Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 CoCr 50µm3 Positive control 
Scale bar 50µm  
 
Figure 4.23 - The genotoxic effects of BIOLOX® Delta model ceramic particles in PBMNCs isolated 
from Donor 5. PBMNCs were cultured with bimodal size micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. DNA damage was determined using the comet assay and 
presented as (A) mean tail moment and (B) images of single cells. Cells that appear circular have no 
DNA damage, whereas nuclei that have tails are indicative of DNA damage. A statistically significant 
difference (p<0.05 ANOVA with post hoc Tukey test) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits. 
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Images of comets (from PBMNCs) stained with SYBR Gold.                        
     
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 Delta 50µm3 
     
Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 CoCr 50µm3 Positive control 
Scale bar 50µm  
 
Figure 4.24 - The genotoxic effects of BIOLOX® Delta model ceramic particles in PBMNCs isolated 
from Donor 7. PBMNCs were cultured with bimodal size micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. DNA damage was determined using the comet assay and 
presented as (A) mean tail moment and (B) images of single cells. Cells that appear circular have no 
DNA damage, whereas nuclei that have tails are indicative of DNA damage. A statistically significant 
difference (p<0.05 ANOVA with post hoc Tukey test) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits.  
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Images of comets (from PBMNCs) stained with SYBR Gold.                        
     
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 Delta 50µm3 
     
Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 CoCr 50µm3 Positive control 
Scale bar 50µm  
 
Figure 4.25 - The genotoxic effects of BIOLOX® Delta model ceramic particles in PBMNCs isolated 
from Donor 25. PBMNCs were cultured with bimodal size micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. DNA damage was determined using the comet assay and 
presented as (A) mean tail moment and (B) images of single cells. Cells that appear circular have no 
DNA damage, whereas nuclei that have tails are indicative of DNA damage. A statistically significant 
difference (p<0.05 ANOVA with post hoc Tukey test) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits.  
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Images of comets (from PBMNCs) stained with SYBR Gold.                         
     
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 Delta 50µm3 
     
Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 CoCr 50µm3 Positive control 
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Figure 4.26 - The genotoxic effects of BIOLOX® Delta model ceramic particles in PBMNCs isolated 
from Donor 26. PBMNCs were cultured with bimodal size micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. DNA damage was determined using the comet assay and 
presented as (A) mean tail moment and (B) images of single cells. Cells that appear circular have no 
DNA damage, whereas nuclei that have tails are indicative of DNA damage. A statistically significant 
difference (p<0.05 ANOVA with post hoc Tukey test) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits.   
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4.4.2.4 Oxidative stress in PBMNCs in response to model ceramic particles  
The aim of this part of the study was to assess the levels of oxidative stress induced by 
increasing doses (0.05-50µm3 per cell) of commercially obtained BIOLOX® Delta ceramic 
model particles in PBMNCs. This assessment was completed in PBMNCs isolated from five 
different healthy volunteer donors to evaluate the variability in response to the particles and 
controls. Oxidative stress was measured by labelling the ROS produced by PBMNCs using a 
DCFDA probe in the cellular reactive oxygen species detection assay kit (protocol outlined 
in section 4.3.2.7.4).  
4.4.2.4.1 Oxidative stress in PBMNCs in response to BIOLOX® Delta ceramic model 
particles  
PBMNCs isolated from five donors (donor 2, donor 5, donor 7, donor 25 and donor 26) were 
seeded at a density of 2x104 cells per well (n=6) in clear bottom black 96-well plates and 
cultured in RPMI culture media with increasing doses (0.05, 0.5, 5 & 50µm3 per cell) of 
BIOLOX® Delta ceramic model particles. The cell only negative control was seeded in the 
same way but with no particles. TBHP (200µM) was used as the positive control as it mimics 
ROS activity to oxidise DCFDA to fluorescent DCF and so it is commonly used to evaluate 
the cellular responses resulting from oxidative stress in cells and tissues (Kucera et al., 2014). 
The presence of ROS within the cells in response to the BIOLOX® Delta ceramic model 
particles was compared with high (50µm3 per cell) and low (0.5 µm3 per cell) doses of 
BIOLOX® Forte ceramic model particles and high (50µm3 per cell) and low (0.5 µm3 per cell) 
doses of clinically-relevant CoCr nano-particles. The plates were incubated for 24 hours at 
37oC in 5% (v/v) CO2 in air. The production of ROS in PBMNCs following incubation with 
the particles and controls was determined using the cellular ROS detection assay (protocol 
outlined in section 4.3.2.7.4). The results were expressed as average fluorescence intensity 
values where higher values of fluorescence intensity was directly proportional to high levels 
of oxidative stress. The data was analysed using one-way ANOVA and Tukey Post hoc 
analysis. The cells present within the wells were also imaged to correlate the fluorescence 
intensity values with the fluorescence emitted from within the cells.  
The images captured of the PBMNCs isolated from donor 2 are shown in Figure 4.27 and are 
representative of all donors. The images depict the fluorescently labelled reactive oxygen 
species that were present in the PBMNCs isolated from Donor 2 after exposure to 485nm for 
1000ms. The cell only, low dose (0.5µm3 per cell) of CoCr nano-particles and all the doses 
(0.05-50µm3 per cell) for both BIOLOX® Delta and BIOLOX® Forte demonstrated less 
fluorescence relative to the high dose (50µm3 per cell) of CoCr nano-particles and positive 
control (200µM TBHP). The brighter images of PBMNCs treated with 50µm3 per cell of 
CoCr nano-particles and TBHP were indicative of high levels of oxidative stress.   
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The production of ROS levels as a function of fluorescence intensity in response to the 
particles and controls is shown in Figure 4.28 (Donor 2), Figure 4.29 (Donor 5), Figure 4.30 
(Donor 7), Figure 4.31 (Donor 25) and Figure 4.32 (Donor 26). High levels of ROS are 
indicated by higher fluorescence intensity relative to the cell only negative control and are 
visualised as brighter green fluorescence in the images (Figure 4.27). The BIOLOX® Delta 
ceramic model particles at all doses had no statistically significant effect on the level of 
oxidative stress (fluorescence intensity) in PBMNCs from all donors when compared to the 
cell only negative control. This was also evident for the BIOLOX® Forte ceramic model 
particles at low (0.5 µm3 per cell) and high (50µm3 per cell) doses, where there was no 
significant increase in ROS production (fluorescence intensity) compared to the cell only 
negative control for all the donors. Similarly, the low dose (0.5 µm3 per cell) of clinically-
relevant CoCr nano-particles showed no significant increase in the level of ROS production 
(fluorescence intensity) when compared to the cell only negative control, except in donor 2 
and donor 5, which showed significantly higher levels of oxidative stress compared with cells 
only negative control (ANOVA; p<0.05). However, the high dose (50µm3 per cell) of 
clinically-relevant CoCr nano-particles caused a significant increase in the levels of ROS 
production in PBMNCs in all donors as indicated by the high levels of fluorescence intensity 
compared to the cells only negative control (ANOVA; p<0.05). The positive control of TBHP 
(200µM) caused significant levels of ROS production (fluorescence intensity) in PBMNCs 
from all donors compared to the cell only negative control (ANOVA; p<0.05).  
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Figure 4.27 – Visualisation of the presence of ROS in PBMNCs (donor 2) cultured with BIOLOX® 
Delta ceramic model particles. PBMNCs were cultured with bimodal sized micrometre and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. Oxidative stress was determined using DCFDA probe to 
detect the presence of ROS, which is visualised as the green fluorescence. The higher the intensity of 
the green fluorescence, the higher the levels of ROS produced by the PBMNCs. TBHP (200µM) was 
used as the positive control. Size-bar 50µm in all images.   
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Figure 4.28 – Oxidative stress in PBMNCs isolated from Donor 2 in response to BIOLOX® Delta 
ceramic model particles. PBMNCs were cultured with bimodal sized micrometre and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. Oxidative stress was determined using a DCFDA probe to 
detect the presence of ROS, which is presented as fluorescent intensity. TBHP (200µM) was used as 
the positive control. A statistically significant difference (p<0.05 ANOVA) in fluorescence intensity 
compared to the cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence 
limits (n=6).  
 
 
Figure 4.29 – Oxidative stress in PBMNCs isolated from Donor 5 in response to BIOLOX® Delta 
model ceramic particles. PBMNCs were cultured with bimodal sized micrometre and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. Oxidative stress was determined using a DCFDA probe to 
detect the presence of ROS, which is presented as fluorescent intensity. TBHP (200µM) was used as 
the positive control. A statistically significant difference (p<0.05 ANOVA) in fluorescence intensity 
compared to the cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence 
limits (n=6).  
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Figure 4.30 – Oxidative stress in PBMNCs isolated from Donor 7 in response to BIOLOX Delta model 
ceramic particles. PBMNCs were cultured with bimodal sized micrometre and nanoscale composite 
(BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-relevant 
CoCr nano-particles for 24 hours. Oxidative stress was determined using a DCFDA probe to detect the 
presence of ROS, which is presented as fluorescent intensity. TBHP (200µM) was used as the positive 
control. A statistically significant difference (p<0.05 ANOVA) in fluorescence intensity compared to 
the cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence limits (n=6). 
 
 
Figure 4.31 - Oxidative stress in PBMNCs isolated from Donor 25 in response to BIOLOX® Delta 
model ceramic particles. PBMNCs were cultured with bimodal sized micrometre and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. Oxidative stress was determined using a DCFDA probe to 
detect the presence of ROS, which is presented as fluorescent intensity. TBHP (200µM) was used as 
the positive control. A statistically significant difference (p<0.05 ANOVA) in fluorescence intensity 
compared to the cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence 
limits (n=6). 
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Figure 4.32 - Oxidative stress in PBMNCs isolated from Donor 26 in response to BIOLOX® Delta 
model ceramic particles. PBMNCs were cultured with bimodal sized micrometre and nanoscale 
composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) ceramic model particles, and clinically-
relevant CoCr nano-particles for 24 hours. Oxidative stress was determined using a DCFDA probe to 
detect the presence of ROS, which is presented as fluorescent intensity. TBHP (200µM) was used as 
the positive control. A statistically significant difference (p<0.05 ANOVA) in fluorescence intensity 
compared to the cell only control is indicated by an asterisk (*). Error bars represent ±95% confidence 
limits (n=6). 
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4.4.3 Biological impact of clinically-relevant ceramic particles 
The biological response to clinically-relevant BIOLOX® Delta ceramic wear particles 
(generated using the Leeds II hip simulator) was assessed using the same tool kit of assays. 
The biological impact of these composite BIOLOX® Delta ceramic wear particles was 
compared with clinically-relevant BIOLOX® Forte ceramic wear particles, which were also 
generated using a hip simulator and clinically-relevant CoCr nano-particles generated using 
a six station PoP wear rig. Stainless-steel wear particles generated using the six-station PoP 
wear rig were also introduced as a particle control in these experiments as the water lubricant 
used to generate the clinically-relevant ceramic wear particles during wear simulation was 
contaminated by stainless-steel wear particles (section 3.4.2.2). This was necessary as the 
particle suspension yielded from the hip simulator was a mixed population of ceramic wear 
particles and stainless-steel wear particles. 
4.4.3.1 The cytotoxic effects of clinically-relevant BIOLOX® Delta ceramic wear 
particles in L929 fibroblast cells 
L929 murine fibroblast cells were seeded at a density of 1x104 cells per well (n=6) in 96-well 
plates and cultured in DMEM culture media with increasing doses of clinically-relevant 
BIOLOX® Delta ceramic wear particles at low to high volumes ranging from 0.05-500µm3 
per cell. The negative cell only control was seeded in the same way but with no particles. The 
cytotoxic effects of the ceramic particles were compared with clinically-relevant CoCr nano-
particles at a dose of 50µm3 per cell, which was used as the positive particle control. 
Camptothecin, at a final concentration of 2 µg.ml-1 was included as the positive control to 
induce apoptosis. The plates were incubated for 0, 1, 3 and 6 days at 37oC in 5% (v/v) CO2 in 
air. The results of the ATP-Lite assay were expressed as average absorbance values (counts 
per second) and as a percentage relative to the cell only negative control. The data was 
analysed using a one-way ANOVA and Tukey Post hoc analysis.  
The cytotoxic effect of increasing doses of clinically-relevant BIOLOX® Delta ceramic wear 
particles on L929 fibroblast cells are shown in Figure 4.33. The average absorbance values, 
which are indicative of cellular metabolic activity and thus viability, for the cell only negative 
controls continued to increase over the course of the 6-day culture period as demonstrated in 
Figure 4.33A. The average absorbance values from day 0 to day 6 for the cells only negative 
control increased by approximately 8-fold, which was indicative of cell proliferation. The cell 
growth was adversely affected in the presence of high volumes of clinically-relevant 
BIOLOX® Delta ceramic wear particles (Figure 4.33B), where at a dose 500µm3 per cell 
caused a statistical significant reduction in cell viability after day 1 (ANOVA; p<0.05). The 
clinically-relevant CoCr nano-particles at a dose of 50µm3 per cell also had a statistical 
significant cytotoxic affect from day 1, where the cell viability was reduced to 71.3% 
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compared to the cell only negative control (ANOVA; p<0.05). Furthermore, the clinically-
relevant BIOLOX® Delta ceramic wear particles at a dose of 50µm3 per cell caused a 
statistical significant reduction in cell viability after 3 days Figure 4.33B, when compared to 
the cell only negative control (ANOVA; p<0.05). However, after 6 days the cells cultured 
with 50µm3 per cell of clinically-relevant BIOLOX® Delta ceramic wear particles recovered 
after 6 days showing no statistical significant difference in cell viability compared to the cell 
only negative control. The highest dose (500µm3 per cell) of clinically-relevant BIOLOX® 
Delta ceramic wear particles caused a significant reduction in cell viability after 6 days, when 
compared to the cell only negative control (ANOVA; p<0.05). The CoCr nano-particles 
significantly reduced the viability of the L929 cells by approximately 54% after 6 days, when 
compared to the cell only negative control (ANOVA; p<0.05). There was no significant 
reduction in the cell viability for all the other particle doses (0.05, 0.5, and 5 µm3 per cell) 
tested for clinically-relevant BIOLOX® Delta ceramic wear particles. A significant reduction 
(ANOVA; p<0.05) in cell viability was measured for the positive control (2µg.ml-1 
camptothecin) after one day in culture, and after 6 days cell viability reduced by 
approximately 96%. 
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Figure 4.33 - Effects of clinically-relevant BIOLOX® Delta wear particles on L929 fibroblast cells 
using the ATP-Lite assay. L929 cells were cultured with bimodal sized micrometre and nanoscale 
composite ceramic wear particles generated using the Leeds II hip simulator. Cell viability was 
determined over a period of 6 days using the ATP-Lite assay and presented as (A) mean counts per 
second and (B) percentage viability relative to the cell only negative control. Positive controls were 
camptothecin (2 µg.ml-1) and 50µm3 per cell clinically relevant CoCr nano-particles as positive particle 
control. A statistically significant reduction (p<0.05 ANOVA) in cell viability in comparison to the 
cells only control, at given time points, is indicated by an asterisk (*). Error bars represent ±95% 
confidence limits, n=6. 
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4.4.3.2 The cytotoxic and inflammatory effects of clinically-relevant ceramic wear 
particles on PBMNCs 
The aim of this part of the study was to determine the release of TNF-α from PBMNCs in 
response to the increasing doses (0.05-50 µm3 per cell) of clinically-relevant BIOLOX® Delta 
ceramic wear particles. This assessment was completed using PBMNCs isolated from the 
same five different healthy volunteer donors (donor 2, donor 5, donor 7, donor 25 and donor 
26) to evaluate the variability in response to the particles and controls.  
4.4.3.2.1 TNF-α release from PBMNCs in response to clinically-relevant BIOLOX® 
Delta ceramic wear particles  
PBMNCs isolated from five donors (Donor 2, Donor 5, Donor 7, Donor 25 and Donor 26) 
were seeded at a density of 2x104 cells per well (n=6) in 96-well plates and cultured in RPMI 
culture media with increasing doses (0.05, 0.5, 5 & 50µm3 per cell) of clinically-relevant 
BIOLOX® Delta ceramic wear particles. The cell only negative control was seeded in the 
same way but with no particles. LPS (20ng.ml-1) was used as the positive control. The 
cytotoxic and inflammatory effects of the clinically-relevant BIOLOX® Delta ceramic wear 
particles were compared with high (50µm3 per cell) and low (0.5 µm3 per cell) doses of 
clinically-relevant BIOLOX® Forte ceramic wear particles and high (50µm3 per cell) and low 
(0.5 µm3 per cell) doses of clinically-relevant CoCr nano-particles (positive particle control). 
Stainless-steel wear particles generated using the six-station PoP wear rig were also 
introduced at dose 50µm3 per cell as a particle control. The plates were incubated for 24 hours 
at 37oC in 5% (v/v) CO2 in air. The cell viability of the PBMNCs following incubation with 
the particles and controls was determined using the ATP-Lite assay, and an ELISA was 
conducted on the culture supernatants to determine the concentration of TNF-α released from 
the cells after the 24hr culture period. The results of the ATP-Lite assay and ELISA were 
expressed as average absorbance values and were analysed using one-way ANOVA and 
Tukey Post hoc analysis.     
The cell viability and TNF-α release from PBMNCs after 24hrs incubation with the particles 
and controls are shown are Figure 4.34 (Donor 2), Figure 4.35 (Donor 5), Figure 4.36 (Donor 
7), Figure 4.37 (Donor 25) and Figure 4.38 (Donor 26). None of the conditions had a 
significant effect on the viability of PBMNCs from all the donors compared to the cell only 
negative control. The high dose (50µm3 per cell) of clinically-relevant CoCr nano-particles 
caused a significant increase in the levels of TNF-α released for all the donors when compared 
to the cell only negative control (ANOVA; p<0.05). Similarly, the highest dose (50µm3 per 
cell) of both clinically-relevant BIOLOX® Forte and BIOLOX® Delta ceramic wear particles 
caused a significant increase in the levels of TNF-α released from all the donors compared to 
the cell only negative control (ANOVA; p<0.05).  
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However, the high dose (50µm3 per cell) of stainless steel wear particles showed no significant 
increase in the levels of TNF-α released for all the donors when compared to the cells only 
negative control. For the other particle volumes of BIOLOX® Delta (0.05-5µm3 per cell) and 
BIOLOX® Forte (0.5µm3 per cell), there was no significant increase in the levels of TNF-α 
released compared to the cell only negative control for all the donors. The low dose (0.5 µm3 
per cell) of clinically-relevant CoCr nano-particles also showed no significant increase in 
TNF-α release compared to the cell only negative control for all the donors. The positive 
control of LPS (200ng.ml-1) caused significant levels of TNF-α released from PBMNCs from 
all donors compared to the cell only negative control (ANOVA; p<0.05).  
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Figure 4.34 – (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 2 in 
response to clinically-relevant BIOLOX® Delta ceramic wear particles. PBMNCs were cultured with 
bimodal sized micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) 
clinically-relevant ceramic wear particles, clinically-relevant stainless-steel wear particles and CoCr 
nano-particles for 24 hours. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) release of TNF-α was measured using ELISA. Positive control 
was 200ng.ml-1 lipopolysaccharide. A statistically significant reduction (p<0.05 ANOVA) in cell 
viability in comparison to the cells only control is indicated by an asterisk (*). Error bars represent 
±95% confidence limits, n=6.  
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Figure 4.35  – (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 5 in 
response to clinically-relevant BIOLOX® Delta ceramic wear particles. PBMNCs were cultured with 
bimodal sized micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) 
clinically-relevant ceramic wear particles, clinically-relevant stainless-steel wear particles and CoCr 
nano-particles for 24 hours. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) release of TNF-α was measured using ELISA. Positive control 
was 200ng.ml-1 lipopolysaccharide. A statistically significant reduction (p<0.05 ANOVA) in cell 
viability in comparison to the cells only control is indicated by an asterisk (*). Error bars represent 
±95% confidence limits, n=6.  
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Figure 4.36 – (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 7 in 
response to clinically-relevant BIOLOX® Delta ceramic wear particles. PBMNCs were cultured with 
bimodal sized micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) 
clinically-relevant ceramic wear particles, clinically-relevant stainless-steel wear particles and CoCr 
nano-particles for 24 hours. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) release of TNF-α was measured using ELISA. Positive control 
was 200ng.ml-1 lipopolysaccharide. A statistically significant reduction (p<0.05 ANOVA) in cell 
viability in comparison to the cells only control is indicated by an asterisk (*). Error bars represent 
±95% confidence limits, n=6.  
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Figure 4.37 – (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 25 in 
response to clinically-relevant BIOLOX® Delta ceramic wear particles. PBMNCs were cultured with 
bimodal sized micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) 
clinically-relevant ceramic wear particles, clinically-relevant stainless-steel wear particles and CoCr 
nano-particles for 24 hours. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) release of TNF-α was measured using ELISA. Positive control 
was 200ng.ml-1 lipopolysaccharide. A statistically significant reduction (p<0.05 ANOVA) in cell 
viability in comparison to the cells only control is indicated by an asterisk (*). Error bars represent 
±95% confidence limits, n=6.  
 
0.E+00
2.E+05
4.E+05
6.E+05
8.E+05
1.E+06
1.E+06
1.E+06
Cells
only
0.05µm3 0.5µm3 5µm3 50µm3 0.5µm3
Forte
50µm3
Forte
0.5µm3
CoCr
50µm3
CoCr
50µm3
SS
LPS
A
T
P
-L
it
e
 c
o
u
n
ts
 p
e
r
 s
ec
o
n
d
 (
c
p
s)
BIOLOX® Delta particle doses
A
0
10
20
30
40
50
60
70
80
90
Cells
only
0.05µm3 0.5µm3 5µm3 50µm3 0.5µm3
Forte
50µm3
Forte
0.5µm3
CoCr
50µm3
CoCr
50µm3
SS
T
N
F
-α
(p
g
.m
l-
1
)
BIOLOX® Delta particle doses
B
0
100
200
300
400
500
600
700
1
T
N
F
-α
(p
g
.m
l-
1
)
LPS
* 
* 
* 
* 
0.05µm
3
 0.5µm
3
 5µm  50µm
3
 0.5µm
3 
Forte 
50µm
3 
Forte 
0.5µm
3 
CoCr 
50µm
3 
CoCr 
50µm
3 
SS 
0.05µm
3
 0.5µm
3
 5µm
3
 50µm
3
 0.5µm
3 
Forte 
50µm
3 
Forte 
0.5µm
3 
CoCr 
50µm
3 
CoCr 
50µm
3 
SS 
Cell 
only 
212 
 
 
 
Figure 4.38 – (A) Cell viability and (B) TNF-α release from PBMNCs isolated from Donor 26 in 
response to clinically-relevant BIOLOX® Delta ceramic wear particles. PBMNCs were cultured with 
bimodal sized micrometre and nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) 
clinically-relevant ceramic wear particles, clinically-relevant stainless-steel wear particles and CoCr 
nano-particles for 24 hours. Cell viability was determined using the ATP-Lite assay and presented as 
(A) mean counts per second and (B) release of TNF-α was measured using ELISA. Positive control 
was 200ng.ml-1 lipopolysaccharide. A statistically significant reduction (p<0.05 ANOVA) in cell 
viability in comparison to the cells only control is indicated by an asterisk (*). Error bars represent 
±95% confidence limits, n=6. 
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4.4.3.3 The genotoxic effects of clinically-relevant ceramic wear particles in 
PBMNCs  
The aim of this part of the study was to assess the genotoxicity of increasing doses (0.05-50 
µm3 per cell) of clinically-relevant BIOLOX® Delta ceramic wear particles that were 
generated using the Leeds II hip simulator as described in section 3.3.3.1. This assessment 
was completed in PBMNCs isolated from five different healthy volunteer donors to evaluate 
the variability in response to the particles and controls.  
4.4.3.3.1 DNA damage in PBMNCs in response to clinically-relevant BIOLOX® Delta 
ceramic wear particles  
PBMNCs isolated from five donors (Donor 2, Donor 5, Donor 7, Donor 25 and Donor 26) 
were seeded at a density of 1x105 cells per well (n=2) in 48-well plates and cultured in RPMI 
culture media with increasing doses of (0.05, 0.5, 5 & 50µm3 per cell) of clinically-relevant 
BIOLOX® Delta ceramic wear particles. The negative control was seeded in the same way 
but with no particles. Hydrogen peroxide (100µM) was used as the positive control as it is 
known to induce single and double strand DNA damage (Driessens et al., 2009). The 
genotoxic effects of clinically-relevant BIOLOX® Delta ceramic wear particles were 
compared with high (50µm3 per cell) and low (0.5 µm3 per cell) doses of clinically-relevant 
BIOLOX® Forte ceramic wear particles and high (50µm3 per cell) and low (0.5 µm3 per cell) 
doses of clinically-relevant CoCr nano-particles (positive particle control). Stainless-steel 
wear particles generated using the six-station PoP wear rig were also introduced at dose 
50µm3 per cell as a particle control. The plates were incubated for 24 hours at 37oC in 5% 
(v/v) CO2 in air and DNA damage in the PBMNCs following incubation with the particles 
and controls was determined using the comet assay (protocol described in section 4.3.2.7.3). 
During the assay protocol, the cells were embedded in agarose gel and underwent single cell 
electrophoresis. The output of the assay output was images of single cells that were analysed 
using the Comet IV software. DNA damage was quantified as the comet tail moment as 
described in section 4.4.2.3 and the results were analysed using one-way ANOVA and Tukey 
Post hoc analysis.     
The genotoxic effects of the particles and controls is shown in Figure 4.39 (Donor 2), Figure 
4.40 (Donor 5), Figure 4.41 (Donor 7), Figure 4.42 (Donor 25) and Figure 4.43 (Donor 26). 
High levels of DNA damage are indicated by longer tails in the images and higher values of 
tail moment relative to the cells only control. Cell nuclei that appear completely circular are 
indicative of no DNA damage. The clinically-relevant BIOLOX® Delta ceramic wear 
particles showed genotoxic effects at high doses (50µm3 per cell), where statistically 
significant levels of DNA damage (tail moment) in PBMNCs was observed in four donors (5, 
7, 25, 26) when compared to the cell only negative control (ANOVA; p<0.05). The clinically-
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relevant BIOLOX® Delta ceramic wear particles also caused DNA damage in PBMNCs at a 
dose of 5µm3 per cell for three donors (5, 7, 26). Furthermore, significant DNA damage was 
also observed in PBMNCs isolated from donor 25 in response to 0.5µm3 per cell of clinically-
relevant BIOLOX® Delta ceramic wear particles (ANOVA; p<0.05). The clinically-relevant 
BIOLOX® Forte ceramic wear particles at high doses (50µm3 per cell) caused significant 
(ANOVA; p<0.05) levels of DNA damage (tail moment) in PBMNCs from all donors. This 
was also evident for the clinically-relevant BIOLOX® Forte ceramic wear particles at low 
doses (0.5 µm3 per cell) whereby there was a significant (ANOVA; p<0.05) increase in tail 
moment compared to the cells only negative control for donors 5, 7 and 25. Similarly, the 
high dose (50µm3) of clinically-relevant CoCr nano-particles caused a significant increase in 
the levels of DNA damage for all donors as indicated by the high levels of tail moment 
compared to the cell only negative control (ANOVA; p<0.05). Additionally, the low dose 
(0.5µm3) of clinically-relevant CoCr nano-particles demonstrated significant levels of DNA 
damage (tail moment) in PBMNCs from donor 2, when compared to the cells only negative 
control (ANOVA; p<0.05). The stainless-steel wear particles at dose 50µm3 per cell caused a 
significant increase in the levels of DNA damage for all donors as indicated by the high levels 
of tail moment compared to the cells only negative control (ANOVA; p<0.05). The positive 
control of hydrogen peroxide caused significant levels of DNA damage in PBMNCs from all 
donors compared to the cells only negative control (ANOVA; p<0.05).  
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Images of comets (from PBMNCs) stained with SYBR Gold.  
    
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 
    
Delta 50µm3 Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 
   
 
CoCr 50µm3 SS 50µm3 Positive control Scale bar 50µm 
 
Figure 4.39 – The genotoxic effects of clinically-relevant BIOLOX® Delta ceramic particles wear in 
PBMNCs isolated from Donor 2. PBMNCs were cultured with bimodal sized micrometre/sub-micron 
and nanoscale composite (BIOLOX® Delta), alumina (BIOLOX® Forte) clinically-relevant ceramic 
wear particles, and clinically-relevant CoCr nano-particles for 24 hours. DNA damage was determined 
using the comet assay and presented as (A) mean tail moment and (B) images. Cells that appear circular 
have no detectable DNA damage, whereas nuclei that have tails is indicative of DNA damage. A 
statistically significant different (p<0.05 ANOVA with post hoc Tukey test) in tail moment compared 
to the cells only control is indicated by an asterisk (*). A minimum of 100 cells were scored using the 
Comet IV software. Error bars represent ±95% confidence limits. 
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Images of comets (from PBMNCs) stained with SYBR Gold.  
    
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 
    
Delta 50µm3 Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 
   
 
CoCr 50µm3 SS 50µm3 Positive control Scale bar 50µm 
 
Figure 4.40 – The genotoxic effects of clinically-relevant BIOLOX® Delta ceramic particles wear in 
PBMNCs isolated from Donor 5. PBMNCs were co-cultured with bimodal sized; micrometre and 
nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) clinically-relevant ceramic 
wear particles, and clinically-relevant CoCr nano-particles for 24 hours. DNA damage was determined 
using the comet assay and presented as (A) tail moment and (B) images. Cells that appear as round 
have no detectable DNA damage whereas cells that have tails is indicative of DNA damage. A 
statistically significant different (p<0.05 ANOVA) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits. 
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Images of comets (from PBMNCs) stained with SYBR Gold.  
    
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 
    
Delta 50µm3 Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 
   
 
CoCr 50µm3 SS 50µm3 Positive control Scale bar 50µm 
 
Figure 4.41 – The genotoxic effects of clinically-relevant BIOLOX® Delta ceramic particles wear in 
PBMNCs isolated from Donor 7. PBMNCs were co-cultured with bimodal sized; micrometre and 
nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) clinically-relevant ceramic 
wear particles, and clinically-relevant CoCr nano-particles for 24 hours. DNA damage was determined 
using the comet assay and presented as (A) tail moment and (B) images. Cells that appear as round 
have no detectable DNA damage whereas cells that have tails is indicative of DNA damage. A 
statistically significant different (p<0.05 ANOVA) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits. 
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Images of comets (from PBMNCs) stained with SYBR Gold.  
    
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 
    
Delta 50µm3 Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 
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Figure 4.42 – The genotoxic effects of clinically-relevant BIOLOX® Delta ceramic particles wear in 
PBMNCs isolated from Donor 25. PBMNCs were co-cultured with bimodal sized; micrometre and 
nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) clinically-relevant ceramic 
wear particles, and clinically-relevant CoCr nano-particles for 24 hours. DNA damage was determined 
using the comet assay and presented as (A) tail moment and (B) images. Cells that appear as round 
have no detectable DNA damage whereas cells that have tails is indicative of DNA damage. A 
statistically significant different (p<0.05 ANOVA) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits. 
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Images of comets (from PBMNCs) stained with SYBR Gold.  
    
Cell only Delta 0.05µm3 Delta 0.5µm3 Delta 5µm3 
    
Delta 50µm3 Forte 0.5µm3 Forte 50µm3 CoCr 0.5µm3 
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Figure 4.43 – The genotoxic effects of clinically-relevant BIOLOX® Delta ceramic particles wear in 
PBMNCs isolated from Donor 26. PBMNCs were co-cultured with bimodal sized; micrometre and 
nanoscale composite (BIOLOX® Delta) and alumina (BIOLOX® Forte) clinically-relevant ceramic 
wear particles, and clinically-relevant CoCr nano-particles for 24 hours. DNA damage was determined 
using the comet assay and presented as (A) tail moment and (B) images. Cells that appear as round 
have no detectable DNA damage whereas cells that have tails is indicative of DNA damage. A 
statistically significant different (p<0.05 ANOVA) in tail moment compared to the cells only control 
is indicated by an asterisk (*). A minimum of 100 cells were scored using the Comet IV software. Error 
bars represent ±95% confidence limits.  
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4.4.3.4 Oxidative stress in PBMNCs in response to clinically-relevant ceramic wear 
particles 
The aim of this study was to assess the levels of oxidative stress induced by increasing doses 
(0.05-50µm3 per cell) of clinically-relevant BIOLOX® Delta ceramic wear particles in 
PBMNCs. This assessment was completed on PBMNCs isolated from five different healthy 
donors to evaluate the variability in response to the particles and controls. Oxidative stress 
was measured by labelling the ROS produced by the PBMNCs using the DCFDA probe in 
the cellular ROS detection assay kit (protocol outlined in section 4.3.2.7.4). 
4.4.3.4.1 Oxidative stress in PBMNCs in response to clinically-relevant BIOLOX® 
Delta ceramic wear particles  
PBMNCs isolated from five donors (donor 2, donor 5, donor 7, donor 25 and donor 26) were 
seeded at a density of 2x104 cells per well (n=6) in clear bottom black 96-well plates and 
cultured in RPMI culture media with increasing doses (0.05, 0.5, 5 & 50µm3 per cell) of 
clinically-relevant BIOLOX® Delta ceramic wear particles. The cell only negative control 
was seeded in the same way but with no particles. TBHP (200µM) was used as the positive 
control as it mimics ROS activity to oxidise DCFDA to fluorescent DCF and so it is 
commonly used to evaluate the cellular responses resulting from oxidative stress in cells and 
tissues (Kucera et al., 2014). The presence of ROS within the cells in response to the 
clinically-relevant BIOLOX® Delta ceramic wear particles was compared with high (50µm3 
per cell) and low (0.5 µm3 per cell) doses of clinically-relevant BIOLOX® Forte ceramic wear 
particles and high (50µm3 per cell) and low (0.5 µm3 per cell) doses of clinically-relevant 
CoCr nano-particles. Stainless-steel wear particles generated using the six-station PoP wear 
rig were also introduced at dose 50µm3 per cell as a particle control. The plates were incubated 
for 24 hours at 37oC in 5% (v/v) CO2 in air. The production of ROS in PBMNCs following 
incubation with the particles and controls was determined using the cellular ROS detection 
assay (protocol outlined in section 4.3.2.7.4). The results were expressed as average 
fluorescence intensity values where higher values of fluorescence intensity was directly 
proportional to high levels of oxidative stress. The data was analysed using one-way ANOVA 
and Tukey Post hoc analysis. The cells present within the wells were also imaged to correlate 
the fluorescence intensity values with the fluorescence emitted from within the cells.  
The images of fluorescently labelled ROS present in the PBMNCs from donor 2 (Figure 4.44) 
after exposure to 485nm for 1000ms are representative of all donors, except for the PBMNCs 
cultured with stainless-steel wear particles from donor 5 and donor 26, which showed brighter 
images of PBMNCs treated with 50µm3 per cell of stainless-steel wear particles. The cell 
only, low dose (0.5µm3 per cell) of CoCr nano-particles and all the doses (0.05-50µm3 per 
cell) for both BIOLOX® Delta and BIOLOX® Forte wear particles demonstrated less 
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fluorescence relative to the high dose (50µm3 per cell) of CoCr nano-particles and positive 
control (200µM TBHP). The brighter images of PBMNCs treated with 50µm3 per cell of 
CoCr nano-particles and TBHP were indicative of high levels of oxidative stress.   
The production of ROS levels as a function of fluorescence intensity in response to the 
particles and controls is shown in Figure 4.45 (Donor 2), Figure 4.46 (Donor 5), Figure 4.47 
(Donor 7), Figure 4.48 (Donor 25) and Figure 4.49 (Donor 26). High levels of ROS are 
indicated by higher fluorescence intensity relative to the cell only negative control and are 
visualised as brighter green fluorescence in the images Figure 4.44. The clinically-relevant 
BIOLOX® Delta ceramic wear particles for all the doses tested had no significant effect on 
the production of ROS (fluorescence intensity) in PBMNCs from all donors when compared 
to the cell only negative control. This was also evident for the clinically-relevant BIOLOX® 
Forte ceramic wear particles at low (0.5 µm3 per cell) and high (50µm3 per cell) doses, where 
there was no significant increase in fluorescence intensity compared to the cell only negative 
control for all the donors. Similarly, low dose (0.5 µm3 per cell) of clinically-relevant CoCr 
nano-particles showed no significant increase in ROS production (fluorescence intensity) 
when compared to the cell only negative control. However, the high dose (50µm3) of 
clinically-relevant CoCr nano-particles caused a significant increase in the levels ROS 
production in PBMNCs from all donors as indicated by the high levels of fluorescence 
intensity compared to the cell only negative control (ANOVA; p<0.05). Similarly, the 
stainless-steel wear particles (50µm3 per cell) caused a significant increase in the levels of 
ROS production in PBMNCs from donors 5 and 26 as indicated by the high levels of 
fluorescence intensity compared to the cells only negative control (ANOVA; p<0.05). The 
positive control of TBHP caused significant (ANOVA; p<0.05) levels of ROS production 
(fluorescence intensity) in the PBMNCs from all donors compared to the cell only negative 
control.  
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Figure 4.44 – Visualisation of the presence of ROS in PBMNCs isolated from Donor 2. PBMNCs were 
cultured with bimodal sized micrometre/submicron and nanoscale composite (BIOLOX® Delta) and 
alumina (BIOLOX® Forte) clinically-relevant ceramic particles, and clinically-relevant CoCr nano-
particles for 24 hours. Oxidative stress was determined using the DCFDA probe to detect the 
production of ROS, which is presented as the green fluorescence. The higher the intensity of the green 
fluorescence, the higher the levels of ROS produced by the PBMNCs. TBHP (200µM) was used as the 
positive control. Size-bar 50µm in all images. 
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Figure 4.45 - Oxidative stress in PBMNCs isolated from Donor 2 in response to BIOLOX® Delta model 
ceramic particles. PBMNCs were cultured with bimodal sized micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta), alumina (BIOLOX® Forte) clinically-relevant ceramic wear particles, 
and clinically-relevant stainless steel and CoCr nano-particles for 24 hours. Oxidative stress was 
determined using a DCFDA probe to detect the production of reactive oxygen species, which is 
presented as mean fluorescent intensity. TBHP (200µM) was used as the positive control. A statistically 
significant different (p<0.05 ANOVA) in fluorescence intensity compared to the cells only control is 
indicated by an asterisk (*). Error bars represent ±95% confidence limits (n=6). 
 
  
Figure 4.46 - Oxidative stress in PBMNCs isolated from Donor 5 in response to BIOLOX® Delta model 
ceramic particles. PBMNCs were cultured with bimodal sized micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta), alumina (BIOLOX® Forte) clinically-relevant ceramic wear particles, 
and clinically-relevant stainless steel and CoCr nano-particles for 24 hours. Oxidative stress was 
determined using a DCFDA probe to detect the production of reactive oxygen species, which is 
presented as mean fluorescent intensity. TBHP (200µM) was used as the positive control. A statistically 
significant different (p<0.05 ANOVA) in fluorescence intensity compared to the cells only control is 
indicated by an asterisk (*). Error bars represent ±95% confidence limits (n=6).  
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Figure 4.47 - Oxidative stress in PBMNCs isolated from Donor 7 in response to BIOLOX® Delta model 
ceramic particles. PBMNCs were cultured with bimodal sized micrometre/sub-micron and nanoscale 
composite (BIOLOX® Delta), alumina (BIOLOX® Forte) clinically-relevant ceramic wear particles, 
and clinically-relevant stainless steel and CoCr nano-particles for 24 hours. Oxidative stress was 
determined using a DCFDA probe to detect the production of reactive oxygen species, which is 
presented as mean fluorescent intensity. TBHP (200µM) was used as the positive control. A statistically 
significant different (p<0.05 ANOVA) in fluorescence intensity compared to the cells only control is 
indicated by an asterisk (*). Error bars represent ±95% confidence limits (n=6).  
 
  
Figure 4.48 - Oxidative stress in PBMNCs isolated from Donor 25 in response to BIOLOX® Delta 
model ceramic particles. PBMNCs were cultured with bimodal sized micrometre/sub-micron and 
nanoscale composite (BIOLOX® Delta), alumina (BIOLOX® Forte) clinically-relevant ceramic wear 
particles, and clinically-relevant stainless steel and CoCr nano-particles for 24 hours. Oxidative stress 
was determined using a DCFDA probe to detect the production of reactive oxygen species, which is 
presented as mean fluorescent intensity. TBHP (200µM) was used as the positive control. A statistically 
significant different (p<0.05 ANOVA) in fluorescence intensity compared to the cells only control is 
indicated by an asterisk (*). Error bars represent ±95% confidence limits (n=6).  
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Figure 4.49 - Oxidative stress in PBMNCs isolated from Donor 26 in response to BIOLOX® Delta 
model ceramic particles. PBMNCs were cultured with bimodal sized micrometre/sub-micron and 
nanoscale composite (BIOLOX® Delta), alumina (BIOLOX® Forte) clinically-relevant ceramic wear 
particles, and clinically-relevant stainless steel and CoCr nano-particles for 24 hours. Oxidative stress 
was determined using a DCFDA probe to detect the production of reactive oxygen species, which is 
presented as mean fluorescent intensity. TBHP (200µM) was used as the positive control. A statistically 
significant different (p<0.05 ANOVA) in fluorescence intensity compared to the cells only control is 
indicated by an asterisk (*). Error bars represent ±95% confidence limits (n=6).  
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4.5 Discussion  
The aim of this chapter was to assess the biological impact of model and clinically-relevant 
BIOLOX® Delta ceramic wear particles in terms of cytotoxicity, inflammation, genotoxicity 
and oxidative stress. In order to meet this aim, the cytotoxic effects of BIOLOX® Forte 
ceramic model particles, BIOLOX® Delta ceramic model particles and clinically-relevant 
BIOLOX® Delta ceramic wear particles on the viability of L929 murine fibroblast cells over 
a period of 6 days was initially investigated. Thereafter, a comprehensive evaluation of the 
biological impact of BIOLOX Delta ceramic model particles and clinically-relevant 
BIOLOX® Delta ceramic wear particles on PBMNCs in terms of cytotoxicity (viability), 
inflammation (release of TNF-α), genotoxicity (DNA damage) and oxidative stress 
(production of reactive oxygen species) was investigated and compared to BIOLOX® Forte 
ceramic model particles and clinically-relevant BIOLOX® Forte ceramic wear particles. The 
findings of this chapter are divided into the following sections: - 
1. Characteristics of ceramic model particles compared to clinically-relevant ceramic 
wear particles 
2. Cytotoxic effects of ceramic wear particles  
3. Inflammatory response to ceramic wear particles  
4. Genotoxic effects of ceramic wear particles 
5. Oxidative stress in response to ceramic wear particles  
6. Limitations of study 
4.5.1 Characteristics of ceramic model particles compared to clinically-relevant 
ceramic wear particles 
The work in Chapter 4 demonstrated that the wear particles generated from alumina 
(BIOLOX® Forte) and composite (BIOLOX® Delta) ceramic hip replacements in water 
lubricants were bimodal in size. The size of the wear particles generated from alumina 
(BIOLOX® Forte) ceramic hips had a very similar size distribution to those isolated from 
retrieved tissues by Hatton et al. (2001) using laser micro-dissection. Furthermore, the present 
study has demonstrated that there was no statistical significant difference in size distribution 
and morphology between the composite BIOLOX® Delta ceramic wear particles generated in 
serum or water under severe edge loading conditions caused by dynamic separation due to 
translational mismatch in the centres of rotation of the femoral head and acetabular cup. This 
suggested that the ceramic wear debris generated in water using the hip simulator were 
representative of the ceramic wear particles generated in vivo, and henceforth can be described 
as clinically-relevant. 
The BIOLOX® Forte ceramic model particles described in this chapter also demonstrated a 
bimodal size range. What’s more, there was no statistical significant difference in size 
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distribution and morphology between the BIOLOX® Forte ceramic model particles and 
clinically-relevant BIOLOX® Forte ceramic wear particles generated in vitro under severe 
edge loading conditions using the hip simulator. Both the model and clinically-relevant 
BIOLOX® Forte ceramic particles consisted of large shard-like alumina and small round 
alumina particles. The BIOLOX® Forte ceramic model particles ranged between 100-3000nm 
for the larger particles, with a mean size of 613nm, whereas the smaller nano-scale particles 
ranged between 10-80nm, with a mean size of 44nm. Similarly, the clinically relevant 
BIOLOX® Forte ceramic wear particles generated under severe edge loading conditions using 
the hip simulator, ranged between 100-4000nm for the larger particles, with a mean size of 
736nm, whereas the smaller nano-scale particles ranged between 10-90nm, with a mean size 
of 50nm. However, the frequency size distributions suggested that the clinically-relevant 
BIOLOX® Forte ceramic wear particles had more particles in the nano-scale range compared 
to the BIOLOX® Forte ceramic model particles that had more particles in the submicron and 
micron size range. Nevertheless, both types of particles contained particles representative of 
the size range of particles isolated from retrieved tissues (Hatton, 2001). The similar size 
range between the two types of particles may be due to the fact that the BIOLOX® Forte 
ceramic model particles used in this study was comprised of the powder used to manufacture 
BIOLOX® Forte CoC hip components. 
The BIOLOX® Delta ceramic model particles demonstrated a multimodal size distribution. 
The third mode of size distribution was due to the large grain-like structures of composite 
ZTA ceramic present in the BIOLOX® Delta powder. Hence, there was a significant 
difference in size distribution and morphology between the BIOLOX® Delta model ceramic 
particles and clinically-relevant BIOLOX® Delta wear particles generated in vitro using the 
hip simulator under severe edge loading conditions. The clinically-relevant BIOLOX Delta 
ceramic wear particles generated in water in the simulator had two distinct modes (bimodal) 
of size distribution i.e. nano scale wear particles that ranged between 20-90nm (mean size: 
48nm) and larger sized wear particles that ranged between 1000->5000nm (mean size: 
3900nm). This bimodal size distribution was very similar to the BIOLOX® Delta wear 
particles isolated from hip simulator serum lubricant from BIOLOX® Delta CoC bearings 
tested under severe edge loading conditions as described in chapter 3 i.e. the larger alumina 
particles ranged between 100->5000nm (mean size: 2308) and the nano-scale particles range 
between 10-90nm (mean size: 44nm). Whereas, the BIOLOX® Delta model ceramic particles 
had a smaller size distribution, where the larger alumina particles ranged between 100-
2000nm with a mean size of 508nm. The nano-scale particles however, had a similar size 
range (30-100; mean size: 64nm) to the clinically-relevant BIOLOX® Delta ceramic wear 
particles generated in the hip simulator under severe edge loading conditions. Even so, the 
frequency of the nano-scale particles for the BIOLOX® Delta model ceramic particles (11.7%) 
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was considerably lower than the frequency of nano-scale particles for clinically-relevant 
BIOLOX® Delta ceramic wear particles (26.6%). The difference in size distributions between 
the model and clinically-relevant BIOLOX® Delta ceramic particles may be due to the larger 
grain-like structures that were only present in the Delta model ceramic particles. These are 
formed during sintering where many elements in the form of raw compound materials are 
added to the mixture, which causes on going solid reaction and the production of these large 
grains and a complex ceramic microstructure. The larger alumina particles that exist in the 
clinically-relevant BIOLOX delta wear particle population may be as a result of grain pull-
out during edge loading. These larger particles are present in the BIOLOX® Delta powder, 
however they exist within the alumina matrix, which can be observed at high magnifications 
as large grain-like structures using CFE-SEM. The wear particles generated from BIOLOX® 
Delta in water using the hip simulator had similar characteristics to those generated in serum, 
which suggested these wear particles can be considered clinically-relevant as they are more 
representative in terms of size and shape to those generated in vivo (Hatton et al., 2002). 
However, as previously mentioned in chapter 3, considerable stainless-steel wear particle 
contaminants were generated in the hip simulator, which need to be considered and mitigated 
for in the cell culture studies. 
4.5.2 Cytotoxic effects of ceramic wear particles  
Particles of composite ceramic (BIOLOX® Delta) have not been tested previously in terms of 
cytotoxic effects. Therefore, the first part of this study evaluated the cytotoxic effects of the 
increasing doses (0.05-500µm3 per cell) of composite ceramic model particles (BIOLOX® 
Delta) on L929 fibroblast cells and compared them with alumina ceramic model particles 
(BIOLOX® Forte) and clinically-relevant CoCr nano-particles that were generated using the 
six-station pin-on-plate wear simulator. The comparison with CoCr nano-particles was chosen 
as it is described in numerous studies in the literature that CoCr wear particles induce 
cytotoxic effects, which led to a decline in the use of MoM THRs  (Germain et al., 2003a; 
Posada et al., 2015; Madl et al., 2015; Amanatullah et al., 2016). In addition, a comparison 
with wear particles from the early generation alumina BIOLOX® Forte CoC hips was also 
included, as many studies (Catelas, Petit, Marchand, et al., 1999; I Catelas, Petit, Zukor, et 
al., 1999; Nkamgueu et al., 2000a; Germain et al., 2003a; Faye et al., 2017) have reported the 
cellular response to commercially available alumina powder, which demonstrated mild 
cytotoxic effects that was dose dependent. Therefore, in the present study L929 fibroblast 
cells were exposed to increasing doses of BIOLOX® Forte alumina ceramic model particles 
ranging from 0.05-500µm3 per cell and the cytotoxic effects of the particles were assessed 
over a period of 6 days. The results showed that the highest dose (500µm3 per cell) of ceramic 
model particles for both BIOLOX® Forte and BIOLOX® Delta caused a significant reduction 
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in cell viability after 6 days when compared to the cell only negative control. All the other 
doses (0.5-50µm3 per cell) for both BIOLOX® Forte and BIOLOX® Delta had a limited effect 
on the viability of the L929 cells, as no significant cytotoxic effects were observed when 
compared to the cell only negative control. Whereas, the CoCr nano-particles (50µm3 per cell) 
had significant cytotoxic effects from day 1, which may have been due to the release of Co 
and Cr ions (Posada et al., 2014; Posada et al., 2015). The metal ions could have been released 
from the CoCr wear particles in the culture medium or within the cells once the particles were 
internalised. Many studies (Catelas, Petit, Marchand, et al., 1999; Catelas, Petit, Zukor, et al., 
1999; Petit et al., 2002; Olivier et al., 2003; Tsaousi et al., 2010) have reported the cytotoxic 
effects of ceramic particles, the source, type, size and doses of these particles, in addition to 
the cell types used in these previous studies are shown in Table 4.14. Indeed, cytotoxicity in 
macrophages and fibroblasts was reported to increase in the presence of alumina wear 
particles, which was dependent on several factors including size and concentration. The 
results in the present study were in agreement with Catelas et al., (1999), who reported 
cytotoxic effects at high concentrations of alumina particles on J774 macrophages and that 
cell death increased with the size (1.3 and 2.4µm) and concentration (5-1500 particles/cell) 
of the alumina particles. The authors reported that a higher concentration of smaller particles 
(1.3µm) compared to larger particles (2.4µm) was required to induce cytotoxic effects, thus 
demonstrating an overall volume effect. For example, to obtain almost the same percentage 
of cell death for 2.4µm at 500 particles per cell, 1500 particles per cell for 3µm alumina 
particles was required. Olivier et al. (2003) also demonstrated the cytotoxic effects of alumina 
particles (0.43µm and 2.81µm) at high concentrations (0.025-0.5mg/ml) in J774.2 
macrophages. This study also demonstrated cytotoxic effects of alumina particles in L929 
fibroblasts however alumina particle size of 0.43 did not affect the viability of L929 cells. 
The alumina particles were more cytotoxic for macrophages than fibroblasts (Olivier et al., 
2003). This trend was also observed by Tsaousi et al. (2010), who demonstrated no significant 
differences in cell viability between the control and fibroblast cells treated with alumina nano-
particles (0.2nm), at all doses (0.1-10mg/T75 flask) and time points (24-120hrs). 
Interestingly, Germain et al. (2003) in contrast demonstrated no cytotoxic affects in both 
U937 macrophages and L929 fibroblast cells cultured with commercial alumina ceramic 
particles (0.5µm) for all doses tested (0.005-50µm3/cell). The discrepancies between the 
results may be partially explained by the use of particle sizes and particle doses which may 
not be clinically relevant. These studies used commercially-obtained alumina particles in the 
phagocytosable range of 0.3-10µm (Green et al., 1998), however it has been demonstrated in 
the present study and in previous studies that wear particles generated from ceramic hip 
replacements have a bimodal distribution of both micron sized and nano-scale particles 
(Hatton et al., 2002). Majority of these studies failed to address the nano-scale particle size 
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range in their cytotoxic assessment of alumina ceramic particles, which may potentially 
induce different cellular responses. Nonetheless, a direct comparison with these studies is 
valid as the model ceramic particles used in this part of the study were also commercially-
obtained.  
Germain et al. (2003) also used alumina wear particles generated in vitro under 
microseparation conditions using a hip simulator, as it is well established that these conditions 
simulate clinically-relevant wear patterns and wear mechanisms (Nevelos et al., 2000a). They 
reported that neither the clinically-relevant nor the ceramic powder demonstrated any 
cytotoxic effects on L929 cells for all the particle doses tested (0.05-50µm3 per cell) 
throughout the 5-day culture period. However, the high volumetric concentrations of 
clinically-relevant alumina wear particles (50µm3 per cell) caused a significant cytotoxic 
effect in U937 human macrophages, whereas at the same concentration the alumina powder 
had no cytotoxic effect. This difference in cytotoxicity seen in the U937 cells was attributed 
to the clinically-relevant alumina wear particles having more particles in the nanometre size 
range, which may be cytotoxic if taken up by cells at high volumes as nano-scale particles 
may release toxic ions. The model and clinically-relevant BIOLOX® Delta composite ceramic 
wear particles tested in the present study also demonstrated a similar pattern observed by 
Germain et al. (2003). The BIOLOX® Delta model ceramic particles had no effect on the 
viability of the L929 cells for all the particle doses tested (0.05-50 µm3 per cell), whereas the 
highest dose of 50µm3 per cell of clinically-relevant BIOLOX® Delta ceramic wear particles 
caused a significant reduction in cell viability after 3 days. Hence, despite the differences in 
composition between BIOLOX® Forte and BIOLOX® Delta, the same deduction can be made 
in the present study, in that the clinically-relevant BIOLOX® Delta composite ceramic wear 
particles may have had more particles in the nanometre size range, which may be cytotoxic if 
taken up by cells at high volumes. This suggestion is supported by the size distribution data 
of clinically-relevant BIOLOX® Delta ceramic wear particles and BIOLOX® Delta powder, 
which showed that there was a higher percentage number of nano-scale particles (mode size: 
40-50nm) for the clinically-relevant BIOLOX Delta ceramic wear particles (26.6%) 
compared to the number of nano-scale particles (mode size: 60-70nm) in the BIOLOX® Delta 
powder (11.8%). These findings were also in agreement with Catelas et al. (1998) and Catelas 
et al. (1999b) who showed that cell death increased with increasing concentrations of alumina 
particles (0.6-4.5µm), but is in disagreement with regards to particle size as the present study 
used both micron sized and nano-scale particles. These findings indicate that a particular 
threshold of wear particles in the biologically active size range may determine the severity of 
the biological response (Green et al., 1998; Ingham and Fisher, 2000).    
The results from the present study suggest that BIOLOX® Delta ceramic particles exhibits 
similar biological activity as BIOLOX® Forte ceramic particles in terms of cytotoxicity, 
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despite the compositional differences. This was expected as zirconia, which is the second 
major constituent of BIOLOX® Delta after alumina, is reported to have a similar low cytotoxic 
potential as that of alumina (Catelas et al., 1998; Catelas, Petit, Marchand, et al., 1999; Faye 
et al., 2017). A study by Roualdes et al. (2010) reported the in vitro and in vivo effects of 
composite alumina-zirconia ceramic powder. They reported no deleterious effects in vitro on 
cell viability, extra-cellular matrix production (human type I collagen and fibronectin) or cell 
morphology in osteoblasts and fibroblasts. In vivo, the histology results showed no major 
inflammation of the synovial membrane with a very moderate and non-specific 
granulomatous reaction. Even so, the results from the present study demonstrated that high 
particle doses or volume concentrations (50-500µm3 per cell) of model and clinically-relevant 
BIOLOX® Delta ceramic wear particles caused significant cytotoxic effects in L929 cells. 
Hatton et al. (2001) reported that the mode of cytotoxicity induced by the particles at these 
high doses may have been due to physical damage by the high volume of debris masking the 
cells, which could have caused nutrient deficiency within the cells and as a result the cell 
viability was reduced.  However, given the low wear rates of ceramic-on-ceramic bearings, it 
is highly unlikely that these particle doses will be achieved in vivo. Nevertheless, osteolysis 
has been associated with CoC bearings in vivo, but this has generally been limited to isolated 
cases of excessive wear (Shishido et al., 2006; Nam et al., 2007). It can be concluded from 
the cytotoxic evaluation of BIOLOX® Delta ceramic wear particles that this composite 
ceramic (ZTA) is relatively bioinert and concerns around its cytotoxic potential are limited 
(Santos et al., 2009). However, a study by Petit et al. (2002) highlighted the particle-induced 
apoptosis phenomenon in J774 macrophages by alumina particles. The authors hypothesised 
that the ability of alumina particles to induce apoptosis in macrophages may explain the lower 
levels of inflammatory cytokines (TNF-α) and the differences observed in osteolysis patterns 
between different types of THRs i.e. ceramic, metal and polyethylene. Hence, in addition to 
cytotoxicity testing, this study set out to conduct a more comprehensive evaluation of 
composite ceramic wear particles in terms of inflammation, genotoxicity and oxidative stress. 
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Table 4.14 – Summary of previous studies that have investigated the biological response to ceramic particles 
 
Authors Cell type 
Particle type and 
mean size 
Particle source Dose Biological test Conclusion 
(Nagase et 
al., 1995) 
human 
polymorphonuclear 
leukocytes 
Alumina - 0.6, 0.8, 
3.2, 7.5, 28 and 
68μm 
Commercially-
obtained  
1mg.ml-1 
Production of reactive oxygen 
metabolites - 
chemiluminescence assay 
 
Particle size of around 3µm caused the 
maximal production of reactive oxygen 
metabolites. 
(Catelas et 
al., 1998) 
J774 macrophage 
cell line 
Alumina – 0.6, 1.3, 
2.4, 4.5µm 
Zirconia- 0.6µm 
HDP – 4.5µm 
Commercially-
obtained 
5-1250 
particles per 
macrophage. 
 
Cell mortality – Flow 
cytometry  
Production of TNF-α – ELISA 
Macrophage response was dependent on 
size and concentration. Cell mortality 
increased with increased size (>2µm) and 
concentration of particles. TNF-α release 
increased with concentration of zirconia 
(0.6µm) and alumina (4.5µm) particles. 
TNF-α release was directly affected by 
particle concentration and composition.  
(Catelas, 
Petit, 
Marchand, 
et al., 1999) 
J774 macrophage 
cell line 
Alumina – 0.6, 1.3, 
2.4, 4.5µm 
Zirconia- 0.6µm 
HDP – 4.5µm 
Commercially-
obtained  
5-2500 
particles per 
macrophage 
Cytotoxicity - Flow cytometry 
Inflammatory mediator tests 
(TNF-α, IL-1α, IL-1β) 
Macrophage mortality increased with both 
particle size and concentration (volume 
effect). Higher concentration of smaller 
particles (1.3µm) compared to larger 
particles (2.4µm) was required to induce 
cytotoxic effects. TNF-α release increased 
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with particle size and concentration. Lower 
concentrations of particles were required to 
stimulate production of TNF-α.  
(I Catelas, 
Petit, Zukor, 
et al., 1999) 
J774 macrophage 
cell line 
Alumina – 0.6, 1.3, 
2.4, 4.5µm 
Zirconia- 0.6µm 
HDP – 4.5µm 
Commercially-
obtained  
5-500 
particle per 
macrophage 
Apoptosis – fluorescence 
microscopy and DNA 
laddering  
Apoptosis increased with particle size and 
concentration. 
Induction of apoptosis reached plateau for 
concentrations higher than 150 
particles/macrophage at 1.3µm. 
(Nkamgueu 
et al., 
2000b) 
Human monocytes 
differentiate into 
macrophages 
Alumina- 55-141µm 
(mean: 73µm) 
Zirconia- 80-175µm 
(mean: 133µm) 
Commercially-
obtained 
5, 10, 30, 
60mg 
Changes in elemental 
composition – X-ray 
microanalysis. 
Cell viability – trypan blue 
exclusion assay  
Oxidative burst measurement 
– DCFH-DA oxidation assay 
Zirconia and alumina particles affected the 
intracellular electrolyte concentration, 
where sodium concentration increased and 
potassium content decreased, thus resulting 
in increased cell mortality. The changes in 
cellular ionic concentration reduced 
phagocytic activity and oxidative 
metabolism, thus resulting in reduced 
production of hydrogen peroxide  
(Petit et al., 
2002) 
J774 macrophage 
cell line 
Alumina – 1.3µm 
UHMWPE – 0.5-
2µm 
Commercially-
obtained 
25, 125 and 
250 
particles/ 
macrophage 
Production of TNF-α – ELISA 
Apoptosis measured by 
protein expression of PARP 
and caspase-3 - Bio-Rad 
protein assay and western blot  
UHMWPE induced higher (8-10 times) 
levels of TNF-α release compared to 
alumina particles. Induction of apoptosis 
was expressed higher in cells cultured with 
alumina particles compared to UHMWPE 
particles.  
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(Germain et 
al., 2003b) 
U937 human 
histiocytic and 
L929 mouse lung 
fibroblast cell lines 
 Clinically-relevant 
CoCr – 29.5nm 
(range size: 5-
200nm). 
Commercial CoCr 
particles– 9.87µm. 
Clinically-relevant 
alumina – Larger 
particles were 0.1-
>10µm and smaller 
particles were 5-
20nm. 
Commercial alumina 
powder– 0.5µm 
Clinically-
relevant CoCr 
wear particles 
generated using 
pin-on-plate 
tribometer and 
clinically-relevant 
ceramic particles 
generated using 
hip wear 
simulator. 
Commercially-
obtained CoCr 
and alumina 
particles  
50, 5, 0.5, 
0.05 and 
0.005µm3 
per cell 
Cell viability – ATP-Lite 
assay 
 
Clinically-relevant CoCr particles at dose 
50 and 5µm3 per cell reduced the viability 
of U937 cells by 97% and 42% and reduced 
the viability of L929 cells by 95% and 73%, 
respectively. The commercial CoCr and 
commercial alumina particles demonstrated 
no cytotoxic affects in both U937 and L929 
cells.  
(Hatton et 
al., 2003a) 
Human primary 
peripheral blood 
mononuclear 
phagocytes 
Clinically-relevant 
alumina – Larger 
particles were 0.1-
>10µm and smaller 
particles were 5-
20nm. 
Commercial alumina 
powder– 0.5µm 
Commercially-
obtained. 
Clinically-
relevant particles 
generated using 
hip wear 
simulator. 
0.1, 1, 10, 
100µm3 per 
cell  
Cell viability – MTT assay 
Measurement of TNF-α 
release - ELISA 
All six donors produced significantly 
elevated levels of TNF-α when stimulated 
with 100µm3, whereas PBMNCs from only 
three of the six donors released significantly 
elevated levels of TNF-α when stimulated 
with 100µm3 of the clinically-relevant 
alumina wear particles. All donors released 
significant levels of TNF-α when 
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stimulated with 500µm3 of clinically-
relevant alumina wear particles. 
(Warashina 
et al., 2003) 
Murine calvarial 
osteolysis model 
(60 CL/BL6 male 
mice aged 12 
weeks) 
Alumina – 2.1µm 
Zirconia-1.5µm 
Titanium – 1.1µm 
High density 
particles (HDP)- 
4.1µm  
Commercially-
obtained  
1x109 
particles per 
ml 
Release of IL-1β, IL-6 and 
TNF-α - ELISA 
The levels of IL-1β and IL-6 were 
significantly elevated in response to HDP 
and titanium particles. Any particle type did 
not increase the levels of TNF-α. There 
were no significant differences observed in 
the levels of proinflammatory cytokines in 
response to alumina and zirconia particles. 
(Olivier et 
al., 2003) 
J774.2 
macrophages and 
L929 fibroblasts 
Alumina – 0.43 and 
2.81 
Polystyrene beads – 
0.45 and 3.53 
Commercially-
obtained 
Alumina - 
0.01, 0.025, 
0.05, 0.1, 
0.5mg/ml 
Polystyrene 
beads – 0.5 
and 
1.0mg/ml 
Cytotoxicity – trypan blue 
exclusion assay 
Apoptosis – Cell DNA 
analysis and Annexin V assay 
Release of IL-6 – ELISA 
The alumina particles at both sizes and 
1.0mg/ml polystyrene beads caused a 
significant decrease in cell number with 
increase in particle concentration.  
Particle size of 0.43 for alumina did not 
affect the viability of L929 cells. Particles 
were more cytotoxic for macrophages than 
fibroblasts. The death in macrophages was 
a combination of necrosis, caused mainly 
by 3.53 polystyrene beads and apoptosis 
caused mainly by 0.45 polystyrene beads. 
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Release of IL-6 had a non-linear correlation 
with cytotoxicity i.e. increase in 
cytotoxicity caused increase in release of 
IL-6.  
(Granchi et 
al., 2004) 
Human osteoblasts 
Osteoclast pre-
cursors obtained 
from PBMCs from 
donor blood. 
Alumina – 1µm 
 
UHMWPE – 
information on size 
not provided 
Alumina was 
commercially-
obtained 
UHMWPE was 
generated using 
CoCr vs. 
UHMWPE ball 
on a flat system.  
1, 0.1, 0.01, 
0.001mg/ml 
Cell viability- Alamar blue 
Commercially available 
reagents were used for the 
immunoenzymatic 
determination of IL6, TNFα, 
GM-CSF, OPG and RANKL. 
Osteoclast formation 
The alumina and UHMWPE particles did 
not affect either cell viability or TNFα and 
GM-CSF release. The release of IL-6 
increased with particle concentration. 
UHMWPE increased the release of 
RANKL from HOB, while OPG and OPG-
to-RANKL ratio were significantly 
inhibited. UHMWPE particles induced a 
large amount of multinucleated TRAP-
positive giant cells, as well as significantly 
reduced the levels of IL6, GM-CSF and 
RANKL. This study showed that alumina 
was less inductive in terms of 
osteoclastogenesis.  
(Rodrigo et 
al., 2006) 
J774 cells and 
primary human 
osteoblasts 
Alumina - 4µm 
(average diameter) 
Commercially-
obtained 
1, 10, 50, 
100, and 
1mg/well 
Release of IL-6 and GM-CSF 
– ELISA 
Expression of IL-6 - PCR 
The levels of TNF-α were increased when 
J744 cells were treated with the higher 
doses (50 & 100mg/well) of alumina 
particles, but the release of TNF-α was 
lower when cells were cocultured with 
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osteoblasts. The release of IL-6 by J744 
cells was only significant when co-cultured 
with osteoblasts, in the presence of 
50mg/well of alumina particles.  
Significant levels of IL-6 and GM-CSF 
were released from osteoblasts when 
stimulated with 10mg/well of alumina 
particles, reaching a plateau at 50mg/well. 
The levels of IL-6 and GM-CSF were 
significantly increased when osteoblasts 
were co-cultured with J744 cells at 
50mg/well of alumina particles.     
(Tsaousi et 
al., 2010) 
Primary human 
fibroblasts 
Alumina - Mean 
grain size 0.2nm 
CoCr – 0.56-4.74µm 
Commercially-
obtained 
0.1–10 
mg/T-75 
flask 
Cell viability - The trypan-
blue exclusion method 
Genotoxicity - Micronucleus 
Cyt-B assay 
Immunostaining of gamma-
H2AX foci - used as a marker 
of DNA double-strand breaks 
There were no significant differences in cell 
viability between control and ceramic 
treated cells, at all doses and time-points 
studied. Cells treated with CoCr particles 
showed both dose- and time-dependent 
cytotoxicity.  
The induction of micronuclei was 
unaffected by the size or shape of the 
ceramic particles. There was an increase in 
micronucleated binucleate cells after 
treatment with CoCr particles. There was 
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no increase in gamma-H2AX foci in cells 
exposed to ceramic particles, whereas there 
was a significant increase of these foci in 
cells treated with CoCr particles. 
(Faye et al., 
2017) 
Dermal fibroblasts 
Alumina or cerium-
zirconia particles 
(50nm) 
Commercially-
obtained 
100 and 
500μg ml-1 
Cell morphology, cytoplasmic 
ceramic incorporation - using 
confocal and transmission 
electron microscopy  
Cell migration -silicon insert. 
Sedimentation field-flow 
fractionation -used to evaluate 
the rate of incorporation of 
ceramic particles into the 
cells. 
Both alumina and cerium-zirconia ceramic 
particles did not cause any deleterious 
effects on cultured cells. 
Confocal and electron microscopy showed 
that both the alumina and cerium-zirconia 
particles were internalized in the cells. The 
fluorescent membrane labelling and 
fluorescent alumina particles showed that a 
membrane formed around the particle-
containing vesicles present in the 
cytoplasm. 
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4.5.3 Inflammatory response to ceramic wear particles 
The inability of macrophages to degrade wear particles causes them to release pro-
inflammatory cytokines for the recruitment, migration and stimulation of other cell types to 
the site of the foreign wear particles. As a result, the formation of a granulomatous 
periprosthetic tissue, which is rich in macrophages, forms around the implant to isolate the 
foreign matter from the surrounding tissues (Ingham and Fisher, 2005). These mediators and 
cytokines affect the behaviour of many cell types, particularly the interaction of osteoblasts, 
osteoclasts and fibroblasts which ultimately causes bone loss that can lead to osteolysis. TNF-
α is a key osteolytic cytokine released by macrophages stimulated by wear particles and is 
reported to play an important role in osteolysis, and has been found in high levels around 
osteolytic implants (Ingham and Fisher, 2000). Therefore, this pro-inflammatory cytokine 
was used in the present study as a marker of the osteolytic response from PBMNCs in 
response to different doses of BIOLOX® Delta composite ceramic wear particles. In addition, 
the viability of the PBMNCs in response to the particles was measured after the 24hr culture 
period. The cellular response was compared with low (0.5 µm3 per cell) and high (50µm3 per 
cell) doses of the BIOLOX® Fore alumina ceramic wear particles. In addition, the cellular 
response was also compared to clinically-relevant CoCr nano-particles, which is known to 
induce cytotoxic and inflammatory responses (Posada et al., 2015). The cell viability and 
TNF-α release from PBMNCs was initially investigated in response to model ceramic 
particles before testing the cellular response to clinically-relevant ceramic wear particles that 
were generated using the hip simulator under edge loading conditions. 
There was no significant effect on the viability of PBMNCs from all the five donors in 
response to all the conditions for both the model and clinically-relevant BIOLOX® Delta 
composite ceramic wear particles. This trend was also true for the CoCr nano-particles, which 
showed no significant effect on cell viability compared to the cell only negative control. This 
limited response in terms of cell viability may have been due to the short 24hr culture period 
with the wear particles and was in agreement with a study by Hatton et al. (2003), who also 
reported the same observation with PBMNCs cultured with alumina powder or alumina wear 
debris generated under microseparation conditions using the hip simulator. The levels of 
TNF-α produced by PBMNCs (all donors) in the present study also showed no significant 
difference compared to the cell only negative control in response to the BIOLOX® Delta 
model ceramic particles, for all the particle volumes tested (50-500µm3 per cell). This was 
also the case for the BIOLOX® Forte model ceramic particles at low (0.5 µm3 per cell) and 
high (50µm3 per cell) volumetric concentrations. Several authors (Table 4.14) have suggested 
similar findings such as Catelas et al. (1998) who reported higher levels of TNF-α release 
were associated with high density polyethylene particles (size: 4.5µm) compared to alumina 
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(size range: 0.6 – 4.5µm) and zirconia (size: 0.6µm) commercial particles. These authors used 
commercially obtained particles in the phagocytosable size range (<5µm) and reported a 
direct positive correlation between TNF-α release and particle concentration. The lower levels 
of TNF-α release in response to alumina particles compared with UHMWPE particles (8-10 
times higher) was also described by Petit et al. (2002), who reported that TNF-α release was 
much more intense with UHMWPE (size range: 0.5-2µm) compared to high density 
polyethylene particles (size: 4.5µm) used by Catelas et al. (1998), which is indicative of the 
importance of particle size in immune response. Petit et al. (2002) hypothesised that the lower 
levels of TNF-α associated with the alumina particles may be due to the ability of the alumina 
particles to induce macrophage apoptosis, which was observed through apoptotic DNA 
fragmentation. The suppression of inflammatory cytokine release through programmed cell 
death in response to ceramic particles may explain the low biological impact of ceramic hip 
replacements (Warashina et al., 2003). The differences between biological activity of ceramic 
wear particles compared to UHMWPE wear particles was also reported by Granchi et al. 
(2004), who described alumina particles as being less inductive of osteoclastogenesis 
compared to polyethylene wear particles. The authors found polyethylene wear particles 
increased the release of RANKL, whilst simultaneously decreasing the release of OPG, which 
as mentioned earlier is an inhibitor of osteoclastogenesis. Hence, these authors demonstrated 
that model ceramic particles were less active in promoting osteoclast formation, thus reducing 
the risk of bone resorption. The low biological activity of ceramic particles has been 
emphasised in many studies by comparing with polyethylene wear particles, which is 
extensively reported in the literature to cause osteolysis. However, the low-density of 
polyethylene wear particles presents difficulties whereby it is inherently difficult to 
manipulate in in vitro studies as it is less dense than culture medium and invariably floats on 
the medium surface preventing interaction with cultured monolayers of macrophages. 
Therefore, clinically-relevant CoCr nano-particles were used in the present study to compare 
the biological activity of ceramic particles. Like the low doses of model ceramic particles 
(0.05-5µm3 per cell), the low dose (0.5 µm3 per cell) of clinically-relevant CoCr nano-particles 
cultured with PBMNCs also showed no significant increase in TNF-α release compared to the 
cells only negative control (all donors). Whereas, the high dose (50µm3 per cell) of clinically-
relevant CoCr nano-particles caused a significant increase in the levels of TNF-α released 
from PBMNCs for all the donors when compared to the cell only negative control. The release 
of osteolytic cytokines in response to CoCr wear particles from MoM implants has been 
reported in numerous studies such as Brown et al. (2006) who reported high levels of TNF-α 
production from PBMNCs in response to 50µm3 per cell volumetric concentration of 
clinically-relevant CoCr wear particles.  
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The model ceramic particles (BIOLOX® Forte and BIOLOX® Delta) used in the present study 
did not stimulate PBMNCs (all donors) to produce significant levels of TNF-α compared to 
the cell only control. In contrast the highest dose (50µm3 per cell) of clinically-relevant 
BIOLOX® Forte and BIOLOX® Delta wear particles incited the PBMNCs from all donors to 
produce significantly higher levels of TNF-α compared to cell only negative control. All the 
other doses (0.05-5µm3 per cell) of clinically-relevant ceramic wear debris from both 
BIOLOX® Forte and BIOLOX® Delta failed stimulate a significant response in terms of TNF-
α release from PBMNCs for all donors. The levels of TNF-α produced by the PBMNCs in 
response to LPS varied greatly between the five different donors evaluated in this study. This 
was perhaps due to the heterogeneity of human individuals as the response is determined by 
polymorphisms in the TNF promoter gene, which affects the susceptibility and severity of 
different human diseases (El-Tahan et al., 2016). Polymorphisms within genes that encode 
the pro-inflammatory cytokines (TNF-α, IL-1 and IL-6) associated with osteolysis may 
influence the risk of developing osteolysis after total hip replacement (Wilkinson et al., 2003; 
Gordon et al., 2008). The present study clearly demonstrated the varied response to wear 
particles between donors, which has been previously reported for UHMWPE wear particles 
(Matthews, Green, et al., 2000a). In the present study, the response of PBMNCs from donor 
2 to LPS was consistently between 1.8- 2.3 times greater than that of the other donors, hence 
this donor was categorised as a more aggressive responder.  
Nevertheless, despite the inherent variability between donors in terms of TNF-α release, the 
results were relatively consistent with respect to the dose of particles that stimulated a 
significant inflammatory response. The high levels of TNF-α released from PBMNCs (all 
donors) in response to clinically-relevant ceramic wear particles was initially attributed to the 
stainless-steel wear particle contaminants that may have been present within the culture of 
PBMNCs and ceramic wear particles. This was because CFE-SEM and EDX analysis of the 
ceramic wear particles generated in vitro using the Leeds II hip simulator revealed an 
abundance of stainless steel particle contaminants for both BIOLOX® Forte and BIOLOX® 
Delta particle samples, a limitation of this study that was described in chapter 3. The 
separation of the stainless-steel wear particles contaminants from the ceramic wear debris was 
extremely difficult, and so the ceramic wear particles cultured with the cells contained a mixed 
population of ceramic and stainless-steel wear particles. EDX mapping of the mixed 
population of BIOLOX® Delta ceramic and stainless-steel wear particles revealed that 
approximately 47.06 ± 42.75% (±CL) of the wear particles were ceramic (chapter 3). The 
percentage ratio between BIOLOX® Forte and stainless-steel wear particle was also similar 
((44.13 ± 31.48% (±CL)). To mitigate the potential biological effects of these stainless-steel 
wear particle contaminants and elucidate the biological impact of the clinically-relevant 
ceramic wear particles, it was necessary to include a stainless-steel wear particle control. The 
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stainless-steel wear particle control was generated from 316L medical grade stainless-steel 
pins and plates using the six-station pin-on-plate wear rig (Lee, 2016). Lee et al., (2016) 
reported that these stainless-steel wear particles had no adverse effects on cell viability 
(primary astrocytes and microglia) over a 5-day culture period, for all the particle doses tested 
(0.5-50 µm3 per cell). The highest dose (50µm3 per cell) of the stainless-steel wear particles 
did however produce significant levels (29.9pg.ml-1) of TNF-α from primary astrocytes and 
microglia compared to the cell only negative control (no TNF-α released) after a 2-day culture 
period. However, these levels of TNF-α production were minimal when compared to the 
PBMNCs negative control in the present study, which produced between 12.7 - 34.6 pg/ml of 
TNF-α. Hence, the cytotoxic and inflammatory effects of the stainless-steel wear particles 
were limited, and the concerns for positive misleading results in response to the stainless-steel 
wear particle contaminants generated from the Leeds II hip simulator was minimal. Even so, 
the presence of the stainless-steel particles has some clinical-relevance, as they have been 
identified in retrieved tissues from hip prostheses. The source of these particles has been 
attributed to the fretting corrosion of the taper and so stainless-steel wear particles most 
definitely have the potential to invoke a biological response (Xia et al., 2017). Lee et al., 
(2016) reported significant DNA damage in primary astrocytes and microglia in response to 
all doses (5-50 µm3 per cell) of stainless-steel particles. These genotoxic effects will therefore 
need be considered in this study when reporting the genotoxic effects of clinically-relevant 
ceramic wear particles in PBMNCs. 
Considering the findings of Lee et al. (2016) regarding the cellular response to stainless-steel 
wear particles, it can be elucidated that the highest dose (50µm3 per cell) of clinically-relevant 
ceramic wear particles for both BIOLOX® Forte and BIOLOX® Delta, in fact caused 
significant levels of TNF-α produced from PBMNCs for all the donors. There is very limited 
literature on the biological activity of clinically-relevant ceramic wear particles generated 
from hip replacements as only two other studies (Germain et al., 2003a; Hatton et al., 2003a) 
used clinically-relevant ceramic wear particles to investigate the in vitro biological response 
to wear particles generated from ceramic hip replacements. These studies used the same 
BIOLOX® Forte alumina powder that was used in this study. But, the findings in this study 
were relatively dissimilar to the findings reported by Hatton et al. (2003) in that the highest 
dose (50µm3 per cell) of clinically-relevant BIOLOX® Forte and BIOLOX® Delta ceramic 
wear particles caused a significant increase in the levels of TNF-α released compared to the 
cell only negative control. The BIOLOX® Forte and BIOLOX® Delta model ceramic particles 
failed to stimulate a significant inflammatory response in terms of TNF-α release for all the 
particle volumes tested. Whereas Hatton et al. (2003) found that the BIOLOX® Forte alumina 
powder caused significantly elevated levels of TNF-α when stimulated with 100µm3 per cell. 
The lower doses (1-10µm3 per cell) of alumina powder showed the same response as the 
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present study, in that none of the donors produced significantly elevated levels of TNF-α. The 
differences in TNF-α release for the model ceramic particles may be because the highest dose 
used by Hatton et al., (2003) was double that used in this study (50µm3 per cell). But, at dose 
50µm3 per cell for the clinically-relevant or microseparation alumina ceramic wear particles, 
Hatton et al. (2003) reported that they failed to stimulate a significant response in terms of 
TNF-α release for three out of six donors. Only when the PBMNCs were stimulated with the 
highest dose (500µm3 per cell) of microseparation alumina ceramic wear particles did all the 
donors produce significant levels of TNF-α. The authors postulated that the clinically-relevant 
or microseparation alumina ceramic wear particles had a greater size range and that a greater 
volume of clinically-relevant ceramic wear particles was required to produce similar levels of 
TNF-α release compared with alumina powder. The results of the present study are in contrast 
to this, where the model ceramic wear particles for both BIOLOX® Forte and BIOLOX® Delta 
were less stimulatory in terms of TNF-α release compared to the clinically-relevant ceramic 
wear particles for both BIOLOX® Forte and BIOLOX® Delta CoC bearings. This may have 
been due to the clinically-relevant BIOLOX® Delta ceramic wear particles having a greater 
size distribution and more larger particles in the phagocytosable range (up to 4.5µm) 
compared to the BIOLOX® Delta model ceramic particles as demonstrated by their frequency 
size distributions. Thus, a lower concentration or volume of particles was required to illicit an 
immune response. This was supported by Catelas et al. (1998) who reported that particle size 
and concentration determined the macrophagic response, where TNF-α release increased with 
alumina particle concentration. These authors stated that macrophages respond to particle 
volume rather than particle number. However, the same cannot be said for the BIOLOX® 
Forte model ceramic particles and clinically-relevant BIOLOX® Forte ceramic wear particles 
as there was no significant difference in characteristics of the particles in terms of size 
distribution and morphology. Nevertheless, the clinically-relevant BIOLOX® Forte ceramic 
wear particles had a slightly larger size distribution compared to the BIOLOX® Forte ceramic 
model particles, and so like the clinically-relevant BIOLOX® Delta ceramic wear particles a 
lower concentration or volume of particles was required to illicit an immune response, when 
compared to the ceramic model particles. This possible suggestion may have been a 
contributing factor towards the stimulation of significantly elevated levels of TNF-α release. 
However, this is speculative and PBMNCs cultured with higher volumes of ceramic particles, 
may have given light to this observation. The only other possible explanation may be due to 
the presence of unknown contaminants from in vitro wear simulation, which may have caused 
a positive immune response. Nevertheless, despite the differences between this present study 
and the study conducted by Hatton et al. (2003), the same conclusion can be drawn in that 
given the low wear rates (0.1-1mm3 per million cycles) of ceramic-on-ceramic bearings, these 
high volumes or doses of ceramic wear particles (50-500µm3 per cell) may never be achieved 
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in vivo, even under malpositioning conditions. Hence, it can be concluded that CoC hip 
replacements have very limited osteolytic potential as they failed to stimulate pro-
inflammatory cytokine (TNF-α) production.   
4.5.4 Genotoxic effects of ceramic wear particles 
Genotoxicity in patients with MoM hips is of great concern regarding CoCr wear particles as 
previous studies have reported chromosome aberrations in patients with MoM implants 
(Ladon et al., 2004; Suner et al., 2012). Therefore, this study investigated the genotoxic effects 
of model and clinically-relevant ceramic wear particles in PBMNCs. The BIOLOX® Delta 
model ceramic particles had no significant effect on the level of DNA damage in PBMNCs 
from all donors when compared to the cell only negative control. Similarly, the BIOLOX® 
Forte model ceramic particles and clinically-relevant CoCr nano-particles at low dose (0.5 
µm3 per cell) caused no significant DNA damage in all the donors, when compared to the cell 
only negative control. However, the high dose (50µm3 per cell) of BIOLOX® Forte model 
ceramic particles triggered significant levels of DNA damage compared to the cell only 
negative control in all donors, except in donor 5. Tsaousi et al., (2010) reported that alumina 
ceramic particles are weakly genotoxic compared to CoCr particles. This conclusion was 
based upon ceramic particles (fibres, nano-particles and micro-particles) at high doses 
(2mg/T-75 flask or 12.5µg/ml) causing significant increases in chromosome loss and 
polyploidy in primary human fibroblasts, but no DNA double-stand breaks were detected. 
However, the results from the present study clearly showed that high doses of model alumina 
particles cultured with PBMNCs can induce DNA damage, which was notably higher than 
the DNA damage caused by clinically-relevant CoCr nano-particles (50µm3 per cell) in donors 
5 and 7. The difference in DNA damage observed between Forte and Delta may be due to the 
Forte having more submicron alumina particles compared to Delta. This is because during 
sintering of the Forte powder, magnesium is added to increase the growth of the grains 
resulting in larger particles, which may have caused significant levels of DNA damage 
compared to Delta that has finer particle granules. Furthermore, the compositional differences 
may have also been a contributing factor as Forte consists of alumina stabilised by yttria, 
whereas Delta consists of ZTA composite ceramic. These differences in composition can 
affect the agglomeration properties of the nano-particles in solution with low pH levels. The 
internalisation by macrophages of alumina particles within vesicles, could have exposed the 
alumina particles to lysosomes that create acidic conditions in order to activate the lysosomal 
enzymes, whose function is to break down any material present within the vesicle. These 
acidic conditions could have caused deagglomeration of the alumina nano-particles and 
potentially induced adverse effects within the cells such as DNA damage (Parry et al., 2010; 
Sood et al., 2011), which was clearly observed in the present study for alumina model ceramic 
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particles. The submicron alumina particles from Forte may suspend different in solution 
compared to Delta, which may also explain the difference observed in terms of DNA damage. 
This statement was made as it was during preparation of the Delta and Forte model particle 
solutions for filtration and characterisation, it was observed that the Forte alumina powder 
created a cloudy solution whereas the Delta ZTA powder settled at the bottom of the universal 
tube. This may have been due to the two mateials having different agglomeration stability/ 
particle dispersion at the pH of water, which may also result in difference in particle 
generation. However, this is highly speculative and requires further investigation. 
Furthermore, it is evident from the literature that ceramic hip replacements do not release ions 
during service (Kretzer et al., 2018). The clinically-relevant CoCr nano-particles at high doses 
(50µm3 per cell) consistently induced significant levels of DNA damage in PBMNCs from all 
donors. This was expected as it is documented in the literature that CoCr wear particles, 
particularly in the nano-scale size range (30 nm) induce more DNA damage than micrometre 
sized particles (2.9µm) (Papageorgiou et al., 2007). Furthermore, Parry et al., (2010) reported 
that CoCr nano-particles at a threshold of 0.0036mg/cm2 caused DNA double strand breaks 
and ten-times lower threshold of 0.00036mg/cm2 caused chromosome aberrations. However, 
these doses were much greater than the wear rates of well-functioning implants, but 
potentially in line with the wear rates of mal-positioned MoM THRs, thus the phenomenon 
of such DNA damage may occur in vivo.  
The clinically-relevant BIOLOX® Forte ceramic wear particles at high doses (50µm3 per cell) 
also caused significant levels of DNA damage in PBMNCs from all donors. In addition, the 
clinically-relevant BIOLOX® Delta ceramic wear particles at high doses (50µm3 per cell) 
caused significant levels of DNA damage in four donors (5, 7, 25 and 26) when compared to 
the cell only negative control. What’s more, at a dose of 5µm3 per cell, significant levels of 
DNA damage was observed for the clinically-relevant BIOLOX® Delta ceramic wear particles 
for three donors (5, 7 and 26). This was also evident for the clinically-relevant BIOLOX® 
Forte ceramic wear particles at low doses (0.5 µm3 per cell), where there were significant 
levels of DNA damage for donors 5, 7 and 25. The significant genotoxic effects caused by 
clinically-relevant BIOLOX® Delta ceramic wear particles and low doses of clinically-
relevant BIOLOX® Forte ceramic wear particles were attributed to the presence of stainless-
steel wear particle contaminants in the co-culture. This was supported by results for the 
stainless-steel wear particle control, which demonstrated significant levels of DNA damage 
at doses of 50 µm3 per cell. This was in agreement with the findings of Lee et al. (2016), who 
reported significant DNA damage in primary astrocytes and microglia in response to all doses 
(5-50 µm3 per cell) of stainless-steel particles. Due to the presence of stainless-steel wear 
particle contaminants, the results ascertained from the experiments that investigated the 
genotoxic effects of the clinically-relevant ceramic wear debris are considered to be 
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unreliable, as the stainless-steel wear particles control demonstrated significant DNA damage 
compared to the cells only negative control. Nevertheless, the findings from the clinically-
relevant Forte wear particles support the findings from the genotoxic assessment of the model 
ceramic particles, as the stainless-steel wear particles were also in the submicron range and 
also caused DNA damage. This study showed that the biocompatibility of a material in bulk 
form can change when the particulate form is considered and subtle but detrimental changes 
such as DNA damage, that are often missed during cytotoxic evaluation of biomaterials, may 
be observed.  
4.5.5 Oxidative stress in response to ceramic wear particles  
The generation of reactive oxygen species (ROS) induced by particles also plays a vital role 
in genotoxicity. High levels of ROS can lead to oxidative stress within cells, which in turn 
can cause DNA damage and unregulated cell signalling that can eventually result in cell 
mortality, apoptosis and even carcinogenesis (Fu et al., 2014). Raghunathan et al. (2013) 
reported that genotoxicity in fibroblasts caused by exposure to CoCr wear particles is 
facilitated by reactive oxygen species (Raghunathan et al., 2013). It is well known that CoCr 
wear particles and ions released from MoM hips cause oxidative stress. Behl et al. (2013) 
reported that 50µm3 per cell of clinically-relevant CoCr nano-particles caused high levels of 
oxidative stress as observed by very strong signals of fluorescence. This was also observed in 
the present study with the high dose (50µm3 per cell) of clinically-relevant CoCr nano-
particles, which caused a significant increase in the levels of oxidative stress in PBMNCs 
from all donors as indicated by the high levels of fluorescence intensity. The quantitative 
method of assessing the level of reactive oxygen species production in the present study was 
much more reliable than the qualitative method used by Behl et al. (2013), which used post-
image analysis of the fluorescence microscopy images to quantify and determine the level of 
oxidative stress within the cells (Behl et al., 2013). Measuring cell fluorescence from images 
using computer software comes with many limitations including poor image quality, which 
can make it difficult to accurately draw around the boundary of fluorescent cells and compute 
meaningful measurements. Other studies (Armstead et al., 2017; Fleury et al., 2006) also 
reported similar findings with high levels of oxidative stress associated with CoCr particles 
and highlighted that oxidative stress was mostly attributed to the combined effects of 
nanoparticles and ion release from the CoCr wear particles. Fleury et al. (2006) reported that 
oxidative stress induced by Co and Cr ions in MG-63 osteoblast cells was due to protein 
oxidation and protein nitration, which are biomarkers for oxidative stress. The study showed 
that the redox state of osteoblasts was disturbed and in turn this caused deleterious effects on 
protein function within the cells. The cytotoxic effects were also attributed to down-regulation 
of antioxidant enzymes by Co ions, which would have otherwise protected the cells from 
247 
 
oxidative stress induced by these ions. The in vivo detection of oxidative stress in tissues from 
patients with total hip replacements was reported by Steinbeck et al. (2014) who looked for 
the presence of five markers (high mobility group protein-B1; cyclooxygenase-2; inducible 
nitric oxide synthase; 4-hydroxynonenal; and nitrotyrosine) associated with oxidative stress. 
These authors found that all five markers were present in increased amounts in patient tissues 
revised for osteolysis when compared to normal tissues. These authors also found the markers 
were expressed at the high levels in localised regions with wear debris and chronic 
inflammation. These studies highlight the role oxidative stress can play in the inflammatory 
response to total hip replacements, leading to osteolysis and implant failure (Steinbeck et al., 
2014). Hence, the nano-scale nature of wear particles from ceramic hip replacements poses 
great concern regarding oxidative stress, thus the present study investigated the production of 
reactive oxygen species in PBMNCs in response to model and clinically-relevant ceramic 
wear particles.  
Interestingly, both the model and clinically-relevant BIOLOX® Delta ceramic wear particles 
for all the doses tested, had no significant effect on the level of oxidative stress (fluorescence 
intensity) in PBMNCs from all donors. The same observation was made for the model and 
clinically-relevant BIOLOX® Forte ceramic wear particles at low (0.5 µm3 per cell) and high 
(50µm3 per cell) doses. What is more, despite the mixed population of clinically-relevant 
ceramic wear particles and stainless-steel wear particles, no significant levels of oxidative 
stress were detected in the PBMNCs in any donor. This was surprising as the stainless-steel 
wear particle control (50µm3 per cell) caused a significant increase in the levels of ROS in 
PBMNCs from donor 5 and donor 26 as indicated by the high levels of fluorescence intensity 
compared to the cell only negative control. However, despite these significant differences, the 
fluorescence intensity for the stainless-steel wear particles was only marginally higher than 
the cells only control, whereas the fluorescence intensity in response to the CoCr nano-
particles was considerably higher. These findings for the ceramic wear particles were in 
agreement with the findings of Wang et al., (2002) who reported no increase in reactive 
oxygen and nitrogen species in response to zirconia particles (mean size: 876nm). However, 
the authors also reported that sub-optimal stimulation of the macrophage cells to produce 
TNF-α in culture with the zirconia particles caused a significant increase in reactive oxygen 
and nitrogen species. This study suggested that there was a synergistic effect between TNF-α 
and ceramic wear particles on the production of reactive oxygen and nitrogen species by 
human macrophage cells (Wang et al., 2002). However, this synergistic effect was not 
observed in the present study as the clinically-relevant BIOLOX® Delta and BIOLOX® Forte 
ceramic wear particles both caused significant release of TNF-α at high doses, but did not 
elicit oxidative stress in PBMNCs. Alumina nano-particles (30-40nm) have also been reported 
to induce significant oxidative stress, but the doses used were considerably higher than the 
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relative wear rates of ceramic-on-ceramic hip replacements, rendering these studies irrelevant 
(Prabhakar et al., 2012). 
4.5.6 Limitations of study 
The clinically-relevant ceramic wear particles generated in chapter 3 for subsequent 
biological testing resulted in a mixed-population of stainless-steel and ceramic wear particles. 
This contamination by stainless-steel wear particles in the resultant ceramic wear particle 
suspensions required mitigation in the cell culture studies, where it was necessary to include 
a stainless-steel wear particle control to determine the potential biological effects this 
contaminant may pose to the cells. According to the results from the stainless-steel wear 
particle control in each biological assay, the stainless-steel wear particles only demonstrated 
complications for the genotoxicity evaluation of the clinically-relevant ceramic wear 
particles. The significant genotoxic effects caused by clinically-relevant BIOLOX® Delta and 
BIOLOX® Forte ceramic wear particles at various doses was attributed to the presence of 
stainless-steel wear particle contaminants in the co-culture and so these results were rendered 
unreliable.  
Another limitation of this study is that the particles used in the biological assays, were not 
tested for the presence of endotoxins after heat sterilisation. The presence of endotoxins on 
the particles could have potentially activated the cells and generated misleading results. 
However, the method of destroying the endotoxins (190oC for 4 hours) used in the present 
study has been previously validated by Germain et al. (2003) and Hatton et al. (2003) using 
Limulus amoebocyte lysate assay. After heat treatment of the wear debris and control standard 
endotoxin solution (90 endotoxin units; EU), the endotoxins levels were shown to be <0.01 
endotoxin units (EU) per ml, which was below the range of the control standard endotoxin 
and below the accepted value of <5 EU per ml, as specified by the pharmaceutical industry 
for injectable pharmaceuticals (FDA, Regulatory Affairs, 1985).  
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4.6 Summary of findings 
This part of the study aimed to investigate the biological impact of wear particles generated 
from CoC total hip replacements using a range of biological assays. A comprehensive 
evaluation of the biological impact of model and clinically-relevant ceramic wear particles 
(generated using a hip simulator) of BIOLOX® Delta ZTA ceramic wear particles in terms of 
cytotoxicity, inflammation, genotoxicity and oxidative stress was investigated, thus 
successfully addressing the aim of this chapter. The results from this comprehensive study 
demonstrated that both Delta composite ceramic wear particles and Forte alumina wear 
particles demonstrated lower biological activity compared to CoCr nano-particles. The 
summary of the findings from this study are presented below: -  
• The present study demonstrated the potential cytotoxic effects of ceramic model particles 
(BIOLOX® Forte and BIOLOX® Delta) in L929 fibroblast cells at very high doses 
(500µm3 per cell), despite their non-clinical relevance. All other doses (0.05-50µm3 per 
cell) of ceramic model particles for both BIOLOX® Forte and BIOLOX® Delta had no 
cytotoxic effects in L929 cells. The clinically-relevant BIOLOX® Delta ceramic wear 
particles demonstrated cytotoxic effects in L929 cells at a lower dose of 50µm3 per cell 
compared to ceramic model particles. However, this dose was still not clinically-relevant 
and all other doses (0.05-5µm3 per cell) had no effect on the viability of L929 cells.  
• The BIOLOX® Delta ceramic model particles failed to stimulate an inflammatory 
response in terms of TNF-α release from PBMNCs for all the doses tested (0.05-50µm3 
per cell). However, the clinically-relevant BIOLOX® Delta ceramic wear particles 
caused significant levels of TNF-α release from PBMNCs at high doses (50µm3 per cell). 
• The BIOLOX® Forte model ceramic particles demonstrated genotoxic effects at high 
doses (50µm3 per cell), whereas the BIOLOX® Delta ceramic model particles did not 
cause any DNA damage in PBMNCs from all donors. The clinically-relevant BIOLOX 
Delta ceramic wear particles also caused DNA damage at high doses (5-50µm3 per cell) 
in PBMNCs from most donors.  
• The model and clinically-relevant BIOLOX® Delta ceramic wear particles for all the 
doses tested, had no significant effect on the production of ROS (oxidative stress) in 
PBMNCs from all donors. 
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CHAPTER 5 
 
5 Final discussion 
5.1 Introduction 
Total hip arthroplasty (THA) is one of the most successful orthopaedic procedures of the 
twentieth century. The National Joint Registry reported that in 2016, there were 101,651 hip 
replacements performed in England, Wales, Northern Island and Island of man a rise of 
approximately 323% from the hip replacements carried out in 2003 (14,454) (National Joint 
Registry, 2017). These numbers revealed a rapid increase in the number of THA procedures, 
which may be due to an ageing population coupled with an increasing number of younger and 
more active patients in need of total hip replacement (THR) surgery (Kurtz et al., 2007). The 
success of THRs is determined by their longevity, their ability to alleviate pain and restore 
patient mobility. Many factors such as implant design and type of material affect the success 
rates of THRs, however, the inevitable phenomenon of wear particle generation from the 
bearing surfaces has a large influence on the in vivo longevity of the implant and the incidence 
of revision surgery. 
The most widely used bearing couple is still the metal head on UHMWPE acetabular cup, 
which made up 87.1% of all cemented primary procedures and 59% of all primary THRs that 
were implanted between 2003 and 2016 (National Joint Registry, 2017). However, 
historically the high prevalence of osteolysis and aseptic loosening associated with wear 
particles of the conventional metal-on-UHMWPE (MoP) bearing couple led to the 
development of alternative hard-on-hard bearings such as metal-on-metal (MoM) and 
ceramic-on-ceramic (CoC). MoM bearings have reported wear rates of between 1-6 mm3 per 
year in comparison to <10-100 mm3 per year for MoP hip implants, which is in the order of 
60 times lower compared to MoP bearings (Cuckler, 2005; Goodman et al., 2009). However, 
concerns over the release of metal wear particles and metal ions from MoM hips led to a 
dramatic decline in the use of MoM hips and an increase in the popularity of alternative CoC 
THRs (Haddad et al., 2011).  
CoC bearings have been shown to have superior wear properties when compared with other 
bearing materials such as cobalt-chromium and UHMWPE. The early CoC bearings consisted 
of pure alumina (Al2O2) and had a reputation for fracture (Fritsch and Gleitz, 1996). More 
recent issues have centered around surgical positioning and squeaking (Nevelos et al., 2000b; 
Owen et al., 2014). The development of better manufacturing processing such as hot isostatic 
pressing (HIP) allowed major improvements of ceramics, which reduced the grain size and 
increased the density of the alumina, making fracture less likely to occur (Tateiwa et al., 
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2008). More recently, composite ceramics such as zirconia-toughened, platelet reinforced 
alumina or ZTA, otherwise commercially known as BIOLOX® Delta have been introduced 
clinically. ZTA is toughened by phase transformation; dispersion of tetragonal zirconium 
oxide submicron/nanoparticles in the microstructure and reinforced by the formation of 
platelet-shaped crystals in the alumina matrix (Burger and Richter, 2000b). Composite 
ceramics have dramatically reduced the wear rates of CoC bearings, which can be 
demonstrated by their wear rates in vitro: BIOLOX® Delta composite ceramic, 0.13mm3 per 
million cycles compared with BIOLOX® Forte HIPed alumina, 1.84mm3 per million cycles 
(Al-Hajjar, Fisher, Tipper, et al., 2013b). In addition, retrieval studies have shown extremely 
low wear compared with other bearing couples (Nevelos et al., 1999; Nevelos, Ingham, et al., 
2001b; Affatato et al., 2011; Esposito et al., 2012). A low wear rate is believed to be critical 
for extending the longevity of a prosthetic joint, and wear volumes produced by CoC bearings 
have been estimated to be 40-100 times lower than the current generation highly-crosslinked 
MoP bearings (Knahr, 2013).   
Excessive wear particles have been linked with the aetiology of periprosthetic osteolysis and 
aseptic loosening. The relative features of wear particles in terms of their size and shape, as 
well as the volume of particles is reported to determine the severity of the biological response 
(Ingham and Fisher, 2000). Hence, there is extensive literature published on the 
characteristics and biological activity of UHMWPE and metal CoCr wear particles generated 
from MoP and MoM hips, respectively. Polyethylene wear particles in the critical size range 
of 0.2-1.0 µm have been reported as being the most biologically reactive in activating 
macrophages (Green et al., 1998). In addition to particle size, the volume of particles has also 
been reported as being critically important in determining the biological response. It has been 
well documented both in vivo and in vitro that UHMWPE wear particles stimulate 
macrophages to release inflammatory cytokines (TNF-α, IL-1 and IL-6), which cause 
osteolysis and eventually result in aseptic loosening and subsequent failure of the hip 
prosthesis (Matthews, Besong, et al., 2000). Furthermore, it is well established that metal wear 
particles and metal ions have been associated with adverse tissue reactions around the 
prosthetic joint in patients such as necrosis, delayed-type IV hypersensitivity reactions, and 
pseudotumors (Haddad et al., 2011). However, there is very limited literature on the 
characteristics and biological activity of ceramic wear particles generated from CoC hips. 
From the literature that is available, the majority of the studies have used commercially-
available ceramic powder to test the biological activity, and reported cytotoxic effects at high 
volumes, which are not representative of the clinically-relevant wear rates of CoC bearings 
(Catelas et al., 1999;  Catelas, Petit, Zukor, et al., 1999; Nkamgueu et al., 2000; Petit et al., 
2002; Tsaousi et al., 2010). Only a few studies have reported the cytotoxic and inflammatory 
effects of clinically-relevant alumina ceramic wear particles, which demonstrated only mild 
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cytotoxic and inflammatory effects at high volumes (Germain et al., 2003b; Hatton et al., 
2003b). In comparison to other bearing materials, the particles released by alumina CoC hip 
prostheses have been shown to induce a mild cellular response, with low cytotoxicity and 
inflammatory potential.  
There are currently no clinically-relevant studies that report the characteristics and biological 
activity of wear debris generated from composite ZTA ceramic bearings, such as BIOLOX® 
Delta. The lack of relevant studies may be due to difficulties in generating and recovering 
high volumes of clinically-relevant ceramic wear debris in vitro. A challenge associated with 
ceramic wear particle isolation is that current particle isolation methods are not sensitive 
enough to reliably isolate the wear particles from hip simulator lubricants, due to the 
extremely low wear rates exhibited by CoC bearings. Hence, wear particles from composite 
ZTA CoC bearings have not been systematically characterised and therefore little is known 
about their size, morphology and biological impact. The purpose of this project was to address 
these gaps in the literature by developing methodology to generate and isolate clinically-
relevant composite ZTA ceramic wear particles for subsequent analysis of their characteristics 
and investigation of their biological impact. The present study used a bank of tests to 
demonstrate the biological impact of Delta ZTA and Forte alumina ceramic wear particles in 
vitro e.g. cytotoxicity test, release of inflammatory cytokines, DNA damage and oxidative 
stress. It is important to mention that there are other forms of ZTA ceramic hip bearing 
materials on the market, which may have a different biological impact to Delta CoC bearings.  
5.2 Development of particle isolation methodology for ultra-low 
wearing composite ZTA ceramic bearings 
Due to the limitations of current particle isolation methods (Doorn et al., 1998b; Catelas, 
Bobyn, J.B. Medley, et al., 2001; Brown et al., 2007), the present study validated and 
optimised a newly developed particle isolation method (Lal et al., 2016) for the isolation of 
composite ZTA ceramic wear particles from hip simulator lubricants. Validation of the 
method demonstrated a recovery rate of 89% from serum spiked with the lowest volumes of 
ZTA particles (0.1 and 0.05 mm3), which were representative of the wear rates of CoC 
bearings. However, the method was ineffective at removing all of the contaminating protein 
from the wear particles, which was observed using CFE-SEM after application of the method 
to hip simulator serum lubricant. Protein contamination of the recovered wear particles is a 
common result for particle isolation methods, hence many studies have incorporated multiple 
enzymes into their digestion regimes i.e. papain and proteinase K, in order to effectively 
remove the proteins from the wear particles (Doorn et al., 1998a; Catelas, Bobyn, J.B. 
Medley, et al., 2001; Brown et al., 2007). The present study incorporated lysozyme, which 
breaks down bacterial cell wall proteins that may have contaminated the serum lubricant 
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during wear simulation testing. This modified digestion regime resulted in lower levels of 
protein contamination, however the isolation of ceramic wear particles remained unsuccessful 
as no ceramic wear particles were identified. 
Another challenge encountered during optimisation of the particle isolation method was the 
presence of stainless-steel wear particles that were observed after batch processing of serum 
lubricant that was collected from one million cycles of hip simulation. This approach was 
implemented as the processing of aliquots of serum lubricant was not a viable approach for 
the low volumes of wear generated from CoC bearings, which resulted in a high ratio between 
the volume of serum to volume of particles (0.1:1500 - 2:1500). Previous studies processed 
aliquots of the serum lubricant that contained wear particles, as the higher wear rates of MoP 
and MoM compared to CoC bearings resulted in successful recovery of wear particles 
(Catelas, Bobyn, J.J. Medley, et al., 2001; Tipper et al., 2006; Brown et al., 2007). Batch 
processing of serum lubricants was a novel approach that had never been implemented before 
in any previous studies. However, the recovered stainless-steel wear particle contaminants 
presented a major challenge, as their large volume masked the recovery of low volumes of 
ceramic wear particles. A magnet was used in an attempt to separate the stainless-steel wear 
particles from the ceramic wear debris, which revealed the presence of large micron-sized 
alumina particles. However, the recovery of nano-scale particles was unsuccessful.  
Further optimisation resulted in a novel two-step particle isolation method that incorporated 
multiple proteolytic digestion and density-gradient ultra-centrifugation steps for the 
purification and recovery of very low volumes of both micron-sized and nano-scale wear 
particles generated from composite ZTA CoC bearings (BIOLOX® Delta). CFE-SEM 
analysis revealed that the particles had a bimodal size range, with large polygonal shaped 
particles of alumina that had a mean size of 2308.11 ± 243.58, and small round granular 
zirconia/alumina particles that were agglomerated and had a mean size of 43.73 ± 0.97nm. 
The tribological properties of materials strongly determines the characteristics of wear 
particles produced from THRs during articulation. Equally, the characteristics of wear 
particles can provide vital information about the underlying wear mechanisms of bearing 
materials. For example, the two modes of particles sizes for wear particles generated from 
CoC bearings is well established in the literature, where the small nano-scale particles are 
believed to be as a result of relief polishing, whereas the larger micron/sub-micron sized 
particles were attributed to inter-granular fracture of the ceramic bearing that results in the 
formation of a wear stripe during edge loading (Nevelos et al., 2000a; Hatton et al., 2002; 
Tipper et al., 2002a). 
This novel two-step particle isolation represents a major breakthrough since it has allowed for 
the first- time comprehensive particle characteristic analysis of clinically-relevant composite 
ZTA ceramic wear particles generated in vitro. Hatton et al. (2002) and Tipper et al. (2002) 
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were the last studies to report the successful isolation and characterisation of wear particles 
from alumina CoC bearings. The work in current study continues to increase the 
understanding of the characteristics of wear debris generated from ceramic hip replacements. 
The optimised particle isolation method will be used as a preclinical testing tool in 
conjunction with hip simulation testing to better understand the likely clinical performance of 
these materials in patients.  
5.3 Generation of clinically-relevant composite ZTA ceramic wear 
particles in vitro 
The development of the two-step particle isolation in chapter 2 allowed the successful 
recovery and characterisation of clinically-relevant ZTA ceramic wear particles from hip 
simulator lubricants. However, these particles could not be used for subsequent biological 
testing due to the risk of residual proteins and adherent endotoxins that could have caused 
cellular activation and produced mis-leading results, which may have not been a response to 
the ceramic wear particles. Therefore, it was decided in the present study to generate ceramic 
wear particles in water lubricants using the hip simulator under severe edge loading conditions 
caused by dynamic separation due to translational mismatch between the centres of rotation 
of the femoral head and acetabular cup. A similar approach was previously employed by 
Hatton et al. (2003) who used water lubricants in hip simulation to generate clinically-relevant 
alumina ceramic wear particles under microseparation conditions. However, there was some 
uncertainty whether this technique would yield sufficient volumes of ZTA ceramic wear 
particles, as the wear rates for composite ZTA CoC bearings (0.16mm3 /million cycles) were 
considerably lower than alumina CoC bearings (1.84mm3 /million cycles), even under 
microseparation conditions (Stewart et al., 2003a).  
The edge loading conditions employed in wear simulation testing of CoC bearings was first 
introduced by Nevelos et al. (2000), who applied a 0.4-0.5mm medial-lateral displacement of 
the cup relative to the head using a spring during the swing phase of the gait cycle, which 
ultimately caused edge loading during heel strike (Nevelos et al., 2000a; Stewart et al., 2001; 
Stewart et al., 2003a; Stewart et al., 2003b). However, fluoroscopic studies have shown that 
separation and the severity of edge loading can vary considerably i.e. 1.9-5.2mm (Lombardi 
et al., 2000; Dennis et al., 2001). Hence, the effect of variations in translational positioning 
with different levels of mismatch between the centres of the cup and head on the magnitude 
of dynamic separation and severity of edge loading have been investigated by O’Dwyer 
Lancaster-Jones et al. (2017). These authors reported wear rates of up to 1.01 ± 0.17mm3 per 
million cycles for composite ZTA CoC bearings tested under severe edge loading conditions 
due to translational mismatch of up to 4mm in the centres of rotation of the femoral head and 
acetabular cup, with inclination angle of 65o. Therefore, the present study used this technique 
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as an opportunity to implement these severe edge loading conditions in order to maximise the 
volume of ceramic wear particles that could be generated for subsequent biological impact 
testing.   
Comparison of the size distribution and morphology (aspect ratio and circularity) between the 
composite ZTA ceramic wear particles generated in water or serum, revealed no significant 
differences. The water lubricant did not alter the characteristics (size and morphology) of the 
ceramic wear particles generated, thus producing ceramic wear particles that were 
representative of those generated in vivo. A study by Rainforth et al. (2012) investigated the 
effects of lubrication (water and 25% (v/v) new-born calf serum) on the friction and wear of 
BIOLOX® Delta. The authors found that the serum lubricant exhibited full-fluid lubrication, 
whilst the water exhibited both full-fluid and mixed-fluid lubrication. The water lubricant 
demonstrated higher wear rates and the characteristics of the worn surfaces for full-fluid 
lubrication regime were reported to be distinctively different compared to the water lubricated 
worn surfaces i.e. the presence of differential wear between grains and abrasive grooves. 
These features were not observed on the worn surfaces for serum lubrication tests. However, 
despite the higher wear rates with water lubrication, the serum lubrication tests demonstrated 
the most pitting. Nevertheless, all the worn surfaces exhibited pitting, which increased with 
load and is consistent with in vitro hip simulation tests that demonstrated stripe wear under 
edge loading conditions. The pitting was mainly attributed to intergranular fracture of the 
individual grains. This pitting feature was also observed in the present study for both 
BIOLOX® Delta and BIOLOX® Forte components. However, in the present study the 
formation of larger and deeper pits were observed for BIOLOX® Delta, which may have been 
due to the severe edge loading conditions employed in the wear simulation tests. Another 
reason for the larger pits may have been due to grain pull-out of both alumina and zirconia 
grains. Rainforth et al. (2012) described the formation of large pits being caused by initial 
grain pull-out, followed by adjacent grains being pulled out, resulting in the pit region 
increasing in size laterally from the source of the initial grain pull-out.  
During wear simulation, the water lubricant was contaminated with stainless-steel wear 
particles that were generated from the fixtures or components other than the bearing surfaces, 
which could not be separated from the ceramic wear particles. Thus, a mixed population of 
stainless-steel wear particles and ceramic wear particles was presented to the cells, which 
required the introduction of stainless wear particle controls in all subsequent biological tests 
to elucidate the biological effects of the clinically-relevant ceramic wear particles. 
Nevertheless, the employment of severe edge loading conditions with water lubricant allowed 
the generation of clinically-relevant ceramic wear particles, which were successfully 
recovered for subsequent assessment of biological impact. The present study demonstrated 
that in vitro hip simulation can be used as a tool for the generation of clinically-relevant 
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ceramic wear particles, thus eliminating the need for wear particle isolation from tissues or 
serum lubricants that often results in particle loss and other complications such as uncertainty 
of complete removal of proteins and endotoxins from particles recovered from tissues or 
serum lubricants.  
5.4 Biological impact of model and clinically-relevant composite 
ZTA ceramic wear particles  
The generation of clinically-relevant ceramic wear particles was conducted in this study due 
to the limited number of studies in the literature using clinically-relevant ceramic wear 
particles for biocompatibility testing. This gap in the literature existed because of the 
difficulties in generating and isolating high volumes of clinically-relevant ceramic wear 
particles in vitro. The alternative was to use ceramic powders for biocompatibility testing. 
The use of ceramic powders to report the biological activity of ceramic wear particles from 
ceramic THRs is well practised in the literature (Nagase et al., 1995; Catelas et al., 1998; I 
Catelas, Petit, Zukor, et al., 1999; Nkamgueu et al., 2000a; Petit et al., 2002; Warashina et al., 
2003; Granchi et al., 2004; Tsaousi et al., 2010; Faye et al., 2017). However, these studies are 
very limited in the information they provide as the characteristics of commercially-obtained 
ceramic particles may not clinically represent the size and shape of ceramic wear particles 
generated in vivo. In order to mitigate this concern, a few studies have used powders in the 
phagocytosable range (<0.45µm) to portray the clinical-relevance of their findings (Catelas 
et al., 1998; I Catelas, Petit, Marchand, et al., 1999; Petit et al., 2002; Warashina et al., 2003; 
Olivier et al., 2003; Granchi et al., 2004; Rodrigo et al., 2006; Tsaousi et al., 2010; Faye et 
al., 2017). However, it is important to remember when considering these findings, that other 
factors such as particle volume, morphology, composition and cell type also play an important 
role in the biological response. There is clearly a need for more studies to report the biological 
effects of clinically-relevant ceramic wear particles in a clinically-relevant model to better 
predict the likely clinical performance, hence the purpose of this thesis.  
In addition to clinically-relevant ceramic wear particles, the present study also used 
commercially-obtained ceramic model particles to investigate the biological impact and allow 
a relative comparison with the published literature. Furthermore, the composite ZTA and 
alumina ceramic model particles used in the present study were the powders used to 
manufacture ceramic hip replacements BIOLOX® Delta and BIOLOX® Forte, respectively. 
Given this fact, the current study presents many advantages over previous studies, as it is 
likely that the characteristics (size and shape) of the ceramic model particles in the powder 
may be more representative of the ceramic wear particles produced in vivo. However, a 
comparison of the frequency (particle size) distributions and morphology (aspect ratio and 
circularity) between the BIOLOX® Delta ceramic model particles and clinically-relevant 
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BIOLOX® Delta ceramic wear particles revealed a significant difference (p<0.05). 
Interestingly, the same comparison between BIOLOX® Forte ceramic model particles and 
clinically-relevant BIOLOX® Forte ceramic wear particles revealed no significant differences 
in particle size distribution and morphology. The similar size range between the two types of 
particles may be because the BIOLOX® Forte ceramic model particles used in this study was 
comprised of the powder used to manufacture BIOLOX® Forte CoC hip components. The 
contradicting significant differences in size distribution and morphology observed between 
the BIOLOX® Delta ceramic model particles and clinically-relevant ceramic wear particles 
was attributed to the large grain-like structure that was present in the ZTA composite ceramic 
model particles and not present in the clinically-relevant ZTA ceramic wear particles. During 
sintering of the Delta powder, many elements in the form of raw compound materials are 
added, which causes on going solid reaction and the production of these large grain-like 
structures.  
A comprehensive evaluation of the biological impact of model and clinically-relevant ceramic 
wear particles of BIOLOX® Delta ZTA and BIOLOX® Forte alumina ceramic wear particles 
in terms of cytotoxicity, inflammatory cytokine release, genotoxicity and oxidative stress 
demonstrated that BIOLOX® Delta composite ceramic wear particles demonstrated lower 
biological impact compared to BIOLOX® Forte alumina wear particles. The initial assessment 
of cytotoxicity of ceramic model particles for both BIOLOX® Forte and BIOLOX® Delta 
demonstrated the potential cytotoxic effects of ceramic model particles (BIOLOX® Forte and 
BIOLOX® Delta) in L929 fibroblast cells at very high doses (500µm3 per cell). This 
phenomenon is reported by many previous studies (Catelas et al., 1998; Catelas, Petit, 
Marchand, et al., 1999; Olivier et al., 2003; Granchi et al., 2004; Tsaousi et al., 2010), but it 
may not be clinically-relevant as it highly unlikely that these high volumes will be achieved 
in vivo due to the extremely low wear rates of CoC bearings, even under edge loading 
conditions. The clinically-relevant BIOLOX® Delta ceramic wear particles demonstrated 
cytotoxic effects in L929 cells at a lower dose of 50µm3 per cell compared to ceramic model 
particles, however again this dose was not clinically-relevant but was indicative of the 
differences in biological activity between ceramic model particles and clinically-relevant 
ceramic wear particles. These results demonstrated the importance of using clinically-relevant 
ceramic wear particles to test for biocompatibility, as cytotoxic effects such as those observed 
in the present study can be missed, which can potentially cause deleterious effects in the in 
vivo situation.  
Macrophages release TNF-α in response to wear particles, which is a key cytokine involved 
in osteolysis and subsequent failure of hip implants (Ingham and Fisher, 2005). Hence, the 
present study investigated the release of TNF-α from PBMNCs in response to model and 
clinically-relevant ceramic wear particles. The BIOLOX® Delta ceramic model particles 
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failed to stimulate an inflammatory response in terms of TNF-α release from PBMNCs for all 
the doses tested (0.05-50µm3 per cell). However, the clinically-relevant BIOLOX® Delta 
ceramic wear particles caused significant levels of TNF-α release from PBMNCs at high 
doses (50µm3 per cell). The results of the present study were in contrast to the findings of 
Hatton et al. (2003), who reported that the alumina powder (model ceramic particles) were 
more inflammatory than the clinically-relevant alumina ceramic wear particle. Hatton et al. 
(2003) reported that higher doses of the clinically-relevant alumina ceramic wear particles 
(500µm3 per cell) were required to illicit the same inflammatory response as alumina powder 
particles (100µm3 per cell) (Hatton et al., 2003a). The present study demonstrated that there 
was no inflammatory response to the model ceramic particles in terms of TNF-α release, but 
significantly elevated levels of TNF-α was released from PBMNCs when stimulated with high 
doses (500µm3) of clinically-relevant BIOLOX® Forte and BIOLOX® Delta ceramic wear 
particles. The possible explanation provided for this observation was that the clinically-
relevant BIOLOX® Forte and BIOLOX® Delta ceramic wear particles had a greater size 
distribution with more larger particles in the phagocytosable range (up to 4.5µm) compared 
to the ceramic model particles, as demonstrated by their size distributions. Therefore, a lower 
concentration or volume of particles was required to illicit an immune response, a finding that 
was also reported by Catelas et al. 1998. Nevertheless, despite the differences between this 
present study and the study conducted by Hatton et al. (2003), the same conclusion was made 
in that given the low wear rates (0.1-1mm3 per million cycles) of ceramic-on-ceramic 
bearings, the threshold of 50µm3 per cell may never be achieved in vivo. Hence, compared to 
UHMWPE wear particles, the osteolytic potential of clinically-relevant ceramic wear 
particles is minimal as the evidence in the present study demonstrated that the clinically-
relevant doses (0.05-0.5µm3 per cell) of ceramic wear particles failed to stimulate pro-
inflammatory cytokine (TNF-α) production. 
The cytotoxic and inflammatory effects of ceramic wear particles were minimal at clinically-
relevant doses as reported by the literature and findings from the present study. Hence, the 
present study investigated other subtler changes in terms of DNA damage and oxidative stress, 
which may occur in exposure to exposure to ceramic wear particles over the longer term. 
Chromosome aberrations in patients with MoM implants have been reported by many 
previous studies, which is a genotoxic effect of CoCr wear particles (Ladon et al., 2004; Suner 
et al., 2012). Regarding ceramic wear particles, Tsaousi et al. (2010) reported alumina ceramic 
particles as being weakly genotoxic at high doses compared to CoCr wear particles. Weakly 
genotoxic means that the ceramic particles caused chromosome loss, but no DNA double-
strand breaks were detected. On the contrary, the present study observed high levels of DNA 
damage for high doses of model and clinically-relevant alumina ceramic particles (BIOLOX® 
Forte), which was assessed using the comet assay that measures breakages in single and 
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double stranded DNA. Considering the literature, the results from the present study clearly 
showed that high doses of model alumina particles were completely genotoxic as they caused 
notably higher DNA damage than the clinically-relevant CoCr nano-particles (50µm3 per cell) 
in some donors. The BIOLOX® Delta ceramic model particles did not cause any DNA damage 
in PBMNCs from all donors, whereas the clinically-relevant BIOLOX® Delta ceramic wear 
particles caused DNA damage at medium to high doses (5-50µm3 per cell) in PBMNCs from 
four donors. The significant genotoxic effects caused by clinically-relevant BIOLOX® Delta 
ceramic wear particles were attributed to the presence of stainless-steel wear particle 
contaminants in the co-culture. This was supported by results for the stainless-steel wear 
particle control, which demonstrated significant levels of DNA damage at doses of 50 µm3 
per cell. Therefore, the genotoxic effects of high doses (50 µm3 per cell) of clinically-relevant 
ceramic wear particles for both BIOLOX® Forte and BIOLOX® Delta were considered 
unreliable and disregarded.   
Oxidative stress has been implicated in playing an important role in the inflammatory 
response to total hip replacements, leading to osteolysis and implant failure (Steinbeck et al., 
2014). The production of ROS and subsequent oxidative stress in cells is an important process 
in terms of cell signalling, and cell survival. Hence, in addition to the appropriate cytotoxicity, 
inflammatory and genotoxicity testing of the ceramic wear particles, the production of 
reactive oxygen species (ROS) in PBMNCs in response to ceramic particles was investigated 
as the bimodal size distribution of ceramic wear particles may have the potential to induce 
oxidative stress, since genotoxic effects at high doses of alumina particles were observed in 
previous assays. Nonetheless, this concern was negated as both the model and clinically-
relevant BIOLOX® Delta ceramic wear particles for all the doses tested, had no significant 
effect on the production of ROS (oxidative stress) in PBMNCs from all donors. Previous 
experiments clearly showed the ingestion of ceramic wear particles by the PBMNCs, but 
clearly the results from the oxidative stress assay showed that the internalised ceramic wear 
particles had no effect in terms of ROS production. The benign response may have been due 
to the bioinert nature of alumina ceramics, which makes it highly suitable for clinical 
applications.  
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5.5 Future work 
The present study isolated and characterised composite ZTA ceramic wear particles from hip 
simulator lubricants, that were generated from BIOLOX® Delta CoC bearings under severe 
edge loading conditions. It is well established that edge loading conditions simulated in vitro 
produce wear rates and wear mechanisms similar to those found in vivo. However, future 
work should include the isolation and characterisation of composite ZTA ceramic wear 
particles from retrieved tissues. This would add weight to the findings of the present study 
and increase the confidence of in vitro generated particles as being clinically-relevant.  
The conditions employed in the wear simulation tests of the present study did not take in to 
account patient specificity in terms of geometry and anatomy. Furthermore, the tests were run 
consistently according to the standard walking gait cycle. The tests did not include the 
kinematics of running, climbing stairs or stumbling. These conditions and factors could 
change the characteristics of the wear particles generated from CoC bearings. Modern hip 
simulators now have the capability of simulating these conditions mentioned previously. 
Hence, using the two-step particle isolation method developed in the present study, future 
studies could isolate, and analyse the characteristics of the wear particles generated under 
different kinematic conditions. These particles could also be used for subsequent biological 
testing.  
In the present study, it was demonstrated that high doses (50µm3 per cell) of clinically-
relevant ceramic wear particles generated from both BIOLOX® Forte and BIOLOX® Delta 
CoC bearings stimulated significantly elevated levels of TNF-α from PBMNCs compared to 
the cell only negative control. Previous studies have demonstrated the release of other 
inflammatory cytokines in response to UHMWPE wear particles, such as IL-1β, IL-6 and IL-
8 (Green et al., 1998; Matthews, Besong, et al., 2000; Ingham and Fisher, 2000; Ingham and 
Fisher, 2005). Whilst the present study showed that ceramic wear particles at clinically-
relevant doses (0.05-0.5µm3 per cell) produced low levels of TNF-α release, a more 
comprehensive evaluation for osteolytic cytokine release would provide valuable information 
for wear particles generated from composite ceramic hip replacements. Furthermore, in 
addition to the investigation of the release of different cytokines in response to wear particles 
from joint replacements, further research into the cellular pathways and mechanisms that lead 
to the release of these inflammatory cytokines may help to better understand the osteolysis 
process. Understanding this process may help to improve the longevity of bearing materials 
through developing therapeutic interventions, which modulates the subsequent inflammatory 
response after implantation. 
The present study used two-dimensional (2D) cell culture to investigate the biological impact 
of ceramic wear particles. Whilst, this conventional technique provides vital information 
about cellular responses in vitro, the 2D cell culture environment is not always representative 
261 
 
of cells in vivo. The in vivo environment consists of an extracellular matrix with a complex 
biological environment that includes other cell types, which interact with each other through 
cell migration, receptors and transcriptional expressions. Hence, the 2D culture system is too 
simple compared to the in vivo environment, as it does not consider many factors that are 
important for accurately reproducing cell and tissue physiology (Haycock, 2011; Edmondson 
et al., 2014). Hence, further research investigating the biological impact of ceramic wear 
particles using 3D cell culture systems would support the finding in the present study. A 3D 
agarose gel system that better mimics the in vivo environment has recently been developed 
by Lal. et al (2017) to investigate the cellular response to prosthetic wear particles (Lal et al., 
2017). The application of this method to clinically-relevant ceramic wear particles would 
increase the knowledge about the biological activity of prosthetic wear particles.  
The present study demonstrated that high doses of alumina ceramic wear particles induced 
DNA damage in PBMNCs. Future studies could investigate the what impact this DNA 
damage has on cellular mechanisms and whether this phenomenon is responsible for the 
cytotoxic effects observed at similar doses. Furthermore, futures studies should investigate 
gene expression of general toxicology-related genes in response to ceramic wear particles. 
This would provide vital information about the cellular pathways leading to an inflammatory 
response or apoptosis/necrosis and which genes are up-regulated or down-regulated during 
these cellular reactions.  
The work in chapter 2 of this study demonstrated that the wear particles generated from 
composite ZTA ceramic hip replacements consisted of both micrometre and nanoscale wear 
particles. Hence, future work should include the investigation of the cellular uptake 
mechanisms of ceramic wear particles as the cellular uptake of nano-scale particles may differ 
from the cellular uptake of larger micron-sized particles. In addition, the interaction of 
composite ceramic wear particles with the cell membrane could also be investigated as this 
could provide more information about the mode of toxicity these particles induce i.e. 
extracellularly or intracellularly.   
Finally, the present study investigated the biological impact of the ceramic wear particles in 
PBMNCs after 24hrs of incubation. Future work should include longer incubation times to 
elucidate the longer term biological effects of ceramic wear particles.  
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5.6 Conclusions 
The present study developed a two-step particle isolation method that allowed successful 
isolation and characterision of composite ZTA ceramic wear particles from hip simulator 
lubricants for the first time. The recovered composite ZTA ceramic wear particles 
demonstrated a bimodal size range with large polygonal shaped particles of alumina that had 
a mean size of 2308nm, and small round granular zirconia/alumina particles that had a mean 
size of 43.7nm. In addition to methodology development that could be used as a tool for pre-
clinical testing of joint replacements, this thesis has contributed to increasing the knowledge 
and understanding of the wear mechanisms and wear particle characteristics of composite 
ZTA (BIOLOX® Delta) CoC bearings. This is new benchmark information that could be used 
for future biomaterial development.  
Wear simulation testing has provided vital information about the tribological performance 
and wear properties of CoC THRs. The recent development of an advanced physiological in 
vitro hip simulator method that used variations in component positioning to simulate edge 
loading, has allowed the generation of high volumes of clinically-relevant ceramic wear 
particles from composite ZTA (BIOLOX® Delta) CoC bearings water lubricant to be used for 
subsequent biological testing. The success of the two-step particle isolation method coupled 
with the novel simulator method allowed the present study for the first time to generate 
sufficient volumes of composite ZTA ceramic wear particles for biological testing, which 
were validated as being clinically-relevant using the composite ZTA particle characteristics 
data generated from the present study.  
A comprehensive evaluation of the biological impact of model and clinically-relevant ceramic 
wear particles (generated using a hip simulator) of composite BIOLOX® Delta ZTA ceramic 
wear particles was performed in terms of cytotoxicity, inflammatory cytokine release, 
genotoxicity and oxidative stress. The results from this study are only relevant for BIOLOX® 
Delta and not other manufacturers ceramics. This bank of tests demonstrated that composite 
BIOLOX® Delta ZTA ceramic wear particles have excellent biocompatibility with low 
osteolytic potential at clinically-relevant doses. The composite ZTA model particles at all 
doses did not illicit any biological effects in terms of cytotoxicity, inflammatory cytokine 
release, genotoxicity and production of ROS. However, high doses of the clinically-relevant 
composite BIOLOX® Delta ZTA ceramic wear particles demonstrated cytotoxic effects in 
L929 cells and significantly elevated levels of TNF-α release from PBMNCs. This study 
demonstrated that there was a threshold volume of clinically-relevant ceramic wear particles 
required to stimulate significant TNF-α release from PBMNCs. However, these doses were 
not clinically-relevant and highly unlikely to occur in vivo due to the extremely low wear rates 
of CoC bearings. Hence, it can be concluded that wear particles from composite ZTA 
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BIOLOX® Delta CoC hip replacements had a low osteolytic potential, which may enhance 
long-term clinical performance.  
From a clinical point of view, the findings from the present study give clinicians and surgeons  
confidence in composite BIOLOX® Delta ZTA CoC bearings as they will be better able to 
provide a long-term prognosis to patients. Furthermore, this work continues to increase our 
understanding of the characteristics of ceramic wear debris and will allow industry to develop 
more biocompatible and longer lasting implants. Bearing materials used for total joint 
replacements will ultimately always produce some wear. Hence, the optimised particle 
isolation method and wear simulation technique developed in this study could be used as a 
preclinical testing technique to better understand the biocompatibility and likely clinical 
performance of these bearing materials in patients. In addition, the optimised bank of tests for 
biological impact could be used to test the biocompatibility of wear particles generated from 
other hard-on-hard bearing materials.  
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